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CHAPTER 1
INTRODUCTION
RNA is a versatile molecule and due to its wide range of biochemical properties it is capable of
multifarious functions. The linear sequence of RNA makes it a simple source of genetic infor-
mation, whereas the property to form secondary and tertiary structures allows its interaction with
other macromolecules and provides environments for catalytic activities. Thus, besides the role
of RNA molecules as information-carrying intermediaries in gene expression, they act as key cat-
alytic, structural, and regulatory elements in the cell. In bacteria, the discovery of a staggering
number of small regulatory RNAs (sRNAs) by systematic searches of sequenced genomes over the
last years led to an increasing recognition of the potential impact of sRNAs on bacterial physiology
(for a review see, e. g., Waters & Storz, 2009). These sRNAs act as post-transcriptional regulators
of bacterial gene expression in response to diverse growth and environmental stress conditions. In
contrast to cis-encoded antisense RNAs of mobile elements such as plasmids, the majority of bac-
terial sRNAs seems to bind by imperfect basepairing to trans-encoded mRNAs and thereby inhibit
translation or lead to mRNA degradation. The early studies have often focused on interactions with
single target mRNAs, but there is growing evidence that sRNAs can regulate many diverse mRNAs
in parallel (reviewed in Papenfort & Vogel, 2009, in press). However, the understanding of how
sRNAs could directly control multiple mRNAs by antisense mechanism has been limited by the
low number of validated sRNA-target interactions and, hence, the difficulty to reliably predict new
interactions.
In this thesis, two aspects of sRNA-mediated regulation in bacteria are investigated: (1) multiple
target regulation and (2) approaches for the identification of novel sRNAs in bacteria. The first part
addresses the question how sRNA targets can be identified and how multiple targets can be directly
regulated by one sRNA. For this purpose, biocomputational and experimental approaches for the
identification and validation of targets of a small RNA, GcvB, from Salmonella enterica serovar
Typhimurium (from here on Salmonella) are presented. Furthermore, it is shown that a conserved
region within GcvB RNA directly interacts with multiple mRNAs of genes involved in amino acid
transport and biosynthesis. It is shown how the identification of this conserved element can be used
to refine experimental and biocomputational target-identification approaches.
The second part deals with the identification of novel sRNAs. Bioinformatics-based approaches
often rely on the prediction of orphan transcription signals and primary sequence conservation of
sRNA candidates within closely related species or on the conservation of RNA structure (reviewed
in Livny & Waldor, 2007). This implies the availability of related genome sequences and well-
defined promoter and terminator models. In contrast, approaches based on shotgun-cloning and
direct sequencing of RNA (so-called RNomics) allow to identify novel sRNAs without prior knowl-
edge but were, until recently, limited by the cost-intensive Sanger sequencing (Hu¨ttenhofer & Vogel,
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2006). In this thesis, the use of high-throughput sequencing for the identification of sRNAs bound
to the RNA-binding protein Hfq in Salmonella is demonstrated. Furthermore, deep sequencing re-
veals the primary transcriptome of the major human pathogen Helicobacter pylori, a bacterium in
which no sRNAs have been described. Moreover, an approach based on selective sequencing of
cDNA libraries specifically enriched for primary transcripts is developed which allows to define a
global map of transcriptional start sites of mRNAs in H. pylori.
Organization of this thesis
First, the biological background of regulation by small RNAs in bacteria is reviewed in Chapter 2
with the main emphasis on strategies for the identification of sRNAs and their targets in bacteria.
In Chapters 3 and 4, multiple target regulation by bacterial sRNAs is investigated by functional
characterization of GcvB RNA from Salmonella. Specifically, Chapter 3 describes the proteomics
and bioinformatics-based identification of seven ABC transporter mRNAs as GcvB targets. Anal-
ysis of target gene fusion regulation in vivo, as well as in vitro structure probing and translation
assays show that Salmonella GcvB sRNA directly binds with a conserved G/U-rich region to ex-
tended C/A rich elements of these target mRNAs. The identified target sites are located inside or
upstream of the ribosome binding site and may also serve as translational enhancer elements. This
suggests mRNA regions distant from Shine-Dalgarno (SD) sequences and highly conserved regions
in sRNAs as important elements for the identification of sRNA targets.
In Chapter 4, this concept is applied to identify additional GcvB targets. Global mRNA changes
upon pulse-expression of GcvB wild-type or mutant RNAs lacking conserved part of this sRNAs
are analysed as well as target-predictions refined by including a motif search for the C/A-rich GcvB
target site. This reveals additional amino acid and peptide transporters as GcvB targets and in
addition genes involved in amino acid biosynthesis.
Chapters 5 and 6 demonstrate the application of next generation sequencing for the identification of
novel sRNAs and analysis of a whole bacterial transcriptome. In Chapter 5, deep sequencing is ap-
plied to identify Salmonella RNA ligands bound to the highly conserved RNA chaperone Hfq which
is a key player in sRNA-mediated regulation of gene expression in bacteria. This recovers known
sRNAs from Salmonella but also identifies novel sRNAs and mRNA targets. The bioinformatics-
based work flow that was developed for the analysis and visualization for deep sequencing data is
presented.
In Helicobacter pylori neither Hfq nor any sRNAs have been described so far. In fact, this bacterium
has been referred to as an example of an organism without riboregulation (Mitarai et al., 2007). A
high-throughput ‘RNA-seq’ approach of total H. pylori RNA reveals in Chapter 6 that H. pylori in
fact harbours diverse sRNA genes. In addition, a strategy for enrichment of primary transcripts in
cDNA libraries is developed which allows global analyis of mRNA transcriptional start sites in the
H. pylori genome.
Finally, the results of this study are summarized including a discussion of some future perspectives
in the concluding Chapter 7. Experimental and biocomputational strategies and methods that were
used or developed in this thesis are described in Chapter 8.
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1. Chapter 3: Multiple targeting of ABC transporter mRNAs by GcvB sRNA
• Cloning of control and GcvB wild-type expression plasmids and preparation of periplas-
mic fractions for 2D analysis was done by Dr. Titia Plantinga (RNA Biology, MPI for
Infection Biology, Berlin).
• Identification of GcvB homologues in diverse bacteria and alignments were done in
collaboration with Titia Plantinga.
• Initial in vitro structure probing experiments were done jointly with Dr. Fabien Dar-
feuille (INSERM U869, Universite´ Victor Segalen, Bordeaux, France).
2. Chapter 4: GcvB RNA, a global regulator of genes involved in amino acid metabolism
• Arabinose inducible plasmids for expression of GcvB wild-type and mutant RNAs were
cloned by Kai Papenfort (RNA Biology, MPI for Infection Biology, Berlin).
• Microarray experiments were done in collaboration with Kai Papenfort.
• Parts of the GFP fusion cloning, Western blot and FACS experiments were done with
technical assistance of Franziska Seifert or by Sandy Pernitzsch during her student in-
ternship under supervision of Cynthia Sharma.
3. Chapter 5: Analysis of Hfq-bound RNAs in Salmonella by high-throughput sequencing
• All wet-lab experiments described in this section (Hfq co-immunoprecipitation and
Northern Blot analysis) were done by Dr. Alexandra Sittka (RNA Biology, MPI for
Infection Biology, Berlin).
• Analysis of mapping results of the deep sequencing data was done in collaboration with
Alexandra Sittka.
4. Chapter 6: Deep sequencing reveals the primary transcriptome of Helicobacter pylori
• For cDNA construction, Helicobacter growth under acid stress and infection conditions
and isolation of RNA were done by Je´re´my Reignier and Fabien Darfeuille (INSERM
U869, Universite´ Victor Segalen, Bordeaux, France).
• Deep sequencing reads were aligned to the H. pylori genome using a new mapping
method (Hoffmann et al., 2009, submitted) by Dr. Steve Hoffmann (Bioinformatics
Group, University of Leipzig, Germany).
• Manual annotation of transcriptional start sites based on deep sequencing data was done
in collaboration with Steve Hoffmann.
CHAPTER 2
BIOLOGICAL BACKGROUND
In addition to the major RNA components of the cell, i. e. tRNA, rRNA and mRNA, bacterial
genomes are now known to harbour also many, perhaps several hundred, loci that encode regulatory
RNAs. These RNAs are often referred to as small noncoding RNAs (ncRNAs) as they do not
contain open reading frames (ORFs). Regulatory RNAs can act as RNA itself or in association with
proteins in so-called ribonucleoprotein (RNP) complexes. They are involved in diverse processes,
e. g., transcriptional regulation, chromosome replication, RNA processing and modification, mRNA
stability and translation, as well as protein degradation and translocation (Storz, 2002).
Abundant small RNA molecules other than tRNA and rRNA were first observed in E. coli four
decades ago (Griffin, 1971; Ikemura & Dahlberg, 1973a), long before the first microRNAs
(miRNAs) and short interfereing RNAs (siRNas) were discovered in eukaryotes. However, nei-
ther the genes encoding them nor their functional role was established. In the early 1980s the
first plasmid-encoded antisense RNA (about 100 nucleotides in length), RNA I, was discovered and
found to control plasmid-copy number in Escherichia coli (Stougaard et al., 1981; Tomizawa et al.,
1981). This was followed by the identification of other antisense RNAs of mobile elements that
control the life cycle or copy number of bacterial phages, transposons, and plasmids (Simons &
Kleckner, 1983). The first chromosomally encoded antisense regulator, MicF RNA, was reported
in 1984; it inhibits translation of the mRNA encoding the major outer membrane porin OmpF
(Mizuno et al., 1984). Unlike the bona fide cis-antisense RNAs of mobile elements MicF RNA is
not transcribed from the DNA strand opposite of its target gene, ompF. Moreover, MicF exhibits
only partial and imperfect sequence complementarity to ompF mRNA, yet its binding to the ompF
mRNA near the start codon strongly inhibits the translation of this protein (Mizuno et al., 1984).
Until 2001, only ten genes of such regulatory RNAs were known in E. coli (Wassarman et al.,
1999). They were discovered fortuitously using genetic screens or through direct labelling and
sequencing. These RNAs included the specialized housekeeping RNAs, namely, RNase P RNA,
tmRNA, and SRP RNA, which were identified as highly abundant RNA species and are involved
in tRNA maturation, ribosome rescue, and protein translocation, respectively. In 2001-2002, four
bioinformatics-based studies identified many new sRNA genes in E. coli (Argaman et al., 2001;
Chen et al., 2002; Wassarman et al., 2001; Rivas et al., 2001). To date, more than 80 sRNAs are
verified in E. coli (reviewed, e. g., in Gottesman, 2004; Waters & Storz, 2009) and diverse screens
have led to the identification of sRNAs in a wide range of bacteria (reviewed in Altuvia, 2007;
Pichon & Felden, 2008; Vogel & Sharma, 2005).
The bacterial sRNAs range in length from ≈ 50 to ≈ 400 nt and can adopt diverse secondary struc-
tures. Figure 2.1 gives some examples of sRNAs from E. coli and Salmonella. Most of the bacterial
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Figure 2.1: Examples of sRNAs from Escherichia coli and Salmonella typhimurium. Secondary struc-
tures of diverse E. coli (DsrA, OxyS, and RyhB) and Salmonella (GcvB, RybB) sRNAs. All of these sRNAs
are conserved between E. coli and Salmonella (Hershberg et al., 2003; Papenfort et al., 2008). Bacterial
sRNAs have different lengths and can adopt diverse secondary structures consisting of several stem-loop
structures which are separated by extended single stranded regions. The secondary structures shown are
based on in vitro structure probing experiments (DsrA: Lease & Belfort, 2000; OxyS: Altuvia et al., 1997;
GcvB: see Chapter 3 and Sharma et al., 2007; RyhB: Geissmann & Touati, 2004; RybB: Bouvier et al.,
2008).
sRNAs have been shown to act as post-transcriptional regulators of gene expression in response
to external stimuli and are strongly regulated under diverse growth and stress conditions (Arga-
man et al., 2001; Wassarman et al., 2001). For example, they can be induced by temperature
changes (cold-shock induced DsrA: Sledjeski et al., 1996), low iron (Fur-repressed RyhB: Masse´
& Gottesman, 2002), oxidative stress (OxyR-activated OxyS: Altuvia et al., 1997), changes in glu-
cose concentration (CRP-repressed Spot42: Møller et al., 2002 and CRP-activated CyaR: De Lay
& Gottesman, 2009; Johansen et al., 2008; Papenfort et al., 2008), elevated glucose-phosphate lev-
els (SgrR-activated SgrS: Vanderpool & Gottesman, 2004), and outer membrane stress (σE-induced
MicA, RybB, and VrrA: Song et al., 2008 and reviewed in Vogel & Papenfort, 2006; Guillier et al.,
2006). This allows bacteria a rapid regulation of gene expression in response to certain stresses.
This Chapter reviews the different modes of action of bacterial sRNAs and introduces additional
factors that are involved in sRNA-mediated regulation in bacteria such as the RNA-binding protein
2.1. Regulation of gene expression by regulatory RNAs in bacteria 7
Hfq. Furthermore, several experimental and bioinformatics-based approaches for the identification
of sRNAs are discussed. Strategies to determine the mRNA targets will then pass into the recent
finding that several sRNAs regulate multiple targets rather than single targets. Finally, the two
model organisms, Salmonella typhimurium and Helicobacter pylori, that were used throughout this
thesis are introduced.
2.1. Regulation of gene expression by regulatory RNAs in bacteria
Regulatory RNAs in bacteria constitute a heterogeneous group of molecules which act by various
mechanisms to modulate gene expression in response to environmental changes. They can be en-
coded in cis or trans relative to their targets and activate or repress gene expression. Cis-encoded
regulatory RNAs include riboswitches, which are part of the 5’ UTRs of the mRNA that they reg-
ulate, as well as cis-encoded antisense RNAs encoded on plasmids or in the chromsome. Several
sRNAs have been shown to bind proteins and antagonize protein activity by a sequestration mech-
anism. However, the majority of enterobacterial sRNAs act as antisense RNAs on trans-encoded
mRNAs by imperfect base-pairing and thereby inhibit translation and/or lead to mRNA degrada-
tion (Majdalani et al., 2005; Storz et al., 2005). Therefore, the latter class is often regarded as
functionally analogous to eukaryotic miRNAs.
2.1.1. Translational repression
The above mentioned MicF RNA was only the first example of an emerging class of trans-encoded
antisense RNAs (Mizuno et al., 1984). For example, two other major outer membrane proteins,
OmpA and OmpC, have also been shown to be regulated at the translational level by their cognate
sRNAs, MicA and MicC (Chen et al., 2004; Udekwu et al., 2005). The canonical model of these
sRNAs is to mask the ribosome binding sites (RBS) of their target via imperfect sequence com-
plementarity and, thus, inhibit ribosome entry (Storz et al., 2004). Specifically, the E. coli MicA,
MicC, OxyS, and Spot42 sRNAs were shown to directly interfere with 30S ribosome binding of
their target mRNAs, ompA, ompC, fhlA, and galK, respectively, by in vitro toeprinting experiments
(see Figure 2.2A and Argaman & Altuvia, 2000; Chen et al., 2004; Møller et al., 2002; Udekwu
et al., 2005). Other well-characterized E. coli sRNA-target pairs that are likely to use the same
mechanism include DsrA-hns, MicF-ompF, RyhB-sodB, and SgrS-ptsG (reviewed in Wagner &
Darfeuille, 2006). Furthermore, sRNAs from other enterobacteria have been shown to act by the
same mechanism, e. g., ompA targeting by VrrA RNA in Vibrio cholerae (Song et al., 2008). In
addition, also sRNAs from Gram-positive bacteria, such as RNAIII from Staphylococcus aureus
and SR1 from Bacillus subtilis, have been shown to inhibit translation by interfering with ribosome
binding (Boisset et al., 2007; Geisinger et al., 2006; Heidrich et al., 2007; Huntzinger et al., 2005).
Since the half-life of bacterial mRNAs is strongly affected by the association with ribosomes (Deana
& Belasco, 2005), translation inhibition will promote the decay of the repressed target, e. g., by
accelerating RNase E-mediated mRNA turnover (Masse´ et al., 2003; Morita et al., 2005). Besides
RNase E, the bacterial Sm-like protein Hfq has been identified as a key player in this type of
translational silencing (see below, Section 2.2.1). Hfq binds all of the aforementioned sRNAs with
high affinity and is most often required for both their intracellular stability and their interaction with
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Figure 2.2: Translational repression and activation mediated by bacterial sRNAs. (A) sRNA-mediated
translational repression. Binding of MicA RNA to the 5’ UTR of ompA mRNA masks the Shine-Dalgarno
sequence and thereby inhibits translation initiation (Udekwu et al., 2005). (B) sRNA-mediated translational
activation. Under non-activating conditions, the rpoS 5’ UTR folds into an inhibitory stem-loop structure
including nucleotides closely upstream of the AUG start codon which occludes the SD sequence and thereby
inhibits translation (Brown and Elliot, 1997). Interaction of DsrA RNA with rpoS mRNA leads to transla-
tional activation by dissolving the fold-back structure of rpoS mRNA in which the ribosome binding site is
masked (Majdalani et al., 1998). Secondary-structures of sRNAs and mRNAs are shown schematically. The
SD sequences are indicated in blue, and ORFs in light blue (ompA) and orange (rpoS).
target mRNAs (Aiba, 2007; Urban & Vogel, 2007; Zhang et al., 2003, and references therein). In
addition, Hfq and some sRNAs were found to form ribonucleoprotein complexes with RNase E to
mediate target mRNA destabilization (Morita et al., 2005).
Translational repression by bacterial sRNAs is not limited to the 5’ UTRs of monocistronic mRNAs
as also intergenic regions of polycistronic messenger RNAs can be targeted by sRNAs. For example,
in E. coli, the galETKM operon, which encodes components involved in galactose metabolism, is
targeted by Spot42 sRNA at internal sequences of the polycistronic mRNA. Upon induction of the
sRNA in response to high glucose levels, Spot42 occludes the RBS of the galK cistron and inhibits
its translation without affecting the upstream galET cistrons (Møller et al., 2002). Therefore, this
case constitutes the prototype of sRNA-mediated discoordinate operon-expression.
Several sRNAs have recently been shown to repress multiple mRNAs (see Section 2.5). These in-
clude, e. g., RybB, OmrA and OmrB, which regulate expression of several outer membrane proteins
(Guillier & Gottesman, 2006; Papenfort et al., 2006) or RyhB RNA which regulates multiple genes
involved in iron metabolism (Masse´ et al., 2005). Most of the characterized antisense RNAs in
bacteria inhibit translation by competing with ribosomes for translation initiation regions (TIR) on
nascent mRNA. However, recent studies show that translational repression can also be achieved
by binding of an sRNA far upstream or downstream of the translation initiation site. One of these
RNAs is GcvB RNA which will be discussed in Chapters 3 and 4 of this thesis. Another example
is IstR-1 RNA in E. coli (Vogel et al., 2004) which prevents translation of the SOS-induced toxin
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TisB by binding ≈ 100 nt upstream of the tisB RBS under non-SOS conditions. Instead of tar-
geting the SD sequence of tisB, IstR-1 competes with ribosomes by base pairing with a ribosome
loading or “standby” site which is required for initiation of translation at the highly structured tisB
TIR. Recently, Salmonella RybB RNA was found to repress ompN mRNA translation by pairing
with the 5’ coding region (Bouvier et al., 2008). Systematic analysis of antisense interference with
30S binding revealed that sequestering sequences within the mRNA down to the fifth codon allows
sRNAs to act as translational repressors.
2.1.2. Translational activation
Bacterial sRNAs can not only repress mRNAs but, in fact, can also upregulate gene-expression by
an anti-antisense mechanism. Besides the best known example, DsrA, several other sRNAs have
been shown to activate gene expression by disrupting an inhibitory secondary structure which se-
questers the ribosome binding site and thereby prevents translation in the absense of the sRNA (re-
viewed in Waters & Storz, 2009). Therefore, activation of translation seems to be more widespread
than previously anticipated. In E. coli, DsrA RNA was found to be a translational activator of the
major stress and stationary phase sigma factor, RpoS, at low growth temperatures (Majdalani et al.,
1998; Sledjeski et al., 1996). The rpoS mRNA contains an extraordinarily long 5’ UTR (≈ 600
nt), which can fold into a translationally-inactive structure by masking the RBS. Upon base-pairing
with DsrA RNA the stem-loop structure is opened and the RBS gets accessible for ribosome bind-
ing (see Fig. 2.2B). A search for additional sRNAs that modulate RpoS expression resulted in the
identification of the 105 nt RprA RNA (Majdalani et al., 2001). Even though both sRNAs, DsrA
and RprA, pair with the same region ≈ 100 nt upstream of the RBS and disrupt hairpin formation
(Majdalani et al., 2001, 1998), the two sRNAs act under different conditions on rpoS mRNA. While
DsrA is induced at low temperatures, RprA expression peaks upon cell surface stress (Majdalani
et al., 2002; Repoila & Gottesman, 2001).
Similar to repressing sRNAs, activating sRNA can also mediate discoordinate operon expression.
Two small RNAs from E. coli, GlmY and GlmZ, have recently been shown to mediate discoordinate
operon expression of the glmUS mRNA in which the downstream gene glmS, an essential enzyme in
amino-sugar metabolism, is activated at the post-transcriptional level (Kalamorz et al., 2007; Urban
et al., 2007). Although the two sRNAs are highly similar in sequence and structure, they act in a
hierarchical manner. GlmZ, together with the RNA chaperone Hfq, directly activates glmS mRNA
translation by disruption of an inhibitory mRNA structure similar to DsrA-rpoS (Reichenbach et al.,
2008; Urban & Vogel, 2008). In contrast, GlmY acts upstream of GlmZ and positively regulates
glmS by stabilizing GlmZ RNA. The current model assumes that this is achieved by titrating an
RNA-processing protein, YhbJ, which processes GlmZ and abolishes its ability to activate glmS
translation. Thus, GlmY competes with GlmZ for binding to the YhbJ protein and activates glmS
expression indirectly by increasing levels of active GlmZ RNA.
Activation of gene expression can also be mediated by cis-encoded RNAs. For example, in E. coli,
the stationary phase-induced GadY RNA is transcribed from the opposite strand to its target mRNA,
gadX, a transcriptional regulator of the acid response (Opdyke et al., 2004; Tramonti et al., 2008).
Base pairing between GadY and the gadX 3´ UTR leads to cleavage of the gadXW polycistronic
mRNA, stabilization of gadX mRNA and, in turn, to accumulation of the GadX protein.
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2.1.3. sRNA mediated sequestration of protein activity
Messenger RNAs are not the only targets of sRNAs. Several E. coli sRNAs, and their homologues
in other bacteria, interact with cellular proteins to modulate their activities. They antagonize the
activity of their target proteins by mimicking the structures of other RNAs or DNA and thereby
affect transcription, translation or processing of other RNAs. The best known examples are 6S
RNA which titrates RNA polymerase and the CsrB/CsrC RNAs which antagonize the CsrA protein.
These RNAs are discussed below in more detail. Furthermore, a plasmid-encoded RNA was found
to mediate stability of ColE1 plasmids by modulating tryptophanase activity in E. coli (Chant &
Summers, 2007). Specifically, Rcd RNA is transcribed from ColE1-plasmid dimers which can occur
during replication. Binding of Rcd RNA to tryptophanase leads to a higher affinity of the enzyme’s
substrate trypotphan and in turn increased production of indole. This causes a cell division arrest
and allows more time to resolve plasmid dimers and to maintain plasmids.
2.1.3.1. 6S RNA
6S RNA, one of the most abundant and conserved RNAs in bacteria, was first detected by in vivo
RNA labelling experiments (Hindley, 1967) and subsequently sequenced by enzymatic digestion
(Brownlee, 1971), but its gene was identified much later (Hsu et al., 1985). It is co-transcribed
with the downstream ygfA gene and processed from this dicistronic transcript (Hsu et al., 1985;
Kim & Lee, 2004). 6S RNA accumulates in stationary phase (Barrick et al., 2005) and folds into a
rod-like structure that is required for binding to the σ70-containing RNA-polymerase holoenzyme
(Trotochaud & Wassarman, 2005; Wassarman & Storz, 2000). It is thought to mimic the DNA tem-
plate of the open promoter complex of RNA polymerase (see Figure 2.3A; reviewed in Wassarman,
2007). Gel-shift experiments showed that 6S RNA interacts with σ70-RNA polymerase but is not
associated with σS-RNA polymerase (Trotochaud & Wassarman, 2005). This induces a change in
the holoenzyme’s promoter recognition specificity and inhibits transcription from certain σ70 pro-
moters, whereas transcription from some σS promoters is increased (Trotochaud & Wassarman,
2004, 2005; Wassarman & Storz, 2000). Recently, it has been shown that 6S RNA not only mimics
an open promoter complex but rather can serve as a template for transcription of 14-20 nt product
RNAs, so-called pRNAs (Gildehaus et al., 2007; Wassarman & Saecker, 2006). It was suggested
that synthesis of the pRNAs is required for release of the RNA polymerase from 6S RNA during
outgrowth from stationary phase or increased NTP concentrations; whether the pRNAs themselves
have a function remains elusive.
Until recently, homologous sequences of E. coli 6S RNA were only known in the γ-subdivision
of proteobacteria. However, based on a covariance model of 6S RNA structure, multiple 6S RNA
homologues could recently be identified in more than 100 bacterial species of diverse eubacterial
lineages (Barrick et al., 2005). During this comprehensive screen, a number of abundant Bacillus
and Synechococcus RNAs of previously unknown function turned out to be 6S RNA homologues
(Ando et al., 2002; Suzuma et al., 2002; Watanabe et al., 1997). Biochemical analysis by others
independently confirmed these Bacillus RNAs as 6S RNA homologues (Trotochaud & Wassarman,
2005). Strikingly, although the E. coli 6S RNA and each of the two Bacillus 6S RNAs share only
≈ 46 % similarity of the primary sequence, key secondary structure elements and functionally im-
portant residues are conserved. An extended covariance model which includes candidates with
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Figure 2.3: Sequestration of protein activity by bacterial sRNAs. (A) DNA in open pomoter conformation
and 6S RNA. Figure adapted from Wassarman (2007). (B) The CsrA protein (red circles) binds to hairpins in
mRNAs and thereby in inhibits translation. When CsrB RNA is expressed, multiple stem-loops in the sRNA
bind to CsrA proteins and, thus, sequester protein activity. This allows translation of otherwise repressed
mRNAs.
slightly deviating structures predicted hundreds of additional 6S RNA sequences in diverse micro-
bial genomes (Barrick et al., 2005). Furthermore, an RNomics-based approach lead to the identifi-
cation of an 6S homologue in the hyperthermophilic bacterium Aquifex aeolicus (see Section 2.3.5
and Willkomm et al., 2005).
2.1.3.2. CsrB, CsrC
In E. coli, two small RNAs, CsrB and CsrC, act as antagonists of the carbon storage regulator pro-
tein, CsrA (reviewed in Babitzke & Romeo, 2007). CsrA modulates (usually inhibits) translation by
binding to GGA motifs in the 5’ UTRs of certain target mRNAs, including some that are involved
in glycogen biosynthesis (see Figure 2.3B). The two conserved RNAs form a regulatory feedback
loop with CsrA protein and, thereby, tightly control the active pool of the protein (Romeo, 1998;
Weilbacher et al., 2003). Instead of directly acting upon mRNAs, CsrB and CsrC commonly se-
quester the abundant RNA-binding protein, CsrA. Both RNAs contain multiple hairpin structures
with GGA sequence motifs in the loops which serve as CsrA binding sites (see Figure 2.3B and Liu
et al., 1997; Weilbacher et al., 2003). Thus, upon increase of CsrB and CsrC levels the sRNAs ef-
fectively sequester the CsrA protein which, in turn, directly modulates mRNA translation (Babitzke
& Romeo, 2007). Many bacterial species contain the global regulator CsrA as well as homologues
of its two regulatory sRNAs, CsrB and CsrC. These include, for example, CsrB, CsrC and CsrD
RNA involved in quorum sensing in Vibrio cholerae (Lenz et al., 2005), PrrB RNA, the functional
CsrB homologue in the biocontrol strain Pseudomonas fluorescens F113 (Aarons et al., 2000), the
RsmB RNAs in diverse Erwinia species (Liu et al., 1998; Ma et al., 2001), and the RsmY and RsmZ
RNAs from Pseudomonas (Heeb et al., 2002; Valverde et al., 2003). Although the described CsrB
homologues from a variety of organisms have little similarity at the primary sequence level, these
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RNAs do share significant similarity at the secondary structure level and in the frequency of occur-
rence of GGA repeats, which are required for CsrA/RsmA recognition (see Romeo, 1998; Valverde
et al., 2004).
2.1.4. Riboswitches and RNA thermosensors
Riboswitches and RNA thermosensors are cis-encoded regulatory elements which are usually found
in the 5’ UTRs of the mRNAs that they regulate in response to environmetal signals, for example
stalled ribosomes, uncharged tRNAs, temperature, or small molecule ligands (reviewed in Grundy
& Henkin, 2006). Riboswitches are built of an aptamer region which can bind a ligand and an
expression platform which regulates gene expression through alternative secondary structures. This
can result in transcription attenuation by formation of a transcriptional terminator or translational
repression by forming a structure where the RBS is occluded (reviewed in Mandal & Breaker, 2004;
Mironov et al., 2002). Generally, the aptamers sense and bind metabolite ligands, such as purines,
S-adenosyl-methionine, flavin mononucleotide, or lysine. Recently, an RNA sensor of Mg2+ was
identified in the 5’ UTR of mgtA mRNA, which encodes an Mg2+ transporter (Cromie et al., 2006).
In addition to ligand-binding riboswitches, RNA structures can also sense temperature changes
which lead to refolding of the 5’ UTR and thereby control gene expression. In Listeria monocyto-
genes, a thermosensor was identified in the 5’ UTR of pfrA, encoding an important transcriptional
activator of virulence genes (Johansson et al., 2002). At 30°C, this sensor forms an inhibitory struc-
ture which sequesters the RBS; however, a higher temperature (37°C) leads to an opening of the
stem-loop structure which, in turn, allows translation of the mRNA. In Salmonella similar RNA
thermometers were discovered in the 5’ UTRs of ibpA and agsA mRNAs (Waldminghaus et al.,
2005, 2007).
Most of the riboswitches in Gram-positive bacteria act by transcriptional attenuation, whereas
riboswitches in Gram-negative bacteria mainly repress translation (reviewed in Mironov et al.,
2002). Furthermore, Gram-positive bacteria rely more on cis-acting riboswitches, contrary to Gram-
negative bacteria for which more trans-acting RNAs are known. For example, the glmS gene is
controlled by a self-cleaving riboswitch in Gram-positive bacteria (Collins et al., 2007; Winkler
et al., 2004), whereas in E. coli the two above mentioned trans-encoded sRNAs, GlmY and GlmZ,
regulate glmS expression.
2.1.5. Cis-endoded sRNAs
As mentioned above, the first bacterial antisense RNAs were identified on plasmids (reviewed in
Wagner et al., 2002). Many of these cis-encoded plasmid sRNAs modulate the synthesis of repli-
cation proteins, e. g., by inhibition of replication primer formation by RNAI and, thus, control the
plasmid copy number (see Brantl, 2007). The cis-encoded RNAs are transcribed as distinct RNAs
from the opposite strand of their targets, and initial interactions to their targets are often medi-
ated by loop-loop interactions and followed by extension of the duplex (reviewed in Brantl, 2007).
Other cis-encoded sRNAs from plasmids repress the synthesis of toxic proteins and act as plasmid-
addiction molecules or post-segregational killing systems (Gerdes et al., 1997). The best known
toxin-antitoxin pair is the hok/sok system of plasmid R1 (Gerdes et al., 1990). Toxin-antitoxin sys-
tems that are homologous to the Hok/Sok system have been identified not only on plasmids but also
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in the E. coli chromosome (for a review see Fozo et al., 2008a). Further chromosomally encoded
cis-acting antisense RNAs have been found in cryptic prophages, such as RatA RNA in B. subtilis
(Silvaggi et al., 2005). Recently, several small toxic proteins that are present in multiple copies
were identified in the E. coli chromosome and were found to be repressed by cis-encoded antisense
RNAs (Fozo et al., 2008b). Other examples for cis-encoded antisense RNAs are SymR RNA in
E. coli which is transcribed opposite to the 5’ end of the SOS-induced toxin SymE and thereby in-
hibits translation of its target (Kawano et al., 2007), or the iron-stress repressed IsrR RNA which is
located within the isiA coding region and was described to control expression of this photosystem
associated protein in Synechocystis (Du¨hring et al., 2006).
Similar to trans-encoded sRNAs, cis-encoded antisense RNAs can also mediate discoordinate
operon expression. These include GadY RNA which stabilizes gadX mRNA by cleavage of the
gadXW polycistronic transcript (see Section 2.1.2). In Vibrio anguillarum, a plasmid-encoded anti-
sense RNA mediates processing of a polycistronic mRNA. However, in this case sRNA binding
leads to transcription termination after the fatA gene of the fatDCBAangRT operon and, hence,
reduces expression of the downstream angRT genes (Stork et al., 2007).
2.1.6. sRNAs with dual functions
Although sRNAs were for a long time considered to be non-coding RNAs, several sRNAs are now
known to be bifunctional, i. e. they contain an open reading frame and in addition act as an antisense
RNA. Thus, regulatory RNAs do not necessarily have to be noncoding RNAs. One example is the
highly structured RNAIII of Staphylococcus aureus which encodes the 26 amino-acid peptide δ-
hemolysin in its 5’ part and modulates the expression of two other virulence genes, e. g., spa and
hla, through base-pairing of its noncoding regions with the mRNAs (Boisset et al., 2007; Huntzinger
et al., 2005; Novick et al., 1993). In E. coli, the 227-nt long SgrS RNA, which is expressed during
glucose-phosphate stress, was shown to contain an 43 amino acid ORF, SgrT, upstream of the
nucleotides that are involved in the antisense function of this sRNA (Wadler & Vanderpool, 2007).
SgrS was previously shown to block translation of the ptsG mRNA encoding a sugar-phosphate
transporter by means of a base-pairing dependent mechanism requiring the RNA chaperone Hfq
(Kawamoto et al., 2006; Vanderpool & Gottesman, 2004). It was suggested that SgrT reinforces
the regulation by SgrS by independently downregulating glucose uptake by directly or indirectly
inhibiting the PtsG transporter (Wadler & Vanderpool, 2007).
2.2. Additional factors involved in gene regulation by bacterial sRNAs
Small regulatory RNAs in bacteria either pair with mRNA targets or modify protein activities.
Moreover, they often act in ribonucleoprotein complexes. Proteins that interact with the sRNAs
can possess catalytic activity, induce conformational changes of the sRNA, or be sequestered by
the sRNA to prevent the action of the protein. The current knowledge of the various proteins that
interact with RNA regulators and the physiological implications of sRNA-protein complexes in
DNA, RNA and protein metabolism, as well as in RNA and protein quality control are reviewed
in Pichon & Felden (2007). Here, the role of the key players Hfq and several RNases in sRNA-
mediated regulation in bacteria is introduced.
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2.2.1. The Sm-like protein Hfq
In bacteria, the majority of the sRNAs base-pair with target mRNAs to regulate their translation
and/or decay and these regulatory events commonly require the bacterial Sm (Smith antigen)-like
protein, Hfq. Hfq is a 102 amino acid protein that was first identified in Escherichia coli as a host
factor required for phage Qβ RNA replication ≈ 40 years ago (Franze de Fernandez et al., 1968).
Hfq is now known to have important physiological roles in numerous model bacteria (Valentin-
Hansen et al., 2004). Almost half of all sequenced Gram-negative and Gram-positive species, and
at least one archaeon, encode an Hfq homologue (Nielsen et al., 2007; Sun et al., 2002). In E. coli,
it is a highly abundant protein with estimated 50,000 to 60,000 copies (≈ 10,000 hexamers) per
cell, the majority being associated with ribosomes and a minor fraction with the nucleoid (Azam
et al., 1999; Franze de Fernandez et al., 1972; Kajitani et al., 1994). The crystal structures of Hfq
proteins from Staphylococcus aureus (Schumacher et al., 2002), E. coli (Sauter et al., 2003), and
Pseudomonas aeruginosa (Nikulin et al., 2005) revealed that Hfq is an Sm protein. The eukaryotic
and archaeal Sm and Sm-like (Lsm) proteins form heteroheptameric rings and are central compo-
nents of RNP complexes involved in diverse aspects of RNA metabolism including splicing and
mRNA decay (reviewed in Wilusz & Wilusz, 2005). In E. coli and related bacteria, Hfq forms
homohexameric rings and preferentially binds A/U-rich single-stranded regions preceded or fol-
lowed by a stem-loop structure (reviewed in Brennan & Link, 2007). It has at least two major RNA
binding sites, a proximal site, first identified in the crystal structure of S. aureus Hfq bound to the
hepta-oligoribonucleotide, AU5 (Schumacher et al., 2002), and a distal site which binds poly(A)
tails (Brennan & Link, 2007).
The importance of Hfq for sRNA-mediated regulation was first evident in studies on OxyS RNA
(Zhang et al., 1998). By now it is known that Hfq interacts with most of the regulatory sRNAs as
well as diverse mRNAs (Sittka et al., 2008; Zhang et al., 2003) and is required for the intracellular
stability of many regulatory sRNAs (Valentin-Hansen et al., 2004). Hfq turned out to have an
RNA chaperone activity as structure changes have been observed for some sRNAs (e. g. OxyS and
Spot42) and mRNAs (e. g. sodB and ompA) in structure probing experiments (Geissmann & Touati,
2004; Moll et al., 2003). Furthermore, it was found that Hfq possesses ATPase acitivity which
might be related to its chaperone function (Sukhodolets & Garges, 2003). Recently, a plausible
ATP-binding site in Hfq was identified by biochemical and genetic techniques, and it was suggested
that ATP binding by the Hfq-RNA complex results in its significant destabilization (Arluison et al.,
2007b).
The proposed role of Hfq in sRNA-mediated posttranscriptional regulation is to facilitate the gen-
erally short and imperfect base-pairing between sRNAs and their mRNA targets (Kawamoto et al.,
2006; Lease & Woodson, 2004; Mikulecky et al., 2004; Møller et al., 2002; Zhang et al., 2002,
2003). Recent fluorescence resonance energy transfer (FRET) studies showed that Hfq enhances
RNA annealing and promotes strand exchange by binding rapidly to both DsrA and rpoS mRNA
(Arluison et al., 2007a; Rajkowitsch & Schroeder, 2007). Although it is known that Hfq binds to
sRNAs and several mRNAs, the mechanisms by which Hfq promotes interactions remain unclear.
Due to its chaperone acitivity it could promote base-pairing by opening the regions of pairing or
facilitate base-pairing by increasing the local concentrations of the interacting RNAs (Storz et al.,
2004). In addition, it is unclear whether one Hfq hexamer binds the sRNA and mRNA simultane-
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ously or if one hexamer binds the sRNA and a second hexamer the mRNA and the two hexamers
could be brought together via interactions between the hydrophobic backs (Schumacher et al., 2002;
Storz et al., 2004).
Contrary to most sRNAs from Gram-negative bacteria which are dependent on Hfq, sRNA-
mediated regulation in some Gram-positive bacteria has been shown to function also without Hfq.
For example, although S. aureus Hfq binds RNAIII, it has no detectable effect on RNAIII-target
mRNA complex formation, as the RNAs interact rapidly and do not require Hfq for their annealing.
Furthermore, the hfq gene is transcribed very weakly in multiple strains of this bacterium and an
hfq deletion strain has no detectable phenotypic effects on virulence (Bohn et al., 2007; Geisinger
et al., 2006). Likewise, the small RNA SR1 and its target ahrC were shown to bind Hfq; however,
Hfq was not required to promote ahrC/SR1 complex formation but to enable the translation of ahrC
mRNA (Heidrich et al., 2007).
In addition to its role in regulation of gene expression in a concerted manner with sRNAs, Hfq
can also act alone as a translational repressor of mRNA (Urban & Vogel, 2008; Vytvytska et al.,
2000). Moreover, it can modulate the decay of some mRNAs, e. g., by binding to their poly(A) tails
and stimulating polyadenylation or protecting messages from polynucleotide phosohorylase (PNP),
RNase II, and RNase E by sequestering binding sites for these RNases (Folichon et al., 2005, 2003;
Hajnsdorf & Re´gnier, 2000; Mohanty et al., 2004). Hfq has also been found to autoregulate its
own expression at the translational level, and roles of Hfq in tRNA biogenesis have recently been
described (Lee & Feig, 2008; Scheibe et al., 2007; Vecerek et al., 2005). Besides binding RNAs,
Hfq interacts with several components of the ribosome, degradosome or other cellular machines
that are involved in RNA metabolism, e. g., RNase E, PNP, poly(A) polymerase I (PAP I) (see
Section 2.2.2, or RNA polymerase in a ribosomal protein S1-dependent manner (Sukhodolets &
Garges, 2003).
The pleiotropy of an hfq deletion mutant was first apparent from the multiple stress response-related
phenotypes in E. coli, including decreased growth rates, increased sensitivity to ultraviolet light,
mutagens and oxidants, and increased cell length (Tsui et al., 1994). Moreover, an hfq mutation
changes expression of more than 50 proteins which is partly reflected by the reduced efficiency
of translation of rpoS mRNA, encoding the major stress sigma factor, σS (Brown & Elliott, 1996;
Muffler et al., 1996). However, Hfq clearly influences bacterial physiology in a much broader
fashion, including the σS-independent control of virulence factors in diverse pathogenic bacteria
(Christiansen et al., 2006; Ding et al., 2004; Fantappie` et al., 2009; Meibom et al., 2009; Nakao
et al., 1995; Robertson & Roop, 1999; Sharma & Payne, 2006; Sonnleitner et al., 2003). A strong
impact on virulence as well as other stress-related phenotypes were also observed for a Salmonella
hfq deletion strain (see Section 2.6.1.1 and Sittka et al., 2007).
2.2.2. Ribonucleases
Besides the RNA-chaperone Hfq, several ribonucleases (RNases) are involved in sRNA-mediated
regulation in bacteria and have been shown to influence the processing and turnover of these
molecules (Viegas et al., 2007). Since RNases are key modulators of RNA decay, the identification
of the RNases that contribute to the decay of individual sRNAs is essential for a more general un-
derstanding of sRNA turnover in vivo (reviewed in Viegas & Arraiano, 2008). For example, poly(A)
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polymerase I modulates RNA stability by adding poly(A) tails to the 3’ end of RNAs which promote
efficient exonucleolytic degradation (Hajnsdorf et al., 1995; O’Hara et al., 1995; Sarkar, 1997; Xu
& Cohen, 1995). PAP I can be a main factor involved in mRNA decay but was also shown to affect
stability of sRNAs such as GlmY (Urban & Vogel, 2008). In addition, Hfq was co-purified in an
sRNA-independent manner with PNP and PAP I, two components of the degradosome (Mohanty
et al., 2004).
One of the major endoribonucleases in E. coli is RNase E which is a single-strand specific endori-
bonuclease with a main role in mRNA decay but being also involved in the processing of riboso-
mal and transfer RNAs (Arraiano & Maquat, 2003; Carpousis, 2002; Re´gnier & Arraiano, 2000).
RNase E is also one of the main enzymes forming the degradosome, a multiprotein complex in-
volved in the decay of many RNAs (Carpousis et al., 1994, 1999). It cleaves single-stranded regions
of structured RNAs and has a preference for 5’ monophosphate termini and AU-rich sequences of
RNAs (Ow et al., 2003). RNase E is not ubiquitous in bacteria but functional homologues, RNase
J1 and J2, were identified in Bacillus subtilis (Even et al., 2005). Besides a role in decay of sin-
gle RNAs, RNase E is important for coupled sRNA-mRNA degradation (Afonyushkin et al., 2005;
Masse´ et al., 2003; Morita et al., 2005). Specifically, RNase E was found to co-purify together
with two sRNAs, SgrS and RyhB, and Hfq and leads to degradation of the mRNA targets ptsG
and sodB (Morita et al., 2005, 2006). In contrast to the degradosome, these specialized ribonucle-
oprotein complexes do not contain PNP, enolase, and the RhlB RNA helicase. Moreover, the Hfq
binding site of RNase E was identified in the C-terminal scaffold domain which is also required for
RyhB-mediated degradation of sodB mRNA (Masse´ et al., 2003). It was proposed that Hfq and the
degradosome components, except enolase, compete for RNase E binding at the C-terminal scaffold
domain. Overall, the RNase E-Hfq-sRNA RNP complex leads to translational repression and rapid
target mRNA degradation. However, Hfq binding in the absence of RNase E and RNA-RNA inter-
action itself are sufficient to mediate translational repression, destabilization, and destruction of the
target mRNA (Maki et al., 2008; Morita et al., 2006).
Another RNase which is involved in post-transcriptional regulation by bacterial sRNAs is the
double-strand specific RNase III. This ubiquitous RNase plays multiple roles in the processing of
rRNA and mRNA (Nicholson, 1999) and can also affect the decay of some mRNAs (Re´gnier &
Grunberg-Manago, 1990; Santos et al., 1997). Interestingly, maturation of eukaryotic siRNAs and
miRNAs is mediated by members of the RNase III family, namely, the double-strand specific en-
zymes Dicer and Drosha (Bernstein et al., 2001). In E. coli, an antisense interaction between the
SOS-induced small RNA IstR-1 and its target tisAB was found to entail RNase III-dependent cleav-
age and thereby inactivates the mRNA for translation (Vogel et al., 2004). Furthermore, the decay of
RyhB in vivo was shown to be mainly dependent on RNase III in contrast to the RNase E-dependent
turnover of its target sodB mRNA. Cleavage of RyhB by RNase III in vitro is facilitated upon base-
pairing with the sodB 5’-UTR (Afonyushkin et al., 2005). Moreover, RNase III is important for
regulation of several virulence factors by RNAIII in Staphylococcus aureus (Boisset et al., 2007;
Huntzinger et al., 2005). In this case, coordinated action of RNase III is essential to degrade the
mRNA and irreversibly arrest translation in vivo.
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2.3. Approaches for the identification of bacterial sRNAs
Due to the diverse functions that are associated with the different structures and features of sRNAs it
is difficult to find a universal method that would allow to detect all classes of sRNAs. The detection
of ncRNAs by biochemical and genetic methods is quite difficult because sRNAs lack character-
istic features like a poly(A)-tail and have mostly only a small size making them a poor target for
mutational screens. Computational identification is also difficult; conventional protein-gene find-
ing programs search for features like open reading frames and exon/intron boundaries, which are
irrelevant to ncRNAs. The first sRNAs were identified fortuitously using genetic screens or through
radiolabelling of total RNA and isolation from gels (Wassarman et al., 1999). Four initial system-
atic screens in E. coli in 2001 and 2002 revealed more than 50 new sRNAs and generated an even
longer list of sRNA candidate loci (Argaman et al., 2001; Chen et al., 2002; Rivas et al., 2001;
Wassarman et al., 2001). Up to now, several experimental and bioinformatics-based approaches
have been developed and have led to the identification of sRNAs in a wide range of bacteria, in-
cluding several pathogens (see Table 2.1). Some of these approaches which will be explained in the
following and include, e. g., bioinformatics-based prediction strategies, shotgun-cloning of RNA
(RNomics), hybridization on microarrays or co-immunoprecipitation with Hfq. Furthermore, the
different identification strategies of sRNAs in diverse bacteria are summarized in several reviews
(Altuvia, 2007; Hu¨ttenhofer & Vogel, 2006; Livny & Waldor, 2007; Pichon & Felden, 2008; Vogel
& Sharma, 2005).
2.3.1. Direct Labelling
The first bacterial small RNAs, other than tRNAs and 5S rRNA, were found by gel-fractionation
of metabolically labelled E. coli total RNA (Griffin, 1971; Hindley, 1967; Ikemura & Dahlberg,
1973a,b). These studies used radio-labelled orthophosphate (32PO 3−4 ) which is readily taken up by
growing bacteria and incorporated into nucleic acids. Following such treatment, total cellular RNA
was isolated, separated by gel fractionation, and selected bands or spots sequenced by digestion
with nucleases (fingerprinting) after excision from the gel. This approach identified the housekeep-
ing RNAs, RNase P RNA, tmRNA, and SRP RNA, as well as other abundant regulatory RNAs
such as 6S RNA, and Spot 42 RNA. Instead of tedious nuclease-fingerprinting assays, the sequence
of isolated RNAs can also be determined by rapid cDNA cloning and Sanger sequencing. Some
abundant sRNAs are already detectable by various staining protocols after separation on polyacry-
lamide gels, e. g., SRP RNA (Ando et al., 2002; Suzuma et al., 2002) as well as the two 6S RNA
homologues of Bacillus subtilis could be visualized after treatment with ethidium bromide.
In vitro labelling of extracted total RNA at 5’ or 3’ termini provides an alternative route to metabolic
or in vivo labelling. This approach employs either T4 polynucleotide kinase and γ-[32P]ATP for
labelling 5’ termini, or T4 RNA ligase and [32P] pCp for labelling the 3’ end. Labelling efficiency
can vary significantly for the two termini in a given RNA pool due to secondary RNA structures
which can affect the accessibility of the 5’ or 3’ end to be labelled, or due to the functional group
at the 5’ end of sRNAs. 5’ RACE (rapid amplification of cDNA ends) experiments have suggested
that many primary sRNA transcripts retain a 5’ triphosphate which, unless removed, will preclude
labelling (Argaman et al., 2001; Vogel et al., 2003).
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Table 2.1: Systematic sRNA screens in diverse bacteria.
Bacterium Strategy Reference
Gram-negative bacteria
Escherichia coli biocomputational Argaman et al., 2001
Escherichia coli biocomputational, oligonucleotide arrays Wassarman et al., 2001
Escherichia coli biocomputational Rivas et al., 2001
Escherichia coli biocomputational Chen et al., 2002
Escherichia coli RNomics Vogel et al., 2003
Escherichia coli Hfq co-immunoprecipitation, microarrays Zhang et al., 2003
Escherichia coli direct cloning Kawano et al., 2005a
Salmonella typhimurium biocomputational Pfeiffer et al., 2007
Salmonella typhimurium biocomputational Padalon-Brauch et al., 2008
Salmonella typhimurium Hfq co-immunoprecipitation, Sittka et al., 2008
deep sequencing
Prochlorococcus marinus, biocomputational Axmann et al., 2005
Synechococcus sp.
Prochlorococcus marinus microarrays Steglich et al., 2008
Borrelia burgdorferi biocomputational ¨Ostberg et al., 2004
Vibrio cholerae biocomputational Lenz et al., 2004
Aquifex aeolicus RNomics Willkomm et al., 2005
Pseudomonas aeruginosa biocomputational Livny et al., 2006
Pseudomonas aeruginosa biocomputational, RNomics Sonnleitner et al., 2008
Sinorhizobium meliloti biocomputational, microarrays Ulve´ et al., 2007
Sinorhizobium meliloti biocomputational del Val et al., 2007
Sinorhizobium meliloti biocomputational Valverde et al., 2008
Caulobacter crescentus tiling array Landt et al., 2008
Gram-positive bacteria
Staphylococcus aureus biocomputational Pichon & Felden, 2005
Bacillus subtilis biocomputational, microarray Silvaggi et al., 2006
Listeria monocytogenes Hfq co-immunoprecipitation Christiansen et al., 2006
Listeria monocytogenes biocomputational Mandin et al., 2007
Streptomyces coelicolor biocomputational Pa´nek et al., 2008
Streptomyces coelicolor biocomputational, sRNA cloning Swiercz et al., 2008
Archaea
Archaeoglobus fulgidus RNomics Tang et al., 2002
Sulfolobus solfataricus RNomics Tang et al., 2005
Haloferax volcanii biocomputational, RNomics Soppa et al., 2009
Haloferax volcanii RNomics Straub et al., 2009
2.3.2. Genetic screens
Several sRNAs, such as MicF and DsrA, were identified during genetic analyses of protein factors
that modulated certain physiological activities. Specifically, in a study of the genetic basis for
regulation of the two E. coli outer membrane proteins, OmpC and OmpF (Mizuno et al., 1984), it
was observed that multiple-copy plasmids carrying a 300 bp DNA segment of the ompC promoter
blocked OmpF expression. Analysis of the insert sequences of these plasmids revealed the above
mentioned first member of the class of trans-encoded antisense RNAs, MicF RNA.
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Similarly, a mucoid phenotype led to the discovery of E. coli DsrA RNA. When studying factors
involved in capsule synthesis, such as the positive regulator RcsA, it was found that multi-copy plas-
mids carrying a region downstream of the rcsA gene caused capsule overproduction. Subcloning
of this region resulted in the isolation of the noncoding dsrA gene. DsrA was further shown to
antagonize hns mRNA translation by an antisense mechanism which finally explained the mucoid
phenotype of multi-copy dsrA plasmids; under normal conditions, the histone-like protein, H-NS,
silences the rcsA gene. Overproduction of DsrA decreases H-NS levels, which abrogates rcsA re-
pression and leads to elevated capsule polysaccharide synthesis (Lease et al., 1998; Sledjeski &
Gottesman, 1995 and references therein). The observation that DsrA can also act as an activator of
rpoS expression (see Section 2.1.2) initiated a genetic screen for rpoS-regulating sRNAs. Majdalani
et al. (2001) transformed a pBR322-based plasmid library of E. coli genomic DNA fragments rang-
ing in size from 1.5 to 5 kb (Ulbrandt et al., 1997) into a strain that harboured an rpoS::lacZ reporter
gene (translational fusion) and a mutated dsrA locus. Screening for colonies exhibiting enhanced
β-galactosidase activity then led to the discovery of RprA RNA (Majdalani et al., 2001). Similarly,
the E. coli CsrC and the P. fluorescens CsrB homologue, PrrB RNA, were discovered in functional
screens for genes affecting glucan biosynthesis (Aarons et al., 2000; Weilbacher et al., 2003). In
summary, multi-copy plasmid libraries are a valuable tool for identifying sRNAs and often provide
an immediate link to a physiological function. However, some sRNAs might be toxic when cloned
on a multi-copy plasmid or regulate only under specific conditions and, hence, will be missed in a
screen.
Besides overexpression of sRNAs based on plasmid libraries, chromosomal inactivation by random
transposon insertion mutagenesis can help to find sRNA genes responsible for a certain phenotype.
For example, transposon insertion mutagenesis in Bradyrhizobium japonicum led to the identifica-
tion of the sra gene which encodes a 213 nt sRNA that is essential for symbiotic nodule development
(Ebeling et al., 1991). In addition, GlmZ, which was previously known as RyiA or SraJ RNA of
hitherto unknown function (Argaman et al., 2001; Wassarman et al., 2001), was identified as an
activator for glmS mRNA in a transposon mutagenesis screen for insertions that abolish the high
glmS expression in a yhbJ mutant (Kalamorz et al., 2007; see section 2.1.2). Fortunately, only a few
sRNAs seem to be essential, namely, E. coli RNase P RNA and SRP RNA (see Wassarman et al.,
1999) as well as Neisseria gonorrhoeae tmRNA (Huang et al., 2000). However, some sRNAs can
be essential under certain stress conditions such as the DNA damage-induced istR locus of E. coli,
encoding two regulatory sRNAs, cannot be deleted in SOS constitutive strains (Vogel et al., 2004).
Another caveat regarding gene-disruption based sRNA screening is that, due to the comparatively
small size of sRNA genes, a transposon is five to ten fold more likely to disrupt a protein-coding
region than an sRNA gene, assuming an average size of bacterial ORFs of 1,000 bp (≈ 960 nt in
E. coli, Blattner et al., 1997).
2.3.3. Biocomputational screens
Computer-based annotation of bacterial genome sequences has been standardized by several pro-
grams for the prediction of protein-coding genes, e. g. GLIMMER (Delcher et al., 1999; Salzberg
et al., 1998). Such programs for prediction of mRNA genes search for the longest possible read-
ing frame and are frequently supported by the existence of orthologues in related bacteria and by
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the occurrence of putative ribosome binding sites in the vicinity of the predicted start codon. As
mentioned above, sRNA genes lack such characteristic identifiers and the use of computational
methods to discover novel bacterial sRNAs is difficult. The ever-increasing number of completed
bacterial genome sequences has greatly facilitated computer-based sRNA searches at the genomic
level. The three pioneering studies that aimed at sRNA identification in E. coli were primarily based
on comparative genomics of closely related enterobacteria such as S. typhimurium and Yersinia
pestis and on prediction of orphan transcription signals in intergenic regions (Argaman et al., 2001;
Wassarman et al., 2001; Rivas et al., 2001).
The prediction strategy used by Argaman et al. (2001) was based on the characteristics of the ten
E. coli sRNA genes known at the time (Wassarman et al., 1999). Upon extraction of intergenic
regions (IGRs) from the annotated E. coli genome, promoters that would match the consensus se-
quence recognized by the vegetative sigma factor, σ70, were predicted. Furthermore, the IGRs
were inspected for strong Rho-independent transcriptional terminators. E. coli IGRs that contained
a promoter and a terminator on the same strand and within a distance of 50 - 400 bp were selected
and compared to the genomes of the Salmonella typhimurium, Yersinia pestis, and Klebsiella pneu-
moniae by BLASTN searches. Conserved IGRs were extracted based on statistically significant
alignment scores. Finally, the genomic locations of sRNA candidates were evaluated; i. e. putative
sRNA genes that were oriented in opposite direction to both adjacent genes scored higher because
these could not be conserved mRNA leaders or trailers. Overall, the prediction strategy led to 23
putative sRNA genes of which 14 could be verified as new sRNAs on Northern blots.
A similar approach was taken by Wassarman et al. (2001) who extracted all E. coli IGR sequences
longer than 180 bp, compared them to Salmonella and Klebsiella IGRs, and evaluated transcription
signals and sRNA gene orientation for those with a high degree of sequence conservation. Fur-
thermore, these predictions were supported by expression analysis of putative sRNA transcripts on
E. coli microarrays. Finally, 23 of 59 final sRNA candidates were confirmed on Northern blots. Of
these, 17 were considered to be new sRNA genes. The remaining six were reclassified as small
protein-coding genes based on reading frame conservation and the presence of putative Shine-
Dalgarno sequences.
Rivas et al. (2001) introduced a conceptual change by scoring conservation of RNA secondary struc-
ture rather than of primary sequence. For this purpose, they combined structure prediction with
comparative analysis of E. coli, Salmonella and Klebsiella genomes. The implemented program,
QRNA, searches for mutational patterns in pairwise sequence alignments that would distinguish
conserved RNA secondary structure from the background of other conserved sequence elements
such as transcription factor binding sites. In contrast to the patterns of synonymous codon substi-
tutions in conserved protein-coding regions, structural RNAs are revealed through compensatory
mutations that are consistent with maintaining predicted secondary structure elements. QRNA pre-
dictions in E. coli yielded a total of 275 candidate RNAs. Of these final candidate genes, 49 were
assayed experimentally, and 11 of these were found to express small transcripts under the sin-
gle growth condition examined. Many sRNAs are known to be expressed in stationary phase or
under specific stress conditions; thus, a broader set of growth conditions (Argaman et al., 2001;
Wassarman et al., 2001) may be likely to increase the number of confirmed candidates.
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The three initial screens mainly relied on conservation of sRNA genes among closely related bac-
teria. However, sometimes genome sequences are not yet available for related bacteria or it is
desired to identify species-specific sRNAs. Another sRNA search in E. coli that relied solely on
transcription signal prediction went into this direction (Chen et al., 2002). Here, the search strategy
was based on the prediction of σ70-type promoter/ Rho-independent terminator pairs in IGRs that
lie on the same strand within a distance of 45 - 350 bp. After removal of putative short protein-
coding genes and orphan tRNA genes, short leaders, tRNA/rRNA operon fragments, or known
sRNA genes, this study ended up with 144 final candidates, and seven out of eight candidates ex-
amined on Northern blots were found to be new sRNA species. Interestingly, a mere ten of the forty
sRNAs known at the time were recognized by the search algorithm. An automated sRNA screening
procedure for the extraction, selection and visualization of candidate IGRs has been implemented
in the software package ‘Intergenic Sequence Inspector’, or ISI (Pichon & Felden, 2003). This
program filters IGRs according to variable input parameters, including length or GC content, and
can select those with significant sequence conservation among phylogenetically related bacteria.
Besides all previously characterized E. coli sRNAs, ISI identified additional candidates in E. coli
(Antal et al., 2005) and also in the Gram-positive bacterium Staphylococcus aureus (Pichon &
Felden, 2005).
Two additional bioinformatic approaches to identify sRNAs in E. coli were conducted. Carter et al.
(2001) developed a machine learning approach that made use of neural networks and support vec-
tor machines to extract the shared features of known sRNAs for the prediction of new candidates
in several prokaryotic and archaeal genomes. Similar to QRNA (Rivas & Eddy, 2001), this ap-
proach seems to be less dependent on prior knowledge of the specific RNA gene features of a
given organism. The underlying algorithm employs both compositional parameters (nucleotide and
dinucleotide composition) and structural motif parameters to discriminate functional RNAs from
random noncoding sequences. The screen predicted ≈ 370 novel sRNA candidates in the E. coli
genome which await experimental verification. More recently, boosted genetic programming was
used to create sRNA classifiers in order to select noncoding functional RNA sequences from inter-
genic sequences which predicted several new sRNA candidates (Saetrom et al., 2005).
Biocomputational approaches were also successfully applied to scan the genomes of entirely unre-
lated bacteria, including four marine cyanobacteria of the Prochlorococcus-Synechococcus lineage
(Axmann et al., 2005). It has been shown that thermodynamic stability values derived from the con-
sensus folding of aligned related sequences allow effective prediction of functional RNAs (Washietl
& Hofacker, 2004; Washietl et al., 2005). Based on this strategy, Axmann et al. (2005) scored align-
ments of IGRs that are conserved among three Prochlorococcus genomes and one Synechococcus
genome using ALIFOLDZ (Washietl & Hofacker, 2004; Washietl et al., 2005). Expression analy-
sis of the highest scoring candidate regions under various growth and stress conditions confirmed
seven new sRNAs in Prochlorococcus marinus, several of which had homologues in the other three
strains. In addition, these searches also uncovered new cyanobacterial 6S RNA orthologues, i. e. in
addition to the 6S RNA-like genes previously reported in other Synechococcus strains (Watanabe
et al., 1997).
The successful use of bioinformatics to identify sRNAs in bacteria other than E. coli has been lim-
ited by the lack of well-defined promoter consensus sequences in most species. However, several
groups have recently demonstrated that sRNA genes can be predicted even without putative pro-
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moters or transcription factor binding sites. For example, the search strategy of Waldor group used
only sequence conservation of IGRs and predictions of Rho-independent terminators. This led to
the successful identification of several sRNAs in Vibrio cholerae and Pseudomonas aeruginosa
(Livny et al., 2005; Livny et al., 2006). Furthermore, the same group conducted genome-wide an-
notations for putative sRNA-encoding genes in the intergenic regions of eleven diverse pathogens
using their sRNAPredict2 program (Livny et al., 2006). In total, they predicted more than 2700
previously unannotated candidate sRNA loci in diverse bacteria which, however, await experimen-
tal verfication. Recently, the extension to kingdome-wide predictions and annotations of intergenic
sRNA-encoding genes in the 932 bacterial replicons in the NCBI database predicted more than
45,000 candidate loci (Livny et al., 2008). Though, how many of the candiates are real sRNAs
remains to be tested.
Despite this high number of predicted candidates, probably diverse sRNA genes have been missed
in predictions. For example, each of the existing sRNA gene finders is unable to identify all the
experimentally validated sRNA genes, indicating that all these in silico methods have limitations.
Furthermore, most of the prediction strategies were initially designed for predictions in E. coli with
serious limitations and the need for adjustments to apply them to other genomes. Moreover, they
are often limited to intergenic regions. Recent studies using a hidden Markov model (Yachie et al.,
2006) enabled identification of sRNAs in protein-coding regions, but their efficiencies need to be
improved.
2.3.4. Identification of sRNAs by transcription factor binding sites
Several sRNAs have been identified due to the presence of specific transcription factor binding sites
in their promoter regions. For example, an sRNA search in Vibrio genomes used many features of
the prior E. coli screens and added yet another layer (Lenz et al., 2004). Based on some previous
observations, the Bassler group assumed that one or more unknown sRNAs could be responsible
for an Hfq-dependent regulation of the quorum sensing master regulator, LuxR. As further results
indicated that such sRNAs would be activated by the sigma factor σ54, a computer-based method
was developed to scan Vibrio cholerae IGRs for pairs of σ54 binding sites and Rho-independent
terminators. Combination with conservation analysis in two other Vibrio species led to the discovery
of four novel sRNAs that are almost identical and conserved in all three investigated Vibrio species.
Similarly, Pseudomonas homologues of the E. coli RyhB RNA were discovered by functional ev-
idence that pointed to the involvement of a hidden sRNA (Wilderman et al., 2004). In many bac-
teria, iron homeostasis is controlled primarily by the ferric uptake regulator (Fur), a transcriptional
repressor. However, some genes, including those involved in iron storage, are positively regulated
by Fur. E. coli RyhB RNA was found to be repressed by Fur, and derepression of the sRNA un-
der iron-limiting conditions allows downregulation of several mRNAs by an antisense mechanism
(Masse´ & Gottesman, 2002). The ryhB gene, along with its promoter and Fur binding site, is well
conserved in enterobacteria but could not be found in Pseudomonas aeruginosa, another organism
in which positive regulation by Fur had been observed and left unexplained (Ochsner et al., 2002).
However, a biocomputational approach based on pattern searches for Fur-consensus binding site in
IGRs combined with predictions for Rho-independent terminators identified two RyhB homologues
in P. aeruginosa (Wilderman et al., 2004). These sRNAs are more than 95% identical to each other
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and are expressed in a Fur-dependent manner. In addition, PrrF1 and PrrF2 RNAs show a stretch of
complementarity with the translation initiation region of sodB mRNA, further suggesting that these
newly discovered sRNAs are functional homologues of RyhB.
In Streptococcus pneumoniae five sRNAs were fortuitously identified during analysis for CiaR bind-
ing sites, which is part of the two-component regulatory system CiaRH (Halfmann et al., 2007).
These small RNAs, designated csRNAs for cia-dependent small RNAs, are non-coding, between
87 and 151 nt in size, and show a high degree of similarity to each other. This suggests that system-
atic screens for transcription factor binding sites could be used to identify novel sRNAs. In addition
this would immediately provide a link to the expression conditions of the sRNA and give a hint of
its function.
2.3.5. RNomics
Shotgun cloning of RNA (also termed experimental RNomics) led to the discovery of hundreds of
noncoding RNAs in several eukaryotes and archaebacteria (see, for example, Hu¨ttenhofer et al.,
2001; Marker et al., 2002; Tang et al., 2002, 2005; Yuan et al., 2003). Typical RNomics proto-
cols include a size-fractionation step of total RNA on polyacrylamide gels, followed by directional
cDNA cloning of the gel-extracted RNA and sequencing of the resulting libraries. This method
of randomly cloning as many small RNA fragments as possible aims to comprehensively iden-
tify RNAs that are expressed from a given genome under a given set of conditions, irrespective of
whether they are primary or processed transcripts.
In the two shotgun cloning studies conducted in E. coli to date the RNA size range was either
50 - 500 nt (Vogel et al., 2003) or 30 - 65 nt (Kawano et al., 2005a). Following size-fractionation,
individual cDNA libraries representing two or three distinct growth phases were constructed, based
on earlier observations that many E. coli sRNAs are expressed in a growth-rate specific manner (e. g.
Argaman et al., 2001; Wassarman et al., 2001). In the first study, extracted RNA was C-tailed with
poly(A) polymerase, followed by reverse transcription and construction of cDNA libraries (Vogel
et al., 2003). Individual library clones (10,000) were spotted on high-density filters and hybridized
with a mix of rRNA and tRNA probes to exclude such clones from further study, and cDNA clones
that passed this test were sequenced. This identified, in addition to sRNA genes, fragments of
mRNA leaders and trailers that accumulated as distinct sRNAs, as well as many sequences derived
from within coding regions. Because cDNA cloning was directional, several of the sequences could
be classified as antisense transcripts of mRNA coding regions.
The cloning strategy of Kawano et al. (2005a) was more similar to that used to discover eukaryotic
miRNAs (Elbashir et al., 2001; Lagos-Quintana et al., 2001; Lau et al., 2001; Lee & Ambros, 2001).
Here, the extracted small-sized RNA fragments were ligated to specific 5’ and 3’ RNA adapter
molecules, reverse-transcribed, and PCR amplified. Prior to cloning, the amplification products
were concatenated in order to increase the sequence information per individual library clone. This
led to the detection of 5’ UTR-derived and 3’ UTR-derived sRNAs as well as cis-encoded antisense
RNAs encoded opposite to protein coding genes. Beyond E. coli, a bacterial RNomics screen was
conducted in Aquifex aeolicus, a hyperthermophilic bacterium (Willkomm et al., 2005). Shotgun
cloning enabled the detection of about half a dozen sRNAs candidates, some from the intergenic
24 CHAPTER 2. Biological Background
space and some that were antisense RNAs. With the exception of housekeeping sRNAs, these can-
didates were the first to be described in hyperthermophilic eubacteria and included the A. aeolicus
6S RNA homologue.
A major limitation of the RNomics approach is the need to evaluate a large number of sequences
and an overrepresentation of the highly abundant rRNAs and tRNAs in the cDNA libraries. Further-
more, less structured RNAs are more easily transcribed into cDNA and, hence, could be overrep-
resented in the libraries. Expression of most sRNAs is often limited to specific growth conditions.
Thus, it will remain difficult to select all possible growth conditions to recover all sRNAs encoded
in a bacterial genome. The strength of cloning-based approaches is their ability to identify sRNAs
from intergenic regions that are not conserved in species related to E. coli, e. g. Salmonella, since
such candidates would not rank highly in screens having sRNA gene conservation as the main cri-
terion. Furthermore, they allow detection of cis-encoded antisense RNAs which were a prominent
class of small RNA molecules found by Kawano et al. (2005b). The methodology could also be
improved in some aspects, e. g., by affinity-based removal of rRNA from the total RNA pool prior
to cloning. In addition, the combination of RNomics with the recently developed high-throughput
sequencing technologies will facilitate analysis of cDNA libaries in more depth. Furthermore, it
avoids the bacterial cloning step and allows parallel sequencing of libraries from different growth
conditions. The use of deep sequencing technologies to analyse cDNA libraries and recent studies
which employ this approach will be discussed in Chapters 5 and 6.
2.3.6. Homology searches
Since many of the global E. coli sRNA screens took advantage of sequence conservation in related
enterobacteria (Argaman et al., 2001; Wassarman et al., 2001; Rivas et al., 2001), most of the
sRNAs that were identfied in E. coli have also homologues in related species such as Salmonella and
Yersinia (Hershberg et al., 2003; Papenfort et al., 2008). However, comprehensive BLAST analysis
of more than one hundred completed bacterial genomes did not yield significant sequence similarity
for most of these 55 E. coli sRNAs beyond Yersinia pestis (Griffiths-Jones et al., 2005; Hershberg
et al., 2003). Conservation of sRNA flanking genes decreases with phylogenetic distance which, in
turn, suggests that an sRNA gene is more likely to be found in distantly related bacteria when both
flanking genes are also conserved. The observed correlation between sRNA gene conservation and
the evolutionary distance of organisms was subsequently confirmed by an independent study (Zhang
et al., 2004). Interestingly, sRNA and protein-coding genes were found to evolve at the same rate in
bacteria. In contrast, tRNA genes tend to be more conserved than other genomic regions, and loci
of unknown function evolve much faster than the average.
Recent studies indicate that functional sRNAs often lack significant sequence similarity. For ex-
ample, the E. coli CsrB and CsrC RNAs show only little sequence conservation to their functional
homologues in Vibrio (Lenz et al., 2005). Similarly, the functional homologues of the Fur-regulated
sRNA RyhB in E. coli (Masse´ & Gottesman, 2002) and Pseudomonas (Wilderman et al., 2004)
share only little sequence similarity. Moreover, the V. cholerae RyhB is more than twice as long as
the E. coli RyhB and the actual sequence similarity between E. coli and Vibrio is limited to a central
28 bp region (Davis et al., 2005).
2.3. Approaches for the identification of bacterial sRNAs 25
2.3.7. Microarray detection
Microarrays have become the method of choice for monitoring mRNA expression profiles at the
genome level and were also successfully used for studying sRNA expression or even for finding new
sRNA transcripts. However, as most of the commercially available arrays are limited to ORFs and
at best include tRNA and rRNA genes, custom arrays which include probes specific to IGRs often
have to be designed. Selinger et al. (2000) introduced a high-density oligonucleotide probe array for
E. coli that covers also IGRs of > 40 bp in addition to strand-specific probes for all mRNA, tRNA,
and rRNA regions. Although this study primarily focused on the sensitivity and reproducibility of
mRNA level profiling, it provided preliminary data on some intergenic and antisense RNAs that
were secondarily detected.
Similarly, Tjaden et al. (2002) used a whole genome array and identified more than 1,000 additional
transcripts in the intergenic regions of the E. coli genome and further classification revealed ≈ 300
novel transcripts with unknown function. The same study, however, emphasizes the need to validate
initial microarray results by independent experimental techniques such as Northern hybridization
or RNase protection assays. Wassarman et al. (2001) supplemented their biocomputational sRNA
prediction by using the same type of array and specific analysis of the intergenic transcriptional
output.
The combination of microarrays with comparative genomics has led to the identification of diverse
sRNAs in E. coli and Staphylococcus aureus, as well as sRNAs under sporulation control in Bacillus
subtilis (Wassarman et al., 2001; Pichon & Felden, 2005; Silvaggi et al., 2006). Recently, several
novel Caulobacter crescentus sRNAs could be identified by analysis of RNA expression levels
assayed using a tiled Caulobacter microarray and a protocol optimized for detection of sRNAs
(Landt et al., 2008). In the cyanobacterium Prochlorococcus, analysis of RNA from different stress
conditions on Affymetrix microarrays revealed in addition to several new sRNA genes and antisense
transcripts many new short mRNAs that are expressed from intergenic regions (Steglich et al.,
2008). Moreover, the sRNAs were found to be clustered in previously identified genomic islands
which carry genes of significance to the ecology of this organism.
Although microarrays have been successfully used for sRNA identification, they have some dis-
advantages. These include the limited availability of high-density arrays for diverse bacteria or
problems inherent to labelling and cDNA synthesis of small structured RNAs to be used as sam-
ples on microarrays. These RNAs could easily be missed on arrays, especially if the resolution
of probes is not high enough. Recent studies report the use of alternative RNA detection methods
which could circumvent this problem (Hu et al., 2006; Zhang et al., 2003). In one of these ap-
proaches, Zhang et al. (2003) immunoprecipitated the Hfq protein (see below, Section 2.3.8) and
directly detected the sRNAs bound to this protein on microarrays with high-affinity and nucleotide
sequence-independent antibodies specific for RNA:DNA hybrids. The same antibody was used by
Hu et al. (2006) to detect unmodified RNA which was hybridized directly to DNA microarrays.
The antibody-based method turned out to detect low abundance small RNAs from E. coli much
more efficiently than the commonly-used cDNA-based method.
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2.3.8. Co-purification with proteins
Many sRNAs are assumed to form RNP complexes with proteins. These include RNA-binding
proteins which help an sRNA to fold into its active conformation, shield it from nucleases prior to
reaching a target, or promote its annealing with target mRNAs, such as Hfq (see Section 2.2.1).
Other sRNAs interact with proteins to directly regulate their activity (see Section 2.1.3). There-
fore, several sRNAs have been discovered by co-purification with abundant RNA-binding proteins.
These include CsrB RNA of E. coli and RsmZ RNA of Pseudomonas fluorescens which were co-
purified with their target proteins CsrA and RsmA, respectively (Heeb et al., 2002; Liu et al., 1997).
As mentioned before, the genes of the CsrB-like RNA family show poor sequence similarity. Hence,
co-purification with interacting proteins could be an alternative strategy for finding sRNAs whose
primary sequences have diverged to an extent that they are unidentifiable by BLASTN searches.
To date, Hfq is the best characterized sRNA binder and has been suggested to interact with more
than one third of the sRNAs known in E. coli (Valentin-Hansen et al., 2004; Zhang et al., 2003).
Immunoprecipitation of Hfq followed by microarray detection of the RNAs bound to the protein
was recently employed as a new screening approach. In this way, half a dozen new sRNAs were
found in E. coli (Zhang et al., 2003). Similar approaches for finding Hfq-binding sRNAs have
been taken in the bacterial pathogens Listeria monocytogenes (Christiansen et al., 2006) and Pseu-
domonas aeruginosa (Sonnleitner et al., 2008). The latter study constructed cDNA libraries of
RNAs which were co-immunoprecipitated by Hfq and subjected them to shotgun-cloning, whereas
the Hfq-binding RNAs were identified by enzymatic RNA sequencing. Since species-specific Hfq
antibodies may not always be available, affinity tags like FLAG or (His)6 provide epitopes that can
be targeted by specific antibodies.
A genomic SELEX approach which would in principle cover all sRNAs that are encoded by a given
genome was recently reported by the Schroeder lab (Lorenz et al., 2006). Here, a representative
library of the E. coli genome was constructed from random sequences of 50 - 500 bp (Singer et al.,
1997). These fragments were in vitro transcribed with T7 RNA polymerase, incubated with Hfq,
and selected for Hfq binding on filters. This approach has the advantage that it circumvents the
need of an sRNA to be expressed under the examined conditions as it generates RNAs in vitro.
2.4. Target identification and verification of bacterial sRNAs
The previous section introduced diverse approaches for the identification of sRNAs and indicated
the presence of many sRNA genes in bacterial genomes which await functional characterization.
For this purpose, diverse experimental and biocomputational methods have been developed to iden-
tify the cellular targets of sRNAs (for reviews see, e. g., Pichon & Felden, 2008; Vogel & Wagner,
2007). However, identification of sRNA targets is only the first step in functional elucidation of an
sRNA, and in vivo validation of target regulation is a crucial step. This can be achieved by several
approaches.
Generally, sRNA-mediated alteration of mRNA or protein levels can be monitored on Northern or
Western blots, respectively. Sometimes antibodies are not available for a designated target and,
therefore, chromosomal or plasmid borne translational reporter gene fusions, for example to lacZ,
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which encodes β-galactosidase, have been used to examine target regulation. Recently, a reporter-
gene system based on green fluorescent protein (GFP) was developed to study sRNA-target inter-
actions in E. coli and also distant bacteria (Urban & Vogel, 2007). This system is based on two
plasmids in which both the sRNA and target-mRNA fusion are expressed under control of a con-
stitutive promoter and are, thus, uncoupled from any transcriptional control. This system provides
a convenient way to examine post-transcriptional target regulation and gives hints whether targets
are regulated directly. However, the most appreciated proof for a direct sRNA-mRNA interaction
are compensatory base-pair exchanges. Mutations in either the interaction site of the sRNA or the
target site should abolish regulation, whereas compensatory mutations in both sites should restore
regulation (Altuvia et al., 1998; Bouvier et al., 2008; Kawamoto et al., 2006; Majdalani et al., 1998;
Papenfort et al., 2008; Udekwu et al., 2005; Vogel et al., 2004).
Furthermore, in vitro experiments can help to validate interactions between two RNAs and provide
insights into the mechanism of action of sRNA-mediated regulation. These biochemical experi-
ments include determination of binding affinities by gel-shift assays of in vitro transcribed RNAs or
exact mapping of interaction sites by footprinting experiments using enzymatic probing or lead(II)-
induced cleavage (reviewed in Chevalier et al., 2009). Moreover, sRNA-mediated inhibition of
translation initiation can be investigated in ribosome toeprinting assays which monitor formation
of the ternary initiation complex on an in vitro transcribed mRNA fragment (Altuvia et al., 1998;
Chen et al., 2004; Hartz et al., 1988; Huntzinger et al., 2005; Udekwu et al., 2005). Overall, there
are a variety of possible strategies to validate putative mRNA targets. These can, in addition, help
to assess the specificity of the diverse approaches for target identification introduced below.
2.4.1. Experimental approaches
2.4.1.1. Proteomics
Perhaps the most direct way to identify putative targets of bacterial sRNAs is to analyse protein
patterns in an sRNA deletion or overexpression strain on 1D- or 2D-gels. Bands or spots of dif-
ferentially expressed proteins can be excised from the gels and analysed by mass spectrometry.
For example, comparison of an E. coli wild-type strain to an isogenic gcvB mutant strain revealed
changes in the levels of several ABC transporter proteins (Urbanowski et al., 2000). Specifically,
the gcvB mutant shows increased levels of the periplasmic transporter proteins OppA, DppA, GltI
and LivK. Similarly, OmpA turned out to be upregulated in deletion mutant of the sRNA VrrA
in V. cholerae when whole-cell protein profiles were compared by SDS-PAGE (Song et al., 2008).
For some sRNAs, deletion is not enough to reveal changed proteins and, in fact, overexpression
is necessary to induce changes in the protein patterns. In E. coli, this strategy identified for exam-
ple OmpA as a target of MicA RNA upon overexpression of the sRNA from a multicopy plasmid
(Rasmussen et al., 2005; Udekwu et al., 2005). Similarly, overexpression of Spot42 RNA reduced
synthesis of the GalK protein, which is translated from the polycistronic galETKM mRNA (Møller
et al., 2002), or the GlmS protein is upregulated when GlmY RNA is overexpressed (Urban et al.,
2007).
One limitation of the proteomics approach is that based on either reduced or increased protein level
when the sRNA is lacking or is overexpressed it can not be distinguished whether the regulation
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is direct, i. e. interaction between the sRNA and the mRNA encoding the protein, or indirect via
additional regulators. Furthermore, the number of individual protein spots or bands that can be
resolved is relatively low. However, if an sRNA inhibits only translation and does not lead to
mRNA degradation, regulated genes can still be identified by proteomics due to altered protein
levels but not based on analysis of mRNA levels on microarrays.
2.4.1.2. Microarrays
The sRNA-mediated activation or repression of translation is often accompanied by changes in
mRNA levels. This can be explained by changes of mRNA stability due to recruitment of RNases
such as RNase E or RNase III upon duplex formation or simply higher accessibility for RNases on
mRNAs that are less associated with actively translating ribosomes. Therefore, several approaches
have used microarrays to monitor mRNA changes upon sRNA regulation. For example, comparison
of mRNA extracted from strains carrying a control vector and an overexpression vector for DsrA
RNA on filter-based DNA arrays revealed several genes that are up- or downregulated (Lease et al.,
2004). Similar to analysis of global changes in protein patterns, this method is not able to distin-
guish between directly and indirectly regulated targets. For this purpose, ‘pulse’-expression of a
given sRNA from an inducible promoter, such as the tightly controlled arabinose-inducible pBAD
promoter (Guzman et al., 1995), was used recently. This strategy is likely to avoid the pleiotropic
effects that can be expected to result from constitutive sRNA expression. A pulse of induction and
analysis of mRNA changes on microarrays after a short time interval (typically 10 to 15 min) is
likely to reveal mainly direct targets and avoid downstream effects. These include alterations of
additional targets after longer induction times if, e. g., a transcriptional regulator is a direct target
of the sRNA. Several sRNAs from E. coli and Salmonella have now been characterized using this
approach. In one of these initial studies, genes regulated by RyhB RNA in E. coli were identified
by pulse-expression of RyhB from a strong inducible promoter and scoring of changes in global
mRNA levels on whole-genome microarrays. For RyhB, this method predicted 18 additional tar-
get mRNAs encoding for 56 proteins most of them with documented functions in iron metabolism
(Masse´ et al., 2005) making RyhB a paradigm for a conserved principle of sRNA-mediated control
in a given physiological circuit, here iron homeostasis. The same approach was successfully used
to identify RybB RNA as a factor that selectively accelerates the decay of multiple major outer
membrane protein (OMP) mRNAs upon induction of the envelope stress response in Salmonella
(Papenfort et al., 2006). Furthermore, two tandem oriented, nearly identical sRNAs, OmrA and
OmrB, were found to repress an overlapping set of mRNAs that encode outer membrane proteins
(Guillier et al., 2006).
2.4.1.3. Co-immunoprecipitation of direct interaction partners
Many of the bacterial sRNAs require the activity of the RNA chaperone Hfq which facilitates the
often imperfect base-pairing interactions between sRNA and mRNA (see Section 2.2.1). There-
fore, co-immunoprecipiation of RNA bound to Hfq could reveal potential mRNA targets. Co-
immunoprecipitation with Hfq-specific antisera and direct detection of the bound RNAs on genomic
high-density oligonucleotide microarrays were combined in an initial global study in E. coli (Zhang
et al., 2003). Although this method successfully detected diverse sRNAs and mRNAs in E. coli,
similar studies in other bacteria are limited by the requirement of high-density microarrays and spe-
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cialized antibodies. An alternative approach identified individual abundant Hfq-associated RNAs
by cDNA cloning or direct sequencing (Antal et al., 2005; Christiansen et al., 2006); however, these
methods are not appropriate for large-scale analyses. Although the co-immunoprecipitation strategy
recovers putative sRNA-regulated mRNAs, the actual sRNA-mRNA pairs remain unclear.
Two groups have tried to capture direct mRNA interaction partners using the sRNA as a bait. The
first study immobilized complexes of His-tagged Hfq and RydC RNA on a nickel column and incu-
bated them with the pool of extracted cellular mRNA (Antal et al., 2005). RNAs that were retained
on the column, were eluted, converted into cDNA and sequenced. This led to the identification of
the polycistronic yejABEF mRNA which encodes a putative ABC transporter as a target of RydC.
The second study used in vitro transcribed and biotinylated RseX RNA, bound to streptavidin mag-
netic beads, to capture mRNAs from E. coli total RNA extracts (Douchin et al., 2006). Affinity
captured RNAs were converted to cDNA, fluorescently labelled, and hybridized onto E. coli whole-
genome microarrays. This revealed the outer membrane protein encoding mRNAs ompA and ompC
as RseX targets.
Capture of direct interaction partners can also be applied to RNAs which sequester protein activity.
For example, RNA affinity chromatography was used to identify tryptophanase as the direct target
of the plasmid-encoded Rcd RNA (Chant & Summers, 2007; see section 2.1.3). In vitro transcribed
Rcd RNA was cross-linked to sepharose, incubated with E. coli cell lysates, and MALDI spec-
troscopy of retained proteins revealed TnaA as a direct interaction partner of Rcd. A recent study
purified and identified sRNA-binding factors from E. coli via affinity chromatography of aptamer
tagged sRNAs and mass spectrometry (Windbichler et al., 2008). This recovered RNA polymerase
beta-subunit, host factor Hfq and ribosomal protein S1 as sRNA-binding proteins in addition to
several other factors. Also in Salmonella, RNA-based affinity chromatography can be successfully
used to purify sRNAs following their expression as aptamer-tagged variants in vivo and to co-purify
Hfq (Said et al., 2009, submitted). These affinity purification strategies should facilitate the isola-
tion of in vivo assembled sRNA-protein complexes in a wide range of bacteria.
2.4.2. Biocomputational target predictions
The enterobacterial sRNAs exhibit short and/or imperfect complementarity to their target(s). Fig-
ure 2.4 gives two examples for experimentally verfied sRNA-target interactions. Nine residues
of RyhB sRNA interact with a region overlapping the start codon of sodB mRNA (Geissmann &
Touati, 2004), and OxyS sRNA targets fhlA mRNA through the formation of two short kissing
complexes of nine and seven basepairs, respectively (Argaman & Altuvia, 2000). Systematic mu-
tational analysis of SgrS-ptsG RNA duplexes revealed that six residues of this interaction are key
to mediating SgrS repression of ptsG mRNA (Kawamoto et al., 2006). This limited sequence com-
plementarity has rendered the identification of new sRNA targets difficult, and for the majority of
the sRNAs studied to date, a single mRNA remains the only experimentally validated target.
For some sRNAs, targets could be identified by simple BLASTN searches. These include interac-
tions between MicC and ompC mRNA as well as IstR-1 with tisAB mRNAs which form rather long
duplexes (Chen et al., 2004; Vogel et al., 2004). However, to identify short and imperfect interac-
tions more complicated algorithms are required. These could include features such as minimization
of hybridization energies, minimal lengths for seed interactions, conservation of the interaction in
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Figure 2.4: Examples for sRNA-target mRNA interactions. (A) RyhB-sodB mRNA. RyhB interacts with
its target sodB mRNA by base pairing across the start codon and thereby inhibits translation (Geissmann
& Touati, 2004). The interaction between the two RNAs is mediated by Hfq, which induces a structural
rearrangement of the sodB 5’-UTR. (B) OxyS-fhlA mRNA. OxyS represses translation of fhlA mRNA by the
formation of a loop-loop kissing complex (Argaman & Altuvia, 2000). The complex involves two interaction
sites of 7 and 9 bp. One site in OxyS mediates base-pairing with a short sequence overlapping the ribosome
binding site and a second site pairs with residues further downstream within the coding region of fhlA mRNA.
Start codons are indicated in red, the SD sequence of fhlA mRNA in blue, respectively.
related bacteria or location of the target site around the RBS and start codon. While several ap-
proaches have been described for identifying targets of miRNA genes in eukaryotes (Brennecke
et al., 2005; Grimson et al., 2007; Krek et al., 2005; Rajewsky, 2006; Rehmsmeier et al., 2004),
only a few programs have been developed for the prediction of bacterial sRNA regulators. One
approach that was successfully applied to the micA-ompA regulation searches for sRNA comple-
mentarities in sequence windows containing translation initiation sites, allowing noncontiguous
pairing, and the candidate target is compared to reiterated searches in related bacteria (Udekwu
et al., 2005). Another computational tool was developed for the prediction of sRNA targets in
Listeria monocytogenes and a set of validated sRNA-target mRNA pairs was used as training set
(Mandin et al., 2007). Furthermore, the program scores thermodynamic pairing energies between
an sRNA and putative mRNA targets, and genes are selected according to their abilities to pair with
the sRNA around the translational start and stop sites. This algorithm predicted several targets in
L. monocytogenes; however, it is not available as a webserver.
The only web-based prediction tool that is so far available for bacterial target predictions is
TargetRNA (Tjaden, 2008). This program calculates optimal hybridization scores between an
sRNA and all the mRNAs from a given genome, focussing around the translational start sites
(Tjaden et al., 2006). The underlying model for hybridization scoring is based on the RNAhybrid
algorithm which was developed for the prediction of miRNA targets (Rehmsmeier et al., 2004).
Furthermore, TargetRNA allows to investigate orthologous sRNA-mRNA interactions. The per-
formance of TargetRNA has been validated experimentally in E. coli using Northern Blots and
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microarray analysis (Tjaden et al., 2006). Several other programs have been developed to predict
RNA-RNA interactions which could be helpful to identify sRNA targets. These include algorithms
for the prediction of secondary structure of two interacting RNA molecules by free energy min-
imization (Alkan et al., 2006), or the RNAup software which allows to determine binding free
energies of short oligomers to mRNA targest by computing probabilities of a sequence interval
to be unpaired (Mu¨ckstein et al., 2006). RNAcofold computes the hybridization energy and the
base-pairing pattern of a pair of interacting RNA molecules and, in contrast to earlier approaches,
accounts for complex internal structures in both RNAs (Bernhart et al., 2006). Furthermore, it was
suggested that other criteria such as target site accessibility and seed interactions could improve
predictions (Busch et al., 2008; Tafer & Hofacker, 2008). Zhang et al. (2006) described a new algo-
rithm for identifying negatively regulated targets, which incorporates five different features: struc-
ture of the sRNAs, Hfq-binding sites, the 5’ end of mRNAs, loop-centred extension alignments, and
conservation profiles.
Despite this number of different approaches, the likelihood of detecting all the mRNA targets of a
given sRNA by computational methods is still low as several known interactions could not be pre-
dicted by these tools. Furthermore, these computational methods still have only low specificity. In
this regard, a combined approach of experimental identification and biocomputational prediction of
interactions would probably be most effective in finding sRNA targets. Several proteins have been
shown to be closely associated with bacterial sRNA function and structures (reviewed in Pichon &
Felden, 2007). In contrast to the majority of enterobacterial sRNAs which act as antisense regula-
tors, some sRNAs have been found to directly interact with proteins and antagonize their activity
(see Section 2.1.3). Currently, these interactions can be detected only by experimental methods
(Section 2.4.1.3). Therefore, the computational prediction of direct sRNA-protein interactions is
one of the next challenges.
2.5. Multiple targeting by sRNAs in bacteria
Although the number of functionally characterized sRNAs and biochemically verified sRNA-target
interactions is still lagging behind the number of newly identified sRNAs, there is growing evi-
dence that sRNAs regulate rather multiple targets than individual mRNAs and thereby reprogram
gene expression at the post-transcriptional level (reviewed in Papenfort & Vogel, 2009, in press).
For example, OxyS sRNA was early observed to alter the steady-state levels of >40 abundant E. coli
proteins (Altuvia et al., 1997). Similarly, pioneering work on E. coli DsrA revealed that such mul-
tiple target regulation can be direct, i. e. this sRNA directly interacted with more than one mRNA
(Lease et al., 1998; Majdalani et al., 1998). Nevertheless, evidence for direct interactions of sRNAs
with multiple mRNAs has been rare in enterobacteria and has come primarily from investigations of
RNAIII of the Gram-positive pathogen Staphylococcus aureus (Boisset et al., 2007). As previously
mentioned, RNAIII is a bifuncional molecule that encodes δ-hemolysin in its 5’ part while it also
acts as a noncoding regulatory RNA (Section 2.1.6). Many of the mRNAs demonstrated to be direct
targets of S. aureus RNAIII encode bacterial virulence factors and a short (≈ 40-nt) region within
the 514-nt RNAIII facilitates base-pairing to multiple mRNAs (Boisset et al., 2007; Geisinger et al.,
2006; Huntzinger et al., 2005).
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Recently, several new targets with functions in iron metabolism of the Fur-repressed RNA RyhB
were identified on microarrays upon pulse-expression of the sRNA (see Section 2.4.1.2). How many
of these genes are directly regulated by RyhB is yet to be seen. At least for three targets, sodB, uof-
fur, and shiA, base-pairing interactions have been experimentally verified so far (Geissmann &
Touati, 2004; Pre´vost et al., 2007; Vecerek et al., 2007). Some of the targets are repressed by RyhB
(sodB, uof-fur), whereas shiA is activated.
In bacteria, the σE (envelope stress sigma factor) response counteracts the accumulation of unfolded
outer membrane proteins in the periplasm, and two sRNAs, MicA and RybB, were found to halt
OMP synthesis when porin production threatens outer membrane homeostasis within this regulon
(Papenfort et al., 2006). In this circuit, the 80 nt RybB sRNA, which is transcriptionally induced
by σE (Papenfort et al., 2006), is the most globally acting OMP regulator of Salmonella as revealed
upon pulse-expression and analysis of mRNA changes on microarrays (see Section 2.4.1.2 and Pa-
penfort et al., 2006). Repression of several OMPs is mediated by base-pairing with the 5’ UTRs
or coding regions of omp target mRNAs; these RNA interactions are generally short and imperfect,
and involve the conserved 5’ end of RybB sRNA (Bouvier et al., 2008; Mika et al., 2009, sub-
mitted). Pulse-expression combined with microarray analysis revealed that two additional, nearly
identical sRNAs, OmrA and OmrB, repress an overlapping set of mRNAs that encode OMPs, e. g.,
the outer membrane protease, OmpT, and the specific gated channels for iron-siderophore com-
plexes, CirA, FecA, and FepA. (Guillier et al., 2006). Specifically, the first nine nucleotides from
the 5’ end, which are conserved beyond E. coli and Salmonella, were recently shown to harbour crit-
ical residues to directly recognize multiple target mRNAs (Guillier & Gottesman, 2008). All these
recent studies indicate that diverse sRNAs are able to directly regulate multiple target mRNAs.
However, the understanding of the underlying mechanisms is just beginning. One of these multiple
target regulators, GcvB RNA, which is conserved in E. coli and Salmonella, will be investigated in
Chapters 3 and 4 of this thesis.
2.6. Model pathogens used in this study
2.6.1. Salmonella enterica Serovar Typhimurium
Salmonella is a Gram-negative bacterium closely related to E. coli K12. Unlike the latter, which
are non-pathogenic, Salmonella species are ubiquitous human and animal pathogens that cause a
variety of food-borne infections such as gastroenteritis or typhoid fever. To invade and replicate
in eukaryotic cells, Salmonella relies upon a range of laterally acquired virulence regions, the so-
called Salmonella pathogenicity islands (SPIs). Of these, SPI-1 and SPI-2 encode type 3 secretion
systems (T3SS), which translocate effector proteins to facilitate either invasion of non-phagocytic
cells (SPI-1) or survival within macrophages (SPI-2). The secreted effectors are encoded by SPI-1
or SPI-2, by other minor SPIs, or by individual genes scattered throughout the Salmonella chro-
mosome. Sequence analysis of Salmonella typhi and Salmonella typhimurium genomes revealed
the presence of many insertions compared to the E. coli genome. More than 25 % of the total
genetic material has been laterally acquired since Salmonella diverged from E. coli (Porwollik &
McClelland, 2003). The evolutionarily close relationship with E. coli and the pathogen-specific as-
pects make Salmonella an attractive candidate for RNA research. The auxiliary proteins (nucleases,
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RNA chaperones) typically involved in RNA-based circuits are highly conserved between the two
species. Besides conserved sRNAs from E. coli, the Salmonella-specific regions could encode for
new sRNAs or other RNA elements whose function would be missed in E. coli.
2.6.1.1. Hfq phenotype
Perhaps the strongest evidence that sRNAs could have important functions in Salmonella is derived
from work on the RNA chaperone Hfq. The numbers of phenotypes and deregulated genes observed
in an hfq deletion mutant of Salmonella exceed those reported for any other pathogen. Deletion of
hfq has for long been known to impair the expression of σS (Brown & Elliott, 1996), a general stress
sigma factor essential for Salmonella virulence in mice (Fang et al., 1992). More recently, an hfq
mutation was shown to attenuate invasion of Salmonella into epithelial cells, secretion of virulence
factors, infection of mice, and survival inside cultured macrophages (Sittka et al., 2007). Loss of
Hfq function also abolishes Salmonella motility and deregulates more than 70 abundant proteins.
This includes the accumulation of outer membrane proteins, which in turn cause chronic activation
of the σE-mediated envelope stress response (Bang et al., 2005; Bossi et al., 2008; Figueroa-Bossi
et al., 2006; Sittka et al., 2007, 2008). Given that Hfq primarily acts in concert with sRNAs, many
of the above mentioned phenotypes in Salmonella may be attributed to loss of gene regulation by
Hfq-associated sRNAs. Moreover, Hfq was implicated in the control of Salmonella gene expression
changes induced by the low gravity condition experienced during spaceflight (Wilson et al., 2007).
2.6.1.2. Salmonella sRNAs
Many of the Salmonella sRNAs were initially identified in E. coli (see Hershberg et al., 2003; Pa-
penfort et al., 2008). However, the horizontally-aquired, Salmonella specific regions could encode
novel sRNAs or other RNA elements that are absent in E. coli. Recently, two bioinformatics-based
studies predicted several Salmonella-specific sRNAs (Padalon-Brauch et al., 2008; Pfeiffer et al.,
2007). Pfeiffer et al., 2007 searched for “orphan” pairs of σ70-type promoters and Rho-independent
transcription terminators in the intergenic regions (IGRs) of the Salmonella LT2 genome which led
to the prediction of 46 sRNA candidates. These sRNA genes are absent from E. coli K12 but most
of them have homologues in the relatively distant Salmonella species, S. bongori. This screen led
to the discovery of the first sRNA from an enterobacterial pathogenicity island, i. e. the 80 nt InvR
RNA that is expressed from the invasion gene locus SPI-1 (Pfeiffer et al., 2007). The second study
examined the genetic islands of Salmonella for the presence for putative sRNA genes, i. e. those
IGRs that were > 100 bps and showed <80% identity to their most similar sequence in E. coli K12
(Padalon-Brauch et al., 2008). The predictions, which were also based upon seraches for orphan
Rho-independent terminators, resulted in 28 sRNA candidate genes. Northern blot analysis con-
firmed expression of 19 island-encoded sRNAs, now denoted Isr (A, B, etc.), under a large panel
of growth conditions reminiscent of the environments encountered by Salmonella upon host cell
infection (Padalon-Brauch et al., 2008). In addition, several validated sRNAs were shown to be
differentially expressed upon Salmonella infection of macrophages. The function of these sRNAs
is yet to be elucidated. A significant number of them overlap with the 5’ or 3’ ends of ORFs,
and modulate the expression of these flanking ORFs or are in turn affected by those same genes.
Overall, both studies predicted additional Salmonella sRNA candidates that remain to be verified
experimentally.
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2.6.2. Helicobacter pylori
The human pathogen Helicobacter pylori is the major cause of chronic superficial gastritis as well
as peptic ulcer disease and furthermore leads to the development of adenocarcinoma and mucosa-
associated lymphoid tissue (MALT) lymphoma of the stomach (reviewed in Blaser, 1998). More-
over, approximately 50 % of the world’s population are infected with this microaerophilic and
spiral-shaped, Gram-negative bacterium of the ǫ-proteobacter group. The Helicobacter species
colonize the stomach of their hosts and are highly adapted to this acidic environment. Sequenc-
ing and annotation of the small and compact 1.67 Mb genomes of three H. pylori strains, namely,
26696, J99 and HPAG1, showed that Helicobacter features a very restricted repertoire of tran-
scriptional regulators such as sigma factors, two-component systems and other response regulators
(Alm et al., 1999; Oh et al., 2006; Tomb et al., 1997). Specifically, Helicobacter contains only
three sigma factors, RpoD (σ80), FliA (σ28), and RpoN (σ54), only three two-component systems
involved in transcriptional regulation, and two additional orphan response regulators. The ArsRS
two-component system has been shown to be involved in gene-expression control during the acid-
response (Pflock et al., 2006). However, in order to cope with the various stresses it encounters
during infection, e. g., pH and nutrient fluctuations, H. pylori must have mechanisms to regulate the
transcription of its genes.
2.6.2.1. Small regulatory RNAs in H. pylori
Several systematic screens have led to the identification of sRNAs in diverse bacteria (see Sec-
tion 2.3). However, no regulatory sRNAs have so far been described in Helicobacter and none of
the known enterobacterial sRNAs, except for the highly conserved housekeeping RNAs, tmRNA,
RNase P RNA, SRP RNA, are conserved in Helicobacter on the primary sequence level (see for
example Rfam1 database). Moreover, biocomputational screens failed so far to find a 6S RNA
(Section 2.1.3.1) homologue in the ǫ-subdivision of proteobacteria, a highly abundant RNA which
could be identified in almost all groups of proteobacteria (Barrick et al., 2005; Willkomm et al.,
2005). In Helicobacter, neither an Hfq nor an RNase E homologue have been described so far (Sun
et al., 2002; Tomb et al., 1997). Thus, Helicobacter was often regarded as an example of a bac-
terium without any riboregulation. However, regulatory RNAs in Helicobacter might have other
characteristics and functions than typical enterobacterial sRNAs and, thus, could involve different
RNA-binding proteins from Hfq. Furthermore, sRNAs have been recently identified in Streptococ-
cus, a bacterium which also lacks Hfq (Halfmann et al., 2007). Similarly, although Hfq is absent
from 10 of the 12 sequenced strains of the cyanobacterium Prochlorococcus, several sRNAs have
been identified by comparative genome analysis in Prochlorococcus strain MED4 which also lacks
Hfq (Axmann et al., 2005). A recent study based on microarray expression profiling reported the
presence of many additional sRNA genes as well as several antisense RNAs in the same strain
(Steglich et al., 2008). As a first hint that riboregulation is also present in H. pylori, Livny et al.
(2006) predicted ≈ 50 sRNA candidates but without any experimental validation.
1 www.sanger.ac.uk/Software/Rfam/
CHAPTER 3
MULTIPLE TARGETING OF ABC
TRANSPORTER MRNAS BY GCVB SRNA
The interactions of numerous regulatory small RNAs (sRNAs) with single target mRNAs have been
characterized extensively. In contrast, how sRNAs can regulate multiple, structurally unrelated
mRNAs is less understood. The majority of the ≈ 20 enterobacterial sRNAs of known function are
antisense RNAs that repress trans-encoded target mRNAs. Many sRNAs mask the ribosome bind-
ing sites (RBS) of their target, thus inhibiting ribosome entry on mRNA (see Section 2.1.1). Since
the half-life of bacterial mRNAs is strongly affected by the association with ribosomes (Deana &
Belasco, 2005), translation inhibition is often coupled to the decay of the repressed target, e. g.,
by accelerating RNase E-mediated mRNA turnover (Section 2.2.2). Besides RNase E, the bacte-
rial Sm-like protein Hfq has been identified as a key player in this type of translational silencing
(Section 2.2.1).
Enterobacterial sRNAs have been shown to bind via short and/or imperfect base-pairing to their
target mRNAs. For example, nine residues of RyhB sRNA interact with sodB mRNA and OxyS
sRNA targets fhlA mRNA through the formation of two short kissing complexes of 9 and 7 bp, re-
spectively (Section 2.1.1). Due to this limited sequence complementarity, the identification of new
sRNA targets is difficult, and for many of the sRNAs studied to date, a single mRNA remains the
only experimentally validated target. However, it was early recognized that some E. coli sRNAs,
e. g., DsrA and OxyS RNA, could regulate multiple genes and, in addition, recent biocomputational
and experimental approaches predicted more sRNAs to target multiple mRNAs (see Section 2.5).
For example, pulse expression of several E. coli and Salmonella sRNAs followed by global tran-
scriptome profiling showed the rapid depletion of many mRNAs (Section 2.4.1.2). The kinetics
of target decay observed in these experiments strongly argues that the regulated mRNAs are direct
sRNA targets.
Multiple mRNA targeting by sRNAs could help bacteria to balance different transcriptional re-
sponses at the post-transcriptional level in response to stress or changes in nutrient availability.
This additional layer of gene expression control could mediate the co-regulation of mRNAs that
belong to different transcriptional regulons. However, only a few direct interactions of sRNAs
with multiple mRNAs have been biochemically characterized in enterobacteria (Guillier & Gottes-
man, 2008; Lease et al., 1998). Insights into the mechanistic aspects of multiple-target regulation
have primarily come from investigations of RNAIII of the Gram-positive pathogen Staphylococcus
aureus (Boisset et al., 2007).
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Figure 3.1: Genomic location and expression of Salmonella GcvB RNA. (A) The Salmonella gcvB gene
is encoded in the gcvA-ygdI intergenic region in opposite orientation to these latter two genes. (B) Northern
blot (autoradiogram) showing gcvB expression in nutrient-rich (L-broth) or nutrient-limiting (M9) media.
Total RNA was prepared from Salmonella wild-type (strain JVS-0007) grown to exponential phase (OD600
of 0.4, lanes 1 and 5), early stationary phase (OD600 1, lanes 2 and 6; OD600 2, lanes 3 and 7), and late
stationary phase cells (lanes 4 and 8). GcvB was detected with γ32P-labelled oligonucleotide JVO-0749
complementary to the GcvB 5’ region. Marker sizes are shown to the left. 5S rRNA probing (panel below)
confirmed equal RNA loading.
In this Chapter, GcvB sRNA of Salmonella enterica serovar Typhimurium has been studied and
turned out to directly act upon multiple mRNAs which commonly encode periplasmic substrate
binding proteins of ABC uptake systems for amino acids and peptides. The gcvB gene was orig-
inally identified in E. coli and is controlled by GcvA/GcvR, the major transcription factors of the
glycine cleavage system (Urbanowski et al., 2000). A gcvB deletion caused constitutive synthe-
sis of OppA and DppA, periplasmic binding proteins of the two major peptide transport systems
(Abouhamad et al., 1991; Higgins & Hardie, 1983), which are normally repressed in nutrient-rich
growth conditions. Gene fusion experiments indicated that GcvB repressed dppA and oppA at the
post-transcriptional level, yet the molecular mechanism remained elusive (Urbanowski et al., 2000).
Furthermore, the pleiotropic nature of E. coli and Yersinia gcvB mutants (McArthur et al., 2006; Ur-
banowski et al., 2000) and biocomputational predictions (Tjaden et al., 2006) suggested that GcvB
may have additional mRNA targets.
This section provides biochemical and genetic evidence that a conserved G/U-rich region within
GcvB mediates translational repression of seven ABC transporter mRNAs. This G/U-rich element,
which was revealed by alignment of GcvB homologues of distantly related bacteria, is strictly re-
quired for GcvB target recognition. Analysis of target gene fusion regulation in vivo, as well as
in vitro structure probing and translation assays showed that GcvB represses its target mRNAs by
binding to extended C/A-rich regions which may also serve as translational enhancer elements. In
some cases (oppA, dppA), GcvB repression can be explained by masking the ribosome binding
site (RBS) to prevent 30S subunit binding. However, GcvB can also effectively repress translation
by binding to target mRNAs at upstream sites, outside the RBS. Specifically, GcvB represses gltI
mRNA translation at a C/A-rich target site located at positions -57 to -45 relative of the start codon.
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This latter mode of action may also apply to other regulatory sRNAs. Taken together, this sug-
gests highly conserved regions in sRNAs, and mRNA regions distant from Shine-Dalgarno (SD)
sequences as important elements for the identification of sRNA targets. Most of the work described
in this section has been published in Sharma et al., 2007.
3.1. Results
3.1.1. Characterization of GcvB sRNA in Salmonella
The Salmonella and E. coli gcvB genes are ≈ 95% identical in the GcvB RNA region (Argaman
et al., 2001; Urbanowski et al., 2000) and both are encoded in the intergenic region between gcvA,
a transcriptional activator of the glycine cleavage system, and ygdI, a protein of unknown function
(Figure 3.1A). Expression of the ≈ 200 nt Salmonella GcvB RNA was confirmed on Northern blots
of RNA extracted from different growth phases and media. GcvB is expressed in exponentially
growing Salmonella in rich medium (L-broth), but is not detectable in stationary phase or upon
growth in minimal medium (Figure 3.1B). This pattern is reminiscent of E. coli GcvB (Argaman
et al., 2001), and in keeping with the postulated GcvB repressor function of peptide transporters
under nutrient-rich conditions (Urbanowski et al., 2000). GcvB RNA folds into a rather unusual
secondary structure (Fig. 3.2A and B). In vitro structure probing revealed the presence of several
stem-loop structures which are separated by two single-stranded linker regions, R1 and R2 (see Fig-
ure 3.2). Especially the linker region R1 is interesting because it consists almost exclusively of G/U
residues. As single stranded regions have been shown to be involved in sRNA/target interactions,
these linker regions could be involved in target recognition by GcvB RNA.
Figure 3.2 (facing page): Structure mapping of 5’end labelled GcvB RNA and proposed secondary
structure. (A) 5’end-labelled GcvB RNA (≈ 5 nM) was subjected to RNase T1, lead(II), and RNase T2
cleavage in absence (lanes 1, 3, 5) and presence of different concentrations of cold dppA leader (lanes 2,
4, 6: ≈ 250 nM final concentration). Lane C: untreated GcvB RNA. Lane T1: RNase T1 ladder of GcvB
under denaturing conditions. The position of cleaved G residues is given at the left of the gel. Lane OH:
Alkaline ladder. The approximate positions of stem-loop structures SL1 and SL2 according to the GcvB
RNA structure shown in (B) are indicated by vertical bars to the right of the gel. The region protected in
GcvB RNA by dppA leader is marked by a magenta bar. (B) Proposed secondary structure of GcvB based
on in vitro structure mapping. Cleavages according to (A) by RNAse T1, T2, or lead(II) are indicated by
black, red, and blue arrows, respectively. Due to low resolution in the gel part that corresponds to the 3’
part of GcvB RNA, no detailed cleavages are indicated in this region. (C) Alignment of a representative
subset of GcvB RNAs identified by computer-based searches (see Figure 10.1 in the Appendix). Numbering
of residues and the positions of stem-loop structures (SL1 to SL5; indicated by arrowheads) follows the
Salmonella GcvB RNA sequence in (B). The conserved regions, R1 and R2, common to all known GcvB
sequences are indicated. (ST) Salmonella typhimurium; (CR) Citrobacter rodentium; (EC) Escherichia coli
K12; (SF) Shigella flexneri; (KP) Klebsiella pneumoniae; (KO) Klebsiella oxytoca; (YP) Yersinia pestis;
(SM) Serratia marcescens; (PL) Photorhabdus luminescens; (EW) Erwinia carotovora; (PM) Pasteurella
multocida; (AS) Actinobacillus succinogenes; (MS) Mannheimia succiniciproducens; (HD) Haemophilus
ducreyi; (VC) Vibrio cholerae; (VV) Vibrio vulnificus.
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Figure 3.3: GcvB stability in Salmonella wild-type and ∆hfq and growth curves. (A) Cultures of
Salmonella wt and a hfq deletion strain were grown to an OD600 of 0.4, and RNA stabilities were deter-
mined by rifampicin treatment (final concentration of 500 µg/ml). 5 ml cells were withdrawn prior to or
1, 2, 4, 8, and 16 min after rifampicin addition, mixed with 0.2 vol of stop solution (5% water-saturated
phenol, 95% ethanol), and snap-frozen in liquid nitrogen. Upon thawing, RNA was isolated and analysed
by Northern hybridization. Quantification of the blots revealed a 3.4-fold reduction in GcvB RNA levels in
the hfq deletion strain. The GcvB half-life (≈ 3 min in wild type) is decreased to ≈ 30 sec in the hfq dele-
tion strain. (B) Both GcvB and Hfq act to repress OppA protein synthesis. Protein samples of Salmonella
wild-type, hfq or gcvB single deletion, and the hfq gcvB double deletion strain (JVS-0007, -0255, -0236, and
-0617, respectively) grown to exponential phase (OD600 of 0.4) were subjected to Western blot analysis with
OppA (upper panel) or GroEL antisera (lower panel; loading control). Quantification of the OppA signals,
followed by normalization to GroEL levels, revealed a 6.1-fold, 5.4-fold or 8.3-fold increase upon gcvB, hfq,
or gcvB hfq double deletion, respectively. (C) OD600 values of triplicate cultures of Salmonella wild-type
(JVS-0007) or gcvB deletion strain (JVS-0236) grown in LB medium were determined in 45 min intervals.
The curves show the OD600 average values and standard deviations that were calculated from the triplicates
(open squares: wild-type; filled triangles: ∆gcvB). No growth defect was observed for the Salmonella ∆gcvB
strain compared to the wild-type strain.
Several observations suggested that GcvB is an Hfq-dependent sRNA. GcvB co-
immunoprecipitates with Hfq in extracts of E. coli (Zhang et al., 2003) and Salmonella (Sittka
et al., 2008), and is unstable in ∆hfq strains of E. coli (Urban & Vogel, 2007) and Salmonella
(Figure 3.3A). Since repression of the predicted GcvB target, oppA, is abrogated in hfq mutants of
both E. coli and Salmonella (Sittka et al., 2007; Ziolkowska et al., 2006), OppA protein levels were
compared in Salmonella strains deleted for gcvB, hfq or both (Fig. 3.3B).
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Figure 3.4: Regulation of Salmonella oppA::gfp and dppA::gfp fusions by GcvB wild-type and mutant
RNAs. (A) GcvB and translational fusions of oppA or dppA to gfp are constitutively expressed from com-
patible plasmids in an E. coli ∆gcvB recA− strain (Urban & Vogel, 2007). The fusions include the entire 5’
UTR (determined by 5’RACE; dppA, 163 bp; oppA, 162 bp) and result in in-frame fusions of the 10th (dppA)
or 17th (oppA) codon to the amino terminus of GFP. (B) Agar plate-based assay of colony fluorescence of
E. coli strains carrying control plasmid pXG-1 (left; expresses full-length gfp), the dppA::gfp (middle; plas-
mid pJL18-1) or the oppA::gfp (right; pJL19-1) fusion plasmid, each in combination with control vector
pTP11, or plasmids expressing Salmonella wild-type GcvB RNA (pPLgcvB) or four of the mutant alleles
(plasmids pPLgcvB∆R1, pPLgcvB∆R2, pPLgcvB5’∆, pgcvB3’∆T) shown in Figure 3.8A. All strains displayed
normal colony morphology (not shown). Reduced colony fluorescence of the dppA::gfp or oppA::gfp fusions
strains upon sRNA co-expression indicates regulation at the post-transcriptional level. (Left) GcvB has no
effect on the expression of gfp alone, confirming that repression is specific to the cloned dppA and oppA
regions (middle and right).
Deletion of gcvB did not impair Salmonella growth in rich broth (Fig. 3.3C), similar to what was
reported for E. coli (Urbanowski et al., 2000). The single gcvB or hfq mutations each elevated OppA
levels, whereas the double mutation had no pronounced cumulative effect (Fig. 3.3B). This predicts
GcvB and Hfq to act in concert, and GcvB to be an Hfq-dependent antisense RNA that regulates
trans-encoded mRNA(s).
3.1.2. GcvB targets dppA and oppA mRNAs in vivo and in vitro
To study dppA and oppA mRNA repression by GcvB, translational fusions to the amino terminus of
green fluorescent protein (GFP) were constructed (Urban & Vogel, 2007). The Salmonella dppA or
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Figure 3.5: Gel-mobility shift assays of GcvB WT RNA and dppA and oppA leader. (A) In-vitro binding
of GcvB RNA and dppA/oppA leader was performed as described in Section 8.3.7 in Material and Methods.
Approximately 5 nM of γ32P-labelled GcvB RNA was incubated with increasing concentrations of unla-
belled dppA or oppA leader (final concentrations in nM above the lanes). Following 15 min incubation at
37°C, samples were run on a native 6% PAA gel. Shown is an autoradiograph of the gel. (B) Same experi-
mental procedure as above but with 5’-labelled dppA/oppA leader and increasing concentrations of unlabelled
GcvB RNA.
oppA 5’ regions spanning the entire 5’ UTR and 30 bp (dppA) or 50 bp (oppA) of the coding region
were cloned into the low-copy gfp fusion vector, pXG10 (Figure 3.4A). The cloning strategy used
here ensures that the fusions are transcribed from the native +1 site of dppA or oppA without adding
additional sequences at the 5’ end. Transcription is driven by a constitutive PLtetO-1 promoter (Lutz
& Bujard, 1997) to specifically assay post-transcriptional regulation. The Salmonella gcvB gene
was placed under control of a constitutive PLlacO-1 promoter on a compatible mid-copy plasmid
(Lutz & Bujard, 1997) resulting in plasmid pPL gcvB (Figure 3.4A).
The fusion plasmids as well as control plasmid pXG-1 expressing full-length GFP were each com-
bined with either pPL gcvB or control vector pTP11 in an E. coli ∆gcvB strain. The specific repres-
sion of dppA::gfp and oppA::gfp by pPL gcvB was evident from strongly reduced colony fluores-
cence of these strains on agar plates (Figure 3.4 B) which established that GcvB regulates dppA and
oppA in the 5’ mRNA region. To map the GcvB interaction sites, RNAs of the previously cloned
dppA and oppA fragments were synthesized in vitro and structural probing experiments were per-
formed. Gel mobility shift assays showed that GcvB formed singular complexes with either of the
two RNAs under standard in vitro conditions (Fig. 3.5). RNA structure probing of these complexes
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Figure 3.6: Identification of GcvB binding sites on oppA and dppA mRNAs by in vitro probing. (A)
5’end-labelled GcvB RNA (≈ 5 nM) was subjected to RNase T1, lead(II), and RNase III cleavage in the
absence (lanes 1, 6, 11) and presence of different concentrations of cold dppA or oppA RNAs (final concen-
tration in lanes 2, 4, 7, 9, 12, 14: ≈ 50 nM; lanes 3, 5, 8, 10, 13, 15: ≈ 500 nM). The synthesized target RNA
fragments comprise regions -163/+72 (dppA) and -162/+57 (oppA) relative to the AUG start codon. (Lane
C) Untreated GcvB RNA. (Lane T1) RNase T1 ladder of hydrolysed denatured GcvB RNA. The position
of cleaved G residues is given left of the gel. (Lane OH) Alkaline ladder. Vertical bars indicate the GcvB
region protected by dppA RNA (red) and oppA RNA (blue). Arrows denote specific RNase III cleavage of
GcvB in the presence of dppA and oppA RNAs. The approximate positions of stem-loop structures SL1 and
SL2 according to the GcvB RNA structure shown in Figure 3.2 B are indicated to the right of the gel. (B)
5’ end-labelled dppA RNA treated with lead(II) (B) or RNase III (C) in the absence (lane -) or presence of
GcvB wild-type or GcvB∆R1 mutant RNA (lacks residues 66-89) as indicated above the gels. GcvB but not
∆R1 mutant RNA protects a ≈ 20 nt region (vertical red bar in B) in dppA from lead(II) cleavage, and only
GcvB WT induces strong RNase III cleavage of the dppA RNA (red arrow in C). Residue G “+3” set in bold
is the G in the dppA AUG start codon. (D) Predicted RNA duplexes formed by GcvB with the dppA or oppA
mRNAs. Vertical arrows denote RNase III cleavage sites. SD and AUG start codon sequences are boxed. The
coloured residues were protected from lead(II) cleavage upon duplex formation (see A-C and Figure 3.7).
with RNase T1 and lead(II) acetate showed that increasing concentrations of dppA or oppA RNAs
resulted in “footprints” on 5’ end-labelled GcvB RNA (Fig. 3.6A), which were most pronounced
with lead(II) probing (lanes 6-10). The dppA and oppA RNAs each protect ≥19 residues within
the single-stranded, highly G/U-rich region between stem-loops SL1 and SL2 of GcvB (compare
Figs. 3.6A and 3.2A & B).
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Figure 3.7: In-vitro footprinting and RNase III cleavage of oppA-leader/GcvB RNA complexes. 5’ end-
labelled oppA leader RNA was treated with lead(II) (A) or RNase III (B) in the absence (lanes 1 and 6) or
presence of different concentrations of cold GcvB wild-type (lanes 2, 3, 7, and 8) or its ∆R1 mutant RNA
(residues 66 - 89 deleted, lanes 4, 5, 9, and 10) as indicated above the gels. Furthermore, lead(II) cleavage
was carried out in the absence (lanes 1 - 5) and presence (lanes 6 -10) of Hfq (50 nM final). GcvB WT but
not ∆R1 protects a ≈ 20 nt region (vertical red bar) in oppA from lead(II) cleavage, and only GcvB WT
induces strong RNase III cleavage of the oppA RNA (blue arrow). Hfq clearly improves binding of GcvB
RNA to oppA leader, since the footprint for the lower GcvB concentration is only visible in the presence of
Hfq (compare lanes 2 and 7). Positions of cleaved G residues in the oppA sequence are given as distance to
the oppA start codon, e. g., position “+ 3” which is indicated in bold corresponds to the G residue of the oppA
start codon AUG.
The reciprocal experiment, i. e. probing of labelled dppA or oppA RNAs in complex with GcvB,
identified the GcvB binding site on the mRNAs. Wild-type GcvB RNA yields a strong footprint
on the dppA (Fig. 3.6B) and oppA (Fig. 3.7) RNAs, which correspond to regions -31 to -14, and
-8 to +16, respectively, relative to the AUG start codon (Fig. 3.6D). In contrast, no footprints were
obtained with a mutant RNA, GcvB∆R1, which lacks the G/U-rich region (Figs. 3.6B and 3.7).
The duplexes shown in Figure 3.6D were further supported by cleavage of the GcvB/dppA and
GcvB/oppA complexes with the double strand-specific nuclease RNase III. While several weak
RNase III-dependent bands were observed in GcvB RNA alone (Fig. 3.6A, lane 11), the enzyme
cleaved GcvB strongly and specifically in the G/U-rich region in the presence of either dppA or
oppA RNA (lanes 12-15). Reciprocally, the dppA and oppA RNAs were specifically cleaved in the
proposed GcvB binding site (Figs. 3.6C and 3.7B). Collectively, these results indicated the single-
stranded, G/U-rich region of GcvB as an important determinant for target recognition.
3.1.3. A conserved G/U-rich region mediates GcvB repression in vivo
The importance of the G/U-rich element was also evident from its strong conservation in GcvB
sequences of distantly related species. Computer-based searches predicted gcvB genes in many
enterobacteria as well as in Pasteurellaceae and Vibrionaceae (Fig. 10.1 in the Appendix). The
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Figure 3.8: Mutant alleles of gcvB and their expression. (A) Horizontal bars below a schematic drawing
of GcvB RNA denote the gcvB fragments expressed from mutant alleles; dotted lines denote internal dele-
tions. Alleles gcvB∆R1 and gcvB∆R2 lack residues 66-89 (deletion of the G/U-rich R1 sequence) or 136-144
(deletion of R2), respectively. The truncated gcvB5’∆ and gcvB3’∆ alleles lack residues 1-91 (SL1 and R1)
or 135-201 (R2 to SL5), respectively. In allele gcvB3’∆T, which derives from gcvB3’∆, SL3 was modified
towards a transcription terminator as shown below. (B) Northern blots showing expression of gcvB or mu-
tant alleles when borne on a mid-copy plasmid under control of the gcvB promoter in Salmonella (lanes
4-9). RNA was isolated from Salmonella grown to an OD600 of 1, and except lane 1 (wild type; JVS-0007)
from a ∆gcvB genetic background (JVS-0236). The strains in lanes 3 to 9 carried control vector, pTP11,
or plasmids pgcvB, pgcvB5’∆, pgcvB∆R1, pgcvB∆R2, pgcvB3’∆, pgcvB3’∆T, respectively. Marker sizes are
shown to the right. The upper blot was probed with labelled oligo JVO-0749, which is complementary to the
GcvB 5’ region (20-4 bp); the lower blot with JVO-0750 complementary to bp 172-150. The asterisk denotes
transcriptional read-through to the rrnB terminator located downstream on the plasmids.
location of these candidate genes adjacent to and divergent from gcvA, and the conservation of pro-
moter and terminator elements argue that these are gcvB homologues. Although the corresponding
RNA sequences proved of enormous sequence diversity, it was obvious that much of the G/U-rich
linker between stem-loops SL1 and SL2 is highly conserved in all identified gcvB sequences (Fig-
ure 3.2C). This linker region will be referred to as R1 (Conserved Region 1). The single-stranded
region between SL3 and SL4 contains another highly conserved sequence (ACUUCCUGUA) found
immediately upstream of SL4; this sequence will be referred to as R2.
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Figure 3.9: 2D analysis of periplasmic proteins. Salmonella ∆gcvB carrying control plasmid pTP11 (left)
or gcvB mid-copy plasmid pTP05 (right), were grown to early stationary phase, and periplasmic protein
fractions of these bacteria were resolved on 2D gels. Relevant subsections of the gels are shown. Protein
spots indicating repression by GcvB are labelled.
To assess the role of these two regions in target regulation, mutant alleles gcvB∆R1, gcvB∆R2, and
gcvB5’∆, the latter being a 5’ truncated gcvB lacking SL1 and R1, were constructed (Figure 3.8A).
Plasmids carrying these alleles expressed distinct GcvB-derived RNAs at levels similar to wild-
type gcvB (Fig. 3.8B). Next, these alleles were cloned under control of the PLtetO-1 promoter to test
their ability to regulate the dppA::gfp and oppA::gfp fusions. Figure 3.4B shows that loss of R1
(gcvB∆R1 and gcvB5’∆) abrogated dppA and oppA fusion repression, whereas loss of R2 (gcvB∆R2)
had no effect.
Is the 5’ part of GcvB (including R1) sufficient to confer target repression in vivo ? Urbanowski
et al. (2000) postulated that SL3 of GcvB, which is followed by a U-stretch in many GcvB species
(Fig. 3.2C), may serve as a ρ-independent transcription terminator, leading to the expression of
a shorter GcvB RNA. However, truncation of gcvB after residue T134 (allele gcvB3’∆, Fig. 3.8A,
expected to yield a ≈134 nt GcvB RNA) did not result in such an RNA (Fig. 3.8B), whereas modi-
fication of SL3 created a functional terminator (Fig. 3.8A; allele gcvB3’∆T) and led to detection of
a ≈130 nt RNA (Fig. 3.8B). Figure 3.4B shows that the 3’ truncated GcvB RNA of gcvB3’∆T was
fully active in dppA and oppA fusion repression. Taken together, these in vivo experiments further
support a key role of the G/U-rich element, R1, of GcvB for dppA and oppA mRNA regulation.
3.1.4. More GcvB targets
The observation that additional periplasmic proteins accumulated in gcvB or hfq mutant strains
(Sittka et al., 2007; Urbanowski et al., 2000) prompted to screen for more GcvB targets. Analysis
of periplasmic proteins from a Salmonella gcvB overexpression strain predicted gltI, livJ, argT,
and STM4351 as further candidate targets (Fig. 3.9). In an independent approach, the RNAhybrid
algorithm (Rehmsmeier et al., 2004) was used to search for stable RNA duplexes of the R1 sequence
of GcvB with the 5’ regions of all Salmonella genes. This biocomputational search supported gltI,
livJ, argT, and STM4351, and further predicted livK as a GcvB target (Fig. 3.10A). Intriguingly,
the predicted GcvB binding sites on these mRNAs do not match in sequence but are rich in C and
A residues, which also holds true for dppA and oppA (Fig. 3.6D).
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Figure 3.10: Summary of in vitro probing results of GcvB-target complexes. (A) Proposed RNA duplexes
formed by GcvB with five periplasmic transporter mRNAs (gltI, livK, livJ, argT, and STM4315). Positions
in the target sequences are given as distance to the start codon. Vertical arrows denote in vitro RNase III
cleavage of the GcvB-gltI complex, and of GcvB in complex with the four other targets (Figs. 3.11A and
3.12B). Residues that showed protection in in vitro footprinting experiments (Figs. 3.11 and 3.12A) are set
in bold and capitalized. Biocomputational prediction of target sites proposed the formation of extended
duplexes around the interaction sites mapped by footprint analysis. Dark circles indicate G:U wobble base-
pairs; open circles indicate more than three consecutive G:U pairs. (B) Location of GcvB binding sites on
target mRNAs. 5’ UTRs of target genes are drawn to scale. Asterisks indicate promoter positions that were
mapped by 5’RACE; ‘#’ indicates promoters according to EcoCyc (www.ecocyc.org) annotations. SD
sequences are shadowed. The GcvB binding sites on the mRNAs are indicated by horizontal bars.
The predicted binding sites were subsequently confirmed by in vitro probing experiments as above
(shown in Figure 3.11; summarized in Figure 3.10). Although the footprint obtained for gltI mRNA
is relatively weak, the predicted interaction is strongly supported by specific RNase III cleavage
in the presence of GcvB (Fig. 3.11A). Conversely, R1 is the GcvB region that is most strongly
protected upon incubation with the target RNA fragments (Fig. 3.12). When in complex with target
RNAs, GcvB was cleaved by RNase III exclusively in the R1 sequence, except with a livK-derived
fragment which also promotes cleavage in the GcvB 3’ part (Fig. 3.12).
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Figure 3.11: Footprinting of several periplasmic transport proteins mRNA leaders in complex with
GcvB RNA. 5’ end labelled target mRNA leader, (A, left panel) gltI, (B) livJ, (C) livK, (D) argT, and (E)
STM4351, were subjected to RNase T1 and lead(II) cleavage, in the absence or presence (indicated by +) of
cold GcvB RNA. Protected regions by GcvB RNA are indicated by pink bars and are located upstream of
the start codon for all targets. Start codons are indicated by black arrows. Lane C: Untreated leader RNA.
Lane T1: RNase T1 ladder of leader RNA under denaturing conditions. Positions of cleaved G residues in
the target sequences are given as distance to the mRNA start codon. Position “+ 3” which is indicated in bold
corresponds to the G residue of the start codon AUG. Lane OH: Alkaline ladder. GcvB binding site on the
gltI leader RNA (A left) is supported by strong RNase III cleavages in this region in the presence of GcvB
WT or 3’∆ mutant RNA (A, middle panel). In contrast, no cleavage is observed in the presence of mutant
GcvB∆R1 RNA, which lacks the G/U-rich region R1. The predicted secondary structure of the 5’ gltI mRNA
(A, right panel) was computed using the mfold algorithm (Zuker, 2003).
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Figure 3.12: GcvB RNA binds to additional periplasmic transporter mRNAs via the GU-rich region
R1. (A) 5’ end-labelled GcvB RNA was subjected to lead (II) cleavage for 2 min at 37°C in the presence
of different concentrations of periplasmic target mRNA leaders. Target mRNAs were added to the following
final concentrations: GltI: 2µM, STM4351: 500 nM, LivK: 500 nM, LivJ: 500 nM, and ArgT: 1µM. These
concentrations are based on preliminary gel shift assays with labelled GcvB RNA in combination with each
target mRNA. For all targets a footprint in GcvB (indicated by a pink bar) is observed that is located in the
GU-rich region R1 (position 66 - 89). Upon addition of LivK and ArgT leader also structural changes in
the 3’ end of GcvB (blue bars) could be observed. (B) RNase III cleavage after 7 min incubation at 37°C
of labelled GcvB RNA in combination with different target mRNA leaders. For target mRNAs that are also
present in (A) the same final concentrations were used; for DppA and OppA leader RNA 500 nM, and for
GFP control RNA 1µM were added. Addition of target RNA but not control GFP RNA leads to specific
cleavage of GcvB RNA in the GU-rich region R1 and supports this region to be the target interaction site.
Only addition of LivK leads to an additional cleavage site in the 3’ part of GcvB RNA.
To examine regulation of the new targets in vivo, translational gfp fusions to all of these genes were
constructed. The gltI and livJ fusions showed fluorescence on agar plates (Fig. 3.13A). Both fusions
were strongly repressed by gcvB alleles with an intact R1 sequence (gcvB, gcvB∆R2 and gcvB3’∆T),
whereas the gcvB5’∆ and gcvB∆R1 alleles lacking R1 failed to repress the fusions (Fig. 3.13A).
Western blot analysis of all five target fusions as well as the dppA::gfp and oppA::gfp fusions
further confirmed that regulation required an intact R1 sequence (Fig. 3.13B).
In addition, regulation of these targets by chromosomal GcvB was examined by quantitative real-
time PCR analysis of target mRNA levels. A Salmonella gcvB deletion strain showed ≈ 8-fold
higher oppA mRNA levels and ≈ 12-fold higher dppA mRNA levels, respectively. Also for the new
targets, gltI, livJ, and STM4351, up to ≈ 6-fold higher mRNA levels were observed, indicating that
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Figure 3.13: GcvB targets additional periplasmic transporter mRNAs. (A) Agar plate-based assay of
colony fluorescence of E. coli strains carrying either gltI::gfp (left; plasmid pJL24-1) or livJ::gfp (right; plas-
mid pJL20-1). Each fusion plasmid was combined with control plasmid, pTP11, or plasmids expressing
Salmonella GcvB and mutant RNAs as in Figure 3.4B. (B) Western blots of target::GFP fusion proteins pre-
pared from E. coli ∆gcvB recA− carrying the indicated fusion plasmids in combination with control plasmid
pTP11, or plasmids expressing wild-type gcvB or the gcvB∆R1 allele. GroEL was probed as loading con-
trol. Fold changes of GFP fusion protein levels (upon normalization to GroEL levels) by gcvB or gcvB∆R1
co-expression relative to the control plasmid were: OppA::GFP, -2.8/-1.2; DppA::GFP, -3.6/-1.3; GltI::GFP,
-1.8/+2.2; LivJ::GFP, -5.3/-1.4; LivK::GFP, -2.1/-1.0; ArgT::GFP, -1.7/-1.1; STM4351::GFP, -1.8/-1.3; GFP
alone, -1.1/-1.2. (C) Quantification of relative target mRNA levels using quantitative RT-PCR. Real-time
PCR analysis of target mRNA levels in wild-type and ∆gcvB Salmonella. Samples were prepared from ex-
ponential phase bacteria (OD600 0.4). Wild-type mRNA levels are set to 1 (grey bars), and blue bars show
fold-upregulation in the absence of gcvB.
translational inhibition of these targets is coupled to mRNA degradation. Only for argT and livK
similar mRNA levels were observed between Salmonella wild-type and the gcvB deletion strain,
arguing for inhibition of translation as the primary mechanism of GcvB regulation for these targets.
Overall, these results increased the number of GcvB targets to seven mRNAs.
3.1.5. GcvB inhibits translation initiation in vitro
GcvB binds near the Shine-Dalgarno sequence of dppA and oppA (Fig. 3.6D), and was thus pre-
dicted to prevent ribosome binding to these mRNAs. To test this, 30S ribosome toeprinting assays
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Figure 3.14: GcvB inhibits 30S binding in vitro. (A) Toeprinting assays: formation of ternary translation-
initiation complexes of 30S subunit and fMet initiator tRNA on an in vitro transcribed mRNA are monitored
in a reverse transcription reaction with a labelled antisense oligo. Only if both, 30S and tRNAfMet, are bound
to the SD and AUG start codon of the mRNA, reverse transcription stops at position ‘+15’ according to the
start codon and leads to the specific “toeprint” signal. (B) Ribosome toeprinting of dppA leader RNA (20
nM) as described in section 8.3.9 in Material and Methods. “+/-” indicate the presence or absence of 30S
subunit (200 nM) and fMet initiator tRNA (1 µM). The dppA AUG start codon position is shown. The arrow
indicates the 30S toeprint. Increasing concentrations of GcvB RNA (lanes 4-7: 20, 60, 100 and 200 nM) in
the reactions inhibit 30S binding whereas the unspecific control RNA, MicA (lane 8, 100 nM), or GcvB∆R1
mutant RNA (lane 10, 100 nM) do not impair binding. Mutant RNAs GcvB∆R2 and GcvB3’∆ (lanes 11 and
12) were added at a final concentration of 100 nM.
(Hartz et al., 1988) were performed (Fig. 3.14A). A dppA mRNA fragment was annealed to an end-
labelled primer complementary to the dppA coding region (+58 to +73), and incubated with 30S
ribosomal subunits in the presence or absence of uncharged tRNAfMet, followed by cDNA synthe-
sis. Analysis of the extension products (Fig. 3.14B) revealed one ribosome-induced, tRNAfMet-
dependent termination site at the characteristic +15/+16 positions (start codon A is +1). This
“toeprint” signal was decreased when wild-type GcvB RNA was added prior to incubation with
30S/fMet (lanes 4-7), suggesting inhibition of 30S binding. Inhibition was also observed with the
GcvB∆R2 and GcvB3’∆ mutant RNAs, which have an intact R1 sequence (lanes 11, 12). In contrast,
the GcvB∆R1 mutant RNA (lane 10) did not inhibit ternary complex formation.
The same assay performed on oppA mRNA confirmed that GcvB inhibited ternary complex forma-
tion, and that it required an intact R1 sequence (data not shown). Since GcvB did not inhibit 30S
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Figure 3.15: GcvB inhibits 30S binding to gltI mRNA from a distance. (A) Ribosome toeprinting of
ompA leader RNA (200 nM) as described in section 8.3.9 in Material and Methods. “+/-” indicate the
presence or absence of 30S subunit (200 nM) and fMet initiator tRNA (1 µM). The ompA AUG start codon
position is shown. The arrow indicates the 30S toeprint. Only MicA (1µM) inhibits 30S binding to ompA
mRNA as previously shown in Udekwu et al. (2005), whereas neither GcvB wild-type (1µM) nor any of the
GcvB mutants RNAs (1µM) are able to interfere with translation initiation. (B) Toeprint on gltI 5’ RNA (20
nM) using 20 nM 30S subunit and 100 nM tRNAfMet. Increasing GcvB concentrations (lanes 4-6: 20, 100
and 200 nM, respectively) inhibit 30S binding. GcvB∆R1 mutant RNA (100 nM, lane 7) does not inhibit the
toeprint. (C) mRNA sequence of Salmonella gltI (5’ end). The gltI coding sequence is set in bold-face. The
asterisk denotes the wrongly annotated gltI start codon in the Salmonella LT2 genome sequence. The gltI
start codon shown here was confirmed by a specific toeprint signal at position +15 which is indicated by an
arrow (cf. B). The SD sequence is underlined, and the C/A-rich GcvB target site is shadowed.
binding to the unrelated ompA mRNA (see Figure 3.15A), it probably acts as a sequence-specific
translation initiation inhibitor by masking the dppA and oppA RBS.
3.1.6. GcvB inhibits gltI translation by binding far upstream of the start codon
GcvB binds to its other five target mRNAs further upstream of SD and start codon as compared
to dppA and oppA (Fig. 3.10). Notably, GcvB binds to region -57 to -45 of gltI, and -57 to -42 of
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Figure 3.16: The C/A-rich upstream element functions both as GcvB target site and as translational
enhancer element. (A) Agar plate-based assay of colony fluorescence of E. coli strains carrying either
the parental gltI::gfp (left; plasmid pJL24-1) or the mutant gltI∆CA::gfp (right; plasmid pJL45-3) fusion.
In the latter plasmid, the C/A-rich GcvB target site (-71 to -44; cf. Fig. 3.15C) is deleted. The fusion
plasmids were combined with control vector pTP-11, or GcvB expression plasmid pPLgcvB. (B) In vitro
synthesized, full-length mRNAs (40 nM) of the gltI::gfp and gltI∆CA::gfp fusions were in vitro translated
with reconstituted 70S ribosomes in the presence of 40 nM Hfq as described in section 8.3.10 in Material
and Methods. Synthesis of GltI::GFP fusion protein levels were determined after incubation for 15 min
(lanes 1, 4, 7, 10, 13, 16), 30 min (lanes 2, 5, 8, 11, 14, 17), and 45 min (lanes 3, 6, 9, 12, 15, 18) by
Western blot analysis. The reactions in lanes 4-9 and 13-18 contained a 10-fold excess of GcvB or GcvB∆R1
mutant RNAs as indicated above the lanes. Fold-regulations upon deletion of the C/A-rich target site or by
addition of GcvB according to quantification of GltI::GFP fusion protein levels are given below the blot. The
results of a representative experiment (out of three) are shown. (C) Confirmation of RNA stability in in vitro-
translation reactions: 0.4 pmol of in vitro synthesized, full-length mRNAs of the gltI::gfp and gltI∆CA::gfp
fusions were translated with reconstituted 70S ribosomes in the presence of 0.4 pmol Hfq as described in
Section 8.3.10 under Material and Methods. RNA samples of all reactions were prepared after translation for
20 min (lanes 1 to 6), and analysed by Northern hybridization along with untreated control RNAs (lanes 7 to
12). Probing for fusion mRNA or GcvB RNA with labelled oligos JVO-0155 and JVO-0749, respectively,
shows that RNAs are stable in this assay. (D) Full-length gltI::gfp mRNA was in vitro translated for 30 min
as above and synthesis of GltI::GFP fusion protein monitored on Western blot. In addition, mutant RNAs
GcvB∆R1 and GcvB3’∆ (rightmost two lanes; 10-fold excess) were included in the assay.
argT. These interaction sites lie outside the -35 to +19 mRNA region covered by 30S ribosomes
(Hu¨ttenhofer & Noller, 1994). Toeprinting of 30S on gltI mRNA (Fig. 3.15B) gave a single toeprint
at +15 relative to the gltI AUG in the presence of 30S/fMet (lane 3), confirming the gltI start codon
shown in Figure 3.15C (note that the gltI coding region is misannotated in the Salmonella genome,
and likely in a number of other bacteria). Strikingly, GcvB dramatically reduced 30S binding on
the gltI mRNA (lanes 4 to 6), dependent on an intact R1 sequence (lane 7). Thus, GcvB can inhibit
mRNA translation by binding upstream of a 30S binding site.
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3.1.7. The C/A-rich target site enhances gltI translation
To further evaluate GcvB regulation at upstream mRNA sites, the C/A-rich target region (-71 to -
44) was deleted in gltI::gfp, yielding fusion gltI∆CA::gfp. This deletion abolished fusion repression
in the presence of pPL gcvB (Fig. 3.16A), further demonstrating that GcvB pairs to this region.
Intriguingly, loss of this region also resulted in lower GFP fluorescence as compared to the parental
gltI::gfp fusion. Since C/A-rich stretches were reported to enhance mRNA translation (Martin-
Farmer & Janssen, 1999), it was determined whether the GcvB target site acts as an enhancer of gltI
translation.
In vitro synthesized, full-length gltI::gfp and gltI∆CA::gfp fusion mRNAs were translated with re-
constituted 70S ribosomes and GltI::GFP fusion protein synthesis was monitored over time. Fig-
ure 3.16B shows a linear increase in GltI::GFP synthesis from both mRNA templates within a 45
min assay. However, the gltI::gfp mRNA gave ≈3-fold higher translation rates compared to that of
gltI∆CA::gfp. Addition of GcvB (tenfold excess) to the reactions strongly inhibited protein synthe-
sis from gltI::gfp but not gltI∆CA::gfp mRNA. None of these variations are due to RNA degradation
since the gltI::gfp and GcvB RNAs were stable during the assay (Fig. 3.16C). In addition, the in-
hibitory activity of various GcvB mutants on gltI::gfp in vitro (Fig. 3.16D) perfectly correlated with
their ability to inhibit expression of the fusion mRNA in vivo (Fig. 3.13A).
3.1.8. Creation of an upstream C/A-rich target site permits translational control of an
unrelated mRNA
Next, the C/A-rich GcvB binding site of gltI was inserted at position -42 of an E. coli ompR::gfp
fusion, yielding ompRCA::gfp (Fig. 3.17A). The Salmonella gltI and E. coli ompR genes are unre-
lated in function, and their 5’ mRNA regions have little sequence identity (Fig. 3.17B). Insertion of
the C/A-rich element resulted in a ≈2-fold increase in OmpR::GFP synthesis in the in vitro trans-
lation assay (Fig. 3.17C; compare lanes 3 and 9), confirming the stimulatory effect of this element
on mRNA translation. When GcvB was present in the reaction, it strongly inhibited translation of
the ompRCA::gfp but not of the parental ompR::gfp fusion mRNA (Fig. 3.17C). Intriguingly, GcvB
inhibits ompRCA::gfp translation ≈ 10-fold, i. e. as strongly as observed with gltI::gfp. In other
words, GcvB effectively represses a structurally unrelated mRNA upon insertion of a C/A-rich tar-
get site at an upstream position.
3.2. Discussion
ABC transporters constitute a major class of amino acid uptake systems and commonly have at
least one periplasmic solute binding protein to take up substrates upon their diffusion through outer
membrane porins (Chen et al., 2004; Hosie & Poole, 2001). Given the key roles of amino acids
in nitrogen and carbon metabolism, regulation of transporter expression and activity is complex.
Intriguingly, genes involved in amino acid uptake and metabolism also are the most strongly mis-
regulated class in hfq mutants E. coli and Salmonella (Guisbert et al., 2007; Sittka et al., 2008),
suggesting that Hfq-dependent sRNAs are involved in the post-transcriptional control of these path-
ways. Here, one such sRNA, GcvB, has been established as a direct regulator of many ABC trans-
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Figure 3.17: Transplantation of the C/A element to an unrelated mRNA enhances translation and
permits regulation by GcvB. (A) Insertion of the 27 nt C/A-rich element of gltI at position -42 relative to
the start codon of an E. coli ompR::gfp fusion yields mutant ompRCA::gfp (plasmids pJU-063 and pJL50-11,
respectively). (B) In vitro translation assay (reconstituted 70S ribosomes) as in Figure 3.16B but with in
vitro-synthesized ompR::gfp and ompRCA::gfp fusion mRNAs (250 nM) and in the presence of 250 nM Hfq.
Synthesis of OmpR::GFP fusion protein was determined on Western blots following incubation for 15 min
(lanes 1, 4, 7, 10), 30 min (lanes 2, 5, 8, 11), and 45 min (lanes 3, 6, 9, 12). A tenfold excess of GcvB
RNA over mRNA was added to the reactions where indicated. The results shown are representative of the
experiment performed in triplicate. (C) ClustalW1 alignment of E. coli ompR and Salmonella gltI mRNAs
(5’ parts, which are contained in the gfp fusions) shows that these RNAs are unrelated in sequence. SD
sequences and start codons are shadowed.
porter mRNAs in Salmonella. The conservation of gcvB genes combined with the previous data
from the Stauffer lab (McArthur et al., 2006; Urbanowski et al., 2000) as well as successful pre-
diction of GcvB-target interactions in related organisms (see Figures 10.2 to 10.6 in the Appendix
and Tjaden et al., 2006) strongly argue that the GcvB function in amino acid uptake is conserved in
many other bacteria. Interestingly, some enterobacteria encode an additional sRNA, RydC, which
regulates the expression of a putative ABC transport system, yejABEF (Antal et al., 2005).
GcvB directly interacts with seven Salmonella mRNAs that belong to various transcriptional reg-
ulons but collectively encode periplasmic substrate binding proteins of ABC transporters (TCDB2;
KEGG3). These proteins are known or predicted to bind di- and oligopeptides (DppA, OppA), polar
(GltI, STM4351, and ArgT) and branched amino acids (LivK, LivJ). Since GcvB is specifically
expressed in rich medium in fast-growing cells (Fig. 3.1B), its function appears to lie in the gen-
eral repression of amino acid uptake when nutrients are plentiful. Consistent with this prediction,
a Salmonella gcvB deletion strain exhibits elevated protein and mRNA levels of almost all estab-
lished GcvB targets (Figs. 3.3B, 3.9, and 3.13C). The increased steady-state levels of nearly all
2 http://www.tcdb.org/
3 www.kegg.org
3.2. Discussion 55
target mRNAs in ∆gcvB (Fig. 3.13C) argue that by repressing mRNA translation, GcvB also pro-
motes the decay of its targets. Western blot quantification of OppA protein levels revealed a 6-fold
increase in ∆gcvB as compared to wild-type (Fig. 3.3B); the corresponding RT-PCR experiment
(Fig. 3.13C) suggests a similar increase in oppA mRNA levels. Comparison of the increases in target
protein levels (spot intensity on Coomassie-stained 2D gels; Fig. 3.9) and mRNA level (Fig. 3.13C)
upon gcvB deletion suggest a similar correlation in mRNA/protein level changes for dppA, gltI, livJ,
STM4351, and argT (LivK was not detected on the 2D gels). Whether RNase III, here used as a tool
for structure probing in vitro, is the primary nucleolytic activity to degrade the GcvB target mRNA
in vivo as previously shown for the IstR-1 sRNA (Vogel et al., 2004) and RNAIII (Huntzinger et al.,
2005) remains to be determined. At least dppA, livK, gltI, and oppA each constitute the first gene of
a polycistronic transporter operon. Considering that the downstream cistrons of these polycistronic
mRNAs are likely to be translationally coupled to the direct GcvB targets, the sRNA may in fact
repress >20 genes (see Section 4.1.2 in Chapter 4). However, since GcvB is intrinsically unstable
(half-life 2-3 min; Vogel et al., 2003 and Figure 3.3), ABC transporter repression will be quickly
alleviated upon decreased availability of amino acids.
The sheer number of sRNA genes discovered by systematic searches of bacterial genomes over the
last years led to an increasing recognition of the potential impact of these riboregulators on bacterial
physiology (see Section 2.3). It is well-established that sRNAs that act to modulate protein activ-
ity can control the expression of many genes, e. g., by binding to RNA polymerase (Wassarman &
Storz, 2000) or to CsrA-like proteins (Babitzke & Romeo, 2007). Small RNAs can also affect the
expression of larger sets of genes by targeting the mRNAs of global transcriptional regulators, e. g.,
RpoS or FhlA (Argaman & Altuvia, 2000; Lease et al., 1998; Majdalani et al., 1998). In contrast,
the understanding of how sRNAs could directly control multiple mRNAs by antisense mechanism
has been limited by the low number of validated sRNA-target interactions and hence the difficulty
to reliably predict new targets. This notwithstanding, the results of several recent studies suggest
that multiple targeting may be more common than previously thought, and common denominators
are beginning to emerge. Tjaden et al. (2006) suggested that functional relationship of the proteins
encoded by target candidates, as it is also seen among the GcvB targets, may add confidence to
predictions. Similarly, the OmrA/B and RybB sRNAs directly target multiple mRNAs that col-
lectively encode for outer membrane proteins (Bouvier et al., 2008; Guillier & Gottesman, 2006,
2008; Johansen et al., 2006; Papenfort et al., 2006). By the same token, the iron stress-responding
E. coli RyhB sRNA was shown to regulate multiple mRNAs that encode proteins involved in iron
metabolism (Masse´ & Gottesman, 2002), and many of the mRNAs demonstrated to be direct targets
of Staphylococcus aureus RNAIII encode bacterial virulence factors (Boisset et al., 2007).
The strong C/A bias of GcvB binding sites may point to yet another feature of multiple target
regulation. CA multimers placed downstream of mRNA start codons were reported to stimulate
translation in vivo, and to increase ribosome binding affinity to mRNAs in vitro (Martin-Farmer &
Janssen, 1999). Whilst the effect of CA-multimers far upstream of a start codon was not addressed
by these authors, here it turned out that the C/A-rich element has a stimulatory effect on the gltI
and ompR fusion mRNAs (Figs. 3.16 and 3.17). Thus, multiple mRNA targeting by GcvB may
have evolved through hijacking a translational enhancer element shared by numerous mRNAs that
encode periplasmic transporters. It is thus tempting to speculate that other evolutionary constrained
mRNA regions, e. g., those encoding signal peptides, may also constitute binding sites for sRNAs
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with multiple targets. However, it has to be emphasized that the effects of GcvB as a translational
repressor are clearly much greater than the effects of removing the C/A-rich target site (Fig. 3.16),
thus GcvB does not primarily act by simply blocking any enhancer effect.
In eukaryotes, the recognition that a 5’ terminal seed sequence of the ≈ 22 nt microRNAs provides
the base-pairing specificity to target mRNAs greatly advanced target predictions. Also some of
the much longer bacterial sRNAs, e. g., OmrA/B and RybB, have recently been shown to have
highly conserved 5’-terminal binding sites for recognition of their target mRNAs (Bouvier et al.,
2008; Guillier & Gottesman, 2008). However, the conserved target interaction sites of sRNAs
are not necessarily located at the 5’ end. An alignment of GcvB RNAs (Fig. 3.2C) revealed two
strongly conserved, internal regions, R1 and R2. Whilst R2 may constitute an interaction region for
yet another target(s), R1 is a key determinant for base-pairing to seven target mRNAs. Although
the structure probing of target mRNAs and GcvB indicates additional, weaker contacts, the C/A-
rich motif in the targets and R1 in the sRNA clearly are the anchoring and essential motifs for
interaction. Recently, a highly conserved, internal target site has also been observed, e. g., for CyaR
RNA (De Lay & Gottesman, 2009; Johansen et al., 2008; Papenfort et al., 2008). Accordingly,
giving higher weight to deeply conserved regions in sRNAs is expected to improve the currently
available target search algorithms. In support of this, several other regulatory sRNAs, e. g., MicA,
MicC, and SgrS, exhibit a higher degree of conservation in their target interaction regions (Chen
et al., 2004; Rasmussen et al., 2005; Udekwu et al., 2005; Vanderpool & Gottesman, 2004). Unlike
these enterobacterial sRNAs, S. aureus RNAIII is not conserved in other species. However, it is still
intriguing that a short (≈ 40 nt) region within the 514 nt RNAIII facilitates base-pairing to multiple
mRNAs (Boisset et al., 2007; Huntzinger et al., 2005). Different from GcvB, however, RNAIII
typically covers the SD and/or the start codon of a target mRNA (Boisset et al., 2007; Huntzinger
et al., 2005).
Competition with ribosome binding explains the inhibitory activity of sRNAs that bind mRNAs
within RBS regions (Argaman & Altuvia, 2000; Chen et al., 2004; Huntzinger et al., 2005; Udekwu
et al., 2005). Here it is shown that the same applies to GcvB inhibition of dppA and oppA, whose
GcvB binding sites are very close to the SD (Fig. 3.6D). However, GcvB binds many of its targets
further upstream of the two sequence elements, SD and start codon, that are the key determinants
of 30S binding (Fig. 3.10B). gltI is the mRNA with the most upstream binding site; probing of
GcvB/gltI RNA complexes as well as transfer of the GcvB site from gltI to the unrelated ompR
mRNA showed that GcvB effectively represses translation by forming a duplex more than 42 nt
upstream of the AUG.
How is translational repression brought about at such upstream sites? Footprinting experiments
revealed the maximal ribosome binding region on mRNAs to range from -39 to +19 relative to the
AUG (Hu¨ttenhofer & Noller, 1994). Since the GcvB binding site on gltI lies outside this window, a
simple interference model in which GcvB occludes mRNA residues required for base-pairing with
16S ribosomal RNA is unlikely. In eukaryotes, ribosomes generally enter mRNAs at their 5’ end
to subsequently scan for downstream AUG triplets. A requirement for scanning is unknown in
prokaryotes, which argues against the possibility that GcvB could act as a roadblock for ribosomes
scanning from the 5’ end of gltI mRNA.
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Figure 3.18: Disruption of the hairpin motif upstream of the gltI SD does not impair regulation of
gltI::gfp by GcvB. (A) The gltI leader can form a hairpin structure (see also Figure 3.11A) which could
bring the C/A-element closer to the SD sequence. This stem-loop was disrupted by mutation of two indicated
residues (M2 mutation: C
−37→G and G−33→C). Successful disruption of this hairpin by the M2 mutation
was confirmed by RNA structure probing (data not shown). (B) Agar plate-based assay of colony fluores-
cence of E. coli strains carrying either the parental gltI::gfp (top; plasmid pJL24-1) or the mutated gltIM2::gfp
(bottom; plasmid pJL56-2) fusion. The fusion plasmids were combined with control vector pTP-11, or GcvB
expression plasmid PL gcvB. Disruption of the hairpin does not impair fusion mRNA repression by GcvB.
(C) In vitro synthesized, full-length mRNAs (40 nM) of the gltI::gfp, gltI∆CA::gfp, and gltIM2::gfp fusions
were in vitro translated with reconstituted 70S ribosomes in the presence of 40 nM Hfq as described in Sec-
tion 8.3.10 under Material and Methods. Synthesis of GltI::GFP fusion protein levels were determined after
incubation for 45 min by Western blot analysis. The reactions in lanes 2, 4, and 6 contained a 10-fold excess
of GcvB RNAs as indicated above the lanes. Fold-regulations upon deletion of the C/A-rich target site, intro-
duction of the M2 mutations or by addition of GcvB according to quantification of GltI::GFP fusion protein
levels are given below the blot.
Two other bacterial sRNAs, IstR-1 and RyhB, were recently reported to repress translation by bind-
ing upstream of the target RBS (Darfeuille et al., 2007; Vecerek et al., 2007), yet the underlying
mechanisms do not seem to apply for GcvB either. IstR-1 targets the tisAB mRNA ≈ 100 nt up-
stream of the tisB start codon. The tisAB mRNA is highly structured and the tisB SD entrapped
in a stable hairpin. Thus, tisB translation requires ribosomes to bind to an upstream “standby”
site, which will be masked upon IstR-1 binding (Darfeuille et al., 2007). Unlike in tisAB, the gltI
5’ UTR is not strongly structured (Fig. 3.11A). Moreover, since GcvB also inhibits the unrelated
ompRCA::gfp mRNA, structure cannot be a primary cause of translational repression. RyhB inhibits
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fur translation by forming an imperfect duplex with the -96 to -48 region of fur mRNA. Translation
of fur is coupled to that of an upstream located reading frame, the direct target of RyhB (Vecerek
et al., 2007). Here no evidence was found for an upstream reading frame in the gltI mRNA, nor for
translation initiation upstream of the determined gltI start codon (Fig. 3.15B).
The gltI 5’ UTR contains a putative hairpin motif (-40 to -7 region), which could bring the C/A-
rich motif in closer proximity to the gltI SD to facilitate repression by GcvB (Fig. 3.18). The
following observations do not support such a model. Firstly, the SD of ompR::gfp is not preceded
by a hairpin that would bring the GcvB target site and SD in closer proximity; yet transfer of the
GcvB site to ompR::gfp yields the same degree of mRNA repression as observed with the gltI::gfp
construct. Secondly, the putative hairpin motif in the gltI 5’ UTR was disrupted by two point
mutations. These mutations did not impair GcvB’s ability to repress the gltI fusion mRNA in
vivo (Fig. 3.18, B). In contrast, in an in vitro translation assay, both mutant mRNAs, gltI∆CA::gfp
and gltIM2::gfp, show ≈ 2-fold lower translation rates compared to that of gltI::gfp (Fig. 3.18, C).
Furthermore, the ability of GcvB to repress translation of the gltIM2::gfp fusion mRNA is ≈ 3-
fold reduced compared to repression of gltI::gfp (Fig. 3.18, C). Thus, the hairpin structure could
have an impact on GcvB regulation within the sequence and structure context of gltI mRNA. The
observation, that the two mutations had no influence on regulation of the gltI::gfp fusion in vivo
could be due to the overexpression of GcvB RNA from the plasmid. High GcvB levels could
facilitate that GcvB can still bind the gltI::gfp fusion mRNA and lead to mRNA degradation by a
double-strand specific RNase rather than inhibition of translation. Introduction of the two mutations
into the chromosomal copy of gltI in the Salmonella wild-type strain and gcvB deletion strains and
subsequent analysis of mRNA levels by quantitative RT-PCR in both strains, could help to clarify
the actual in vivo situation.
Consequently, the current results suggest that either the first three GcvB stem-loops, or the
G/U:C/A-rich helix of the GcvB-target mRNA complex, constitute an inhibitory signal for 30S
entry on the gltI and argT mRNAs. However, the underlying mechanism may be a more general
one since it was found that Salmonella RybB sRNA also represses several targets by binding up-
stream of the RBS (F. Mika and J. Vogel, unpublished). It might therefore be of interest to consider
the possibility that target searches are not yet exhausted for those sRNAs that do not show obvious
complementarity to RBS sequences.
In summary, Salmonella GcvB RNA was shown to target C/A-rich elements in the 5’UTRs of
seven periplasmic ABC transporter mRNAs (see Fig. 3.19). A highly conserved G/U-rich region
R1 within GcvB was identified which is strictly required for regulation and mediates direct binding
to the C/A-rich target sites. The GcvB target sites are located inside and upstream of the ribosome
binding site of the target mRNAs. However, in both cases, GcvB binding leads to inhibition of
translation by interfering with ribosome binding. Furthermore, the C/A-rich elements were shown
to act as translational enhancers in the 5’ UTRs of the ABC transporter mRNAs. Thus GcvB RNA
has probably captured an evolutionarily conserved element to regulate a class of functionally related
genes.
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Figure 3.19: GcvB RNA targets multiple ABC transporter mRNAs inside and outside of ribosome
binding sites. GcvB RNA binds with its highly conserved G/U-rich region R1 (red bar) to C/A-rich target
sites (green boxes) inside and upstream of the ribosome binding sites (indicated by a blue box). In both cases,
GcvB binding leads to inhibition of translation by interfering with ribosome binding. All seven periplasmic
ABC transporter mRNAs which are repressed by GcvB carry a C/A-rich target site within their 5’ UTR which
in addition acts as a translational enhancer.
CHAPTER 4
GCVB RNA, A GLOBAL REGULATOR OF
GENES INVOLVED IN AMINO ACID
METABOLISM
In the previous Chapter, expression of seven ABC transporter mRNAs was shown to be repressed
at the post-transcriptional level by the small noncoding RNA, GcvB, of Salmonella. GcvB directly
binds with a highly conserved G/U-rich region to C/A-rich elements in the 5’ UTRs of all these
target mRNAs. This initial set of GcvB targets was based on proteomic analysis and bioinformatic
predictions of interactions with 5’ regions (-/+ 50 nt of start codon) of mRNAs. However, in both
approaches mainly periplasmic proteins were investigated based on known targets from E. coli. The
pleiotropic nature of E. coli and Yersinia gcvB mutants (McArthur et al., 2006; Urbanowski et al.,
2000) and biocomputational predictions (Tjaden et al., 2006) suggested that GcvB may have addi-
tional mRNA targets. Furthermore, there is growing evidence that sRNAs regulate multiple targets
rather than individual mRNAs, thereby reprogramming gene expression at the post-transcriptional
level (as outlined in Section 2.5).
Global approaches using co-immunoprecipitation coupled to microarray (Zhang et al., 2003) or
deep sequencing analysis (Sittka et al., 2008; see Chapter 5) have identified numbers of Hfq-
associated mRNAs that surpass those of known sRNAs, e. g., ≥700 mRNAs versus ≈ 100 sRNAs
in Salmonella. These Hfq-bound mRNAs represent potential sRNA targets, but it remains difficult
to identify direct sRNA-mRNA partners. The few bioinformatics based approaches for bacterial
sRNA target predictions (see Section 2.4.2) often predict many targets including a high number of
false positives. Based on the low number of biochemically-verfied interactions, they often rely on
the canonical model which considers sRNA pairing to the Shine-Dalgarno (SD) or AUG start codon
sequence as a hallmark of productive target repression. However, several groups have recently re-
ported regulation outside this narrow and low sequence complexity region (Bouvier et al., 2008;
Darfeuille et al., 2007; Sharma et al., 2007; Vecerek et al., 2007); these studies have expanded the
sequence space for productive targeting on the mRNA side. Furthermore, sRNA-mediated pull-
down of interacting mRNAs (Douchin et al., 2006) or microarray-based experimental approaches
using sRNA pulse-expression (see Section 2.4.1.2) have predicted with high confidence diverse
sRNAs to directly regulate more than one mRNA. The latter strategy is likely to avoid the pleiotropic
effects that can be expected to result from constitutive sRNA expression and has been successfully
applied to the identification of targets of several sRNAs, such as RyhB and RybB, as well as OmrA
and OmrB (see Section 2.4.1.2).
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This Chapter describes an extended search for additional GcvB targets by global analysis of mRNA
changes on microarrays after GcvB pulse-overexpression. The analysis included GcvB mutants,
lacking the conserved regions R1 or R2, to identify potential targets that are dependent on these
regions. Additional consensus R1-dependent targets were identified by bioinformatics-based pre-
dictions of C/A-rich GcvB target sites within the 5’ UTRs of all annotated Salmonella mRNAs.
In total, the combination of microarray analysis and prediction of C/A-rich target sites led to the
identification of >30 potential GcvB consensus R1-dependent targets, whereof at least ten could be
validated by Western blots or FACS (fluorescence activated cell sorting) analysis of GFP reporter-
gene fusions. Regulation of one target, cycA mRNA, turned out to be independent of the G/U-rich
consensus R1, which is strictly required for regulation of all other identified targets. Because all
currently known targets are amino acid or peptide transporters or genes involved in amino acid
biosynthesis, it is speculated that GcvB RNA has a global role in amino acid metabolism.
4.1. Results
4.1.1. Expression of GcvB from an arabinose inducible plasmid
To identify additional GcvB targets besides the known ABC transporter mRNAs, an sRNA
pulse-overexpression strategy similar to previously described experimental target identification ap-
proaches was taken (see Section 2.4.1.2). For this purpose, plasmid pBAD-GcvB (pKP1-1) was
used which expresses GcvB wild-type RNA under control of an arabinose-inducible PBAD promoter.
In addition, plasmids pBAD-GcvB∆R1 (pKP2-6) and pBAD-GcvB∆R2 (pKP30-1) were included for
expression of GcvB∆R1 and GcvB∆R2 mutant RNAs, in which either the highly conserved G/U rich
region R1 or consensus R2 are deleted (Fig. 4.1, left panel). To confirm inducible expression of
these sRNAs, Salmonella wild-type carrying a pBAD control plasmid (pKP8-35) and a Salmonella
gcvB mutant carrying either pBAD control (C), pBAD-GcvB wild-type (GcvB), pBAD-GcvB∆R1
(∆R1), or pBAD-GcvB∆R2 (∆R2) plasmid were grown to mid exponential phase (OD600 1.0) and
treated with L-arabinose (0.2% final concentration) for up to 15 min. RNA samples were taken prior
to and at different time-points after induction (2.5’, 5’, 10’, 15’). Expression of GcvB wild-type
and the mutant RNAs was confirmed on Northern Blots and they accumulated to comparable levels
after, e. g., 10 min of induction (see Figure 4.1). Chromosomal GcvB shows an ≈ 2-fold increase
after arabinose addition; however, induction of GcvB RNAs from the plasmids lead to ≈ 2.5-fold
higher levels than the chromosomal GcvB after 10 min.
4.1.2. Microarray-based identification of GcvB target mRNAs in Salmonella
The same strains as described above were grown to an OD600 of 1.0, and RNA samples were taken
after 10 min of L-arabinose induction (0.2% final concentration). Subsequently, mRNA changes
upon sRNA induction were monitored on whole-genome S. typhimurium microarrays. Figure 4.2
shows a venn diagram for the different microarray sets with the number of genes that show≥2-fold
changes and a p-value ≤0.01 when compared to Salmonella ∆gcvB carrying the pPBAD control
plasmid. Of the 4716 S. typhimurium open reading frames represented on the microarrays, multiple
transcripts were altered more than 2-fold in Salmonella wild-type compared to the ∆gcvB mutant
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Figure 4.1: PBAD-inducible expression of GcvB variants. GcvB wild-type (GcvB) and GcvB∆R1 (∆R1,
deletion of residues 66-89) or GcvB∆R2 (∆R2, deletion of residues 136-144) mutant RNAs were expressed
in Salmonella SL1344 ∆gcvB from the PBAD-inducible promoter by addition of L-arabinose (0.2% final con-
centration) to cultures grown to an OD600 of 1.0. The highly conserved regions, R1 and R2, that are deleted
in the mutant RNAs are shown in red in the simplified GcvB structure on the left. Samples were taken prior
to (0 min) and at the indicated time-points (2.5, 5, 10, and 15 min) after induction. Northern Blot analy-
sis indicates strong induction of GcvB wild-type and mutant RNAs after 10 minutes of induction. Samples
taken from Salmonella wild-type harbouring a pBAD control plasmid (C) revealed that chromosomal GcvB
is ≈ 2-fold increased after 10 min of arabinose addition.
strain or upon GcvB pulse-expression (see Table 4.1). The known GcvB targets oppA and dppA
were repressed in the three sets ‘WT + C’, ‘∆gcvB + GcvB’, and ‘∆gcvB + ∆R2’ (Table 4.1, genes
indicated in blue). As expected, they are not repressed upon pulse-overexpression of GcvB∆R1
mutant RNA, as consensus R1 is strictly required for binding of these targets (Table 4.1, column
‘∆gcvB + ∆R1’). Also gltI mRNA is downregulated more than 2-fold in two sets (‘∆gcvB + GcvB’
and ‘∆gcvB + ∆R2’), but did not pass the p-value in the set ‘WT + C’ (Table 4.1, genes regulated
in two sets are indicated in red). These three known targets all encode the first genes of the operons
oppABCDF, dppABCDF, and gltIJKL, respectively. Also the downstream genes of oppA, dppA,
and gltI are significantly downregulated in the microarray experiments (see Table 4.1), indicating
that GcvB probably reduces expression of the whole polycistronic mRNAs of these operons. For
all of these genes, relatively consistent fold-changes were observed after pulse-expression of GcvB
wild-type and the ∆R2 mutant RNA (Table 4.1, compare columns ‘∆gcvB + GcvB’ and ‘∆gcvB
+ ∆R2’). Only gltI mRNA showed ≈ 2-fold higher downregulation upon pulse-expression of the
GcvB∆R2 mutant RNA. The previously characterized targets livJ, livK, STM4351, and argT are not
included in any of the venn diagram groups, as they show less than 2-fold changes in all microarray
sets, which was set as the threshold here. For example, argT and STM4351 are downregulated
1.5-fold and 1.9-fold, respectively, upon GcvB wild-type pulse-expression (see Table 4.1, genes
indicated in grey). Almost no change is observed for these genes between the wild-type and gcvB
deletion strain (Table 4.1, column ‘WT + C’). This indicates that additional, so far unknown GcvB
targets could also show only slight mRNA changes and will be missed due to setting the 2-fold
change threshold. Furthermore, genes that are not expressed at all under the examined growth
condition will be missed in this approach.
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Figure 4.2: Overlap between different microarray experiments. Venn diagram showing the overlap of
genes that are regulated more than 2-fold (p-value≤0.01) in different microarray experiments of GcvB pulse-
overexpression. The number of genes changed in Salmonella wild-type harbouring the pBAD control plasmid
(C) or Salmonella ∆gcvB carrying the pBAD-GcvB wild-type (GcvB), pBAD-GcvB∆R1 (∆R1), or pBAD-
GcvB∆R2 (∆R2) compared to the expression in Salmonella ∆gcvB carrying the pBAD-control plasmid (C)
are shown. The venn diagram was generated by VENNY (bioinfogp.cnb.csic.es/tools/venny/index.html) using
the names of the genes which are changed in the different experiments as input sets.
Besides the oppABCDF, dppABCDF, and gltIJKL operons, harbouring the known direct targets,
oppA, dppA, and gltI, additional genes that are repressed by GcvB wild-type or GcvB∆R2 RNA but
not by GcvB∆R1 were identified: gdhA, ydgR (tppB), ygjU, yhjG (Table 4.1, genes indicated in blue
are repressed in three sets), and acs, asd, lrp, rplT, rpmE, rpmI, yaeC, ydiJ, yfiD, yggH, STM1368,
and STM3333 (Table 4.1, genes indicated in red are repressed in two sets). Of these, ydgR, ygjU,
and yaeC encode for amino acid transport proteins, whereas gdhA and asd encode for proteins
involved in biosynthesis of several amino acids, and lrp for a transcriptional regulator, respectively.
The Lrp protein belongs to the AsnC family of transcriptional regulators and affects expression of
diverse operons (Hung et al., 2002). It controls, for example, several genes involved in the high-
affinity branched-chain amino acid transport system and is a mediator of the leucine response in
E. coli (Haney et al., 1992; Willins et al., 1991).
To confirm regulation of these genes, translational gfp fusions were constructed as described in Ta-
ble 8.13 and Table 8.14 under Materials and Methods. The different gfp fusions contain between
seven and 19 amino acids of the N-termini of these target genes and 5’ UTR parts that start at tran-
scriptional start sites derived from one of the following sources: own 5’ RACE results, promoters
described in the EcoCyc1 database or the literature, or deep-sequencing results of Hfq-bound RNA
in Salmonella (Sittka et al., 2008).
1 www.ecocyc.org/
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Table 4.1: Genes which show more than 2-fold change in at least two GcvB microarray experiments and
previously known target genes.
The last four columns indicate the fold-changes for the genes given in the first column in the four differ-
ent microarray experiments. The values correspond to the fold-changes of a gene in the indicated strains
compared to the expression level in the Salmonella ∆gcvB strain harbouring the pBAD-control plasmid (set
‘∆gcvB + C’). A negative value corresponds to downregulation and a positive value to upregulation of the
mRNA, respectively. Brackets indicate fold-changes ≥2.0 which did not satisfy the p-value threshold of
0.01; fold-changes ≥2-fold are set in bold. The known GcvB targets from the previous section (argT, livJ,
livK, and STM4351) which did not satisfy the 2-fold change or p-value threshold, are listed in grey. Genes
that show more than 2-fold change (p-value < 0.01) in all experiments are indicated in green, whereas those
with a significant ≥2-fold change in the three sets WT + C, ∆gcvB + GcvB, and ∆gcvB + ∆R2 or in the two
sets ∆gcvB + GcvB and ∆gcvB + ∆R2 are indicated in blue and red, respectively.
Gene Description WT + C ∆gcvB +
GcvB
∆gcvB +
∆R1
∆gcvB +
∆R2
acs acetyl-CoA synthetase -1.5 -3.4 +1.2 -5.2
argT ABC superfamily (bind-prot),
lysine/arginine/ornithine transport protein
-1.3 -1.5 ±1.0 -1.5
asd aspartate-semialdehyde dehydrogenase +1.0 -2.1 +1.3 -2.0
bfr bacterioferrin, iron storage homoprotein +1.6 +2.1 +2.2 +1.3
caiF transcriptional regulator of cai and fix operon +2.7 (+3.3) +3.2 +2.3
carA carbamoyl-phosphate synthetase,
glutamine-hydrolysing small subunit
(+6.3) +7.8 +7.8 +10.2
cycA APC family, D-alanine/D-serine/glycine
transport protein
-3.4 -5.1 -3.6 -6.0
dppA ABC superfamily (peri-perm), dipeptide
transport protein
-6.8 -13.2 -1.7 -12.9
dppB ABC superfamily (membrane), dipeptide
transport protein 1
-2.1 -3.1 -1.2 -3.0
dppC ABC superfamily (membrane), dipeptide
transport protein 2
-2.6 -3.2 -1.2 -3.5
dppD ABC superfamily (ATP-bind.), dipeptide
transport protein
-3.8 -6.9 -1.3 -9.1
dppF ABC superfamily (ATP-bind.), dipeptide
transport protein
-2.9 -4.0 -1.3 -4.1
dps stress response DNA-binding protein; starvation
induced resistance to H2O2
+1.8 +2.1 +2.2 +1.4
elaB putative inner membrane protein +2.2 +2.3 +2.4 +1.5
fbaB 3-oxoacyl-[acyl-carrier-protein] synthase I +1.8 +2.1 +2.2 +1.2
fimF putative fimbrial protein -2.7 -1.2 +1.4 -2.1
fimI fimbrial protein internal segment -4.4 -1.1 +1.7 -2.6
flgB flagellar biosynthesis, cell-proximal portion of
basal-body rod
+2.5 +2.4 +1.8 +1.8
flgD flagellar biosynthesis, initiation of hook
assembly
+2.5 +2.0 +1.7 +1.6
gapA glyceraldehyde-3-phosphate dehydrogenase A +1.5 +2.1 +2.1 +1.6
garL 2-dehydro-3-deoxy-galactarate aldolase -2.1 -2.1 -1.9 -1.8
gdhA glutamate dehydrogenase, NADP-specific -2.3 -3.4 -1.8 -3.2
gltI ABC superfamily (bind-prot),
glutamate/aspartate transporter
(-4.2) -8.5 -1.1 -14.8
gltJ ABC superfamily (membrane),
glutamate/aspartate transporter
-2.7 -3.1 -1.4 -3.5
gltK ABC superfamily (membrane),
glutamate/aspartate transporter
-2.7 -4.2 -1.6 -4.7
continued on next page
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Gene Description WT + C ∆gcvB +
GcvB
∆gcvB +
∆R1
∆gcvB +
∆R2
gltL ABC superfamily (ATP-bind.),
glutamate/aspartate transporter
(-3.0) -5.6 -1.7 -6.2
glyS glycine tRNA synthetase, beta subunit (-2.6) (-2.8) -2.5 -2.4
grxB glutaredoxin 2 (+2.4) +2.8 +2.7 +2.5
hepA RNA polymerase associated protein, putative
SNF2 family RNA helicase
(-2.0) -2.4 -2.2 -2.7
katE catalase; hydroperoxidase HPII(III), RpoS
dependent
(+2.1) +2.2 +2.3 +1.3
livJ ABC superfamily (bind-prot), branched-chain
amino acid transporter, high-affinity
±1.0 -1.6 -1.2 -1.4
livK ABC superfamily (bind-prot), branched-chain
amino acid transporter, high-affinity
-1.1 -1.2 ±1.0 -1.1
lrp regulator for lrp regulon and high-affinity
branched-chain amino acid transport system;
mediator of of leucine response (AsnC family)
-1.2 -3.1 (-2.1) -2.1
miaE hydroxylase for synthesis of
2-methylthio-cis-ribozeatin in tRNA
(+8.3) -1.1 +8.2 +11.8
msyB acidic protein suppresses mutants lacking
function of protein export
(+2.3) +3.0 +3.4 +1.8
ompW outer membrane protein W; colicin S4 receptor;
putative transporter
+2.4 (+2.6) +3.6 +1.5
oppA ABC superfamily (periplasm), oligopeptide
transport protein with chaperone properties
-7.3 -18 -1.4 -23.2
oppB ABC superfamily (membrane), oligopeptide
transport protein
-3.3 -6.3 -1.3 -7.2
oppD ABC superfamily (ATP-bind.), oligopeptide
transport protein
-2.9 -4.7 -1.5 -5.8
oppF ABC superfamily (ATP-bind.), oligopeptide
transport protein
-2.4 -2.8 -1.3 -3.9
phoL putative phosphate starvation-inducible protein,
ATP-binding
+1.9 +2.9 +2.4 +1.7
pipC pathogenicity island encoded protein:
homologous to ipgE of Shigella
+2.4 +2.2 +1.9 +1.3
ptsG sugar specific PTS family, glucose-specific IIBC
component
-2.6 (-2.1) -2.1 -1.9
pyrB aspartate carbamoyltransferase, catalytic subunit (+65.5) +74.6 +68.4 +89.8
pyrE orotate phosphoribosyltransferase (+5.7) +7.1 +6.7 +7.7
pyrI aspartate carbamoyltransferase, regulatory
subunit (allosteric regulation)
(+52.8) +56.8 +47.2 +52.2
pyrL pyrBI operon leader peptide +2.3 +2.6 (+2.6) +2.8
rnpA RNase P, protein component (protein C5),
processes tRNA, 4.5S RNA
(-2.2) -2.8 -2.9 -2.6
rplT 50S ribosomal subunit protein L20 (-2.6) -2.9 (-2.1) -2.7
rpmE 50S ribosomal subunit protein L31 (-2.3) -2.0 -1.9 -2.2
rpmI 50S ribosomal subunit protein L35 (-2.1) -2.5 -1.8 -2.3
rpoB RNA polymerase, beta subunit (-2.4) (-2.7) -2.5 -2.6
rpsL 30S ribosomal subunit protein S12 (-2.0) -2.8 -2.3 -2.4
rtsA putative AraC-type DNA-binding
domain-containing protein
+3.7 +3.3 +2.7 +2.6
rtsB putative bacterial regulatory proteins, luxR
family
(+3.7) (+2.9) +2.6 +2.5
ssaJ Secretion system apparatus: homology with the
yscJ/mxiJ/prgK family of lipoproteins
-3.1 +1.2 -1.1 -2.6
uraA NCS2 family, uracil transport protein (+2.8) (+3.4) +4.7 +2.3
wraB trp-repressor binding protein +1.7 +2.1 +2.4 +1.3
continued on next page
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Gene Description WT + C ∆gcvB +
GcvB
∆gcvB +
∆R1
∆gcvB +
∆R2
yaeC putative outer membrane lipoprotein,
D-methionine transport system substrate-binding
protein (metQ)
-1.8 -2.4 -1.4 -2.2
ybbN putative thioredoxin protein +2.0 +3.5 +3 +1.1
yccJ putative cytoplasmic protein (+2.3) +3.0 +3.0 +1.8
ydgR putative POT family, peptide transport protein
(tppB)
-2.2 -3.7 -1.4 -3.8
ydiJ putative oxidase -1.9 -3.0 -1.3 -3.1
yeeF putative APC family, amino acid transport
protein
(-3.7) -3.0 -2.7 -2.5
yegQ putative protease (-2.6) -3.1 -3.0 -2.2
yfiD putative formate acetyltransferase +2.4 +4.3 (+4.4) +4.9
yggH putative S-adenosylmethionine-dependent
methyltransferase
-1.8 -2.2 -1.7 -2.1
ygjU (sstT), serine/threonine transporter SstT, putative
dicarboxylate permease
(-4.2) -6.4 +1.2 -5.5
yhjG putative inner membrane protein -6.1 -14.1 -1.5 -14.1
yidC putative preprotein translocase subunit YidC (-2.2) (-2.4) -2.2 -2.4
yjgF putative translation initiation inhibitor +4.4 +6.1 +6.5 +5.4
ymdA putative periplasmic protein +2.1 +2.0 +1.7 +1.7
SL1344-0022 SL1344 specific protein +1.7 +2.0 +2.0 (+2.0)
SL1344-0031 SL1344 specific protein +1.9 +2.9 +2.5 (+2.4)
STM1055 Gifsy-2 prophage +2.1 +2.1 +2.0 +2.2
STM1368 putative Na+-dicarboxylate symporter +1.8 +2.5 (+2.1) +2.2
STM17471 putative inner membrane protein -3.0 -4.3 -1.3 -5.0
STM2746 putative excinuclease ATPase subunit +1.8 +2.4 +2.4 +2.5
STM2747 putative cytoplasmic protein +1.9 +2.6 +2.6 +2.7
STM3333 putative purine-cytosine permease (codB) (+4.5) +5.6 (+5.4) +7.5
STM3334 putative cytosine deaminase (+4.6) +4.9 +5.2 +4.8
STM3841 putative inner membrane protein (-2.0) (-2.6) -2.6 -2.8
STM4313 putative cytoplasmic protein +2.9 (+2.4) +2.1 +1.8
STM4351 putative arginine-binding periplasmic protein -1.6 -1.9 -1.3 -1.8
STM4535 putative PTS permease (-2.1) -2.3 -2.6 -1.4
STM4537 putative PTS permease -2.8 -2.7 -2.9 -1.8
STM4538 putative PTS permease -1.8 -2.3 -2.5 -1.5
STM4539 putative glucosamine-fructose-6-phosphate
aminotransferase
-2.8 -2.8 -3.0 -1.7
STM4540 putative glucosamine-fructose-6-phosphate
aminotransferase
(-3.5) -2.6 -3.1 -1.6
The resulting fusion plasmids and control plasmid pXG-1 (gfp) were each combined with either
pPLgcvB, pPLgcvB∆R1, pPLgcvB∆R2, which express the sRNAs from a constitutive PLlacO−1 pro-
moter, or control vector pTP011 in an E. coli gcvB deletion strain as described in the previous
section and in Sharma et al. (2007). Figure 4.3A shows reduced colony fluorescence monitored on
agar-plates for the ygjU, yaeC, tppB (ydgR), gdhA, and lrp fusions in the strains harbouring pPLgcvB
or pPLgcvB∆R2 similar to the pattern observed for the known target oppA. The asd::gfp fusion was
neither regulated on agar plates, nor on Western Blots and in FACS analyses of GFP fusion pro-
tein levels (Fig. 4.3). In contrast, a consensus R1 dependent regulation could be confirmed for the
ygjU::gfp and gdhA::gfp fusions on Western blots (Fig. 4.3B) and by FACS analysis (Fig. 4.3C). No
1 STM17147 is located antisense to the oppA 5’ UTR. Thus, as due to cDNA construction no strand differentiation is
possible it is unclear whether repression is a direct effect of GcvB or of co-hybridization with oppA cDNA.
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clear regulation as previously observed on agar plates could be confirmed for tppB::gfp, yaeC::gfp,
and lrp::gfp on Western Blots, however, FACS analysis indicated regulation by GcvB for yaeC::gfp.
Moreover, an ≈ 3-fold increase of chromosomal lrp mRNA level was observed on Northern blots
for a Salmonella gcvB deletion strain at mid-log growth compared to the isogenic wild-type strain
(data not shown), indicating a direct or indirect influence by GcvB RNA consistent with the mi-
croarray results.
4.1.3. Prediction of C/A elements reveals further targets
In Chapter 3 it was shown, that GcvB targets C/A-rich regions in the 5’ UTR of seven ABC trans-
porter RNAs. Also the validated new GcvB targets, ygjU, yaeC, and gdhA are predicted to be bound
by GcvB consensus R1 sequence at C/A-rich sites within their 5’ UTRs (Fig. 4.4A, left). Similar-
ily, asd and ydgR contain potential C/A-rich interaction sites that could interact with GcvB RNA
(Fig. 4.4A, right). This extended target set including the new microarray targets was used to define
a consensus motif for the GcvB target site. The gfp fusion sequences of the seven previously known
targets (dppA, oppA, livJ, livK, argT, STM4351, and gltI), the six R1 dependent (ydgR, ygjU, yaeC,
gdhA, asd, and lrp) targets from the microarray analysis, as well cycA, which was repressed in all
microarray sets (Table 4.1, indicated in green) and will be discussed in more detail below (Sec-
tion 4.1.5), were used as input for MEME motif identification (Bailey et al., 2006) with the following
parameters: number of different motifs: 10; minimum number of sites: 8; maximum number of
sites: 14; minimum motif width: 6; maximum motif width: 25. This allows the identification of
up to ten motifs with a length between 6 and 25 bp within the input sequences. The upper size
restriction of 25 nt was selected to cover long interaction sites in the size range of the 24-nt long
G/U rich R1 linker sequence. Furthermore, the motif has to be present in at least 50% of the 14
input sequences as defined by the parameters for minimum and maximum number of sites.
Figure 4.3 (facing page): New targets identified on microarrays upon GcvB pulse-expression. (A) Agar
plate-based assay of colony fluorescence of E. coli ∆gcvB recA− strains carrying control plasmid pXG-1
which expresses full-length gfp, the oppA::gfp (pJL19-1), ygjU::gfp (pFS133-3), yaeC::gfp (pFM27-1),
tppB::gfp (pJL70-9), gdhA::gfp (pJL69-5), asd::gfp (pFS116-1), or lrp::gfp (pFS103-3) fusion plasmid,
each in combination with control vector pTP11, or plasmids expressing Salmonella wild-type GcvB RNA
(pPLgcvB) or two of the mutant alleles (plasmids pPLgcvB∆R1 or pPLgcvB∆R2). (B) Western blots of tar-
get::GFP fusion proteins prepared after growth for 14 hours to stationary phase from E. coli ∆gcvB recA−
carrying the indicated plasmids as in A. GroEL was probed as loading control. Fold changes of GFP fusion
protein levels (upon normalization to GroEL levels) by gcvB, gcvB∆R1, or gcvB∆R2 co-expression relative
to the control plasmid were: OppA::GFP, -2.6/-1.1/-3.8; YgjU::GFP, -3.6/-1.3/-7.1; GdhA::GFP, -5.3/-1.4/-
4.3; TppB::GFP, +1.1/-1.1/-1.4; YaeC::GFP, 1.0/-1.1/-1.8; Asd::GFP, +1.3/+1.1/1.0; Lrp::GFP, 1.0/1.0/-1.5;
GFP alone, -1.0/-2.1/-1.4. (C) E. coli ∆gcvB recA− strains carrying control plasmid pXG-1 (gfp), a non-
fluorescent control plasmid pXG-0 (no gfp), the oppA::gfp, ygjU::gfp, gdhA::gfp, yaeC::gfp, tppB::gfp,
asd::gfp, or lrp::gfp fusion plasmids in combination with control vector pTP11 (black), or plasmids ex-
pressing Salmonella wild-type GcvB RNA (pPLgcvB, red) or two of the mutant alleles (pPLgcvB∆R1, blue;
pPLgcvB∆R2 , green) were grown to stationary phase and were subjected to flow cytometry analysis. All data
acquired from the experiments are plotted in fluorescence histograms realized on all events measured (30,000
events). Cellular fluorescence is given in arbitrary units (GFP intensity). Regulation by GcvB wild-type or
GcvB∆R2 is visible as a shift of the fluorescence curves to the left to lower GFP intensities.
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Figure 4.4: Predicted target interactions of GcvB and identification of a C/A-rich motif. (A) Pro-
posed RNA duplexes formed by GcvB with five new target mRNAs (ygjU, yaeC, gdhA, asd, and ydgR).
Positions in the target sequences are given as distance to the mRNA start codon. C/A-rich motifs are high-
lighted in blue in the interactions. For ydgR two interactions are predicted, whereof the first one is located
in the coding sequence. (B) A consensus motif for the C/A-rich GcvB target sites was determined by MEME
(http://meme.nbcr.net/meme4 1/cgi-bin/meme.cgi) and visualized with WebLogo (weblogo.berkeley.edu/).
(C) Location of the C/A-rich motif in the input sequences. (D) Proposed RNA duplexes formed by GcvB
with eight additional target mRNAs (iciA, ilvC, ybdH, serA, ndk, thrL, ilvE, and brnQ).
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Table 4.2: Genes with predicted C/A elements and more than 2-fold change in at least one microarray
experiment. All fold changes are normalized to expression in Salmonella ∆gcvB + pBAD-control. Brackets
indicate fold-changes ≥2.0 which did not satisfy the p-value threshold of 0.01.
Gene Description WT + C ∆gcvB +
GcvB
∆gcvB +
∆R1
∆gcvB +
∆R2
brnQ LIVCS family, branched chain amino acid
transporter system II (LIV-II)
-1.3 -2.0 -1.2 (-2.0)
serA D-3-phosphoglycerate dehydrogenase -1.3 (-2.0) 1.0 -2.1
rho transcription termination factor Rho -1.3 -1.3 -1.1 -2.0
ydiJ putative oxidase -1.9 -3.0 -1.3 -3.1
mglC ABC superfamily (membrane),
methyl-galactoside transport protein
(-3.2) (-4.2) (-2.2) -5.0
ilvB acetolactate synthase I, large subunit -1.8 (-2.4) (-2.0) -2.4
ygdL putative enzyme -1.6 -1.7 -1.6 -2.8
STM0148 putative cytoplasmic protein -1.3 -1.3 1.2 -3.1
STM3334 putative cytosine deaminase (+4.6) +4.9 +5.2 +4.8
STM0293 putative cytoplasmic protein +1.4 +1.6 +1.2 +2.1
flgE flagellar biosynthesis, hook protein +2.1 +1.5 +1.4 +1.4
pipC pathogenicity island encoded protein:
homologous to ipgE of Shigella
+2.4 +2.2 +1.9 +1.3
ycfR putative outer membrane protein -1.1 +1.0 -1.4 +2.1
Figure 4.4B shows the best motif identified by MEME. It is 10 nts long and present in all input se-
quences (Fig. 4.4C). For all input sequences, except for lrp, the identified motif overlaps with a
mapped or proposed GcvB interaction site. For ydgR, the motif overlaps with the second proposed
interaction in Figure. 4.4A. Thus, although all the targets are overall unrelated in sequence, they
share one common motif which could be targeted by the G/U rich R1 sequence of GcvB RNA and
thereby mediate regulation of these targets. However, direct binding has to be confirmed experimen-
tally in future work either by compensatory base-pair exchanges or in vitro footprinting analyses of
GcvB-target mRNA complexes.
4.1.4. Identification of additional mRNAs that contain the GcvB target site
Altough several new GcvB targets could be identified based on the microarray approach, some
further targets could have been missed due to low or no expression under the examined growth
condition. Moreover, some targets could not have reached the 2-fold change or significance thresh-
olds like the previously characterized targets livJ, livK, STM4351, and argT which show less than
2-fold downregulation. In contrast, bioinformatics-based predictions should in principle be able
to predict all targets; however, they often predict also a high number of false positives. To refine
a bioinformatics-based target identification, the search was restricted to the identification of addi-
tional R1-dependent GcvB targets involving a C/A-rich target site. To see if the 10-nt long motif
which was identified in the previous targets (Fig. 4.4B) can be found in additional mRNAs and
might reveal further GcvB targets, MAST (Bailey & Gribskov, 1998) searches were performed with
the corresponding position-specific weight matrix for the C/A-rich GcvB target site in a database
composed of the sequences -70 to +30 (according to the start codon) of all annotated Salmonella
ORFs. In this set of 4424 sequences, the motif could be identified in 245 sequences with an E-value
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< 200. With this E-value threshold, all 14 input sequences, except for lrp, are found in the list of
the 245 mRNAs (data not shown). To narrow down the set of additional GcvB targets for exper-
imental verification, it was examined which of these mRNAs are also regulated in at least one of
the microarray datasets. The mRNAs of brnQ, serA, rho, ydiJ, mglC, ilvB, ygdL, and STM0148 are
downregulated, whereas STM3334, STM0293, flgE, pipC, ycfR are upregulated by GcvB in at least
one microarray set (see Table 4.2).
Additionally, potential target interactions were predicted using RNAhybrid (Rehmsmeier et al.,
2004) between the regions -70/+30 of these 245 mRNAs and an extended GcvB region R1 (the
24-nt long R1 region plus 12 and 13 nt flanking regions) with two parameter sets, one without
limitations for bulge/internal loops and another where these loops were restricted to a length of
one nucleotide. After removal of interactions that had no helix with at least nine consecutive base-
pairs, the lists contained 88 predicted GcvB-target interactions without limitations for loops and 91
interactions with loops of maximal one nucleotide, respectively. Helices of nine base-pairs were
observed as some of the shortest biochemically-validated interactions, e. g., in case of OxyS:fhlA
and RyhB:sodB (Argaman & Altuvia, 2000; Geissmann & Touati, 2004). In this step, livJ, asd, and
ydgR were sorted out. With both parameter sets, the best interaction in terms of free energy is the
one with dppA mRNA which was also mapped experimentally in the previous Chapter. In both sets
of predicted interactions, the second ranked target is ilvC, which encodes for an acetohydroxy acid
isomeroreductase and is involved in isoleucine and valine biosynthesis. However, this target was
not regulated in the microarray list.
To further narrow down the lists, targets were selected from the predictions which showed strong
interactions (no more than one G:U basepair in the middle of the longest helix, except for the known
targets) leading to 35 and 33 final interactions. These included nine (dppA, gltI, argT, oppA, livK,
gdhA, STM4351, yaeC, and ygjU) and eight (dppA, gltI, argT, oppA, livK, gdhA, STM4351, and
cycA) of the input targets, respectively, that were used for the motif identification. Interactions
for ygjU, yaeC, and cycA were included in only one of each set, as the different loop parameters
sometimes lead to differences in the predicted interactions. For example, the longest helix in the
Figure 4.5 (facing page): New GcvB targets based on biocomputational predicions. (A) Agar plate-based
assay of colony fluorescence of E. coli ∆gcvB recA− strains carrying the same sRNA plasmids like in Fig-
ure 4.3A in combination with the brnQ::gfp (pFS105-3), ilvC::gfp (pJL68-1), ilvE::gfp (pSP25-7), thrL::gfp
(pSP20-1), ybdH::gfp (pSP21-2), iciA::gfp (pFS121-1), or ndk::gfp (pFS115-2) fusion plasmid. (B) Western
blots of target::GFP fusion proteins prepared after growth to stationary phase from E. coli ∆gcvB recA−
carrying the indicated plasmids as in A or a serA::gfp fusion plasmid (pFS117-1). GroEL was probed
as loading control. Fold changes of GFP fusion protein levels (upon normalization to GroEL levels) by
gcvB, gcvB∆R1, or gcvB∆R2 co-expression relative to the control plasmid were: BrnQ::GFP, -2.0/-1.1/-2.0;
SerA::GFP, -1.4/+1.1/-1.2; IlvC::GFP, -1.9/+1.4/-1.2; IciA::GFP, -2.6/-1.7/-3.6; and Ndk::GFP, -1.4/+1.2/-
1.1. (C) E. coli ∆gcvB recA− strains carrying the ilvC::gfp, thrL::gfp, iciA::gfp, ybdH::gfp, serA::gfp,
ilvE::gfp, ndk::gfp, or brnQ::gfp fusion plasmids in combination with control vector pTP11 (black), or plas-
mids expressing Salmonella wild-type GcvB RNA (pPLgcvB, red) or two of the mutant alleles (pPLgcvB∆R1,
blue; pPLgcvB∆R2, green) were grown to stationary phase and were subjected to flow cytometry analysis.
All data acquired from the experiments are plotted in fluorescence histograms realized on all events mea-
sured (30,000 events). Cellular fluorescence is given in arbitrary units (GFP intensity). Regulation by GcvB
wild-type or GcvB∆R2 is visible as a shift of the fluorescence curves to the left to lower GFP intensities.
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interaction predicted for cycA with no restrictions for bulge loops is only eight base-pairs long and,
hence, was rejected in the step in which interactions that had no helix with at least nine subsequent
base-pairs were sorted out. In contrast, limitation of the loop length to one nucleotide leads to the
prediction of a different interaction which satisfies the nine base-pair threshold and is thus kept in
the list of final interactions.
Five genes (brnQ, serA, rho, mglC, and ilvB) of the set of targets with a predicted C/A-rich element
which are downregulated in at least one microarray experiment (Table 4.2) were also included in
the final lists of predicted interactions. Translational gfp fusions were constructed for these five
genes, and in addition ilvC, ilvE, thrL, ybdH, sbp, mltC, yieG, and STM2179 were selected from
the interaction list for construction of GFP fusions. Additional predictions for interactions of GcvB
R1 with the -70/+30 regions of all annotated Salmonella ORFs indicated that also iciA and ndk
could form long duplexes with GcvB RNA (see Fig. 4.4D). Therefore these two genes were also
selected for construction of GFP fusions.
Only seven of the new fusions, brnQ::gfp, ilvC::gfp, ilvE::gfp, thrL::gfp, ybdH::gfp, iciA::gfp
and ndk::gfp, displayed sufficient GFP levels to monitor colony fluorescence on agar plates and
indicated an R1-dependent repression of these genes (Fig. 4.5A). Regulation of brnQ::gfp, ilvC::gfp
and iciA::gfp could be confirmed on Western blots (Fig. 4.5B). On the Western blot in Figure 4.5B
the ndk::gfp fusion seems to be strongly downregulated by GcvB∆R2. However, normalization to
GroEL levels indicates a loading artefact as also a lower GroEL amount was detected in this lane.
FACS analysis showed a strong R1-dependent regulation for ilvC::gfp, thrL::gfp, and iciA::gfp
(Fig. 4.5C, upper row), a slight regulation for ybdH::gfp, serA::gfp, ilvE::gfp and ndk::gfp, but
almost no regulation for brnQ. However, an ≈ 3-fold increase of chromosomal ndk mRNA level
was observed on Northern blots for a Salmonella gcvB deletion strain at mid-log growth compared
to the isogenic wild-type strain (data not shown), giving an additional evidence for an influence
of GcvB RNA. The proposed interactions as well as locations of C/A-rich elements are shown in
Figure 4.4D. Of these new targets, brnQ encodes for an amino acid transporter, ilvC, ilvE and serA
for genes involved in amino acid metabolism or biosynthesis, and thrL for the thr operon leader
peptide.
4.1.5. GcvB represses expression of the glycine transporter CycA
One target, cycA, was the only one which is repressed in all microarray sets (Table 4.1, indi-
cated in green). CycA belongs to the superfamiliy of APC (amino acid/ polyamine/ organocation)
transporters and acts as a permease for glycine, D-alanine, D-serine, and D-cycloserine in E. coli
(Cosloy, 1973; Robbins & Oxender, 1973; Russell, 1972; Wargel et al., 1971). In Salmonella
wild-type + C vs ∆gcvB + C, cycA mRNA is repressed ≈ 3.4-fold. Upon pulse-overexpression of
GcvB wild-type, GcvB∆R1, and GcvB∆R2 mutant, cycA mRNA levels drop to ≈ 20%, 28%, and
17%, respectively. Thus, although a slight reduction of regulation was observed for the GcvB∆R1
mutant, regulation of this target seems to be independent of consensus R1 and R2 indicating alter-
native binding sites for GcvB RNA. This pattern of regulation was confirmed for a cycA::gfp fusion
(Fig. 4.6A and B). Quantification of regulation on Western blots also indicated a slight loss of reg-
ulation for the GcvB∆R1 mutant compared to GcvB wild-type and the R2 deletion (Fig. 4.6B). This
effect was not visible during FACS analysis. Furthermore, also a double mutant GcvB∆R1&∆R2,
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Figure 4.6: Regulation of the glycine/D-alanine/D-serine permease CycA by GcvB. (A) Agar plate-
based assay of colony fluorescence of E. coli ∆gcvB recA− strains carrying the cycA::gfp (pJL30-14) fu-
sion in combination with control vector pTP11, or plasmids expressing Salmonella wild-type GcvB RNA
(pPLgcvB) or five of the mutant alleles (plasmids pPLgcvB∆R1 or pPLgcvB∆R2, pPLgcvB∆R1∆R2, pPLgcvB5’∆,
or pgcvB3’∆T). (B) Downregulation of cycA::gfp by GcvB wild-type and mutant RNAs GcvB∆R1 and
GcvB∆R2 after growth to stationary phase was confirmed on Western blots and by FACS analysis. Fold
changes of GFP fusion protein levels on Western Blots (upon normalization to GroEL levels) by gcvB,
gcvB∆R1, or gcvB∆R2 co-expression relative to the control plasmid were: -8.3/-3.4/-6.3. The different colours
in the FACS diagram indicate plasmids expressing Salmonella wild-type GcvB RNA (pPLgcvB, red), two of
the mutant alleles (pPLgcvB∆R1, blue; pPLgcvB∆R2, green), or a control plasmid (black). (C) Alignment
of promoter regions and N-terminal coding sequences of cycA homologues in diverse enterobacteria. The
transcriptional start site mapped by 5’ RACE is indicated by a yellow box and the putative -10 box framed in
blue, respectively.
as well as 5’ end and 3’ end truncated GcvB mutants, GcvB5’∆ and GcvB3’∆T, which lack residues
1-91 (SL1 and R1) or 135-201 (R2 to SL5), are still able to repress translation of the cycA::gfp fu-
sion (Fig. 4.6A). Furthermore, quantitative real-time PCR analysis of RNA harvested at an OD600
of 0.4 indicated an ≈ 3.5-fold upregulation of cycA mRNA in a gcvB deletion strain compared to
the Salmonella wild-type strain (data not shown). This is in agreement with the 3.4-fold change
between the Salmonella wild-type and gcvB deletion strain observed in the microarray (Table 4.1,
column WT + C).
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Figure 4.7: Identification of GcvB binding sites on cycA mRNA by in vitro probing. (A, B) 5’ end-
labelled cycA RNA (≈ 5 nM) treated with RNase T1, lead(II) (A), or RNase III (B). The synthesized cycA
RNA fragment comprises region -163/+72 relative to the AUG start codon. The ‘G’ of the AUG start codon
corresponds to position ’+3’. (Lane C) Untreated cycA RNA. (Lane T1) RNase T1 ladder of hydrolysed
denatured cycA RNA. The position of cleaved G residues is given left of the gel. (Lane OH) Alkaline ladder.
(A) Probing of cycA in the absence (lane 1 and 4) or presence of GcvB wild-type (lanes 2 and 5), GcvB∆R1
(lane 7), or GcvB3’∆ mutant RNAs (lanes 3 and 6); final concentrations in lanes 2, 3, 5, 6, 7: ≈ 500nM .
Protected regions in cycA mRNA are indicated by red and blue bars and RNase III cleavage sites (B) in the
same regions by red and blue arrows, respectively. The green arrows denote an additional specific RNase III
cleavage site of cycA RNA in the presence of GcvB wild-type or mutant RNAs.
4.1.6. GcvB binds to cycA mRNA in vitro
To map the GcvB interaction sites, the RNA of the previously cloned cycA fragment was synthesized
in vitro and subjected to structure probing experiments. RNA structure probing with RNase T1 and
lead(II) acetate showed that the presence of GcvB wild-type or mutant RNAs results in ‘footprints’
on 5’-end-labelled cycA leader (Fig. 4.7A). GcvB wild-type protects around seven residues and
GcvB∆R1 ≈ 18 residues starting at position -7 according to the start codon of cycA (Fig. 4.7A, red
bars). Deletion of the 3’ end of GcvB RNA in the GcvB3’∆ mutant RNA leads to an additional
protected region of around eight nucleotides more upstream in the 5’ UTR (Fig. 4.7A, blue bar).
These interactions were supported by specific RNase III cleavages for each of the GcvB forms
(Fig. 4.7B).
The reciprocal experiment, i. e., probing of labelled GcvB RNA in the presence of cycA leader,
identified multiple cycA binding-sites on GcvB RNA (Fig. 4.8A) which were supported by strong
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Figure 4.8: Identification of cycA binding sites on GcvB RNA by in vitro probing. (A) 5’ end-labelled
GcvB RNA (≈ 5 nM) was subjected to RNase T1, lead(II) in the absence (lanes 1 and 3) or presence of
cold cycA RNAs (final concentration in lanes 2 and 4: ≈ 500 nM) or duplexes were confirmed by RNaseIII
cleavages in the absence (lanes 1) or presence of cold cycA or as a negative control, gfp mRNA leader (final
concentration in lanes 2 and 3: ≈ 1 µM). (Lane C) Untreated GcvB RNA. (Lane T1) RNase T1 ladder of
hydrolyzed denatured GcvB RNA. The position of cleaved G residues is given left of the gel. (Lane OH)
Alkaline ladder. Protected regions are indicated by red and blue vertical bars and RNase III cleavage sites by
red and blue arrows, respectively. The approximate positions of stem-loop structures SL1 and SL2 according
to the GcvB RNA structure shown in C are indicated to the right of the gel. Note that parts of the original gel
with unrelated samples were cut out of the picture (indicated by a dashed line). (B) Two proposed interaction
sites of GcvB-cycA complexes. SD and AUG start codon sequences are boxed. The coloured residues were
protected from lead(II) cleavage upon duplex formation (see A). (C) Secondary structure model of GcvB
RNA and location of the G/U-rich consensus R1 (blue bar) and consensus R2 (red bar). Two interaction sites
derived from the structure probing experiments in (A) and predictions in (B) are indicated by red and blue
boxes, respectively.
RNase III cleavages (Fig. 4.8B). At least two binding sites could be derived from the structure
probing experiments and predictions for interactions: one involving consensus R1 (Fig. 4.8B and
C, marked in blue) and the other involving R2 (Fig. 4.8B and C, marked in red). The first interaction
involves a C/A-rich element upstream of the SD sequence in the cycA 5’ UTR, the second ovelaps
the SD and start codon of cycA.
4.1.7. Diverse GcvB mutants indicate multiple binding sites for cycA mRNA
To define a minimal GcvB fragment which represses the cycA::gfp fusion, diverse GcvB mutant
alleles were constructed by subsequent shortening (as described below) of GcvB fragments that are
78 CHAPTER 4. GcvB RNA, a global regulator of genes involved in amino acid metabolism
B
A
SL1
SL2
SL3
SL4
SL5
gcvB (WT)
gcvB
gcvB
gcvB
gcvB
5' 3'
R2R1
DR1
DR2
3' TD
5'D
T
gcvB 5' & R2D D
gcvB
DSL2
gcvB
DR1& R2D
gcvB
DSL2 & SL3D
SL1
SL2
SL3
SL4
SL5
5' 3'
R2R1
gcvB
SL1, SL4 & SL5
gcvB
SL4 & SL5
gcvB R2, SL 4 & SL5
gcvB
DR1 & 3' TDT
gcvB
SL1 & SL5
gcvB
5’ 12nt, SL1 & SL5D
gcvB M2, R2, SL 4 & SL5
C G
gcvB 5’ 12nt, R1 & 3' TD D DT
gcvB
DPL
g
c
v
B
co
n
tro
l
g
c
v
B
g
c
v
B
g
c
v
B
g
c
v
B
g
c
v
B
D
R
1
D
R
2
DgcvB
R
2,
S
L
4
&
S
L
5
D
R
1
&
3’
T
D
S
L
1
&
S
L
5
5S
**
g
c
v
B
D
P
L
g
c
v
B
S
L
1,
S
L
4
&
S
L
5
g
c
v
B
S
L
4
&
S
l5
g
c
v
B
5’
12
n
t,
S
L
1
&
S
L
5
D
g
c
v
B
M
2,
R
2,
S
L
4
&
S
L
5
g
c
v
B
5’
12
n
t,
R
1
&
3
’
T
D
D
D
5S
242
190
147
110
g
c
v
B
co
n
tro
l
g
c
v
B
g
c
v
B
g
c
v
B
g
c
v
B
g
c
v
B
D
R
1
D
R
2
DgcvB
R
2,
S
L
4
&
S
L
5
D
R
1
&
3’
T
D
S
L
1
&
5
S
L
g
c
v
B
D
P
L
g
c
v
B
S
1,
S
L
4
&
S
L
5
L
g
c
v
B
S
L
4
&
5
S
L
g
c
v
B
5’
12
n
t,
S
L
1
&
5
D
S
l
g
c
v
B
M
2,
R
2,
S
l4
&
5
S
L
g
c
v
B
5’
12
n
t,
R
1
&
3
’
T
D
D
D
3' probe5' probe
242
190
147
110
1 2 3 4 5 6 7 8 9 10 11 12 13 14 1 2 3 4 5 6 7 8 9 10 11 12 13 14
Figure 4.9: Diverse mutant alleles of gcvB and their expression. (A) Horizontal bars below two schematic
drawings of GcvB RNA denote the gcvB fragments expressed by mutant alleles; dotted lines denote internal
deletions. Details of the parts that are deleted for each mutant are given in the Chapter Material and Methods
in Tables 8.11 and 8.12. In allele gcvB3’∆T, which derives from a gcvB3’∆ mutant, SL3 was modified to a
transcription terminator. Furthermore, all mutant alleles that carry the gcvB3’∆T mutant part are expressed
from the native gcvB promoter. The mutant allele gcvB∆PL lacks the constitutive PLlacO promoter region.
Mutant alleles that are indicated in magenta do not repress expression of the cycA::gfp fusion. (B) Northern
blots showing expression of gcvB or mutant alleles from a mid-copy plasmid under control of the PLlacO
promoter (or gcvB promoter for 3’ end truncations) in E. coli ∆gcvB (lanes 3-13). Deletion of the PLlacO
promoter region leads to a loss of GcvB expression (lane 14). RNA was isolated from E. coli grown to an
OD600 of 1, and except lane 1 (TOP 10 wild type; JVS-2000) from a ∆gcvB genetic background (JVS-6081).
The strains in lanes 2 to 14 carried control vector, pTP11, or GcvB mutant plasmids as indicated. Marker
sizes are shown to the left. The left blot was probed with labelled oligo JVO-0749, which is complementary
to the GcvB 5’ region (20-4 bp); the right blot with JVO-0750 complementary to bp 172-150. The asterisks
denote transcriptional read-through to the rrnB terminator located downstream of gcvB on the plasmids.
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still able to regulate the cycA::gfp fusion (Fig. 4.9A). Plasmids carrying these alleles under control
of the constitutive PLlacO promoter expressed distinct GcvB-derived RNAs at levels similar to wild-
type gcvB (Fig. 4.9B). To rule out any influence of the DNA region itself encoding GcvB RNA, a
plasmid carrying a promoter deletion mutant, pgcvB∆PL, was constructed where no GcvB RNA was
expressed. To investigate which of the gcvB mutant alleles can repress expression of the cycA::gfp
fusion, each of the GcvB mutant plasmids was co-transformed with the cycA::gfp fusion plasmid
in E. coli ∆gcvB and assayed for colony fluorescence on agar plates (Figure 4.10A). Regulation of
cycA::gfp expression by the different mutant RNAs was quantified by FACS analysis and confirmed
the regulation pattern observed on agar plates (Figure 4.10B).
Starting from the GcvB wild-type sequence, deletion of consensus R1 or R2 alone or in combi-
nation, as well as 5’ end or 3’ end truncations of GcvB RNA had no impact on regulation of the
cycA::gfp fusion as previously shown in Figure 4.6A (Fig. 4.10A and B, number 3 to 7). In con-
trast, the promoter deletion (gcvB∆PL) does not repress GFP expression of the cycA::gfp fusion
and indicates that the DNA sequence of the gcvB gene itself has no effect on regulation of cycA
(Fig. 4.10A and B, number 8).
Next, the impact of the two internal stem-loop structures SL2 and SL3 on GcvB regulation was
examined, but their deletion had also no influence on repression of the cycA::gfp fusion (Fig. 4.10A
and B, 9 and 10). As both proposed interactions in Figure 4.8B cover extended regions includ-
ing consensus R1 and R2, deletion of R1 and R2 might not be sufficient to abolish cycA::gfp
regulation, and thus, 5’ end and 3’ end truncations were combined with R2 or R1 deletions, re-
spectively. However, also these GcvB truncations still regulated cycA (Fig. 4.10A and B, 11 and
17, pPLgcvB5’∆&∆R2 and pgcvB∆R1& 3’∆T). Even further shortened GcvB mutants, where only
SL1, SL4, and SL5 (pPLgcvBSL1, SL4 & SL5) or consensus R2, SL4, and SL5 (pPLgcvBR2, SL4 & SL5)
were present, did not abolish cycA regulation (Fig. 4.10A and B, 12 and 13). A plasmid habour-
ing only SL4 and SL5 (pPLgcvBSL4 & SL5) turned out to be instable (data not shown). Although
in plasmid pPLgcvBR2, SL4 & SL5 already 134 nt of GcvB are deleted, it could still form the second
proposed interaction which involves base-pairs between consensus R2 and the cycA SD sequence
and a second helix that was confirmed by structure probing (Fig. 4.8B, red interaction). To dis-
rupt these interaction sites, a single-nucleotide exchange was introduced in each of these helices
(pPLgcvBM2, R2, SL4 & SL5). Although this led to a slight loss of regulation (Fig. 4.10A and B, 14),
the GcvB fragment seems to be still able to bind to cycA mRNA. Similarily, deletion of residues
66-177 (pPLgcvBSL1 & SL5) leads only to a partial loss of regulation, although both proposed inter-
action regions are completely deleted (Fig. 4.10A and B, 15). This indicates that GcvB probably
carries multiple sites which can interact with cycA mRNA.
However, further deletion of the first 12 nt from the 5’ end in allele gcvB∆5’12nt,SL 1 & 5 leads to a
complete loss of regulation (Fig. 4.10A and B, 16). Similarily, deletion of these 12 first nucleotides
from the pgcvB∆R1& 3’∆T plasmid resulting in allele pgcvB5’∆12nt,∆R1 & 3’∆T, abolished more than
half of the cycA regulation (Fig. 4.10A and B, 18). The first 12 nt from the 5’-end of GcvB RNA are
predicted to bind to the SD sequence of cycA (Fig. 4.10B). Single base-pair mutations at position
3, 8, or 11 introducted into the gcvBSL 1 & 5 allele are sufficient to abrogate regulation by the GcvB
mutant RNA (Fig. 4.10D). Overall, this indicates at least three major GcvB interaction sites for
binding of cycA mRNA around the SD sequence.
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Figure 4.10: Diverse GcvB mutants can regulate cycA. (A) Agar plate-based assay of colony fluorescence
of E. coli ∆gcvB recA− strains carrying the cycA::gfp (pJL30-14) fusion in combination with control vec-
tor pTP11 (1), or plasmids expressing Salmonella wild-type GcvB RNA (pPLgcvB) (2), a promoter deletion
mutant gcvB∆PL (8), or 15 of the gcvB mutant alleles (2-7, and 9-18). (B) Regulation of cycA::gfp expres-
sion by the different mutant RNAs was quantified by FACS analysis. E. coli ∆gcvB recA− strains carrying
the cycA::gfp reporter in combination with the sRNA plasmids were grown for 14 hours and analyzed by
FACS. Reporter activity is given in arbitrary units (relative GFP fluoresence) and plotted as average from
two independent experiments including error bars. Blue numbers indicate sRNA plasmids as in (A). (C)
Proposed interaction between the first 12 nucleotides of GcvB RNA and the cycA SD sequence (indicated by
bold letters). Single base-pair exchanges that were introduced in GcvB at position 3, 8 and 11 are indicated
by arrows. (D) E. coli ∆gcvB recA− strains carrying the cycA::gfp reporter in combination with the control
plasmid pTP011, or plasmids carrying the gcvB wild-type or mutant alleles, gcvBSL 1 & 5, gcvB∆5’12nt,SL1 & 5,
and single base-pair exchanges in gcvBSL1 & 5, were grown for 14 hours and analyzed by FACS. Reporter
activity is given in arbitrary units (relative GFP fluoresence) and plotted as average from two independent
experiments including error bars.
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Figure 4.11: GcvB inhibits 30S binding to cycA mRNA in vitro. (A) An in vitro synthesized cycA::gfp
fusion mRNA fragment was used in the toeprint assay. The SD sequence is indicated by a box. Uppercase
letters indicate the coding sequence, whereof bold letters correspond to the cycA fusion part and plain letters
to the gfp fusion part, respectively. (B) Ribosome toeprinting of cycA::gfp leader RNA (20 nM) as described
in Material and Methods. ‘+/-’ indicate the presence or absence of 30S subunit (200 nM) and fMet initiator
tRNA (1 µM). The cycA::gfp AUG start codon position is shown. The arrow indicates the 30S toeprint.
Increasing concentrations of GcvB RNA (lanes 4-6: 20, 100 and 200 nM) in the reactions inhibit 30S binding
whereas the unspecific control RNA, MicA (lane 10, 200 nM) does not impair binding. Mutant RNAs
GcvB∆R1, GcvB∆R2, and GcvB3’∆ (lanes 7-9) were added at a final concentration of 200 nM. Fold-repression
values for the different GcvB forms and concentrations are given below the gel.
4.1.8. GcvB inhibits translation initiation of cycA mRNA in vitro
GcvB RNA can bind with multiple sites near the Shine-Dalgarno sequence of cycA (Fig. 4.8B and
4.10C), and was thus predicted to prevent ribosome binding to this mRNA. To test this, 30S ri-
bosome toeprinting assays (Hartz et al., 1988) were performed. A cycA 10th::gfp fusion mRNA
fragment (10th amino acid of cycA was fused to gfp, Fig. 4.11A) was annealed to an end-labelled
primer complementary to the cycA::gfp coding region (+68 to +92), and incubated with 30S sub-
units in the presence or absence of uncharged tRNAfMet, followed by cDNA synthesis. Analysis
of the extension products (Fig. 4.11B) revealed one ribosome-induced, tRNAfMet-dependent termi-
nation site at the characteristic +15/+16 positions (start codon A is +1). This ‘toeprint’ signal was
decreased when increasing concentrations of wild-type GcvB RNA were added prior to incubation
with 30S/fMet (lanes 4-6), suggesting inhibition of 30S binding. In contrast, the unrelated MicA
RNA (lane 10) did not inhibit ternary complex formation.
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Inhibition was also observed with the GcvB∆R1, GcvB∆R2 and GcvB3’∆ mutant RNAs, but to a
lesser extent (lanes 7-9). Specifically, a 10-fold excess of GcvB wild-type reduced 30S binding to
the cycA 10th::gfp fusion mRNA ≈ 7-fold, whereas the mutant RNAs GcvB∆R1, GcvB∆R2, and
GcvB3’∆ reduced 30S binding only 4.6-, 2.9-, and 4.8-fold, respectively. Although this indicates
different binding affinities of the different GcvB variants to cycA mRNA, probably all of them act
as inhibitors of translation initiation by masking the cycA RBS.
4.2. Discussion
It has become increasingly clear that bacterial sRNAs regulate multiple rather than individual
mRNAs. Early studies often focussed on the regulation of a single target for a given sRNA; in fact,
ompF mRNA has remained the only investigated target of MicF sRNA in 25 years (Mizuno et al.,
1984). However, several studies in E. coli and Salmonella revealed extended regulatory networks
that rely on multiple-targeting by bacterial sRNAs (see Section 2.5). For example, the OmrA/B
and RybB were reported to target multiple mRNAs that collectively encode for outer membrane
proteins (Guillier & Gottesman, 2006; Johansen et al., 2006; Papenfort et al., 2006) or the iron
stress-responding E. coli RyhB sRNA was shown to regulate multiple mRNAs that encode pro-
teins involved in iron metabolism (Masse´ & Gottesman, 2002). Though, due to the low number
of validated sRNA-target interactions the mechanistic details of how sRNAs could directly con-
trol multiple mRNAs by antisense mechanism have remained largly unclear. In addition, reliable
prediction of new targets is still a challenging task.
In the previous Chapter it was shown that GcvB RNA from Salmonella directly interacts by a
highly conserved G/U rich region with C/A-rich elements in the 5’ UTRs of seven ABC-transporter
mRNAs and thereby represses translation. The approaches for the identification of GcvB targets in
the previous Chapter were restricted to periplasmic proteins, as E. coli GcvB RNA has been shown
to regulate several periplasmic transporters (Urbanowski et al., 2000). Here, an extended search
for additional GcvB targets by global analysis of mRNA changes on microarrays after GcvB pulse-
overexpression was undertaken to analyse the GcvB regulon. Pulse-overexpression of sRNAs has
previously been used for the successful identification mRNA targets (Section 2.4.1.2). In addition to
wild-type GcvB RNA, also global mRNA changes upon pulse-expression mutant RNAs lacking the
consensus sequences R1 and R2 were analysed. In these GcvB microrray experiments, almost half
of the known GcvB targets from the previous Chapter (dppA, oppA, and gltI) were downregulated by
GcvB along with the downstream genes of the corresponding operons (Table 4.1). Furthermore, the
previously characterized R1-dependent regulation of these targets was also visible in the microarray
experiments as regulation of these targets was abolished upon pulse-expression of the GcvB∆R1
mutant (Table 4.1, compare columns ‘∆gcvB + GcvB’ and ‘∆gcvB + ∆R1’). In contrast, pulse-
expression of the GcvB∆R2 mutant RNA leads to comparable mRNA changes as for GcvB wild-type
(Table 4.1, compare columns ‘∆gcvB + GcvB’ and ‘∆gcvB + ∆R2’), except for gltI mRNA which
is ≈ 2-fold more downregulated upon pulse-expression of the GcvB∆R2 mutant RNA. Deletion of
R2 could change the affinity of GcvB for several other targets by removing an additional binding
site and increase the affinity for this target.
Pulse-expression of the sRNA should avoid the pleiotropic effects that can be expected to result
from constitutive sRNA expression and allows identification of direct targets, i. e. mRNAs which are
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directly bound by a given regulatory RNA due to short expression times. For example, chromosomal
GcvB itself showed an≈ 2-fold increase after arabinose addition, however, induction of GcvB RNA
from the plasmid led to ≈ 2.5-fold higher level than the chromosomal GcvB after 10 min. Thus the
pulse-expression is probably comparable to wild-type gcvB expression. This is also reflected by
≈ 7-fold changes for dppA and oppA mRNAs by chromsomal GcvB RNA compared to ≈ 13-fold
and ≈ 18-fold changes by GcvB wild-type expressed from the pBAD-plasmid (Table 4.1).
In addition, similar levels of regulation by chromosomal GcvB RNA were observed in the mi-
croarray experiment (Table 4.1, dppA: -6.8-fold, oppA: -7.3-fold, and gltI: -4.2-fold) compared to
the fold-changes determined by quantitative real-time (qRT) PCR in Figure 3.13C in Section 3.1.4
(dppA:≈ 12-fold, oppA:≈ 8-fold, and gltI:≈ 6-fold). In contrast, livJ and STM4351 which showed
≈ 6-fold and 4.5-fold downregulation by GcvB in the qRT-PCR experiment (Figure 3.13C) are not
or only slightly (-1.6-fold for STM4351) downregulated in the microarray experiment. This might
be due to different or low expression of these genes in the growth conditions used for these exper-
iments (OD600=1 in the microarray and OD600=0.4 for qRT PCR, respectively). Both remaining
known targets, argT and livK, did also not reach the 2-fold threshold in all microarray experiments.
However, as these genes showed also only slight mRNA changes in the qRT PCR in Figure 3.13C,
GcvB probably mainly inhibits translation of these genes without promoting RNA degradation.
Including also the GcvB mutant RNAs in the pulse-expression approach, allowed to identify further
consensus R1-dependent targets. All R1-dependent targets from the previous Chapter are bound
at C/A-rich regions by GcvB RNA and also the new targets from the microarray approach were
predicted to have C/A-rich target sites. Thus this extendend set of R1-dependent targets was used to
define a consensus motif for the GcvB R1 target site using MEME. Motif-searches for the presence
of the consensus motif in the 5’ regions of all Salmonella RNAs in combination with predictions for
potential interactions using RNAhybrid (Rehmsmeier et al., 2004) clearly improved target predic-
tions and revealed additional R1-dependent GcvB targets. In total, >30 potential GcvB consensus
R1-dependent targets were identified in the two approaches, whereof at least ten could be validated
by Western blots or FACS analysis of GFP reporter-gene fusions (cycA, ygjU(sstT), gdhA, yaeC,
ilvC, thrL, iciA, ybdH, serA, and brnQ,). Recently, additional GcvB targets were also described
in E. coli (Pulvermacher et al., 2009a,b) based on a microarray analysis of RNA isolated from
wild-type and a gcvB deletion strain in a comparable growth condition as in this study. A large
overlap of regulated genes was found between E. coli and Salmonella indicating a conserved reg-
ulatory function of GcvB RNA. Specifically, the L-serine and L-threonine transporter sstT (ygjU)
is also repressed in E. coli (Pulvermacher et al., 2009b), but also gdhA, serA, ilvB, and ilvC were
up-regulated besides the previously known targets in the E. coli gcvB deletion strain (Pulvermacher
et al., 2009a).
For some of the targets, e. g., asd derived from the microarray data (Fig. 4.3), regulation could not
be confirmed by GFP-fusions although the fusion contained a region which was predicted to interact
with GcvB (Fig. 4.4A). Thus, either it is not a direct target or the cloned region is not sufficient for
GcvB binding. For example, OxyS RNA binds fhlA mRNA at two interaction sites (Altuvia et al.,
1998). The 5’ parts of the putative GcvB targets that were cloned in the GFP-fusions started at tran-
scriptional start sites identified by 5’RACE or at promoters derived from the literature. However,
alternative transcriptional start sites could lead to longer/ shorter transcripts which are targeted by
GcvB. Transcripts of different length could also fold into different secondary structures which could
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be necessary for efficient GcvB binding. For some GFP fusions, regulation was observed by moni-
toring colony-fluorescence on agar plates but not in Western blot or FACS experiments. One reason
for these discrepancies in regulation could be the different growth conditions between agar plates
and liquid cultures, which were used for Western blot and FACS analysis. In addition, expression
of an additional trans-acting factor, such as Hfq, could be required for regulation. Furthermore, the
constitutive expression of the sRNA could lead to pleiotropic effects, such as Hfq titration which
was previously reported for OxyS RNA (Zhang et al., 1998) and is also proposed for SraH RNA
in Salmonella (K. Papenfort and J. Vogel, unpublished). This could unintentionally change the sta-
bility of other sRNAs that are expressed under a specific growth condition which in turn affects
the expression of their target mRNAs. In addition, the expression of larger sets of genes can be
altered by targeting the mRNAs of global transcriptional regulators, e. g. RpoS or FhlA (Argaman
& Altuvia, 2000; Lease et al., 1998; Majdalani et al., 1998).
Regulation of one target that was identified in the microarray experiment, cycA mRNA, turned
out to be independent of the G/U-rich consensus R1, which is strictly required for regulation of
all other identified targets. Furthermore, it turned out that diverse GcvB mutants are still able to
repress cycA mRNA, indicating multiple, alternative binding sites within GcvB RNA for this target.
Toeprinting analysis confirmed that GcvB RNA can directly inhibit translation initiation of cycA
mRNA. In addition, cycA was also identified in the above mentioned microarray-based approach as
a GcvB target in E. coli (Pulvermacher et al., 2009a). In the same study it turned out that diverse
mutations within GcvB RNA have no impact on cycA regulation. Here, at least three independent
binding sites could be identified within GcvB RNA but it is not clear which of the different binding
sites actually bind the cycA mRNA in vivo. The fact that diverse GcvB mutants are still able to
repress the cycA::gfp fusion mRNA to the same level could be an effect of the overexpression
from the plasmid. Whereas regulation of the cycA::gfp fusion mRNA seems to be comparable
for, e. g., GcvB wild-type and the R1 and R2 deletion mutants, toeprinting analysis indicated a
reduced inhibition of translation initiation by the mutant RNAs. Further toeprinting experiments,
with several of the shorter GcvB mutants could give additional hints at the amount of regulation
by the different fragments. Furthermore, integration of the different mutants into the Salmonella
chromosome under control of the native gcvB promoter could help to avoid these overexpression
effects.
The cycA gene is particularly interesting as a GcvB target because of its function as a glycine
transporter. Stauffer & Stauffer (2005) showed that the transcriptional activator GcvA binds to a
single region in the gcvB promoter and binding of GcvA to this region is required for both GcvA-
mediated activation in the presence of glycine and GcvA-GcvR mediated repression in the absence
of glycine in the medium. Regulation of cycA might be important as it is a glycine transporter, and
thus regulation might provide a negative feedback/autoregulatory loop for GcvB expression which
will be the subject of further investigations.
Besides several downregulated targets, a large fraction of genes was upregulated in the different mi-
croarray sets. Especially the pyr genes showed strong elevations in mRNA levels (up to ≈ 90-fold)
upon GcvB pulse-expression (Table 4.1). However in qRT PCR experiments, the amount of, e. g.,
pyrB mRNA, was not significantly changed in a gcvB deletion strain compared to the Salmonella
wild-type strain indicating these genes as false-positives (data not shown). Furthermore, these genes
and also, e. g., the fim genes are known to be highly sensitive to small changes in growth conditions
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as they show aberrant changes in diverse microarray experiments (K. Papenfort and S. Lucchini,
personal communication). Thus, these genes have a higher probability of being false positives and
were therefore excluded from further analysis. Nevertheless, it could be intersting to test if several
of the other activated genes are directly upregulated by GcvB RNA as sRNA-mediated activation
seems to be more widespread than previously anticipated. Besides the first example, DsrA, sev-
eral other sRNAs have been shown to activate gene expression, e. g., by disrupting an inhibitory
secondary structure which masks the ribosome binding site and thereby prevents translation in the
absense of the sRNA (see Section 2.1.2). Also in E. coli, diverse genes were upregulated by GcvB
RNA, but none of them overlapped with the genes identified in this study (Pulvermacher et al.,
2009a).
Pulse-expression of the GcvB consensus R2 deletion mutant changed the expression of >150
mRNAs which were not regulated in the three other microarray sets (Fig. 4.2). Although further
evidence was obtained for regulation of some of these targets (e. g. ndk and serA), most of these
targets are probably due to ‘off-target’ effects. The effect of ‘off-targeting’ has also been observed
for siRNAs as a sequence-specific effect by binding unintended transcripts in eukaryotes. This un-
specific binding cannot be reliably predicted nor avoided as there is relatively high tolerance for
mismatches between a short RNA and its target, leading to undesirable regulation of further targets
(Svoboda, 2007). This could also be the case for the GcvB∆R2 mutant, where the pulse-expression
could result in unspecific binding of many mRNAs by the G/U-rich region R1 which allows several
wobble-base-pairs in addition to canonical Watson-Crick pairing. Thus, consensus R2 might have
a function in discrimination of actual GcvB targets from ‘off-targets’, whereas most of the target
affinity is determined by consensus R1. This implies conserved domains with different functions in
GcvB RNA. Furthermore, only one R2-dependent operon (STM4535 to STM4540, encoding for a
putative PTS permease system and a putative glucosamine-fructose-6-phosphate aminotransferase)
that is downregulated by GcvB RNA was detected in the microarrays (Table 4.1). Whether these
are really direct targets of GcvB RNA and if R2 is strictly required for binding remains to be further
investigated. In eukaryotes, it was shown that transcriptional repression by Alu RNA during the cel-
lular heat shock response involves two loosely structured domains that are modular (Mariner et al.,
2008). Also RNAIII from S. aureus is a bifunctional molecule that encodes the δ-hemolysin protein
in its 5’ end while it also acts as a noncoding regulatory RNA, primarily with its 3’ domain (Boisset
et al., 2007; Huntzinger et al., 2005; Janzon et al., 1989). Similarly, SgrS RNA, which is expressed
in E. coli during glucose-phosphate stress, encodes a short ORF within its 5’ end, whereas the 3’ end
mediates target interaction with ptsG mRNA (Kawamoto et al., 2006; Wadler & Vanderpool, 2007).
Thus, a modular architecture consisting of multiple functional domains, a property reminiscent of
classical protein transcriptional regulators, can also be found in RNA regulators.
Conserved subregions, or ‘domains’, in sRNAs which harbour critical residues for multiple inter-
actions seem to be more widespread than previously anticipated. These conserved domains can be
an internal region such as the highly conserved G/U rich region of GcvB RNA which directly in-
teracts with C/A-rich elements in the 5’ UTRs of seven ABC-transporter mRNAs from Salmonella.
Also, CyaR RNA uses a conserved internal region with an almost perfect anti-SD sequence for
binding of multiple target mRNAs (De Lay & Gottesman, 2009; Johansen et al., 2008; Papenfort
et al., 2008). In contrast, other bacterial sRNAs use a conserved 5’ end to interact with multiple
targets. For OmrA and OmrB, the first nine nucleotides from the 5’ end, which are conserved be-
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Figure 4.12: GcvB network. GcvB sRNA represses mRNAs of the periplasmic substrate proteins of many
ABC transporters involved in amino acid uptake. Seven targets which have been validated by in vitro struc-
ture probing in the previous Chapter 3 are shown as blue ovals; grey ovals denote additional proteins of
transport systems or with roles in amino acid biosynthesis, and whose synthesis has been shown to be di-
rectly regulated by GcvB in Salmonella. The preferred amino acid, di- or oligopeptide substrates of relevant
periplasmic binding proteins are shown in yellow ovals. Control of the gcvB gene by two transcription factors
(GcvR, GcvA) of the glycine cleavage system is indicated based on extensive work in E. coli by the Stauffer
laboratory (see, e. g., Urbanowski et al., 2000).
yond E. coli and Salmonella, were shown to directly recognize multiple target mRNAs (Guillier
& Gottesman, 2008). Also RyhB RNA uses 16 nt from its conserved 5’ end for direct binding to
multiple OMP mRNAs (Bouvier et al., 2008; Mika et al., 2009, submitted). The identification of
conserved sRNA parts and limiting the sequence space for sRNA-target predictions to these regions
will clearly improve bioinformatics-based target identification approaches. However, there are now
several mRNAs that are repressed at non-RBS positions, either in the 5’ UTR or CDS, and by a
diversity of recently deciphered mechanisms (Bouvier et al., 2008; Darfeuille et al., 2007; Heidrich
et al., 2007; Vecerek et al., 2007). This leads to larger sequence space for predictions of interactions
within the mRNA part. Therefore, additional features, e. g., whether or not an mRNA is bound by
Hfq (Sittka et al., 2008; Zhang et al., 2003) or the presence of single-stranded regions that could be
accessible for sRNA-target interactions (Busch et al., 2008; Tafer & Hofacker, 2008) will be needed
to improve target prediction algorithms.
One of the newly identified targets, thrL, encodes for the leader peptide of the thr operon. It will
be interesting to see if also the downstream genes thrABC are downregulated by GcvB RNA. This
would be comparable to the case of fur regulation by RyhB RNA (Vecerek et al., 2007). Specifically,
the fur gene is co-transcribed with an upstream ORF (uof ) and translation of the uof is a requisite
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for Fur protein synthesis. RyhB RNA targets the RBS of this upstream located short ORF and
constitutes a new paradigm of sRNA action. Similarily, the ThrL leader peptide controls expression
of the thrLABC operon, which encodes four out of the five enzymes of threonine biosynthesis
pathway, by an attenuation mechanism in response to threonine and isoleucine levels in E. coli
(Lynn et al., 1982). Thus, translational inhibition of thrL by GcvB RNA is very likely to affect also
the downstream operon.
The global target identification approaches showed that GcvB targets not only periplasmic trans-
porters but also genes that are involved in amino-acid metabolism. As almost all of the previous
and newly identified targets constitute amino acid or peptide transporters or genes involved in amino
acid biosynthesis, this argues for a global regulatory role of GcvB RNA in amino acid metabolism
(see Figure 4.12). For this purpose, GcvB regulates several functionally related mRNAs. This has
also been observed for other sRNAs, for example RyhB which regulates multiple genes involved
in iron metabolism (Masse´ et al., 2005). Many of the mRNAs demonstrated to be direct targets of
Staphylococcus aureus RNAIII encode bacterial virulence factors, and OmrA/B and RybB sRNAs
were predicted to directly target multiple mRNAs that collectively encode for outer membrane
proteins (Guillier & Gottesman, 2006; Johansen et al., 2006; Papenfort et al., 2006). Tjaden et
al. (2006) suggested that functional relationship of the proteins encoded by target candidates may
add confidence to biocomputational target predictions. Furthermore, conserved sRNA parts like the
G/U-rich region R1 will help to narrow down the list of target interactions. Increasing numbers of
biochemically mapped interactions will then, in turn, improve target predictions. Overall, multi-
ple mRNA targeting by bacterial sRNA turns out to be more common than previously thought and
could allow bacteria to rapidly regulate functional modules in response to environmental changes.
CHAPTER 5
ANALYSIS OF HFQ-BOUND RNAS IN
Salmonella BY 454 PYROSEQUENCING
Although sRNAs have become an important new mediator of bacterial mRNA regulation, biocom-
putational identfication of novel sRNAs without any conservation information still remains difficult.
Recent advances in high-throughput sequencing (HTPS) technology now allow a thorough analysis
of RNA bound to cellular proteins and, therefore, of post-transcriptional regulons including sRNA
regulators. In bacteria, the majority of sRNAs basepair with target mRNAs to regulate their trans-
lation and/or decay, and these regulatory events commonly require the bacterial Sm-like protein
Hfq (see Section 2.2.1). Hfq interacts with both regulatory sRNAs and mRNAs, and much of its
post-transcriptional function is caused by the facilitation of the generally short and imperfect anti-
sense interactions of sRNAs and their targets (Section 2.1). Furthermore, it is one of the most
abundant RNA-binding proteins in bacteria and almost half of all sequenced Gram-negative and
Gram-positive species, and at least one archaeon, encode an Hfq homologue (Section 2.2.1). Hfq
has an important physiological role in numerous model bacteria, and the pleiotropic effects of an hfq
deletion mutation as well as an impact of Hfq on virulence have been observed in diverse bacteria
(Section 2.2.1). Also in Salmonella, reduced virulence and motility as well as deregulation of more
than 70 abundant proteins have been observed (Section 2.6.1.1). This indicates an important role
of post-transcriptional regulation in Salmonella involving probably also Salmonella-specific sRNA
regulators.
A first step to elucidate the pleiotropic Hfq effects involves the identification of small regulatory
RNAs that are involved in the post-transcriptional regulons. Several systematic screens have been
developed to identify small RNAs in bacteria (see Section 2.3). However, the bioinformatics-based
approaches often rely on the prediction of orphan transcription signals and primary sequence con-
servation of putative sRNA candidates within closely related species or on conservation of RNA
structure (Section 2.3). For some bacteria, the lack of available genome sequences of related bac-
teria does not allow a thorough conservation analysis. Furthermore, RNAs with a potential role
in virulence are probably species-specific due to adaptation to different hosts. Therefore, de novo
identification of sRNAs remains a major task.
In Salmonella, diverse sRNAs have been identified. Many of the Salmonella sRNAs, such as GcvB
RNA which was described in the two previous Chapters, were initially identified in E. coli (see
Section 2.6.1.2). As 25% of the total genetic material has been laterally acquired since Salmonella
diverged from E. coli (Porwollik & McClelland, 2003), these Salmonella-specific regions could
probably encode new sRNAs or other RNA elements that are absent in E. coli. Two bioinformatics-
based studies (Padalon-Brauch et al., 2008; Pfeiffer et al., 2007) predicted Salmonella-specific
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sRNAs, which led to the discovery of the first sRNA from an enterobacterial pathogenicity island,
i. e. the 80 nt InvR RNA that is expressed from the invasion gene locus, SPI-1 (Pfeiffer et al., 2007).
Padalon-Brauch et al. (2008) showed expression of 19 island-encoded sRNAs under a large panel
of growth conditions reminiscent of the environments encountered by Salmonella upon host cell
infection. Both studies predicted additional Salmonella sRNA candidates that remain to be verified
experimentally.
One strategy to find novel sRNAs is to look for the sRNA binding partners of known RNA-
binding proteins (see Section 2.3.8). As one of the key players in sRNA-mediated regulation,
Hfq, is highly conserved in a wide range of bacteria, this protein is a perfect candidate for co-
immunoprecipitation of bound RNAs. In a pioneering global study in E. coli, Zhang et al. (2003)
used co-immunoprecipitation with Hfq-specific antisera and direct detection of the bound RNAs on
genomic high-density oligonucleotide microarrays. Although this method proved highly effective
for detecting diverse sRNAs and mRNAs in E. coli, the requirement of high-density microarrays
and specialized antibodies has hampered similar studies in other bacteria. An alternative approach
identified individual abundant Hfq-associated RNAs by cDNA cloning or direct sequencing (Antal
et al., 2005; Christiansen et al., 2006); however, these methods are not appropriate for large-scale
analyses due to technical and cost limitations of the conventional Sanger sequencing.
To overcome these limitations for the global identification of Hfq targets in Salmonella in this
work high-throughput sequencing of RNA associated with an epitope-tagged Hfq protein was used
which allows parallel sequencing of hundreds of thousand cDNAs in one sequencing run. Deep
sequencing analysis of ≈ 350,000 cDNAs, derived from RNA co-immunoprecipitation (coIP) with
epitope-tagged Hfq or a control coIP, recovered Hfq-binding sRNAs with high specificity and iden-
tified their boundaries with unprecedented resolution. Additionally, many conserved enterobacterial
sRNA genes as well as novel Salmonella sRNA genes could be detected. In total, the cDNA analysis
more than doubled the number of sRNAs known to be expressed in Salmonella to 67. Furthermore,
727 genes mRNAs were identified whose transcripts are Hfq-bound in vivo. The complete study
including also analysis of Hfq-bound mRNAs and validation of the sequencing data by hybridiza-
tion of Hfq-coIP cDNA on high density microarrays has been previously published in Sittka et al.
(2008). Furthermore, it includes a transcriptomic analysis of Salmonella wild-type and hfq deletion
mutant strains on microarrays.
In future, the combination of epitope-tagging and HTPS of immunoprecipitated RNA will allow the
characterization of sRNAs and mRNAs in different genetic backgrounds or in bacteria grown under
various environmental conditions. This approach overcomes the limited availabilty of high-density
microarrays that have constrained expression-based sRNA discovery in microorganisms. Thus, this
strategy is ideal for the global analysis of the post-transcriptional regulons of RNA-binding proteins
and for sRNA discovery in a wide range of genetically tractable bacteria.
5.1. Results 91
wild-typecells hfq
FLAG
cells
make extract
coIP with -FLAG antibodya
extract RNA
convert to 5'P RNA, polyadenylation,
5' linker ligation, cDNA synthesis
pyrosequencing (170,000 cDNAs per library)
to detect Hfq-associated RNA
Identify genes directly bound by Hfq
Figure 5.1: Deep sequencing strategy to identify Hfq-bound RNAs. RNA was co-immunoprecipitated
with Hfq in extracts from ESP-grown Salmonella cells (wild-type and chromosomal hfqFLAG strain) using an
anti-FLAG antibody. The extracted RNA was converted to 5’ monophosphate RNA, and subsequently into
cDNA, followed by direct pyrosequencing. (Figure was adapted from Sittka et al., 2008.)
5.1. Results
5.1.1. Experimental setup for deep sequencing of Hfq-associated RNAs
The pleiotropic effects of an hfq mutant indicate the existence of a variety of transcriptional reg-
ulons that show Hfq-dependent expression patterns which are either mediated by the binding of
certain regulatory sRNAs or of specific mRNAs by Hfq. As a first step to unravel the Hfq regu-
lon, the RNAs that are directly bound by Hfq have to be identified. For this purpose, RNA was
co-immunoprecipitated with the chromosomally FLAG epitope-tagged Hfq protein expressed by a
Salmonella hfqFLAG strain (Pfeiffer et al., 2007) and the Hfq-bound RNAs were analysed by deep
sequencing (see Figure 5.1). Co-immunoprecipitation was performed with an α-FLAG antibody
in extracts prepared from early stationary phase (ESP)-grown bacteria of a Salmonella wildtype
(coIP-Ctr) and the hfqFLAG strain (Hfq-coIP). The Hfq-associated RNA was converted to 5’mono-
phosphate RNA by treatment with tobacco acid pyrophosphatase (TAP). Upon 5’-linker ligation and
poly(A) tailing RNA was converted into cDNA, and a total of ≈ 175,000 cDNAs for each library
pooled from two independent biological experiments was then characterised by high-throughput
pyrosequencing (Margulies et al., 2005).
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Figure 5.2: Work flow for the analysis of 454 sequencing data. Several Perl scripts have been developed
for the analyses of 454 sequencing data. The work-flow including input files and generated output files is
shown. The general analysis steps are indicated in red, genome sequence or annotation files in green, and
output files in black. The developed Perl scripts are framed in black.
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5.1.2. Biocomputational analysis of 454 data
After sequencing different libraries together in a 454 sequencing run, first the source of each read
from the multiplex samples has to be determined by the help of specific barcode sequences that were
attached to the 5’ adaptor sequence during cDNA synthesis. Furthermore, 5’end linker sequences as
well as poly(A)-tails have to be clipped from each read. After removal of short sequences, the next
step in the bioinformatics analysis is alignment against a reference genome sequence, in this case
Salmonella enterica subsp. enterica serovar Typhimurium str. LT2, as the SL1344 sequence is not
annotated yet. Finally, visualization of mapped reads in an appropriate genome browser as well as
determining how many reads overlap annotated genes are subsequent steps in the 454 sequencing
analysis pipeline.
For this purpose, several Perl1 (Practical Extraction and Report Language) scripts were developed.
Figure 5.2 gives an outline of the analysis workflow. The scripts are explained in more detail in the
following sections.
5.1.2.1. Removal of 5’ end linker sequences and poly(A) tails
During 454 sequencing, several libraries, that can be distinguished by their specific 5’ linker tags,
were mixed together. From this mixed 454 run, reads for the Hfq-coIP library (Hfq-coIP) and a
control library (coIP-Ctr) could be identified via their specific 5’ linker 4-mer barcode tags: ‘CGCA’
and ‘GCTC’, respectively.
A typical 454 read looks as follows:
tag 5’-adapter cDNA insert (1-800nt) polyA-tail 3’-adapter
5’-CTNNNNGACCTTGGCTGTCACTCANNNNNNNNN...NNNNNNNNNNNAAAAAAA...AAAAAAAGCGGGGCGATGTCTCGT-3’
The four ‘N’ nucleotides indicated in bold correspond to the 4-mer barcode tag which was attached
to the 5’ end linker and which is specific for each library. For long inserts, reads are often not long
enough to reach the poly(A) tail and 3’-adaptor due to 454 sequencing length limitations. Thus,
reads can either cover the full 3’-end adaptor or end at any point within the insert, poly(A)-tail or
3’-adapter.
To sort out reads for a specific library from a 454 run with mixed libraries, a Perl script
clip linker.pl was written which extracts reads for a given tag and in the same step clips
the 5’end linker and poly(A) tail sequences. The usage is as follows:
1 www.perl.org
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Usage:
clip_linker_seq.pl extracts sequences with a specific 4-mer linker tag
out of a multi-FASTA file from a 454 run with mixed libraries.
In addition 5’end linker sequences and poly(A) tails will be clipped.
If the option -l all is specified, all sequences will be clipped and
not only those with a specific linker tag.
clip_linker.pl -f 454_sequence_file.fasta -l linker_tag (4mer) [-p prefix outfile]
[-o] [-t]
Options:
-f 454_sequence_file.fasta
-l linker_tag (4mer)
[-p prefix outfile]
[-o] clips only 5’end linker sequences
[-t] clips only poly(A) tail
[-h] print this message
The script generates an outfile *.inserts in plain Vienna format with all clipped inserts of reads
that contained the user defined tag. In case only one library was sequenced in the 454 run, the
barcode identification is not necessary and all sequences can be clipped by the option -l All.
Identification of 5’end linker and poly(A) tails is achieved by a pattern search (Dsouza et al., 1997).
For example, for the specified tag ‘CGCA’, clip linker.pl calls the pattern matching program
Patscan2 with the following nucleotide pattern:
%Patscan Pattern for 454 sequencing data
CTCGCA
GACCTTGGCTGTCACTCA[1,1,1]
1...3000
( (AAAAA 1...15 AAA[1,0,0] (G | 0...0) CGGGGCGATGTCTCG[1,1,2] | AAAAA AAAAAAAAA[1,0,0] )
\ | ( AAAAA AAAAAAAAA[0,0,1] | AAAAA AAAAAAAAA[1,1,0]))
The user specified 4-mer tag is indicated in bold and will be set during each run of the script
according to the user defined sequence. The first part of the pattern recognizes the 5’ linker, the
middle part the insert, and the last part defines several alternative patterns for recognition of the
poly(A) tail alone or in combination with the 3’ adapter. As mentioned above, some reads do not
reach the poly(A)-tail. To recognize also these reads with the above specified pattern, an artifical
poly(A)-tail A25 is added to every read before the pattern search is started. Thus, for reads without
poly(A)-tail the whole read down to its 3’end will be taken after clipping.
5.1.2.2. Read length distribution
To get an overview of the cDNA insert lengths distribution for a single library or a complete run,
the script lengths statistics.pl counts the observed read lengths for a given insert file. It
is used as follows:
2 http://www-unix.mcs.anl.gov/compbio/PatScan/HTML/patscan.html
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Usage:
seq_length_statistics.pl counts the read length for each sequence of a given insert file.
In addition it generates a text output file with the corresponding insert length
distribution.
statistics_for_sequences.pl -f inserts_file
Options:
-f inserts_file
[-h] print this message
It produces two text output files. The first one (* lengths.txt) lists for each read the actual
sequence number, name, length, and sequence:
Number Name Length Sequence
1 >000021_2729_0305:[6,67] 27 TTCCAGAGTTCGAATCTCTGCGAACTT
2 >000011_2713_0289:[6,70] 30 GGTGAGGTGTCCGAGTGGCTAGAAGGAGAC
3 >000012_2717_0300:[6,108] 67 TTAGGCATTAACGGGAACCGGAGCGTTCCCGATTCACCATGGATGGCCTTTTCGG
4 >000015_2740_3628:[6,105] 66 TAAATTGAAGAGTTTGATCATGGCTCAGATTGAACGCTAGGCGGC
...
The second one (* distribution.txt) contains the read length distribution:
Total number of sequences: 15384
Sequence_length Number_of_sequences Per_mille_reads_of_library
1 5 0.3250130005
2 1 0.0650026001
3 2 0.1300052002
4 16 1.0400416017
5 74 4.8101924077
6 94 6.1102444098
7 144 9.3603744150
8 210 13.6505460218
...
5.1.2.3. Removal of short reads
As very short sequences can not be specifically mapped to the genome, a script which sorts out the
sequences according to a user defined threshold l was developed. The usage is as follows:
Usage:
Sort_out_short_sequences.pl sorts out sequences with a length shorter than
a user defined threshold
Sort_out_short_sequence.pl -f inserts_file -l length cut-off[nt]
Options:
-f inserts_file
-l length cut-off[nt]
[-h] print this message
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For the analysis of the Salmonella Hfq-coIP and coIP-Ctr libraries, a threshold of 18 bp was
selected based on some initial BLAST test searches with reads of different lengths against the
Salmonella genome. The script Sort out short sequence.pl produces two output files of
which * less 18nt.inserts contains all sequences with a length shorter than the user defined
cut-off l (here 18 bp) and * min 18nt.inserts all sequences with a length ≥l, respectively.
5.1.2.4. Read mapping to a reference genome
After linker clipping and removal of short reads, the sequence reads have to be aligned to a reference
sequence, usually a reference genome. Here, the best-known pairwise alignment algorithm, BLAST
(Basic Local Alignment and Search Tool) was selected for mapping. It uses a seed-and-extend
strategy, whereby alignments that are extended form short, identical seed substrings. Although this
approach does not work well for short query sequences that contain mismatches, it works quite well
for alignment of 454 sequencing results as these produce on average longer reads compared to other
sequencing methods like Solexa3 and Solid4.
Here, all reads ≥18 nt were mapped to the Salmonella genome (NC 003197) using WU-Blast5
2.0 with the following parameters:
% blastn database * min 18nt.inserts -B=1 -V=1 -m=1 -n=-3 -Q=3 -R=3
\ -gspmax=1 -hspmax=1 -mformat=2 -e=0.0001
which have the following meanings:
• −B = 1 maximal number of database sequences to report alignments from
• −V = 1 maximal number of reported alignments for a given database sequence
• −m = 1,−n = −3 match, mismatch scoring system
• −Q = 3 penalty score for a gap of length 1
• −R = 3 penalty score for extending a gap by each letter after the first
• −gspmax = 1 max. number of gapped high-scoring pairs (GSPs) saved per subject sequence
(default 0; 0→ unlimited)
• −hspmax = 1 max. number of ungapped HSPs saved per subject sequence (default 1000; 0
→ unlimited)
• −mformat = 2 specifies tabular output format (default 1)
• −e = 0.0001 Expectation value (E) [Real] default = 10.0
3 www.illumina.com
4 solid.appliedbiosystems.com
5 http://blast.wustl.edu/
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Note that with these settings only the highest-scoring hit (first hit in the BLAST table) was reported.
This means that for reads matching to multiple locations in the genome only the first hit was consid-
ered. As a read corresponds to a transcript which can only derive from one location of the genome,
this approach was taken to simplify the counting of mapped reads and overlaps to annotations later
on.
5.1.2.5. Overlaps to annotations
Next, the questions how many reads overlap to annotated genes and what are the fractions of e. g.
rRNA, tRNA, mRNA etc. in the Hfq-coIP and coIP-Ctr libaries were addressed. Therefore, a
script called overlaps blast table to annotations.pl with the following usage was
generated:
Usage:
overlaps_blast_table_to_annotations.pl sorts out any specified annotated genes like
tRNAs and rRNAs from tabular WU-Blast output file and also sequences with no blast
hit if the option -n is specified.
The blast input file has to be a WU-Blast output file in tabular format (-mformat=2).
The annotation file can be either in *.rnt or *.ptt format and has to be specified by
the option -a annotation.rnt/ptt OR in tabular text format and has to be specified by
-t annotation.txt.
The tabular format contains the following fields separated by tab:
Product_name Start End Strand Length GeneID Locus Locus_tag Links
Sort_out_annotated_seqs_from_454_sequences.pl
Options:
-i insert_file
-b WU-Blast_file in tabular format (generated by mformat = -2)
-a annotation file in *.rnt (rRNA and tRNA) or *.ptt (mRNA) format with gene
positions of genes that should be sorted out
!OR! option:
-t annotation file in *.txt format with gene positions of genes that should be
sorted out
[-n] write outfile with sequences that have no blast hit
[-l] write also all gene names with 0 overlaps in sense hits
[-p overlap_length (nt)] allows partial overlap for sorting out, p defines
minimum required overlap
[-h] print this message
The script requires an input file with inserts, e. g., * min 18nt.inserts, which is used as in-
put for the WU-Blast mapping, and a second input file with the BLAST results in tabular format
(generated by the option −mformat = 2 by WU-Blast) *.blastn. In addition, a file with
annotations of genes that should be used for the overlap has to be provided. Annotations of tRNAs,
rRNAs, hkRNAs (housekeeping RNAs), and several ncRNAs for Salmonella can be downloaded
from NCBI6 and are listed in the file NC 003197.rnt. Annotations for proteins can be found
in the file NC 003197.ptt, respectively. Annotations in the *.rnt and *.ptt format can be
passed by the option −a annotationfile. In addition, own annotations can be provided as a text
6 ftp://ftp.ncbi.nih.gov/genomes/Bacteria
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file and passed to the program by the option −t annotationfile. For the *.txt annotation file,
the following tab delimited text format is required:
Product Name Start End Strand Length GeneID Locus Locus_tag Links
16S ribosomal RNA 289189 290732 + 1544 1251767 rrsH STM0249 -
Ile tRNA 290800 290873 + 74 1251768 ileV STM0250 -
Asx tRNA 290986 291058 + 73 1251769 alaV STM0251 -
Met tRNA 738643 738716 - 74 1252199 metT STM0679 -
Lys tRNA 818775 818847 + 73 1252271 lysT STM0751 -
...
For the Salmonella Hfq libraries, three files with annotations were compiled in this for-
mat: (1) rRNAs, tRNAs, and hkRNAs (LT2 rRNA tRNA hkRNA.txt), (2) known sRNAs
(LT2 known sRNAs.txt), and (3) predicted sRNAs (LT2 predicted sRNAs.txt), and are
provided in the Appendix (Tables 10.5, 10.6, and 10.7). Furthermore, a user defined cut-off p has
to be specified. The script counts a read x as overlapping to an annotation y if the read is located
within the annotation or at least p nucleotides of the read x overlap with the annotation y. The script
generates four main output files:
1. * pPnt annotation file.sense hits
contains all inserts that are located sense to the annotations in the given annotation file and
overlap the annotation for at least P nucleotides specified by the option −p.
2. * pPnt annotation file.antisense hits
contains all inserts that are located antisense to the annotations in the given annotation file
and overlap the annotation for at least P nucleotides specified by the option −P .
3. * pPnt annotation file.igr
contains all inserts that do not overlap the annotations that have been specified.
4. * pPnt annotation file igr.blast
contains the blast results in tabular format for all inserts that do not overlap the annotations
that have been specified.
In the first two files, overlaps to annotated regions are sorted in decreasing order of number of
overlapping reads. That means, annotations with the highest numbers of overlapping reads are listed
first and also the total number of reads that overlap the annotation is given in the first line of each
overlap. In case the option−n is specified, an additional output file (*.not hit) will be generated
which contains all inserts for which no hit in the BLAST table is provided. The two files *.igr and
*.blastwith the remaining BLAST hits and inserts can then be used as input files for a new round
of overlaps with the next annotation file and so forth. This is helpful when, for example, several
annotations overlap each other at certain genome positions. Furthermore, certain classes of RNAs
can be sorted stepwise, e. g., first very abundant RNAs like rRNAs, tRNA, next mRNAs, and finally
sRNAs. For the Salmonella libraries, first overlaps to rRNA, tRNA and hkRNAs were made, then
for known sRNAs, followed by mRNA annotations, and finally annotations for predicted sRNAs in
Salmonella. To facilitate the extraction of overlap numbers, two more output files are generated,
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*sense hits.numbers and *antisense hits.numbers, which summarize the overlaps
in the following format:
Sense overlap numbers for Hfq_CoIP_mixed_min_18nt_p20_LT2_rRNA_tRNA_hkRNA.txt
STM0249 11209 rrsH
STM0252 11091 rrlH
STM1944 6200 glyW
STM2411 3488 alaX
STM3934 2296 proM
STM0253 2285 rrfH
...
The first column indicates the gene name, the second the number of overlapping reads, and the third
column the alternative gene name or description, respectively. The option−l writes also annotations
with zero overlaps to the output file which facilitates comparison of overlap numbers if, e. g., the
numbers of different libraries should be copied into one table.
5.1.2.6. Visualization of mapped sequences
For visualization of the location of blast hits, graph files were calculated that can be loaded
into the Integrated Genome Browser (IGB)7 of Affymetrix. This browser allows the visual-
ization of both whole genomes and individual genomic regions. Graphs representing the num-
ber of mapped reads were calculated from BLAST tables and loaded together with the sequence
(NC 003062.fa) and annotation (NC 003062.gff) of the Salmonella chromosome. The script
blast table to IGB graph file.pl can be used as follows:
Usage:
blast_table_to_IGB_graph_file.pl generates an x/y graph file for visualization in the
Integrated Genome Browser (Affymetrix) from a tabular WU-Blast output file (-mformat=2).
For each read in the blast table that was mapped to position x to y in the genome
it will add +1 from position x to y if the read was mapped on the plus strand, and -1
if it was mapped on the minus strand, respectively.
If the option [-n NF] is used, the mapped reads per nucleotide position will be divided
by the value of the normalization factor NF and multiplied by 1000. Thus, the y values
are given as ‘‘per mill’’ reads of the given normalization factor. Per default, NF is set
to one and the y-values correspond to the actual number of mapped reads per nucleotide.
blast_table_to_IGB_graph_file.pl -b blast_table -o outputname
[-n normalization_factor (default = 1)]
Options:
-b blast_table (generated by Wu-Blast with option -mformat=2)
-o outputname
[-n normalization_factor (default = 1)]
[-h] print this message
It generates the two output files, * NF x plus.gr and * NF x minus.gr, which contain a
list of x / y coordinates for the plus (* plus.gr) and the minus (* minus.gr) strand. The x
coordinate corresponds to the nucleotide position in the genome, the y coordinate to the number
7 http://www.affymetrix.com/support/developer/tools/download_igb.affx
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of mapped reads at this position x. The files were generated by iterating through all reads in the
BLAST table and adding +1 (-1 for hits on the minus strand) at each nucleotide position x to y
in the chromosome to which the read was mapped from position x to y by WU-Blast. Thus,
the * plus.gr visualizes BLAST hits on the plus strand, the * minus.gr BLAST hits on the
minus strand, respectively. To compare different libraries, a normalization factor (NF), e. g. the
total number of mapped reads for a given library, can be passed to the script by the option −n. If
so, the number of mapped reads per nucleotide position is divided by the normalization factor n
and multiplied by 1000. This is necessary in case libraries have big differences in the number of
sequenced reads. The normalization factor used for the calculation of the y-value is indicated in the
output file name ‘...NF x ...’.
The graphs described above contain x/y-values only at positions in the genome where at least one
read was mapped. In the IGB, it is possible to apply several mathematical operations to graph
files. However, to divide the values of one graph by the values of a second graph to calculate
enrichment factors, the graphs must have the same number of, and equal, x-values. Therefore,
a slightly modified script blast table to complete IGB graph file.pl was generated
which sets the regions where no read was mapped to “+1” for the plus strand and to “-1” for the
minus strand, respectively. The usage is as follows:
Usage:
blast_table_to_complete_IGB_graph_file.pl generates an x/y graph file for visualization in
the Integrated Genome Browser (Affymetrix) from a tabular Wu-Blast output file
(-mformat=2).
For each read in the blast table that was mapped to position x to y in the genome
it will add +1 from position x to y if the read was mapped on the plus strand, and -1 if
it was mapped on the minus strand, respectively.
Genome positions where no read was mapped will be set to 1 (-1 for the minus graph) to
allow mathematical operations between two graphs in the IGB which requires the same number
of x coordinates for the two graphs.
If the option [-n NF] is used, the mapped reads per nucleotide position will be divided
by the value of the normalization factor NF and multiplied by 1000. Thus, the y values are
given as ‘‘per mill’’ reads of the given normalization factor. Per default, NF is set to
one and the y values correspond to the actual number of mapped reads per nucleotide.
blast_table_to_complete_IGB_graph_file.pl -b blast_table -o outputname -l genome_length
[-n normalization_factor (default = 1)]
Options:
-b blast_table (generated by Wu-Blast with option -mformat=2)
-o outputname
-l genome_length
[-n normalization_factor (default = 1)]
[-h] print this message
5.1.3. Analysis of cDNA sequencing results of Hfq-associated RNA
For both libraries, Hfq-coIP and coIP-Ctr, ≈ 175,000 cDNA reads were sequenced (see Table 5.1).
The resulting sequences for the Hfq-coIP, from here on referred to as ‘Hfq cDNAs’, ranged in length
from 1 to 145 bp, and 92% were≥ 18 bp (Fig. 5.3 A). Disregarding small cDNAs (<18 bp), 122,326
5.1. Results 101
Table 5.1: Read distribution of Hfq-coIP and coIP-Ctr libraries. The total number of sequenced reads
for the Hfq-coIP and coIP-Ctr libraries as well as fractions of reads < or ≥ 18 bp are given. Furthermore,
the number of mapped reads (BLAST hits) for sequences ≥ 18 bp and the number of reads overlapping to
annotated genes, known and predicted sRNAs as well as intergenic regions (IGR) are listed.
Hfq-coIP coIP-Ctr
total reads 176,907 175,142
< 18 bp 13,736 12,069
≥ 18 bp 163,171 163,073
BLAST hits 122,326 145,873
≥ 18 bp, but no hit 40,845 17,200
rRNA, tRNA, hkRNAa 57,529 132,148
known sRNAs 11,922 1445
mRNA 34,136 7911
predicted sRNAs 647 139
antisense mRNA 2174 342
antisense ncRNA 42 7
IGR 15876 3881
a This set includes the housekeeping RNAs (hkRNAs) tmRNA, M1 RNA, and SRP RNA.
sequences could be unequivocally mapped to the Salmonella genome by WU-BLAST8(Table 5.1).
About half of the mapped cDNAs (57,529) were derived from rRNA, tRNA, and housekeeping
RNAs (tmRNA, M1 RNA, and SRP RNA; Fig. 5.3 B). Of the remaining 64,797 sequences, the
majority corresponded to mRNA regions (53% matched the sense strand of protein-coding regions),
followed by known/predicted conserved sRNAs (18%; Hershberg et al., 2003; for distribution see
Fig. 5.3 C), predicted Salmonella-specific sRNAs (1%; Pfeiffer et al., 2007) and sequences that
were antisense to ORF regions (3%). The remaining 25% of cDNAs mostly represented intergenic
regions (IGRs) and 5’ or 3’ UTRs, with a few antisense transcripts to tRNAs, rRNAs, and sRNAs
(0.1%; Fig. 5.3 B).
To confirm that the procedure did effectively enrich Hfq-associated RNAs, the 175,142 cDNAs
from the control coIP using wild-type Salmonella (expressing untagged Hfq) were analysed. Of
these ‘Control cDNAs’ which ranged in length from 1 to 290 bp (Fig. 5.3 A), 145,873 sequences
were≥18 bp in size and could be mapped to the Salmonella chromosome. Most of the inserts (91%)
were abundant rRNA, tRNA, and housekeeping RNA transcripts (Fig. 5.3 B). The remaining 13,725
sequences were used to calculate the level of enrichment of Hfq-bound RNA (see below).
5.1.4. Visualizing Hfq-dependent RNAs at the nucleotide level
Upon WU-BLAST matching, the number of cDNA hits for each nucleotide position
for either strand of the Salmonella chromosome was calculated using the Perl script
blast table to IGB graph file.pl and visualized using the Integrated Genome Browser
(IGB, Affymetrix). Figure 5.4 shows the distribution of cDNA sequences over a subsection of the
8 http://blast.wustl.edu/
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Figure 5.3: Statistical analysis of the cDNA sequencing results of Hfq-associated RNA. (A) The py-
rosequencing results were analysed by plotting the number of cDNA reads vs the length of the clipped reads
in bp. The length distribution of all resulting sequences is shown. (B) Pie diagram of the different RNA
species contained in all sequences that mapped to the Salmonella genome. The rRNA, tRNA and house-
keeping RNAs are shown in grey. Left panel: Hfq-coIP, right panel: control coIP. (C) Pie diagram for all
Hfq-associated sequences that unequivocally mapped to known sRNA sequences. The names of the six most
strongly recovered sRNAs are given. (Figure was adapted from Sittka et al., 2008.)
genome, i. e. the ≈ 40 kb SPI-1 virulence region, for which a strong enrichment of Hfq cDNAs
over the Control cDNAs was observed. As well as the 35 mRNAs of protein-coding genes, SPI-1
encodes the Hfq-dependent InvR sRNA (Pfeiffer et al., 2007). SPI-1 represents an example of
an entire genomic region highly enriched in the Hfq-coIP library. In contrast, very few cDNA
sequences mapping to SPI-1 are contained in the coIP-Ctr library. The flanking genes of invR (i.e.
the border of SPI-1) give a nice example of the specificity of the method (Fig. 5.4). While cDNAs
mapping to the InvR sRNA gene represent the most abundant cluster in the Hfq-coIP library, the
genes in the closest proximity are barely represented in this library. In addition, the example
of InvR underlines the reliability of the method to identify Hfq-dependent sRNAs. Enrichment
of InvR by coIP with FLAG-tagged Hfq was previously demonstrated by Northern blot analysis
(Pfeiffer et al., 2007), and this result is confirmed by the strong cDNA peak seen at the invR locus
located at the right-hand SPI-1 border (Fig. 5.4).
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Figure 5.4: Visualization of pyrosequencing data for the Salmonella pathogenicity island 1 (SPI-1).
The upper panel shows an extraction of the screenshot of the Integrated Genome Browser, with the mapped
Control and Hfq cDNAs of the SPI-1 region. Shown are the annotations for the (+) and (-) strand (blue), the
cDNA sequence distribution from the Hfq-coIP for the (+) and (-) strand (red), the cDNA-clone distribution
for the control coIP for the (+) and (-) strand (black), and the genome coordinates in the center for the entire
SPI-1. The annotation for SPI-1 and the Hfq-coIP peaks for hilD and the sRNA InvR in the Hfq-coIP are
indicated. Note that the clone numbers per nucleotide are scaled to a maximum of 250 for the Hfq and the
control coIP, which truncates the high peak for InvR in the Hfq-coIP library (>3,000 cDNAs). The lower
panel shows a close-up of the invR locus and its adjacent genes. (Figure was adapted from Sittka et al., 2008.)
5.1.5. Hfq-dependent sRNAs are highly associated with Hfq
Inspection of the cDNA libraries revealed that a major class of reads was derived from sRNA
regions. These sRNAs, as well as their enrichment by Hfq coIP, are listed in Table 5.2 and Ta-
ble 10.8 in the Appendix. The three most abundant sRNAs according to the numbers of Hfq cDNA
sequences are InvR, SraH (a.k.a. RyhA) and SroB (RybC) and are known to be strongly bound
by Hfq (Pfeiffer et al., 2007; Zhang et al., 2003); coIP of Hfq enriched these three sRNAs by 30-
to 57-fold in comparison to the control set. For example, InvR, which binds Hfq with a KD of
10 nM (Pfeiffer et al., 2007), was represented by 3,236 Hfq cDNAs and 113 Control cDNAs (see
Table 5.2). In contrast, other sRNAs not expected to be Hfq-dependent were found in equal num-
bers in the two samples, e. g., the CsrB or CsrC sRNAs which target the conserved RNA-binding
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InvR 89nt
(3236 / 113 cDNAs)
SraH 120 + 58 nt
(2292 cDNAs/ 55 )
SroB 84 nt
(1530 / 27 cDNAs)
GTCACTTTTACGGTTGGCCATTTGTCTCTTACGTTGCATTTATCAATCTGCTTTTTGATACAGCAGCACCTCGCTGCTGCTTTTTTTAT
processing
GTCACTTTTACGGTTGGCCATTTGTCTCTTACGTTGCATTTATCAATCTGCTTTTTGATACAGCAGCACCTCGCTGCTGCTTTTTTTAT
T
GTCACTTTTACGGTTGGCCATTTGTCTCTTACGTTGCATTTATCAATCTGCTTTTTGATACAGCAGCACCTCGCTGCTGCTTTTTTTAT
T
Hfq
coIP
Control
coIP
3000 450
2000 300
1000 150
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2000 300
1000 150
6S RNA 183 nt
(451 / 836 cDNAs)
GTCACTTTTACGGTTGGCCATTTGTCTCTTACGTTGCATTTATCAATCTGCTTTTTGATACAGCAGCACCTCGCTGCTGCTTTTTTTAT
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Figure 5.5: Visualization of the clone distribution of exemplary Hfq dependent and independent sRNAs
in Salmonella. Clone distribution for sequences mapped to InvR, SroB, SraH, or 6S sRNAs (red: Hfq-coIP,
black: control coIP). The vertical axis indicates the number of cDNA sequences that were obtained. A bent
arrow indicates the sRNA promoter, a circled ‘T’ its transcriptional terminator. (Figure was adapted from
Sittka et al., 2008.)
protein CsrA (Babitzke & Romeo, 2007) were represented by almost equal numbers in the Hfq
and Control cDNAs (CsrB, 67/69; CsrC, 63/64; Table 5.2). Moreover, cDNAs of the abundant yet
Hfq-independent 6S RNA (Wassarman et al., 2001) were found in smaller numbers in the Hfq than
in the control library (451 versus 836; Table 5.2).
Fig. 5.5 illustrates the distribution of cDNAs of the three predominant Hfq-bound RNAs and of
the Hfq-independent 6S RNA. The cDNAs of both the InvR (Pfeiffer et al., 2007) and SroB (Vogel
et al., 2003) sRNAs mapped along the entire RNA coding sequence from the transcriptional start
site to the Rho-independent terminator. SraH, which is transcribed as an unstable 120 nt precursor
and is processed into an abundant ≈ 58 nt RNA species (3’ part of SraH; Argaman et al., 2001;
Zhang et al., 2003), was almost exclusively recovered as the processed sRNA. Notably, the borders
of the cDNA clusters were in perfect agreement with previous 5’ and/or 3’ end mapping data of the
four sRNAs (Argaman et al., 2001; Brownlee, 1971; Pfeiffer et al., 2007; Vogel et al., 2003). In
other words, the present cDNA sequencing approach not only detects association with Hfq but also
identifies the termini of expressed sRNAs at nucleotide-level resolution.
5.1.6. Identification of expressed Salmonella sRNAs
To evaluate the sRNA expression profile of Salmonella more extensively, three classes of sRNA
candidate loci were analysed for coverage by the Hfq and Control cDNAs. First, cDNAs of E. coli
sRNA candidate loci with predicted conservation in Salmonella were inspected (Argaman et al.,
2001; Hershberg et al., 2003; Kawano et al., 2005a; Wassarman et al., 2001; Rivas et al., 2001;
Vogel et al., 2003; Zhang et al., 2003). Second, cDNAs of Salmonella-specific sRNAs predicted in
two recent global screens (Padalon-Brauch et al., 2008; Pfeiffer et al., 2007) were counted. Third,
cDNAs from one third of the Salmonella chromosome (first 1.6 Mb) and all major five pathogenicity
islands were manually inspected for expression patterns of IGRs indicative of new sRNA genes,
and for possible enrichment by Hfq coIP. Of the latter two classes of candidates (summarized in
Table 10.8 in the Appendix), those with an Hfq enrichment factor ≥10 and/or candidates showing
good promoter/terminator regions, were selected for Northern blot analysis.
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Table 5.2: Compilation of expressed Salmonella sRNAs and their enrichment by Hfq-coIP.
sRNA1 Alternative IDs2 Reference3 Adjacent genes4 Orientation5 Start6 End6 Reads Reads Enrichment9 Northern
coIP-Ctr7 Hfq-coIP8 blot10
sgrS ryaA I yabN/leuD ←→← 128574 128812 3 61 20.3
isrA - II STM0294.ln/STM0295 →→→ 339338 339760 0 0
sroB rybC I ybaK/ybaP ←→← 556005 556085 27 1530 56.7
sroC - I gltJ/gltI ←←← 728913 728761 26 898 34.5
rybB p25 III STM0869/STM0870 →←← 942632 942554 3 103 34.3
STnc49011 - IV clpA/tnpA 1 →←→ 1024975 1025165 75 385 5.1 ≈ 85nt
isrB-1 - II sbcA/STM1010 ←→← 1104179 1104266 2 4 2.0
STnc500 - IV STM1127/STM1128 ←←← 1216157 1216440 7 84 12.0 ≈ 65nt
STnc150 - V icdA/STM1239 →←→ 1325914 1325649 0 1 ≥1.0 ≈ 90nt
isrC - II envF/msgA ←→← 1329145 1329432 0 1 ≥1.0
STnc520 - IV STM1248/STM1249 →←← 1332809 1334044 12 100 8.3 ≈ 80nt
isrD - II STM1261/STM1263 →←→ 1345788 1345738 0 0
ryhB-2 isrE II STM1273/yeaQ →←→ 1352987 1352875 0 0
STnc540 - IV himA/btuC →→→ 1419369 1419570 7 23 3.3 ≈ 85nt
rprA IS083 I ydiK/ydiL ←←← 1444938 1444832 37 286 7.7
rydB tpe7, IS082 I ydiH/STM1368 →→← 1450415 1450519 4 10 2.5
STnc57012 yneM ORF IV ydeI/ydeE →←← 1593723 1594413 2 21 10.5 ≈ 190nt
STnc560 IV ydeI/ydeE →→← 1593723 1594413 10 290 29.0 ≈ 90nt
isrF - II STM1552/STM1554 →←← 1630160 1629871 1 0
rydC IS067 I STM1638/cybB →→← 1729673 1729738 5 245 49.0
micC IS063, tke8 III nifJ/ynaF →←→ 1745786 1745678 0 15 ≥15.0
STnc580 - IV dbpA/STM1656 ←←← 1749662 1750147 11 311 28.3 ≈ 100nt
ryeB tpke79 I STM1871/STM1872 →←← 1968155 1968053 24 653 27.2
dsrA - I yodD/yedP →←→ 2068736 2068649 6 149 24.8
rseX - I STM1994/ompS ←→→ 2077175 2077269 0 3 ≥3.0
ryeC tp11 I yegD/STM2126 →→→ 2213871 2214016 42 72 1.7
cyaR ryeE III yegQ/STM2137 →→→ 2231130 2231216 31 659 21.3
isrG - II STM2243/STM2244 ←→→ 2344732 2345013 0 0
micF - III ompC/yojN ←→→ 2366913 2367005 0 11 ≥11.0
continued on next page
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sRNA1 Alternative IDs2 Reference3 Adjacent genes4 Orientation5 Start6 End6 Reads Reads Enrichment9 Northern
coIP-Ctr7 Hfq-coIP8 blot10
isrH-2 - II glpC/STM2287 →←→ 2394582 2394303 0 0
isrH-1 - II glpC/STM2287 →←→ 2394753 2394303 0 0
STnc25012 ypfM ORF V acrD/yffB →←→ 2596882 2596789 6 24 4.0 ≈ 220nt
ryfA tp1 I STM2534/sseB →→← 2674934 2675228 3 6 2.0
glmY tke1, sroF I yfhK/purG ←←← 2707847 2707664 20 92 4.6
isrI - II STM2614/STM2616 →←← 2761576 2761329 0 2 ≥2.0
isrJ - II STM2614/STM2616 →←← 2762031 2761957 1 0
isrK - II STM2616/STM2617 ←←← 2762867 2762791 0 0
isrB-2 - II STM2631/sbcA →←→ 2770965 2770872 0 0
isrL - II smpB/STM2690 →←→ 2839399 2839055 0 0
isrM - II STM2762/STM2763 ←→→ 2905050 2905378 0 0
isrN - II STM2764/STM2765 ←→← 2906925 2907067 0 0
micA sraD I luxS/gshA ←→← 2966853 2966926 1 128 128.0
invR STnc270 III invH/STM2901 →→→ 3044924 3045014 113 3236 28.6
csrB - III yqcC/syd ←←← 3117059 3116697 69 67
gcvB IS145 III gcvA/ygdI ←→← 3135317 3135522 12 402 33.5
omrA rygB III aas/galR ←←→ 3170208 3170122 0 51 ≥51.0
omrB t59, rygA, sraE III aas/galR ←←→ 3170408 3170322 1 52 52.0
STnc290 - V tnpA 4/STM3033 ←←← 3194996 3194914 2 72 36.0 ≈ 85nt
isrO - II STM3038/STM3039 ←→→ 3198380 3198580 0 0
ssrS - I ygfE/ygfA →→→ 3222098 3222280 836 451
rygC t27 I ygfA/serA →→← 3222913 3223065 14 17 1.2
rygD tp8, C0730 I yqiK/rfaE →←← 3362474 3362327 17 104 6.1
sraF tpk1, IS160 I ygjR/ygjT →→→ 3392069 3392261 0 25 ≥25.0
sraH ryhA I yhbL/arcB ←→← 3490383 3490500 55 2292 41.7
ryhB-1 sraI, IS176 I yhhX/yhhY ←←→ 3715495 3715401 0 2 ≥2.0
istR-1 VI ilvB/emrD ←←→ 3998147 3998018 0 0 ≈ 75nt
istR-2 VI ilvB/emrD ←←→ 3998147 3998018 0 0 ≈ 140nt
STnc400 - V STM3844/STM3845 →→→ 4051145 4051340 112 42 ≈ 55nt
glmZ k19, ryiA, sraJ I yifK/hemY →→← 4141650 4141854 20 196 9.8
spf spf I polA/yihA →→← 4209066 4209175 2 33 16.5
continued on next page
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sRNA1 Alternative IDs2 Reference3 Adjacent genes4 Orientation5 Start6 End6 Reads Reads Enrichment9 Northern
coIP-Ctr7 Hfq-coIP8 blot10
csrC sraK, ryiB, tpk2 III yihA/yihI ←→→ 4210157 4210400 63 64
isrP - II STM4097/STM4098 ←→← 4306719 4306866 0 2 ≥2.0
oxyS - I argH/oxyR →←→ 4342986 4342866 0 10 ≥10.0
STnc620 - IV ssb/STM4257 →→→ 4476817 4477856 4 41 10.3 nd
sraL ryjA III soxR/STM4267 →←→ 4505010 4504870 0 0
STnc440 - V STM4310/tnpA 6 →→→ 4559193 4559277 9 456 50.7 ≈ 85nt
STnc460 - V STM4503/STM4504 →←→ 4758332 4758187 0 0 np
isrQ - II STM4508/STM4509 ←→→ 4762997 4763158 0 0
1 Gene names of Salmonella sRNAs identified in this and previous studies. The identification method is given in the third column. sRNA names follow the Salmonella and/or E. coli
nomenclature referenced in Hershberg et al. (2003), Padalon-Brauch et al. (2008), and Papenfort et al. (2008).
2 Alternative sRNA IDs. References in Hershberg et al. (2003), Padalon-Brauch et al. (2008), and Papenfort et al. (2008), except STnc490, 500, 520, 540, 560, 570, 580, which
have been newly predicted in this study.
3 Evidence for sRNAs in Salmonella. (I) Conserved sRNA found in Salmonella cDNA libraries, and expression previously shown in E. coli (relevant ref. in Papenfort et al., 2008;
Table 1). (II) sRNA previously predicted and validated on Northern blots in Salmonella by Padalon-Brauch et al. (2008). (III) sRNA previously validated on Northern blots in
Salmonella (Altier et al., 2000a; Figueroa-Bossi et al., 2006; Fortune et al., 2006; Papenfort et al., 2006, 2008; Pfeiffer et al., 2007; Sharma et al., 2007; Viegas et al., 2007). (IV)
sRNA predicted through cDNA sequencing and validated on Northern blots in this study. (V) sRNA previously predicted by Pfeiffer et al. (2007) is recovered in cDNA sequences
and validated on Northern blots in this study. (VI) IstR sRNAs (Vogel et al., 2004) were not recovered in cDNA sequences but their expression in Salmonella was validated by
Northern blot analysis in the complete study (Sittka et al., 2008).
4 Flanking genes of the intergenic region in which the sRNA candidate is located.
5 Orientation of sRNA candidate (middle) and flanking genes on the clockwise (→) or the counterclockwise (←) strand of the Salmonella chromosome.
6 Genomic location of sRNA candidate gene according to the Salmonella typhimurium LT2 genome. For STnc470 through STnc640 start and end of the entire intergenic region are
given.
7 Out of 145,873 sequences in total.
8 Out of 122,326 sequences in total.
9 Enrichment factor calculated by dividing the number of reads from Hfq-coIP by the number of reads from the coIP-Ctr.
10 Denotes verification on Northern blot for new RNA transcripts; the estimated size is given in nucleotides (np = not probed; nd = no detectable transcript).
11 The cDNA reads map antisense internally of the IS200 element. Based on sequence identity they map to all IS200 elements (tnpA 1 to tnpA 6).
12 STnc250 and STnc570 contain small ORFs annotated as ypfM and yneM, respectively, in E. coli (Wassarman et al., 2001).
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To assess sRNA expression under relevant environmental conditions, RNAs from five stages of
growth in standard LB media from exponential to stationary phase and from two conditions known
to strongly induce the expression of the major SPI-1 (Lee & Falkow, 1990; Song et al., 2004) or SPI-
2 (Deiwick et al., 1999) virulence regions were probed. The results of this analysis are summarized
in Table 5.2 (the whole set of candidates tested is shown in Table 10.8 in the Appendix). Including
the 26 previously detected Salmonella sRNAs (Altier et al., 2000a; Figueroa-Bossi et al., 2006;
Fortune et al., 2006; Padalon-Brauch et al., 2008; Papenfort et al., 2006, 2008; Pfeiffer et al., 2007;
Sharma et al., 2007; Viegas et al., 2007), a total of 67 Salmonella sRNAs can now be considered to
be experimentally validated.
It was determined whether eight of the new Salmonella sRNAs showed an Hfq-dependent pattern
of transcript abundance that correlated with Hfq binding (Fig. 5.6 A). The STnc290, 440, 490, 520,
540 and 560 sRNAs were all enriched by Hfq coIP (Table. 5.2) by factors up to 51-fold (STnc440).
The expression of the four sRNAs with the highest enrichment factors (STnc290, 440, 520, 560)
was strongly reduced in ∆hfq and so classified as Hfq-dependent; in contrast, the accumulation
of STnc150, STnc490 and STnc540 (≥=1.0-, 5.1-, and 3.3-fold enrichment, respectively) was
unaffected in the absence of Hfq. Three sRNAs expressing stable transcripts of ≈ 85 to 90 nts
originate from close to, or within, IS200 transposable elements (Fig. 5.6 B). STnc290 and STnc440
are expressed just upstream of tnpA 4 and tnpA 6, respectively, whereas STnc490 is antisense to the
translational start site of the IS200 transposase ORF. IS200 elements generally posses two stem-loop
structures, one of which is a Rho-independent transcription terminator that prevents read-through
from genes located upstream of the integration site (Beuzo´n et al., 1999). Given their location,
the STnc290 sRNA could originate from processing of the STM3033 transcripts reading into the
tnpA 4 terminator structure; by analogy, STnc440 would be derived from STM4310 transcripts. If
so, this would constitute interesting cases in which transposon insertion has created stable sRNAs.
The other IS200 stem-loop functions as a translational repressor by sequestering the start codon of
the transposon ORF (Beuzo´n et al., 1999); STnc490 overlaps with this structure on the opposite
strand and by acting as an antisense RNA may function as an additional repressor of IS200.
Furthermore, on Northern blots 10 of the 31 newly identified Salmonella sRNAs could be detected
under the environmental conditions that were tested (Tables 5.2 and 10.8). These sRNAs yielded
stable transcripts, predominantly in the 50 to 100 nt range. Generally, with one exception only can-
didates represented by ≥20 cDNAs in a cDNA pool yielded a signal on Northern blots (Tables 5.2
and 10.8). While this suggests some correlation between intracellular abundance and cDNA fre-
quency, the case of STnc150 was observed, for which a single cDNA was recovered yet a strong
signal was obtained on Northern blots. In contrast, several candidates with >20 cDNAs failed the
Northern blot validation (Table 10.8). The corresponding cDNAs were probably derived from 5’ or
3’ UTRs of larger mRNA transcripts. This was tested on Northern blots of agarose gels (data not
shown). 14 of such candidates had the appropriate orientation to flanking mRNA genes for being
UTR-derived. Six of these showed signals ranging in size from 500 to 2000 nucleotides (STnc180,
Stnc190, STnc330, STnc470, STnc610, and STnc640; Table 10.8 in the Appendix) and are likely
to be processed mRNA species.
In addition to the sRNAs listed above, the cDNAs included two loci predicted to encode small
peptides, i. e. shorter than the 34 amino acid cut-off used to define ORFs in the current Salmonella
genome annotation (McClelland et al., 2001). These are referred to as STnc250 and STnc570 in Ta-
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Figure 5.6: Expression of novel sRNAs in Salmonella. (A) RNA abundance of selected new sRNAs in
wild-type (+) versus hfq mutant (-) Salmonella cells at early stationary phase (OD600 of 2). The enrich-
ment factor of each of these sRNAs in the coIP experiment is given below the blots for comparison. (B) A
schematic presentation of the position of the sRNAs according to the IS200 element is shown to the right.
The upper drawing indicates the two stem-loop structures, start codon, and stop codon of the transposase-
encoding mRNA of the IS200 elements. The three detected sRNAs are indicated by black arrows. (Figure
was adapted from Sittka et al., 2008.)
ble 5.2 and correspond to the predicted small ypfM and yneM mRNA-encoding genes, respectively,
of E. coli (Wassarman et al., 2001).
5.2. Discussion
To understand how bacterial RNA binding proteins such as Hfq mediate the control of global gene
expression at the post-transcriptional level, direct targets need to be identified. These targets in-
clude, besides direct mRNA targets, the small noncoding RNA regulators which mediate post-
transcriptional regulation of diverse mRNAs. In this Chapter, deep sequencing was applied to iden-
tify Salmonella RNA ligands bound to Hfq. This approach not only recovered most of the known
sRNAs but also identified novel sRNAs and mRNA targets. Identification of novel Salmonella-
specific sRNAs is particularly interesting as they could have a potential role in virulence regulation.
The first global approach for the identifcation of Hfq-bound RNAs involved detection of RNA co-
immunoprecipitated with Hfq-specific antibodies on high-density oligonucleotide microarrays and
identified new E. coli sRNAs (Zhang et al., 2003). Similarly, microarray-based detection following
co-immunoprecipitation of eukaryotic mRNA-protein complexes (mRNPs) identified endogenous
organization patterns of mRNAs and cellular proteins (Tenenbaum et al., 2002). Epitope-tagging
of the yeast La homologue was successfully used for global coIP analysis (Inada & Guthrie, 2004).
However, the requirement of custom high-density microarrays and/or species-specific antibodies
has impeded similar studies in other organisms. The ideal sRNA discovery approach would not only
detect sRNAs but would also define their exact sequence. Given the typical genome size of model
bacteria (≈ 5 Mb), a high-density oligonucleotide microarray with ≈ 10 million oligonucleotide
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probes would be required to achieve single basepair resolution. Such arrays do not exist for any
organism, and even today’s high-density arrays (with 0.5 million features) come with extraordinarily
high set-up and printing costs and are available for very few bacteria. The deep sequencing strategy
remedies these technical and financial limitations.
The identification of Hfq-associated RNAs in Salmonella is based on a chromosomal epitope-
tagging approach (Uzzau et al., 2001), followed by coIP with a commercially-available antibody,
and sequencing of hundreds of thousand cDNAs. The earlier shotgun-cloning studies in bacteria
(see Section 2.3.5) and many other organisms (reviewed in Hu¨ttenhofer, 2005; Hu¨ttenhofer et al.,
2002) were limited by costly Sanger-type sequencing of individual cDNA inserts from plasmid
vectors. The deep sequencing approach described here avoids a cloning step and is able to detect
small RNAs with unparalleled sensitivity by defining the 5’ and 3’ ends of transcripts at basepair
resolution.
Deep sequencing of cDNAs has identified the small RNA component of eukaryotic transcriptomes
(e. g., Lu et al., 2005; Ruby et al., 2006) and new classes of noncoding RNAs associated with eu-
karyotic RNA-binding proteins (Aravin et al., 2006; Girard et al., 2006). Furthermore, immunopre-
cipitation and deep sequencing has been successfully applied to characterize small RNAs associated
with human Ago1 and Ago2 proteins, which are part of the eukaryotic RNA-induced-silencing-
complex (RISC), and also to identify bound mRNA targets (Beitzinger et al., 2007). In addition, an
unexpected class of RNAs that originate from small nucleolar RNAs (snoRNAs) was identified in
Ago complexes (Ender et al., 2008). Thus, coIP followed by deep sequencing allowed to identify
novel RNA binding partners. These studies in eukaryotes primarily focussed on the class of 20-30
nucleotide long microRNAs and short interfereing RNAs and typically included size-fractionation
steps. Bacterial riboregulators are considerably larger (80-280 nucleotides), and in this study it was
shown that even without prior size fractionation deep sequencing can capture and define the termini
of these large sRNAs.
Analysis of deep sequencing results of Hfq-bound RNAs in Salmonella extends the tally of confi-
dently identified sRNAs to 67 in this model pathogen (Table 5.2). Thirty eight of these are conserved
sRNAs that were initially identified in E. coli, but only a few of their homologues have previously
been shown to be expressed in other enteric bacteria (Altier et al., 2000b; Bossi & Figueroa-Bossi,
2007; Fortune et al., 2006; Julio et al., 2000; Papenfort et al., 2006, 2008; Sharma et al., 2007;
Viegas et al., 2007). The finding, from this and other studies, that highly-conserved sRNAs are
commonly expressed should prove useful to researchers working in other bacterial systems. A sig-
nificant number of the Hfq-associated cDNAs correspond to sRNA loci that are absent from E. coli
(Padalon-Brauch et al., 2008; Pfeiffer et al., 2007 and Table 5.2). Of these, invR exemplifies a sRNA
gene that was probably horizontally acquired with the SPI-1 virulence region, early in Salmonella
evolution (Pfeiffer et al., 2007). Intriguingly, InvR is the most frequently recovered sRNA (>3,000
cDNAs in the Hfq-coIP library), which shows that this approach is not only effective in detecting
conserved but also species-specific sRNAs of acquired pathogenicity regions. Horizontal transfer
of virulence islands is a driving force in the evolution of bacterial pathogens (Dobrindt et al., 2004),
and knowledge of the functional elements of these islands is key to understanding pathogenesis.
Whereas ORF identification in such islands has become routine, island-specific sRNAs are more
difficult to recognize by bioinformatic-based approaches. These RNA factors could interconnect
expression of the Salmonella core genome and virulence regions at the post-transcriptional level.
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Besides confirming InvR, the present study found evidence for the expression of five of the
47 Salmonella sRNA candidate loci listed by Pfeiffer et al. (2007) who predicted orphan pro-
moter/terminator pairs in IGRs (Table 10.8). Padalon-Brauch et al. (2008) recently reported the
discovery of 18 Salmonella expressed sRNA loci. cDNAs of eight of these sRNAs could be recov-
ered (IsrB-1, C, E, I-L, and P; Table 5.2). The fact that ten of these sRNAs were not recovered prob-
ably reflects their low-level expression under the growth condition used here (Padalon-Brauch et al.,
2008). This observation suggests an improvement that could be made to this method. RNomics-
or microarray-based sRNA discovery methods require sRNAs to be expressed under the chosen
assay condition, unlike bioinformatics-aided approaches that score for orphan transcription signals
and primary sequence conservation (Argaman et al., 2001; Chen et al., 2002; Livny et al., 2006;
Wassarman et al., 2001) or for conservation of RNA structure (Rivas et al., 2001). However, as most
sRNAs are involved in specific stress responses, it remains challenging to identify the appropriate
growth condition that induces expression of certain sRNAs. Thus, future studies combining several
different growth conditions with increasing sequencing depth are likely to identify even more novel
sRNAs.
Similar to other global methods for RNA identification (Altuvia, 2007; Hu¨ttenhofer & Vogel, 2006),
this approach is likely to show certain biases regarding its specificity. For example, unspecific Hfq
binding partners can be caused by cross-hybridization in the immunoprecipitation step or from the
limited ability of reverse transcriptase to deal with stable RNA structures in cDNA synthesis, and
these will need to be studied in more detail. However, it is clear that deep sequencing resolved the
termini of many expressed and/or Hfq-bound sRNAs at basepair resolution (Fig. 5.5), which has
not been achieved by other methods.
In addition to the Hfq-bound sRNAs, also the ≈ 35,000 reads derived from Hfq-bound mRNA tar-
gets (≈ 19% of all reads in the Hfq-coIP; see Table 5.1 and Fig. 5.3) were analysed in the complete
study which was published in Sittka et al., 2008. This led to the identification of 727 Hfq-bound
mRNAs. For a lot of mRNAs, especially sequences in the 5’ UTRs or in intergenic regions of poly-
cistronic mRNAs were specifically enriched in the Hfq-coIP libraries and often corresponded to
known sRNA binding sites. Furthermore, the deep sequencing approach for the detection of Hfq-
bound mRNAs was validated by comparison with the conventional approach, namely, hybridization
of the RNA from the coIP samples to a S. typhimurium oligonucleotide microarray. Nearly half
(45%) of the 365 enriched mRNAs in this coIP-on-Chip experiment correspond to regions iden-
tified by the deep sequencing approach. The overlap increased to 67% when genes that showed
enrichment values above 5 were taken into consideration. Although coIP-on-Chip displays a lower
sensitivity than deep sequencing these two independent methods do generate comparable results for
the identification of mRNA-protein interactions.
In the complete study (Sittka et al., 2008), the 454 sequencing results were additionally compared
to mRNA profiles of the Salmonella wild-type and the hfq deletion strain using transcriptomic
analysis on whole-genome microarrays. In total, expression of at least 785 genes, or 18% of the
Salmonella genome, was changed either directly or indirectly by Hfq, and 32% of the affected
mRNAs were bound to Hfq in the deep sequencing analysis. Conversely, 33% of the Hfq-bound
mRNAs showed an Hfq-dependent pattern of gene expression. The proportion of genes identified
to be Hfq-dependent is similar to Pseudomonas aeruginosa (≈ 15% of all genes; Sonnleitner et al.,
2006) but bigger than for E. coli (6.3%; Guisbert et al., 2007) or Vibrio cholerae (5.6%; Ding
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et al., 2004). However, the different growth conditions and scoring parameters used for these other
organisms preclude a direct comparison with the data obtained for Salmonella in this work. With
regard to functional analysis of several Hfq-bound mRNAs, the combined transcriptomic and coIP
data revealed that Hfq exerts a direct role in gene expression through the control of specific check-
points in well-defined transcriptional regulons.
Transcriptomic profiling by itself is clearly unable to differentiate between transcriptional and post-
transcriptional effects of Hfq. However, enrichment of a regulated mRNA in the Hfq-coIP library
can successfully hint at post-transcriptional regulation by sRNAs. The current data set comprises
several hundreds of such candidate mRNAs (see Table S4 in Sittka & Vogel, 2008) including many
experimentally confirmed targets of Salmonella sRNAs. Integrating the score for Hfq-association
deduced from present experiments and, where applicable, from the available E. coli data (Zhang
et al., 2003) into available algorithms such as TargetRNA (Tjaden et al., 2006) could significantly
improve target predictions for the large class of Hfq-dependent sRNAs.
A recent study based on sample-matched transcriptomics and proteomics by Ansong et al. (2009)
also found that >20% of all annotated Salmonella genes are regulated post-transcriptionally either
directly or indirectly by Hfq or SmpB, an RNA-binding protein which specifically interacts with
tmRNA (Karzai et al., 1999). For example, based on their proteomics analysis, expression of 781
proteins was found to be affected by Hfq, of which 25% overlap with the Hfq-associated mRNAs
that were identified in this deep sequencing analysis.
Collectively, the method presented provides a first picture of the impact of Hfq on Salmonella gene
expression at both the transcriptional and post-transcriptional level. A more detailed inspection of
this data set, in particular of the ≈ 60% of the chromosome that remain to be fully analysed as well
as sampling under different growth conditions, will probably expand the gamut of Salmonella small
mRNA and noncoding RNA genes. In addition, the data sets could help to discover whether Hfq
controls the expression of cis-antisense sRNAs that overlap with mRNA coding regions (Kawano
et al., 2005a) or whether certain Salmonella tRNAs are selectively associated with this protein (Lee
& Feig, 2008; Scheibe et al., 2007). Furthermore, the same approach was now also successfully
applied to analyse RNA-binding properties of foreign Hfq proteins expressed in Salmonella (Sittka
et al., 2009). This in vivo approach identified endogenous Salmonella sRNAs as a major target
of the foreign Hfq proteins from two eubacteria (Neisseria meningitides, Aquifex aeolicus) and an
archaeon (Methanocaldococcus jannaschii) and additionally identified further novel sRNAs from
Salmonella. In addition, specific RNA processing defects, e. g., suppression of precursor processing
of SraH sRNA, or aberrant accumulation of target mRNAs of the Salmonella GcvB, MicA or RybB
sRNAs were observed. This indicated that the expression of heterologous RNA-binding proteins
combined with deep sequencing analysis of RNA ligands can be used as a molecular tool to dissect
individual steps of RNA metabolism in vivo.
Bacterial genomes encode a large number of RNA binding proteins (Anantharaman et al., 2002)
including globally acting proteins such as the CsrA/RsmA (Babitzke & Romeo, 2007) and Csp
families (Yamanaka et al., 1998). The combination of epitope-tagging and high-throughput se-
quencing of immunoprecipitated RNA could be used to identify the RNA targets of these proteins
in any genetically tractable bacterium. This could help to unravel the post-transcriptional regulons
in a wide range of bacteria.
CHAPTER 6
DEEP SEQUENCING REVEALS THE
PRIMARY TRANSCRIPTOME OF
Helicobacter pylori
The intense study of Helicobacter pylori (see Section 2.6.2), one of the most prevalent human
pathogens, has contributed much to understanding bacterial virulence mechanisms. The availabil-
ity of the ≈ 1.67 Mb H. pylori genome sequence has greatly facilitated these studies, including the
discovery of proteins with important functions in gastric infections. In comparison, much less is
known about the overall transcriptional organization and the noncoding regions of the H. pylori
genome. Genome annotation of H. pylori strain 26695 predicted 1,590 open reading frames (Tomb
et al., 1997), yet experimental studies over the years identified only≈ 55 promoters in this organism
(see Table 10.11 in the Appendix). Thus, it remains largely unknown where and when the transcrip-
tion of the majority of the H. pylori genes is initiated. In addition to the lack of clear transription
signals, Helicobacter contains only a very limited repertoire of transcriptional regulators, e. g., only
three sigma factors, three two-component systems, and two additional orphan response regulators
(Section 2.6.2). However, in order to cope with the various stresses it encounters during infection,
e. g., pH and nutrient fluctuations, H. pylori must have additional mechanisms to regulate its gene
expression.
Besides protein regulators, small noncoding RNAs (sRNAs) have been identified in all kingdoms of
life as modulators of gene expression, and several systematic screens have led to the identification
of sRNAs in diverse bacteria (see Section 2.3). So far, no small regulatory RNAs have been de-
scribed in the ǫ-subdivision of proteobacteria, except for the highly conserved housekeeping RNAs,
tmRNA, RNaseP RNA, and SRP RNA (see Figure 6.1). Homology searches based on sRNA se-
quences from other bacteria have not been helpful in identifying sRNA candidates in H. pylori,
suggesting that either sRNA genes are absent or have diverged beyond the limit of detection. Due
to a lack of a known Hfq homologue (Sun et al., 2002), the approach based on combination of
epitope-tagging and HTPS of immunoprecipitated RNA that was described for identification of
novel sRNAs in Salmonella in the previous Chapter could not be applied to Helicobacter. This
indicated a requirement of de novo identification approaches, such as bioinformatics-based predic-
tions (Section 2.3.3) or direct RNomics (Section 2.3.5).
Previous RNomics screens for sRNA identification in bacteria, e. g., E. coli, the two archaeons Sul-
folobus solfataricus and Archaeoglobus fulgidus, and Aquifex aeolicus, were at that time based on
the conventional Sanger sequencing method (Section 2.3.5). The development of deep sequencing
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Figure 6.1: Northern Blot of Helicobacter housekeeping RNAs. Total RNA was extracted from H. pylori
26695 cultures in different growth phases and probed with DNA oligos (listed in Table 10.14) on Northern
blots. Samples were taken at OD600 values between 0.3 (log phase) and 2.0 (late stationary phase). Equal
amounts of RNA were loaded. The Helicobacter homologues of tmRNA, RNase P RNA, SRP RNA, and 5S
rRNA were initially predicted by Brown (1999); Regalia et al. (2002); Williams & Bartel (1996), and Tomb
et al. (1997), respectively.
technologies allows a more complete and rapid coverage of small RNA profiles in diverse organ-
isms, e. g., in plants using massively parallel signature sequencing (Lu et al., 2005). Furthermore,
high-throughput pyrosequencing (Margulies et al., 2005) of size-fractionated RNA has been suc-
cessfully applied to the discovery of small RNAs, e. g., in C. elegans (Ruby et al., 2006) and the
single-cell algae Chlamydomonas (Molna´r et al., 2007; Zhao et al., 2007). With the advent of
next-generation sequencing technologies it is now possible to generate tens of millions of short
sequences in a single assay. This development has enabled the recent ‘RNA sequencing’ (RNA-
Seq) technology via random cDNA libraries, which was successfully applied to the transcriptomes
of Arabidopsis (Lister et al., 2008), mouse embryonic stem cells (Cloonan et al., 2008) and other
mouse tissues (Sultan et al., 2008), budding (Nagalakshmi et al., 2008) and fission yeast (Wilhelm
et al., 2008) at single nucleotide resolution.
In this study, an initial biocomputational approach based on prediction of orphan pro-
moter/terminator pairs in intergenic regions (IGRs) was used for the identification of sRNAs
in H. pylori. However, it led to the identification of only a small number of sRNAs in H. pylori
and, hence, a direct RNomics approach was chosen. To specifically enrich cDNA libraries for
primary transcripts and by depleting processed RNAs, such as highly abundant rRNA fragments,
a method based on an exonuclease which digests RNAs with a 5’-monophosphate was developed.
Subsequently, the H. pylori transcriptome was analysed by sequencing a total of ≈ 3.7 million
cDNAs derived from H. pylori grown under standard laboratory and stress conditions or in contact
with eukaryotic cells. This identified many additional sRNAs both from intergenic regions and
from regions antisense to annotated open reading frames (ORFs) as well as the ubiquitous 6S
RNA and its associated pRNAs. Moreover, differential analysis of primary and processed RNA
species facilitated the identification of≈ 800 transcription start sites of mRNAs across the H. pylori
genome. The results of the H. pylori transcriptome analyses will improve the functional annotation
of the H. pylori and related genomes, and the approach used here should facilitate the global
transcriptome analysis of mixed pathogen-host populations.
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Figure 6.2: In silico prediction of novel sRNAs in H. pylori 26695. To predict novel sRNA candidates
in H. pylori 26695, intergenic regions ≥ 60 bp were scanned for orphan promoter/terminator pairs. Rho-
independent transcription terminators were predicted using RNAMotif (Lesnik et al., 2001) and the de-
scriptor file for the terminator model specified in Chen et al. (2002). Putative promoters were determined
by simple pattern searches for H. pylori promoter motifs with PatScan (Dsouza et al., 1997). After re-
moval of putative, non-annotated ORFs, sRNA candidates that were conserved in the H. pylori strain J99
were subjected to experimental confirmation by 5’ RACE and Northern Blots.
6.1. Results
6.1.1. Biocomputational prediction of ncRNAs in H. pylori
As a first approach to identify novel sRNA candidates in Helicobacter pylori strain 26695, a
bioinformatics-based strategy similar to Chen et al. (2002) and Argaman et al. (2001) was un-
dertaken (see Section 2.3.3). Specifically, intergenic regions ≥ 60 bp were scanned for orphan
promoter/ terminator pairs as outlined in Figure 6.2. Since there is only little information about pro-
moter consensus sequences and transcription termination signals in Helicobacter, this approach was
based on similarities to known sRNA features from E. coli. Most of the known E. coli sRNAs are
116 CHAPTER 6. Deep sequencing reveals the primary transcriptome of Helicobacter pylori
terminated by Rho-independent transcription terminators, which is a common termination mecha-
nism also for mRNAs in this bacterium. However, two previous studies predicted only few Rho-
independent terminators in H. pylori (Ermolaeva et al., 2000; Washio et al., 1998). In contrast, it
has been recently shown that Helicobacter might rely more on Rho-independent termination than
previously assumed (de Hoon et al., 2005; Kingsford et al., 2007).
For this first screen, Rho-independent transcription terminators were predicted using the
RNAMotif descriptor file specified by Lesnik et al. (2001) that was also previously used for
sRNA prediction in E. coli (Chen et al., 2002). Additionally, putative promoter sequences were
identified by simple pattern searches for H. pylori RpoD (σ80) promoter motifs using PatScan
(Dsouza et al., 1997; Vanet et al., 2000). Only promoter and terminator pairs within a distance of
40-400 nt were considered as sRNA candidates. After removal of putative, non-annotated ORFs
and conservation analysis of candidates in Helicobacter pylori strain J99 this rather constrained
screen ended up with a final list of six candidates (Intergenic regions (IG): IG75, IG433, IG449,
IG480, IG494, and IG550) for experimental verification by 5’ RACE and Northern blot analyses
(see Table 10.10 in the Appendix).
The 5’ ends of four candidates (IG75, IG433, IG480, and IG550) could be confirmed by 5’ RACE
(indicated in the alignments in Figures 10.7-10.11 and for the H. pylori 26695 specific IG550 can-
didate in Fig. 10.12 in the Appendix). However, only one candidate, IG480, gave a strong signal on
Northern Blots (see Figure 6.3A), while for IG75, 433 and 550 only weak signals could be detected
(data not shown). The identified sRNA IG480 is also included in the list of sRNAs predicted in
Helicobacter by Livny et al. (2006). BLAST1 searches revealed that this RNA has five additional
homologues in the H. pylori 26695 genome (see Figure 6.3 B, asRNA B to F), whereof four could
be detected on Northern Blots under the conditions examined (Fig. 6.3 A). These additional homo-
logues were missed in the bioinformatics-based predictions because they either overlap annotations
and are, hence, not included in the list of IGRs or did not pass the terminator threshold.
As two of the identified homologues (asRNA E and F) are located antisense to ORFs annotated
as short hypothetical proteins (HP0024 and HP1515), the identified sRNAs could act as antisense
RNAs and thereby inhibit expression of the peptides. Thus, they were named H. pylori antisense
RNA (asRNA) A to F. Alignment of the antisense RNAs revealed the presence of highly conserved
Rho-independent terminators and promoter elements that are in accordance with transcriptional start
sites mapped by 5’ RACE (Fig. 6.4 A & B). Otherwise, the sequences are less conserved. However,
all of the sRNAs are predicted to fold into two highly stable stem loop structures (Fig. 6.4 C).
Alignment of the nucleotide sequences of the opposite strand of the IGRs carrying the antisense
RNAs A, C, D, E, and F revealed a highly conserved Shine-Dalgarno sequence followed by an AUG
start codon (Fig. 6.5 A). The corresponding RNAs encode all for short peptides of 30 amico acids
and were, thus, termed short peptide RNAs (spRNAs). Only spRNA D encodes for a shorter peptide
of 23 aa, as a deletion of one nucleotide in the coding sequence (position 176 in the alignment in
Fig. 6.5 A) leads to a premature stop codon and a truncated peptide. The spRNAs C and D could be
detected in vivo as ≈ 230 nt long transcripts on Northern blots (see Fig. 6.5B), and also expression
of spRNA A and F was confirmed on Northern Blots (data not shown). The peptides encoded
by spRNA E and F correspond to the ORFs annotated as HP0024 and HP1515 in the H. pylori
1 blast.ncbi.nlm.nih.gov/Blast.cgi
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Figure 6.3: A family of small RNAs in H. pylori 26695. (A) Total RNA samples of H. pylori strain 26695
from OD600 0.3 to 2 were separated on denaturing PAA gels and analysed on Northern blots. Under these
conditions, signals have been observed for asRNAs A to F except for asRNA E. The homologues, A through
F, vary in length between ≈ 67 and ≈ 90 nt. Bands corresponding to smaller species in the blots for sRNA A
and C are likely to be processing products. DNA oligonucleotides used for Northern blot hybridization are
listed in Table 10.14. (B) Location of asRNA A to F in the H. pylori 26695 genome. H. pylori asRNA B
overlaps with an ORF encoding a short hypothetical protein (HP1176), whereas asRNA E and F are located
antisense to ORFs annotated as short hypothetical proteins (HP0024 and HP1515). Blue arrows indicate
short peptide encoding RNAs (spRNAs) A to F.
genome but the other three ORFs have not been annotated yet. As the two annotated ORFs are
indicated as hypothetical proteins and also BLAST searches did not reveal any similarity to other
proteins, the function of these peptides is unclear. However, the peptides A, C, E , and F contain
a lot of positively charged amino acids, lysine (K), arginine (R), or histidine (H), leading to a
positive net charge between ‘+6’ and ‘+8’. Moreover, as the peptides are very hydrophobic and
transmembrane domains could be predicted using the TMPred2 program (shaded in grey for each
protein in Fig. 6.5C), an interaction with membranes is very likely. In addition, the peptides can
probably form alpha helical structures and were predicted to be potential antimicrobial peptides
using the prediction program on the Antimicrobial Peptide Database3 (Wang & Wang, 2004). Thus,
2 www.ch.embnet.org/software/TMPRED_form.html
3 aps.unmc.edu/AP/main.php
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Figure 6.4: Sequences and structures of a family of small RNAs in H. pylori 26695. (A) Alignment of the
family of sRNAs shows high conservation of promoter elements and predicted Rho-independent terminators.
Brackets indicate paired bases within the terminator stem-loop structure of asRNA A; red letters indicate
terminator base-pairs in each sequence. Promoter elements are indicated by blue boxes, transcriptional start-
sites determined by 5’ RACE in B by red boxes, respectively. Asterisks indicate conserved nucleotides. (B)
The predicted 5’ ends were verified by 5’ RACE analysis. (C) All of the asRNAs are predicted to fold into two
highly stable stem loop structures. Secondary structures were computed with RNAstructure (Mathews
et al., 2004) and drawn with RnaViz (Rijk et al., 2003).
they could eventuelly act as toxins for H. pylori itself or, in case they are secreted, also be toxic for
other bacteria in the mucosa.
Conservation analysis by BLAST searches showed that all of the asRNAs/spRNA cassettes are
present in several Helicobacter strains (see Figure 6.6) and some of them, asRNA C and F, are
present in several copies in H. pylori J99. For some of the spRNAs, mutations within the ORF lead
to truncated peptides or a start codon mutation results in a complete loss of translation. For example,
spRNA D which is truncated in H. pylori 26695 is not truncated in the other strains, whereas for
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Figure 6.5: A family of small ORFs in H. pylori 26695. (A) Nucleotide alignment of a family of small
ORFs shows high conservation of the Shine-Dalgarno sequence and start codon (green boxes) as well as the
stop codon (light blue box). The -10 promoter element of the short peptide encoding RNAs is highlighted
in yellow, the -10 box of the asRNAs encoded on the opposite strands is framed in blue. (B) Expression
of spRNA C and D was confirmed on Northern blots. (C) Protein alignment of peptides A, C, D, and E.
Transmembrane domains were predicted using the TMPred program and are shaded in grey for each protein.
‘+’ indicates a positively charged amino acid (H, K, or R) in at least one sequence in the alignment.
example spRNA A harbours a STOP mutation in H. acinonychis. Thus, the peptides could have
redundant functions and probably expression of not all peptides is required in H. pylori. Overall,
the asRNAs are very likely to act as cis-encoded regulators that bind to the spRNAs and thereby
probably repress translation of the peptides and/or lead to degradation by the double-strand specific
RNase III.
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Figure 6.6: Conservation of antisense RNAs A to F and short ORF cassettes. Locations of homologues
of asRNA A to F and peptide encoding RNAs spRNA A to F on the opposite strand in diverse Helicobacter
strains. HP: H. pylori 26696, jhp: H. pylori J99, HPAG1: H. pylori HPAG1, and Hac: Helicobacter acinony-
chis. Stripes indicate inserted genes or different flanking genes than in strain H. pylori 26695.
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6.1.2. Depletion of processed RNAs
The biocomputational strategy based on approaches for the identification of sRNAs in E. coli pre-
dicted only a few sRNAs in Helicobacter. However, sRNAs in Helicobacter might have different
sequence and secondary structure features than sRNAs from E. coli, and a de novo approach to
identify sRNAs might be required. Thus, a direct RNomics approach based on massively parallel
pyrosequencing of cDNA libraries derived from a variety of growth conditions was chosen. Instead
of size-fractionating RNA as it was done in previous RNomics screens in bacteria based on Sanger
sequencing methods (Section 2.3.5), a method for depletion of processed RNAs and selective se-
quencing primary transcripts was developed.
In bacteria, newly initiated (primary) mRNA and sRNA transcripts carry a characteristic
5’ triphosphate (5’PPP) end, whereas processed RNA species, including abundant ribosomal and
transfer RNAs (rRNA, tRNA), have 5’ monophosphate (5’P) ends. Treatment of total RNA with
5’ monophosphate dependent terminator exonuclease (TEX) which degrades 5’P but no 5’PPP RNA
depletes these processed RNAs and in parallel enriches for primary transcripts (Fig. 6.7 A).
To selectively identify primary transcripts in total RNA samples of H. pylori, two differential cDNA
libraries for each of the tested conditions were constructed: one library (-) from the original RNA
pool covering both primary and processed transcripts, and a second one (+) from RNA treated
with TEX in which primary transcripts are enriched. After TEX treatment of total RNA samples
of Helicobacter and Salmonella, the bands for 23S and 16S rRNA are almost completely elimi-
nated (Fig. 6.7 B). Northern Blot analysis confirmed specific degradation of a 23S rRNA fragment
in Helicobacter (Fig. 6.7 C). In contrast, 5S rRNA is neither in H. pylori nor in S. typhimurium
accessible for TEX-mediated degradation (Fig. 6.7 D). Probably its 5’ end is masked in a very sta-
ble, unaccessible secondary structure. However, primary transcripts, such as asRNA A, sRNA B
(identified below, see Section 6.1.7), and the Salmonella sRNA InvR (Pfeiffer et al., 2007) are not
degraded. In contrast, a processed fragment of Salmonella SraH RNA, which was originally iden-
tified in several genome-wide screens in E. coli (Argaman et al., 2001; Wassarman et al., 2001),
is completely degraded as expected (Fig. 6.7 D). The protection of asRNA A is not as prominent
as for other sRNAs, e. g., sRNA B or InvR. Probably, for part of the asRNA A transcripts, the 5’-
triphosphate was cleaved by an endogenous pyrophosphatase or the first nucleotides were cleaved
off by an endonuclease in both cases leading to a 5’-monophosphate. The processed fragment of
Helicobacter asRNA A is not degraded, as it is derived from the 5’end and, thus, still carries the
5’-triphosphate. Based on these preliminary experiments, total RNA treated with TEX should be
specifically enriched for sRNAs and, in addition, probably also for primary transcripts of mRNAs.
6.1.3. Deep sequencing of Helicobacter cDNA libraries
Helicobacter cDNA libraries were prepared from five different growth conditions: culture in brain-
heart-infusion media to mid-log phase (C-/+ libraries), and following 30 min acid stress (AS-/+);
growth in cell culture flasks in the absence (PL-/+) or presence of two eukaryotic cell types, i. e.
AGS human gastric epithelia cells (AGS-/+) in which H. pylori induces motility and cellular elon-
gation upon contact, and Huh7 cells (Huh7-/+) which the bacteria can adhere to but fail to induce
morphological changes (see Figure 6.8). In total, 2.15 million reads were sequenced for the acid
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Figure 6.7: Enrichment of primary transcripts. (A) 5’ monophosphate dependent terminator exonuclease
(TEX) specifically degrades RNAs with 5’-monophosphates, while primary transcripts with a 5’triphosphate
group are not affected. (B) Treatment of total RNA with TEX eliminates most of the processed RNAs,
especially ribosomal RNAs (indicated by arrows). Total RNA from H. pylori harvested at an OD600 of 0.6
(HP) and total RNA from S. typhimurium harvested at an OD600 of 2.0 (ST), respectively, were separated on
a TBE-agarose gel and stained with ethidium bromide; -/ + indicates prior treatment with TEX. (C) Northern
blots for several Helicobacter RNAs -/ + TEX treatment. (D) Northern blots for several Salmonella RNAs
-/ + TEX treatment. DNA oligonucleotides used for Northern Blot probing are listed in Table 10.14 in the
Appendix.
stress libraries and 1.79 million reads for the infection libraries on a Roche FLX sequencer. This
resulted in 220,000-530,000 cDNAs per library and a total of ≈ 3.7 million cDNAs (see Table 8.15
in Material and Methods).
After 5’end linker clipping, reads were mapped to the Helicobacter genome using the program
segemehl which is based on an error-tolerant suffix array method (Hoffmann et al., 2009, sub-
mitted). For this mapping method, clipping of tailing sequences is not necessary as they will be
removed during the mapping step. However, for very short sequences the poly(A) tail often leads
to mapping errors. Therefore, a filtering step was introduced which removed all sequences with
an A-content of more than 70% (see Table 8.15 in Material and Methods). For these sequences,
the poly(A) tail was clipped separately. Of the clipped reads, all sequences ≥12 nt were mapped
again with segemehl. This procedure allowed to map also very short sequences of at least 12 nu-
cleotides. In total, between 62% and 84% of the reads for the individual libraries could be mapped
to the Helicobacter genome. Of the mapped reads, between 26% and 75% uniquely mapped to the
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Figure 6.8: H. pylori 454 cDNA libraries. Total RNA of H. pylori from acid stress samples or infection
samples was -/+ TEX treated. For cDNA library construction, RNA was converted to 5’-mono-P-RNAs
by TAP (tobacco acid pyrophosphatas) treatment, followed by addition of poly(A)-tails, linker ligation and
reverse transcription. Libraries were sequenced on a Roche FLX sequencer. After linker and poly(A)-tail
clipping, reads were mapped to the H. pylori 26695 genome using an error-tolerant suffix array technique
(Hoffmann et al., 2009, submitted). In total, 217 million nucleotides were mapped which corresponds to a
≈ 136-fold genome coverage of the 1.67 Mb H. pylori genome.
Helicobacter genome (Table 8.15 in Material and Methods). The lengths of mapped reads varied in
a range from 12 to ≈ 350 bp (Fig. 6.9 A and B), whereof 12 bp was the length cut-off for mapping.
Figure 6.10 shows for each library the distribution of reads <12 bp, reads with no match to the
H. pylori genome, and reads that overlap with annotated regions (for actual numbers see Table 10.12
in the Appendix). The fraction of reads that could not be mapped to the Helicobacter genome is
higher for the AGS-/+ and Huh7-/+ libraries as they also contain human reads from the host cells
(see also Table 8.15 in Material and Methods). The fraction of uniquely mapped reads is generally
higher in the enriched libraries due to the removal of a large number of ribosomal rRNA reads.
Reads which derive from these transcripts map at least twice to the Helicobacter genome due to
the presence of two 16S and 23S rRNA genes and three 5S rRNA genes. Figure 6.10 shows that
the fraction of ribosomal RNAs (orange) is reduced in the enriched (+) libraries compared to the (-)
124 CHAPTER 6. Deep sequencing reveals the primary transcriptome of Helicobacter pylori
Mapped read length distribution INF libraries
0,00
10,00
20,00
30,00
40,00
50,00
60,00
70,00
10 30 50 70 90 110 130 150 170 190 210 230 250 270 290 310 330 350
Mapped read length [nt]
P
e
rm
il
le
o
f
m
a
p
p
e
d
re
a
d
s
[0
/0
0
]
PL -
PL +
AGS -
AGS +
Huh7 -
Huh7 +
Mapped read length distribution AS libraries
0,00
5,00
10,00
15,00
20,00
25,00
30,00
35,00
40,00
45,00
50,00
10 30 50 70 90 110 130 150 170 190 210 230 250 270 290 310 330 350
Mapped read length [nt]
P
e
rm
il
le
o
f
m
a
p
p
e
d
re
a
d
s
[0
/0
0
]
C -
C+
AS -
AS +
ASlibraries
INF libraries
A
B
P
er
m
ill
o
f
m
ap
p
ed
re
ad
s
[
/
]
0
00
P
er
m
ill
o
f
m
ap
p
ed
re
ad
s
[
/
]
0
00
5
1
15
2
25
3
35
4
45
5
0
10
20
30
70
40
60
50
Figure 6.9: Mapped read length distribution of H. pylori 454 cDNA libraries. (A) and (B): Mapped read
length distribution for the acid stress (AS) and infection (INF) libraries, respectively. Per mill reads of each
library are plotted vs the observed mapped read length.
libraries. For example, in the C- library ≈ 63% of all reads derive from rRNAs, but only ≈ 25% in
the C+ library. In contrast, the fraction of tRNAs increased upon TEX treatment, e. g., 7.3% tRNA
reads in the C- and 27% tRNA reads in the C+ library, probably also due to a strong pairing of the
5’ and 3’ end within the tRNA structure. A large fraction of reads maps to mRNAs (8.8% and 5.8%
for the C- and C+ libraries, respectively). This is most prominent in the acid stress libraries (32.5%
and 18.9% for the AS- and AS+ libraries). Moreover, a fraction of reads mapping antisense to
annotated genes was observed (5.4% and 7.9% for the AS- and AS+ libraries, respectively). These
reads probably derive from cis-encoded antisense RNAs. In addition, the fraction of reads from
intergenic regions contains promising candidates for novel sRNAs in H. pylori (e. g., 3.4% and 15%
for the C- and C+ libraries, respectively). Furthermore, the increase of reads in intergenic regions
in the TEX+ libraries shows the successful enrichment of primary transcripts upon TEX treatment.
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Figure 6.10: Read distribution on annotated genes. Bar diagrams showing the relative proportions of
different RNA species in the acid stress (AS) and infection (INF) libraries.
Next, the number of cDNA hits for each nucleotide position in both genomic strands was calcu-
lated for all libraries similarly as described in Section 5.1.2 for the Hfq-CoIP libraries. The result-
ing graphs were visualized using the Integrated Genome Browser (IGB, Affymetrix). To get an
overview of the read distribution along the Helicobacter chromosome, all positions mapped for the
enriched libraries (+TEX) and all positions mapped for the untreated libraries (-TEX) were pooled
and plotted along the plus and minus strand of the H. pylori 26695 genome (Figure 6.11A, up-
per panel). The distribution of reads along the H. pylori chromosome indicated an overall genome
coverage.
The lower panel in Figure 6.11A shows the read distributions for the C-/+ and AS-/+ libraries on
part of the cag pathogenicity island. While reads are distributed along the whole mRNAs in the
unenriched libraries (black graphs), the 5’end of mRNAs are enriched in the TEX treated libraries.
These enrichment peaks correspond exactly to experimentally mapped promoters for cagA and
cagB as indicated by green arrows (Spohn et al., 1997). Also the two known promoters for the
urease operon, which has an important function in acid resistance of Helicobacter, show the sharp
enrichment peaks in the TEX treated libraries compared to the untreated libraries (Fig. 6.11B).
Transcription of this operon starts upstream of ureA (Shirai et al., 1999; Spohn & Scarlato, 1999a)
and upstream of ureF (Akada et al., 2000; Pflock et al., 2005). Furthermore, a strong induction of
this operon in the acid stress libraries is visible. The lower amount of reads mapping to the 3’ part of
the ureIEF-HP0068-ureH polycistronic mRNA and the relatively sharp decrease of mapped reads
within ureE in the untreated libraries indicate a previously described processing site in ureE (Akada
et al., 2000).
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Figure 6.11: Cag island and urease operon. (A) (Upper panel) Screen shot of the IGB showing the read
distribution for all untreated libraries (-TEX, blue curves) and all libraries enriched for primary transcripts
(+TEX, orange curves). The reads for all untreated and for all enriched libraries were pooled, and the log2
values of the number of mapped reads for the plus and minus strand at each nucleotide position were plotted
along the genome. Positions of tRNA, rRNA, and mRNA genes are indicated by green, blue, and grey bars,
respectively. (Lower panel) Read distribution for the C-/+ libraries and AS-/+ libraries on part of the cag
pathogenicity island. Green arrows indicate the experimentally mapped transcriptional start sites for cagA/B
(Spohn et al., 1997). Note that cagB is not annotated in H. pylori 26695 but located between cag25 and cagA
in strain G27. (B) Read distribution on the minus strand for the C-/+ libraries and AS-/+ libraries on the
urease operon. Green arrows indicate the experimentally mapped transcriptional start sites for ureA (Shirai
et al., 1999; Spohn & Scarlato, 1999a) and ureI (Akada et al., 2000; Pflock et al., 2005).
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Figure 6.12: Enrichment patterns allow an exact mapping of transcriptional start sites. (A) A typical
TSS enrichment pattern is show exemplarily for cagA. A strong enrichment of cDNAs clustering at the +1
site of cagA mRNA in the TEX-treated C+ (red) library could be observed, whereas in the untreated C-(black)
library the reads are spread along the whole mRNA. The cDNA reads of the C+ library cluster exactly at the
transcriptional start site published in Spohn et al. (1997), which is indicated by a green arrow. (B) In total,
74 experimentally mapped promoters from the literature or based on 5’ RACE analysis (see Table 10.11 in
the Appendix) were compared to the TSSs based on the 454 sequencing data. The histogram indicates the
number of observed distances between experimental TSS and 454 TSS.
6.1.4. Mapping of transcriptional start sites
Figure 6.11 exemplifies how the different cDNA library data reveal both the transcriptional start
site (TSS) and the growth-condition dependent regulation of a given gene. Mapping of the individ-
ual cDNA sequences to the H. pylori genome showed that nuclease-treatment had counter-selected
processed rRNAs in favor of transcripts matching to intergenic regions. These latter regions also
contain the TSSs of mRNA genes. Figure 6.12A shows the typical enrichment pattern of cDNAs
clustering at the +1 site of an mRNA, here cagA mRNA. Intriguingly, the 5’ ends of these cDNA
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clusters matched exactly the previously mapped first nucleotide of cagA mRNA. In contrast, cDNAs
from the TEX- library were dispersed over the 5’ mRNA region. In other words, scoring for dif-
ferences in the two cDNA libraries revealed a pattern indicative of the genomic TSS positions of
primary transcripts (Figure 6.12A).
To assess the quality of TSS determination based on the 454 mapping, a set of 54 promoters was
compiled from the literature and 20 additional promoters were mapped by 5’ RACE (see Table 10.11
in the Appendix). Of these 74 TSSs, 69 were covered by the 454 data. Comparison between the
experimentally determined start sites and the ones observed in the deep sequencing data shows that
most start sites map exactly to the same nucleotide (Figure 6.12, distance of 0). For some genes,
large differences were observed which probably correspond to alternative promoters. However,
the significant overlap between experimentally verified TSSs from the literature based on primer
extension or 5’ RACE and TSSs from the 454 data gives good confidence to annotate new promoters
based on the 454 data.
6.1.5. Global TSS annotation
To annotate TSSs in H. pylori at a genome-wide level, all libraries were simultaneously loaded
into the IGB and altogether analysed by manual inspection. Generally, regions showing the typical
enrichment pattern of the 5’ flanking nucleotide in the (+) over the corresponding (-) library in at
least two of the five samples were annotated as TSSs. For some genes no clear enrichment pattern
was observed. In these ambiguous cases, additional criteria such as the position of a putative TSS
to adjacent genes were included. For example, a TSS was annotated although it did not show a
convincing enrichment pattern if it was located between two divergent genes and no other TSS was
annotated for the respective gene. As the two genes are divergent, each must have its own promoter.
The global TSS analysis predicted a total of 1,906 putative TSSs, whereof 938 (≈ 49%) were an-
notated on the minus strand and 968 (≈ 51%) on the plus strand. As depicted in Figure 6.13A,
all annotated TSSs were classifed into one out of five categories: primary (P), secondary (S), in-
ternal (I), antisense (A) or orphan (O). TSSs with the highest expression that are located ≤ 500
bp upstream on the same strand of an annotated gene were classified as primary. If a gene had
an additional alternative transcriptional start site with lower expression, this TSS was classified as
secondary. A TSS which started within an annotation on the same strand was classified as internal,
whereas TSSs that were located on the opposite strand of an annotation or started on the opposite
strand within a range of -/+100 bp of an annotation were classified as antisense. TSSs which had
no related annotation in close proximity (-/+100 basepairs to annotations of the opposite strand or
>500 basepairs to downstream genes on the same strand) were called orphan (Fig. 6.13A).
As outlined in Figure 6.13B, TSS can have multiple associations with different annotations, e. g., the
TSS within gene 3 is internal to gene 3 but also primary to gene 4. Thus, in total 2,495 annotated
TSS features (1,265 on the (-) strand and 1,230 on the (+) strand, respectively) were annotated.
The distribution of TSSs into the different classes is shown in Figure 6.13B. A large fraction of
antisense transcripts was observed for the Helicobacter transcriptome. Around 27% of the primary
transcripts (216 out of 810 unique primary TSSs) were also annotated as antisense to another gene
(Fig. 6.13C). Conversely, ≈ 23% of the antisense TSSs are also primary TSSs (219 out of 969
unique antisense TSSs). Around 18% (145 out of 810) of the primary TSSs are also internal TSSs,
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Figure 6.13: Global annotation of transcriptional start sites in H. pylori. (A) Schematic drawing of the
criteria used for manual TSS annotation. All annotated TSSs were classifed into one of five categories:
primary (P), secondary (S), internal (I), antisense (A) or orphan (O) based on their expression strength and
distance to flanking or overlapping annotations. (B) Pie chart showing the relative proportions of different
TSS classes. (C) Venn diagram showing the overlap between different TSS classes. Some TSSs can be asso-
ciated to multiple genes and therefore be represented in different classes, e. g., primary to gene x and antisense
to gene y. The diagram was generated by VENNY (http://bioinfogp.cnb.csic.es/tools/venny/index.html) using
the TSS positions for the four classes P, S, I, and A as input.
i. e. the TSS is located sense within an annotated gene, and conversely 33% (145 out of 440) of the
internal TSSs are also primary. This observation indicates a very dense distribution of promoters
along the Helicobacter genome and hints at the existence of alternative transcription start sites for
genes that are located within operons.
For 717 of the 1,576 annotated H. pylori ORFs a primary TSS was annotated and 105 genes showed
an additional secondary TSS. This set of 822 primary and secondary TSSs was used for further
analysis, e. g., calculation of the UTR length distribution (see Figure 6.14). Surprisingly, 25 of the
822 mRNAs (≈ 3%) turned out to be leaderless, i. e. they lack a 5’ UTR and their transcription
starts exactly on the ‘A’ of the AUG start codon (Table 10.13 in the Appendix). Only a few mRNAs
had a 5’ UTR length <20 nt. A peak in the UTR length distribution was observed between 20 to
50 nt (396 TSS = 48%). This is in good accordance with the experimentally determined region
known to be covered by the 30S subunit during translation initiation (Murakawa & Nierlich, 1989;
Platt & Yanofsky, 1975; Steitz & Jakes, 1975). Upon anchoring to the Shine-Dalgarno sequence
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Figure 6.14: UTR length distribution. The distribution of UTR lengths was based on 822 primary and
secondary TSSs of mRNA genes. The frequency of the observed UTR length is plotted vs the UTR length. In
total, 25 leaderless mRNAs (5’ UTR of 0 nt) were identified which are listed in Table 10.13 in the Appendix.
Almost half of the 5’ UTRs range in size between 20 and 50 nt. The inlet shows schematically the region of
the mRNA that is covered during fomation of the translation initiation complex.
and the start codon, the 30S subunit covers a region ranging from ≈ -20 bp upstream of the start
codon to ≈+19 bp downstream of the start codon (Beyer et al., 1994; Hu¨ttenhofer & Noller, 1994;
see inlet in Figure 6.14). More recently, X-ray analyses mapped the path of an mRNA through
70S ribosomes and indicated that a region of -/+15 nt around the start codon is wrapped around the
30S subunit and passes two separate tunnels (Yusupova et al., 2006, 2001). Thus, for very short
UTRs (<20 bp) the sequence upstream of the start codon is probably not long enough to contain a
SD sequence or binding sites for the ribosomal protein S1. For several genes, long 5’ UTRs with a
length of up to 500 bp, which was the distance threshold for primary TSSs, were observed. These
could harbour cis-regulatory elements such as riboswitches.
6.1.6. 454 sequencing reveals a 6S RNA homologue of H. pylori
One highly transcribed region in all libraries is located upstream of purD (HP1218) and antisense to
the hypothetical protein HP1219 (Fig. 6.15 and 6.16A). From this region, an almost constitutively
expressed RNA of ≈ 180 nt is transcribed (Fig. 6.16B). The hypothetical ORF HP1219 is not con-
served in any of the other H. pylori strains and might therefore be misannotated (see Fig. 6.16A).
The same region has recently been described to contain a candidate structured RNA motif identified
by the CMfinder tool (Weinberg et al., 2007). The authors suggested this RNA to be a riboswitch
aptamer but could not detect any structural modulation by binding of a panel of purine compounds
in vitro.
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Figure 6.15: Deep sequencing reveals a 6S homologue in H. pylori. Screen shot of the IGB showing a
highly transcribed region opposite to the hypothetical protein HP1219 in the C-/+ and AS-/+ libraries. The
180-nt long RNA upstream of purD is very likely a 6S homologue in Helicobacter. Furthermore, 6S-specific
pRNAs on the opposite strand of 6S RNA are marked in green and additional pRNAs* are indicated in blue.
Secondary structure prediction and in vitro structure probing of the 180-nt long RNA, which is
extended at the 5’ end compared to the RNA motif identified by Weinberg et al., 2007, revealed a
long hairpin structure similar to 6S RNA from E. coli (Trotochaud & Wassarman, 2005) as shown in
Figure 6.16C. The RNA polymerase inhibitor 6S RNA has been identified in almost every bacterial
clade, but no 6S homologue has been described so far in the ǫ-subdivison of proteobacteria (Barrick
et al., 2005; Willkomm et al., 2005). Although no sequence similarities to the E. coli 6S RNA can
be found, the putative H. pylori 6S RNA contains some of the conserved secondary features, such as
the large central bubble, a 1-nt bulge in the closing stem, and some of the conserved base-pairs of the
previously described consensus structure (Barrick et al., 2005). Indeed, consensus shape analysis
(Reeder & Giegerich, 2005) of the regions upstream of the purD genes of other bacteria from the
ǫ-subdivision, such as Campylobacter, Wollinella, as well as the deep-sea bacteria Nitratiruptor
and Sulfurovum, indicated that they can also form into the 6S RNA like secondary structure (see
Fig. 6.17). However, on the primary sequence level they show a high level of diversity compared to
Helicobacter.
6S RNA adopts a structure similar to an open promoter complex and has recently been shown to be
a template for RNA-mediated synthesis of pRNAs (Gildehaus et al., 2007; Wassarman & Saecker,
2006). Thus, detection of these 14 to 20 nt-long pRNAs in the cDNA libraries would strongly argue
for this RNA to be an 6S homologue. Indeed, several reads for pRNAs could be detected in the
TEX treated library (Fig. 6.15). The Helicobacter pRNAs start exactly at the same position in the
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Figure 6.16: Genomic location, expression, and structure of H. pylori 6S RNA. (A) Genomic locations
of putative 6S RNA homologues in diverse Helicobacter strains. The hypothetical protein HP1219 is not
conserved in two other H. pylori strains and probably misannotated. (B) Expression of the 180-nt long 6S
RNA was confirmed on Northern Blots. RNA samples were taken at OD600 values between 0.3 (log phase)
and 2.0 (late stationary phase). Equal amounts of RNA were loaded. (C) (Left) In vitro structure probing of
Helicobacter 6S RNA and proposed secondary structure. 5’end-labelled 6S RNA (≈ 5 nM) was subjected
to RNase T1, lead(II), RNase T2, and RNase III cleavage. Lane C: Untreated 6S RNA. Lane T1: RNase
T1 ladder under denaturing conditions. The position of cleaved G residues is given left of the gel. Lane
OH: Alkaline ladder. (Right) Proposed secondary structure of 6S RNA based on in vitro structure mapping.
Cleavages by RNase T1, T2, or lead(II) are indicated by black, red, and blue arrows, respectively. The
transcriptional start of pRNAs is indicated by a green arrow and the transcribed nucleotides are indicated in
green. Location of additional pRNAs* according to Fig. 6.15 that start in the reverse direction of the central
bubble are indicated in blue.
central bubble as in E. coli (Fig. 6.16C, green arrows). Therefore, the libraries are also suitable for
detecting very short transcripts and, thus, for the first time allow detection of pRNAs in vivo.
6.1.7. Novel sRNAs
The current annotation of H. pylori genomes is largely focussed on mRNA, tRNA, and rRNA genes,
and only a small number of sRNAs was identified in the biocomputational approach (Section 6.1.1).
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Figure 6.17: RNAshapes secondary structure of 6S homologues from diverse ǫ-proteobacteria. To identify 6S homologues in diverse ǫ-proteobacteria,
BLAST searches for purD (HP1218) homologues were carried out, the purD upstream regions corresponding to the genomic location of 6S RNA in H. pylori 26695
extracted and manually inspected for -10 promoter elements. Based on the assumption that the 6S RNA location is conserved, 6S homologues could be identified in
diverse members of the ǫ-subdivision. HP26695: H. pylori 26695 (NC 000915), HPAG1: H. pylori HPAG1 (NC 008086), J99: H. pylori J99 (NC 000921), Hac:
Helicobacter acinonychis str. Sheeba (NC 008229), Cje: Campylobacter jejuni subsp. jejuni NCTC 11168 (NC 002163), Hhe: Helicobacter hepaticus ATCC
51449 (NC 004917), Nsb: Nitratiruptor sp. SB155-2 (NC 009662), Wsu: Wolinella succinogenes DSM 1740 (NC 005090), Tde: Thiomicrospira denitrificans
(NC 007575). Prediction of consensus RNA shapes using RNAshapes (Reeder & Giegerich, 2005; Steffen et al., 2006) showed that all putative 6S RNAs can
fold into the conserved long stem-loop structure. Only the thermodynamically best shape is shown. First, the common shape type ([]), and the absolute and relative
score are listed. In addition, for each input RNA, the sequence, the predicted shrep, (thermodynamically best structure which adopts this shape), its energy, and its
individual rank in the shape space is given. Note that sequences are not aligned. Regions that are transcribed into pRNAs and pRNAs* are indicated in the H. pylori
26695 sequence in green and blue, respectively. Note that the central bubble shows additional base-pairs compared to the experimentally derived secondary structure
in Fig. 6.16C, as the algorithm tries to find the thermodynamically best structure.
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In contrast, the sequencing data revealed hundreds of candidate sRNA transcripts expressed from
IGRs, from regions antisense to annotated ORFs, and in a few cases from the sense strand of pro-
tein coding regions. During the manual annotation of all H. pylori TSSs, also putative sRNA candi-
dates were annotated. In total, ≈ 840 putative ncRNA TSSs were identified. These include orphan
transcripts, which are putative sRNA candidates, cis-encoded antisense RNAs, and strong internal
transcripts which are located sense to mRNA genes.
Figure 6.18 shows some examples of the different classes of novel ncRNAs that were identified in
Helicobacter pylori. The first one, sRNA A is an independent transcript of ≈ 87 nt and encoded in
the intergenic region between HP1044 and HP1043, whereof the latter encodes for one of the orphan
response regulators (Fig. 6.18A). For some sRNA candidates it remains unclear from the 454 data
whether they are independent transcripts or actually correspond to 5’ UTRs of mRNA genes, and
reads stop upstream of the annotation due to 454 sequencing length limitations. The next two
candidates, sRNA B and D are clearly detectable as ≈ 142 nt and ≈ 213 nt long RNAs correlating
with the read patterns observed in the 454 data. However, some sRNA candidates already turned
out to be 5’ UTRs as only a long RNA corresponding to the size of the full length mRNAs was
detected on Northern blots (data not shown). Candidate sRNA D is especially interesting as it is
encoded in the cag pathogenicity island and, thus, could have a function in virulence.
Besides separate standing sRNAs, a large fraction of cis-encoded antisense RNAs was detected
(for examples see Fig. 6.18B). Some of the antisense RNAs are located on the opposite strand of
hypothetical proteins (for example asRNAs 1a/b, 7) which could be misannotated; however, some
were also found antisense to conserved proteins, e. g., sRNA L which is antisense to a gene encoding
for a short chain alcohol dehydrogenase. In addition, antisense transcripts to tRNAs or the 23S
rRNA leader (for example asRNA 11a/b) were observed. Furthermore, antisense RNAs were found
on the opposite strands of 5’ or 3’ UTRs or within mRNA genes. In addition, these antisense RNAs
are often present in different lengths (see for example sRNA L). Besides RNAs that are located
within mRNA genes on the opposite strand, several sense encoded internal sRNAs were identified
(Fig. 6.18C). These sense RNAs are also often transcribed or processed into RNAs of different
length and their expression seems to be growth or stress regulated, e. g., ssRNA I and IIIa/b which
are both strongly induced upon 30 min of acid stress. Some of the ncRNAs are duplicated in the
H. pylori genome (for example asRNA 1a/b, asRNA 11a/b, and ssRNA IIIa/b). In total, expression
of more than 30 sRNAs could be confirmed on Northern blots so far (data not shown), but the
functional roles of the identified sRNAs remain to be elucidated.
6.1.8. Additional short ORFs within the H. pylori genome
In addition to new sRNAs, the transcripts detected in intergenic regions could also encode for small,
non-annotated peptides. In the biocomputational screen, a family of spRNAs and associated asR-
NAs was identified. Two additional transcripts, HPnc4160 (asRNA G) and HPnc4170 (spRNA G),
that were detected in the 454 data and could be validated on Northern blots (Fig. 6.19A), are located
antisense to each other (Fig. 6.19B). The longer transcript, HPnc4170, could encode for a 44 aa long
peptide which is conserved in several other strains (Fig. 6.19A). The smaller transcript HPnc4160
could act as a cis-encoded antisense RNA that represses translation of the peptide similarly to the
previously identified asRNAs A to F.
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Figure 6.18: Examples of novel sRNAs in Helicobacter. (A-C) Blots showing the detection of stable
transcripts of nine novel sRNAs in H. pylori. Total RNA was isolated from Helicobacter pylori at different
growth or stress conditions: (C 30’) culture in BHI medium to mid-log phase, reference sample for the 30’
timepoint, (AS 30’) 30 min acid stress pH 5.2, (C 2h) culture in BHI medium to mid-log phase, reference
sample for the 2h timepoint, (AS 2h) 2 hours acid stress pH 5.2, (PL) growth in cell culture medium, (AGS)
growth in the presence of AGS cells, and (Huh7) growth in the presence of Huh7 cells. 10 or 15 µg RNA of
each sample were analysed on Northern blots and expression of sRNAs validated by hybridization with DNA
oligonucleotide probes. (A) Examples for sRNAs encoded in intergenic regions, (B) cis-encoded antisense
RNAs, and (C) sRNAs that are located internal and sense to mRNA genes. The genomic context for each
sRNA (red arrows) is indicated schematically next to the blots. Note that HP0488 and HP1116, as well
as HP0423 and HP1412, are gene duplications. HP0488 and HP1116 have an additional asRNA, namely,
asRNA2a/b.
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Figure 6.19: Additional spRNA/asRNA families. (A) Northern blots of RNA harvested from differ-
ent growth conditions as in Fig. 6.18 confirmed expression of two new RNA transcripts, HPnc4160 and
HPnc4170, which are encoded antisense to each other. Alignment of the putative peptide encoded by
HPnc4170 and homologues that were identified in diverse H. pylori strains. (B) Genomic location of ad-
ditional short-peptide encoding RNAs (blue arrows) and associated asRNAs (red triangles). (C) Northern
blots of antisense RNAs HPnc2090/HPnc5320 and HPnc4590. (D) (Top) and (Middle): Alignments of puta-
tive peptides encoded on the opposite strand of HPnc2090/HPnc5320 (peptide C1/2) and HPnc490 (peptide
I) and homologues predicted in diverse H. pylori strains. Transmembrane domains were predicted using
the TMPred (www.ch.embnet.orgsoftwareTMPRED form.html) program and are shaded in grey for each
protein. (Bottom) Alignment of the Ibs peptide family from E. coli adapted from Fozo et al. (2008a).
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Furthermore, two of the newly identified sRNAs, sRNA C1/2 (HPnc2090/HPnc5320) which is
100% duplicated in the genome and sRNA I (HPnc4590) (Fig. 6.19C) contain a nearly perfect
anti-Shine-Dalgarno sequence ‘TCTCCT’ and are highly expressed. On the opposite strands of
sRNAs C1/2 and sRNA I only few reads were detected but inspection of the genomic sequences
revealed that they could encode for small peptides of 16 and 11 aa (Fig. 6.19D). Conservation anal-
ysis showed that the Shine-Dalgarno sequences, start codons, and peptides are highly conserved in
other H. pylori strains. Moreover, the spRNAs/asRNA pairs are present in different copy numbers
at the same genomic locations in different strains (see Fig. 6.20A and B).
Additional cassettes that are similar in sequence to both, sRNA C1/2 and sRNA I, were identified
in the other strains (Fig. 6.20C). Thus, regarding also the sequence similarity between peptides I
and C1/2 they could constitute one large family. Furthermore, they have sequences similar to the
short hydrophobic peptides of the Ibs family which has recently been identified in E. coli (Fozo
et al., 2008b). Similar to the peptides encoded by spRNAs A to F, also for peptides C1/2 and I
transmembrane domains could be predicted (Fig. 6.20C). Overall, in addition to the spRNA A to
F familiy, four additional spRNA/asRNA cassettes in the H. pylori 26695 genome were identified
(Fig. 6.20D).
6.2. Discussion
An increasing number of regulatory RNAs is being characterized from all three domains of life.
The first sRNAs have been identified in E. coli, but the number of bacteria where sRNAs have been
identified is rapidly growing. Most of them regulate trans-encoded target mRNAs by antisense
pairing mechanisms for which they require the ubiquitous bacterial RNA-binding protein, Hfq.
However, regulatory sRNAs have so far evaded detection in H. pylori, including the exceptionally
wide-spread 6S RNA, a regulator of RNA polymerase activity. Moreover, the H. pylori genome
lacks an hfq gene (Sun et al., 2002) and has significantly less intergenic space than sRNA-rich bac-
teria such as E. coli. These observations questioned that H. pylori encoded sRNAs and, therefore,
the universal occurrence of bacterial riboregulators.
One the one hand, the previous paucity of transcriptional regulators of cellular adaptive responses
in H. pylori may be explained by the rather constant gastric environment H. pylori faces upon host
infection. On the other hand, the recent discoveries of myriads of small noncoding RNAs (sRNAs)
in virtually all organisms have provided ample evidence for intricate regulation of adaptive and
stress responses at the post-transcriptional level. In this thesis, only a few sRNAs could be pre-
dicted in H. pylori using a biocomputational approach (Section 6.1.1). This appoach was limited
to prediction of orphan promoters and terminators in intergenic regions and was based on known
sRNA features from E. coli. As H. pylori does not encode an Hfq homologue (Sun et al., 2002),
sRNAs in this bacterium might have different functions as well as sequence and secondary struc-
ture features. Thus, a direct RNomics approach including selective sequencing of RNAs enriched
for primary transcripts was taken. This identified diverse sRNA genes in H. pylori and, in addition,
allowed a global analyis of mRNA transcriptional start sites in this bacterium.
Previous RNomics screens for sRNA identification in bacteria, e. g., in E. coli, were at that time
based on the conventional Sanger sequencing method and, therefore, limited by the number of se-
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Figure 6.20: Conservation and location of diverse peptide families in H. pylori. (A) and (B): Genomic
locations of putative spRNA/asRNA cassettes belonging to the asRNA C1/2 and asRNA I families. Short-
peptide encoding RNAs are indicated by blue arrows and associated asRNAs by red triangles, respectively.
Helicobacter strains are given right of the locations: H. pylori 26695, J99, P12, HPAG1, and G27, and
H. acinonychis (Hac). (C) Additional cassettes that are similar to the asRNA C1/2 and asRNA I families but
encoded at different genomic locations were identified in H. pylori J99, H. pylori G27, and H. acinonychis.
(D) Locations of spRNA/asRNA cassettes on the H. pylori 26695 chromosome. The cag island and urease
operon are indicated in blue, the two plasticity zones (Alm et al., 1999) by red boxes. The circular represen-
tation of the 26695 chromosome (taken from CampyDB: (http://xbase.bham.ac.uk/campydb/) indicates the
G/C content for each gene based on the color code shown on the right.
quenced cDNA clones (see Section 2.3.5). In contrast, next-generation sequencing methods have
enabled the recent ‘RNA sequencing’ (RNA-Seq) technology, which generates tens of millions of
short sequences of random cDNA libraries in a single assay but has not been applied to bacteria so
far (reviewed in Wang et al., 2009). Two initial studies applied deep sequencing to identify novel
genes in bacteria (Frias-Lopez et al., 2008; Mao et al., 2008). In this study, RNA-Seq using 454
pyrosequencing was applied to the transcriptome of H. pylori. During preparation of this thesis,
two studies which also applied deep sequencing to transcriptome analysis in bacteria were pub-
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lished (Liu et al., 2009; Yoder-Himes et al., 2009). Liu et al. (2009) used a tRNA and 5S rRNA
depletion treatment which is based on RNase H digestion of RNA bound to complementary DNA
oligonucleotides and analysed size-fractionated RNA of Vibrio cholerae by 454 sequencing. They
identified 500 new putative intergenic sRNAs, 127 putative asRNAs and also transcripts from the
sense strand within ORFs. The second study used Illumina RNA-Seq to analyse the transcrip-
tome of two Burkholderia cenocepacia strains under two relevant environmental conditions. Here,
rRNAs were depleted using the MicrobeExpress kit (Ambion). This kit is also based on capture
oligonucleotides that bind to the bacterial 16S and 23S rRNAs; however, the rRNA hybrids are
removed from the solution using derivatized magnetic microbeads instead of an RNase H diges-
tion. Besides the identification of 13 new putative sRNAs in Burkholderia, several genes that are
strain-specifically induced in one of the analysed conditions were identified giving a first glimpse
at the application of transcriptional profiling using deep sequencing in bacteria. However, both ap-
proaches did not provide a global annotation of mRNA TSSs. The approach based on enrichment of
primary transripts described in this thesis requires no size-fractionation step and no organism spe-
cific antisense oligos for tRNA/rRNA depletion. In parallel, also mRNA TSSs can be enriched, and
this strategy should in principle also be applicable to eukaryotic mRNAs where the cap structure
also prevents degradation by TEX.
In comparison to the bioinformatics-based approach, the RNA-Seq approach led to the identification
of hundreds of sRNA candidates in H. pylori, whereof more than 30 could be verified on Northern
blots so far. Diverse sRNAs located in intergenic regions as well as sense or antisense to annotated
genes were detected. For some sRNA candidates it is unclear from the 454 sequencing data whether
they are independent transcripts or actually correspond to 5’ UTRs of mRNA genes as reads stop
upstream of the annotation due to 454 sequencing lengths limitations. This requires further exper-
imental investigation of actual transcript lengths on Northern blots. Recently, two studies tried to
identify sRNAs in H. pylori by a bioinformatics-based approach (Xiao et al., 2009a) and antisense
transcripts by an experimental approach based on an RNase I protection assay (Xiao et al., 2009b).
However, they identified only two sRNAs and two antisense RNAs, but none of them was recovered
in the 454 sequencing data.
Among the novel sRNAs, a homologue of the highly abundant 6S RNA was identified which previ-
ous bioinformatics-based approaches failed to detect (see Section 2.1.3.1 and Barrick et al., 2005;
Willkomm et al., 2005). It is encoded upstream of purD, and the same region was previously
suggested to be a riboswitch based on comparative structure analysis (Weinberg et al., 2007). In
contrast, the experimentally verified conserved 6S structure as well as detection of the pRNAs in the
454 data that are specifically transcribed from 6S RNA argue that this region encodes a 6S homo-
logue. In E. coli, it was shown that 6S RNA facilitates transcription of σS-dependent promoters by
titrating σ70-bound RNA polymerase (Wassarman, 2007). So far, no homologue of σS is known in
H. pylori. However, it was recently reported that promoters with a weak -35 element are senstitive
to 6S RNA regulation and that an extended -10 element similarly determines inhibition by 6S RNA
except when a consensus -35 element is present (Cavanagh et al., 2008). As there is no common
-35 element known in H. pylori, an extended set of genes could be sensitive to 6S RNA regulation
also in this bacterium.
Besides 6S RNA and sRNAs in intergenic regions, a large number of antisense transcripts were
identified in H. pylori which are located antisense to 5’ or 3’ UTRs or within open reading frames.
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These cis-encoded antisense RNAs probably base-pair with the RNAs encoded on the opposite
strand and thereby inhibit translation of their targets or lead to degradation by the double-stranded
specific RNase III. Especially, cis-encoded antisense RNAs to 5’ UTRs could act by inhibition of
translation as described for SymR RNA in E. coli, which is transcribed opposite to the 5’ end of the
SOS-induced toxin SymE (Kawano et al., 2007). In cyanobacteria, an internal antisense RNA was
described to control expression of a photosystem associated protein in response to environmental
changes (Du¨hring et al., 2006). Therefore, the diverse antisense transcripts could also allow rapid
regulation of gene expression in Helicobacter upon different stresses. Recently, transcription of
the ubiGmccBA operon of Clostridium acetobutylicum, which is involved in methionine to cysteine
conversion, was shown to be controlled by a cysteine-specific T-box riboswitch in the 5’ UTR but
mainly by several antisense RNAs which are themselves controlled by an S-box riboswitch (Andre´
et al., 2008). The abundance of sense and antisense transcripts was inversely correlated with the
sulfur source availability, and the antisense RNAs were shown to modulate the level of ubiG tran-
script and of MccB activity. Alternatively, the antisense RNAs could lead to 3’ or 5’ end processing
of mRNAs and alter transcript stabilities as shown for GadY sRNA in E. coli (Opdyke et al., 2004).
Specifically, the gadY gene was shown to overlap the 3’ end of the gadX gene, and this overlapping
region was found to be necessary for the GadY-dependent increase of gadX mRNA stability. In
Vibrio anguillarum, a plasmid-encoded antisense RNA leads to transcription termination after the
fatA gene of the fatDCBAangRT operon and, hence, reduces expression of the downstream angRT
genes (Stork et al., 2007).
As most of the computational screens are focussed on the identification of independent sRNA genes
in intergenic regions they will miss sRNAs which are located antisense or internal to annotated
genes (see Section 2.3.3). In E. coli, a global low level antisense transcription has been previously
reported based on a whole-genome microarray (Selinger et al., 2000). Moreover, a cloning-based
screen of small RNAs <65 nt identified several cis-encoded antisense RNAs as well as 5’- and
3’-UTR-derived small RNAs in E. coli (Kawano et al., 2005a). Meanwhile, this approach was lim-
ited to the conventional Sanger sequencing similar to the first RNomics screens. Thus, a higher
sequencing depth could reveal additional cis-encoded sRNA genes. In a second approach, the same
group detected promoter activities within open reading frame sequences in E. coli by cloning ran-
dom fragments upstream of a promoterless lacZ gene on a plasmid and measuring β-galactosidase
activities (Kawano et al., 2005b). However, they failed to detect defined transcripts for the iden-
tified promoters on Northern blots and suggested that these promoters do not give rise to stable
transcripts. Although this indicates that it is difficult to identify and detect such transcripts in global
approaches, the deep sequencing strategy presented in this Chapter successfully identified many
antisense RNAs and sRNAs sense to ORFs.
The first bacterial antisense RNAs were actually identified on plasmids (see Section 2.1.5). Some
of these cis-encoded plasmid sRNAs repress the synthesis of toxic proteins and act as plasmid-
addiction molecules or post-segregational killing systems (Gerdes et al., 1997). In this case, a very
unstable RNA inhibits translation of a very stable mRNA that encodes the toxin. As soon as the
plasmid is lost, the unstable asRNA gets quickly degraded which allows translation of the more
stable mRNA, and the toxin produced kills the bacteria. The best known toxin-antitoxin pair is the
hok/sok system of plasmid R1 of E. coli (Gerdes et al., 1990). The biocomputational prediction
and the deep sequencing approach identified several potential asRNA/short-peptide encoding RNA
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cassettes in the H. pylori genome. For example, asRNAs A to F and the associated spRNAs con-
stitute a family which is present in different copy numbers in diverse Helicobacter strains. Some
of these copies show mutations, indicating that they could have a redundant function and not all
are required at the same time. The hydrophobic and positively charged peptides that are encoded
by the spRNAs could interact with membranes and thereby act as chromosomally encoded toxins.
Recently, several small toxic proteins that are present in multiple copies in the chromosome were
identified in E. coli and were found to be repressed by cis-encoded antisense RNAs (Fozo et al.,
2008b). In addition, there is growing evidence that short ORFs have been largely overlooked in
E. coli and S. typhimurium during genome annotations (Alix & Blanc-Potard, 2009; Fozo et al.,
2008a; Hemm et al., 2008). As the short peptides in Helicobacter could probably act as toxins, it
can be difficult to detect them in vivo. At least in an in vitro translation system it could be shown
that they are effectively translated and that a 1:1 ratio of the corresponding asRNA is sufficient to
repress translation of the peptide (F. Darfeuille, unpublished data). In total, at least three different
families of putative short peptide/asRNA cassettes in the 1.67 Mb Helicobacter genome were iden-
tified, which fits well with the number of at least six families described in the 4.6 Mb E. coli (Alix
& Blanc-Potard, 2009; Fozo et al., 2008a).
Interestingly, some of the asRNA/peptide cassettes are located close to the highly variable plasticity
zones of Helicobacter (Alm et al., 1999; Gressmann et al., 2005) and could have a potential function
in genome integrity. These plasticity regions show a lower G/C content than the rest of the genome
and contain several insertion sequences. Based on the following observations, it was suggested
that they were aquired by horizontal transfer from plasmids (Alm et al., 1999). First, H. pylori and
Campylobacter spp. plasmids have a G/C content in this lower range and, second, two copies of the
insertion-sequence element as well as neighbouring 26695-strain specific chromosomal DNA from
the plasticity zones are present in H. pylori plasmid pHPM186 (Lee et al., 1997).
The newly identified peptides could have a role in altruistic autolysis of Helicobacter which was
suggested as a mechanism for the release of several cytoplasmic proteins (Dunn et al., 1997; Marcus
& Scott, 2001; Phadnis et al., 1996; Vanet & Labigne, 1998). For example, the presence of urease
both in the cytoplasm and bound to the outside surface of the bacteria was observed in vitro (Phadnis
et al., 1996) and in vivo in human gastric biopsies (Dunn et al., 1997). Fujita et al. (2005) observed
that autolysis occurred after late-log phase of culture and identified a heat-stable and hydrophobic
peptidergic fraction of < 3,500 Da as the autolysis-inducing factor (AIF). The partially purified AIF
had a lytic activity which is specific for H. pylori and Campylobacter jejuni, but not, e. g., for E. coli
and Salmonella. Maybe some of the newly identified hydrophobic peptides are part of this AIF.
The ubiquitous RNA-binding chaperone Hfq is required for the action of most of the enterobacterial
sRNAs that regulate trans-encoded target mRNAs by antisense pairing mechanisms. So far, no Hfq
homologue has been identified in H. pylori. Therefore, the Hfq-coIP strategy from the previous
Chapter that was applied to detect novel sRNAs in Salmonella (Sittka et al., 2008) could not be
applied for sRNA identification in Helicobacter. Nevertheless, the question remains whether the
newly identified sRNAs that were identified by the deep sequencing approach require RNA binding
proteins or chaperones for their function or stability. To screen for auxiliary RNA-binding proteins
in H. pylori, aptamer tags could be added to several of the new H. pylori sRNAs and sRNA-binding
proteins isolated by affinity chromatography similar to previously described approaches in E. coli or
Salmonella (Windbichler et al., 2008, and Said et al., 2009, submitted). Another approach would be
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to co-immunoprecipitate RNAs with epitope-tagged putative RNA-binding proteins from H. pylori
as decribed for the Hfq-coIP in Salmonella in the previous Chapter. One interesting candidate is an
82 aa-long RNA binding protein (HP0827) which is also present in various species of cyanobacteria
and Treponema pallidum but absent from almost every other completely sequenced prokaryotic
genome (Maruyama et al., 1999). This protein contains a single RNA recognition motif (RRM)
which is also found in several eukaryotic RNA-binding proteins involved in splicing or control of
mRNA translation. Interestingly, also in the cyanobacterium Prochlorococcus strain MED4 several
sRNA and antisense RNAs have been identified despite a lack of an Hfq homologue (Axmann
et al., 2005; Steglich et al., 2008). It was suggested that maybe novel mechanisms for RNA-RNA
interactions may exist in this group. It would be interesting to see if any of the new sRNAs and
antisense RNAs that were identified in H. pylori or cyanobacteria are specifically bound by this
protein.
In addition to the identification of diverse sRNAs, the enrichment of primary transcripts allowed
a global annotation of ≈ 800 transcriptional start sites of mRNAs in H. pylori (Section 6.1.5). As
Helicobacter encodes only 1,576 ORFs and genes are often transcribed as polycistronic mRNAs
in bacteria, probably most of the mRNA TSSs were covered. In Helicobacter, not much is known
about promoter signals as well as transcription factor binding sites, and biocomputational promoter
predictions identified only a limited number of promoter motifs (Vanet et al., 2000). Based on the
global transcription map defined in this study, it is now possible to extract regions upstream of the
TSSs and to try to identify common promoter motifs or special promoter patterns for functional
classes of genes, for example using MEME (Bailey et al., 2006). Preliminary analysis identified a
highly conserved -10 box (TATAAT) but instead of a -35 box a very strong periodic variation in the
AT-content and semi-conserved T-stretches, with a period of 10-11 nucleotides (data not shown)
similar to what was reported for Campylobacter (Petersen et al., 2003).
Furthermore, the mRNA TSS map allowed calculating the UTR lengths distribution in H. pylori
(Fig. 6.14). Most of the genes were preceded by UTRs of 20-50 bp, whereas almost no shorter
UTRs, except for leaderless mRNAs, could be identified. This is in accordance with the region
known to be covered by the 30S subunit during translation initiation ranging from ≈ -20 bp up-
stream of the start codon to ≈+19 bp downstream of the start codon as derived from biochemi-
cal footprinting experiments (Beyer et al., 1994; Hu¨ttenhofer & Noller, 1994). Morerover, X-ray
analyses showed that a region of ≈ 30 nt involving the SD sequence is wrapped around the 30S
subunit (Yusupova et al., 2006, 2001). In E. coli, mRNAs with a weak SD sequence usually carry
a pyrimidine-rich region 5’ to the SD that acts as a recognition motif for the ribosomal protein S1
and anchors the mRNA on the ribosome (Boni et al., 1991; Komarova et al., 2005). Thus, in very
short UTRs (<20 bp) there would not be enough space for a ribosome binding site. In addition,
several quite long UTRs up to 500 bp (which was the cut-off for the distance of a primary or sec-
ondary TSS) were identified. These could potentially harbour regulatory elements and, for example,
secondary-structure clustering (Will et al., 2007) with known riboswitches from, e. g., Bacillus sub-
tilis and E. coli, or comparison of RNA shapes with Rfam4 families (Janssen et al., 2008) could be
used to identify known riboswitch types.
4 www.sanger.ac.uk/Software/Rfam/
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Figure 6.21: Reannotation of rocE based on deep sequencing. (A) Screen shot of the IGB showing
the read distribution of the C-/+ and AS-/+ libraries on the plus strand in the genomic region harbouring
pgsA, rocE, HP1018, and htrA. Transcription of rocE starts within its annotated ORF (blue arrow), and the
downstream gene HP1018 is transcribed from an additional TSSs (green arrow). (B) Protein alignment of
the N-terminal sequences of RocE homologues from diverse H. pylori strains shows that the N-terminus is
shorter in the other strains. The probably correct start position of the protein is marked by a yellow box.
(C) Nucleotide alignment of promoter regions and 5’ parts of rocE genes from dfferent H. pylori strains. The
annotated start codon in H. pylori 26695 is marked by a blue box, the suggested start codon for reannotation
by a yellow box, respectively. The -10 promoter element and the transcriptional start site based on the 454
data are shown in grey and by a blue arrow, respectively. A potential Shine-Dalgarno sequence upstream of
the suggested correct start codon is marked in green.
During the analysis of UTR lengths, 25 mRNAs were found to be leaderless in H. pylori. In contrast
to translation initiation by 30S binding on mRNAs which contain a 5’ UTR, translation of leader-
less mRNA was shown to be initiated by the assembled 70S ribosome and thereby bypassing the
dissociation process (Moll et al., 2004; Udagawa et al., 2004). Ribosome binding assays revealed
that a leaderless mRNA’s 5’-AUG is required for stable binding to the ribosome and that addition of
a 5’-terminal AUG triplet to a random RNA fragment can make it both competent and competitive
for ribosome binding (Brock et al., 2008). Indeed, the transcriptional start sites of the 25 leader-
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less mRNAs in H. pylori exactly mapped to the ‘A’ of the AUG start codon. Leaderless mRNAs
appear to be rather infrequent in Gram-negative bacteria. These include, e. g., the λcI mRNA (Walz
et al., 1976) and the Tn1721 tetR mRNA (Baumeister et al., 1991) derived from accessory genetic
elements in E. coli. Their number in different Gram-positive genera such as Streptococci, Lacto-
cocci, Streptomyces and Corynebacterium by far exceed that identified in Gram-negative species,
and leaderless mRNAs are quite common in archea (reviewed in Moll et al., 2002). In Helicobac-
ter, several hypothetical genes were found to be transcribed as leaderless mRNAs but also those of
some proteins with important cellular functions, such as DnaA, RecR, and HemH (see Table 10.13).
The functional relevance of why these genes are leaderless, however, remains to be identified. In
E. coli is has been shown recently that prolonged exposure of ribosomes to the translation-initiation
inhibiting antibiotic kasugamycin triggers the spontaneous loss of small subunit proteins and pro-
duces a reduced ribosomal particle that exclusively translates leaderless mRNAs (Kaberdina et al.,
2009).
The analysis of transcriptomes by deep sequencing is not only appropriate for identification of novel
sRNAs and mapping of transcriptional start sites but can also help to reannotate genomes based on
actual transcription of genes. During the manual TSS annotation, it was observed that transcription
for several mRNAs started downstream of the annotated start codon, and no convincing TSS up-
stream of the ORF was observed (see for example Figures 6.21 and 6.22). This raised the question,
whether the start codons of these proteins are misannotated and that translation actually starts down-
stream of the transcriptional start site. Conservation analysis of protein and nucleotide sequences of,
e. g., HP0112 and rocF indicated that the N-termini of these proteins are actually shorter in diverse
H. pylori strains and that they have to be reannotated in H. pylori 26695 (Figs. 6.21 and 6.22, B
and C). Furthermore, no promising SD-sequence is located upstream of the old start codon of rocF,
whereas a perfect and highly conserved SD sequence is located upstream of the proposed correct
start codon (Fig. 6.21C). In case of HP0112, the protein starts with an alternative start codon ‘TTG’
which is not conserved in the other strains. Based on the 454 data, the ORF starts on the ‘A’ of the
proposed new start codon leading to a leaderless mRNA. Interestingly, immediately downstram of
the reannotated start codon a C/A rich element is located. These elements have been shown to act
as translational enhancers of leadered and unleadered mRNAs in E. coli (Martin-Farmer & Janssen,
1999). In total, about 19 ORFs were identified that probably have to be reannotated based on the
454 data and conservation analysis (data not shown). Most of them are also included in a previously
published list of genes for a revised annotation based on comparison between the two strains 26695
and J99 (Boneca et al., 2003). Thus, the global mapping of the actual transcriptional start sites of
genes could help to identify the correct start codons of ORFs and to reannotate bacterial genomes
based on actual gene expression data. The application of deep sequencing for genome annotations
has been successfully used also in eukaryotes (Weber et al., 2007; Yassour et al., 2009). Thus, in
future, probably not only DNA but also RNA will be sequenced for improved genome assembly
and subsequent annotation of bacterial genomes.
In bacteria, the 5’ end of newly synthesized RNAs bears a triphosphate derived from the first
transcribed nucleotide. Thus, the approach for selective sequencing primary transcripts to map
mRNA transcriptional start sites or to identify novel sRNA is not limited to H. pylori and could,
in principle, be applied to diverse bacteria. Moreover, it should generally be applicable also to
eukaryotic mRNAs where the distal phosphate is replaced by an inverted, methylated Guanosine-
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Figure 6.22: Reannotation of HP0112 based on deep sequencing. (A) Screen shot of the IGB showing the
read distribution on the plus strand of the C-/+ and AS-/+ libraries on two hypothetical proteins, HP0112 and
HP0113. Transcription of HP0112 starts within its annotated ORF (blue arrow), and the downstream gene
HP0113 is transcribed from an additional TSSs (green arrow). (B) Protein alignment of HP0112 homologues
from diverse H. pylori strains shows that the N-terminus is shorter in the other strains. Furthermore, the
protein starts with an alternative start codon ‘TTG’ in H. pylori 26695 which is not conserved in the other
bacteria as shown in (C). The probably correct start position of the protein is marked by a yellow box. (C)
Nucleotide alignment of HP0112 homologues from different H. pylori strains. The annotated start codon in
H. pylori 26695 is marked by a blue box, the suggested start codon for reannotation is marked in yellow. The
-10 promoter element and the transcriptional start site based on the 454 data are shown in grey and by a blue
arrow, respectively. A C/A rich element downstream of the suggested correct start codon is marked in green.
monophosphate to form the m7GpppX cap and prevents degradation by TEX. Therefore, this ap-
proach could be helpful in global TSS annotation of diverse bacteria as well as eukaryotes and, thus,
help to refine current annotations.
CHAPTER 7
CONCLUSIONS
In this thesis, two aspects of sRNA-mediated regulation in bacteria have been investigated: multiple
target regulation and approaches for the identification of novel sRNAs in bacteria. In the first
part, the functional characterization of a multiple-target regulator, GcvB RNA, of Salmonella, was
presented. Proteomics and bioinformatics-based approaches led to the identifcation of seven ABC
transporter mRNAs as GcvB targets. Alignment of GcvB homologues of distantly related bacteria
revealed a conserved G/U-rich element, R1, that is strictly required for GcvB target recognition.
Analysis of target gene fusion regulation in vivo, and in vitro structure probing and translation
assays showed that GcvB represses its target mRNAs by binding to extended C/A-rich regions
inside and upstream of the ribosome binding site. The presence of the C/A rich element - which can
act as a translational enhancer - in all ABC transporter mRNAs indicated that this small RNA has
hijacked a conserved element to regulate a class of functionally related genes. Pulse-expression of
GcvB wild-type and mutant RNAs followed by global analysis of mRNA changes on microarrays
led to the identification of additional R1-dependent GcvB targets and one R-1 independent target,
cycA. The definition of a consensus motif for the C/A-rich target sites could be successfully used to
refine bioinformatics-based target-predictions using RNAhybrid (Rehmsmeier et al., 2004). These
predictions revealed additional GcvB targets, which might have escaped the microarray approaches
due to low expression or only slight changes on mRNA levels. Overall, GcvB RNA was found to
directly regulate multiple genes involved in amino acid transport or metabolism. Furthermore, a
highly conserved region turned out to be critical for regulation.
This work and several other recent sudies have revealed multiple-targeting as a widespread mode
of action for diverse bacterial sRNAs (Section 2.5). The presence of conserved, single-stranded
elements in sRNAs mediating multiple target recognition of frequently functionally related genes
now seems to be a common denominator. Furthermore, mRNA regions distant from Shine-Dalgarno
(SD) sequences can also be targeted by sRNAs as revealed in this and other studies. Therefore,
future target-prediction programs could probably be improved by including the following criteria:
(1) identification of conserved sRNA parts to limit the search space within the input sequence, (2)
incorporation of mRNA regions outside the ribosome binding site, and (3) scoring for functional
relation between targets. Furthermore, it could be helpful to include criteria such as target-site
accessibility, Hfq-binding and/or prediction of Hfq-binding sites as previously suggested (Busch
et al., 2008; Tafer & Hofacker, 2008; Zhang et al., 2006).
In the other part of this thesis, deep sequencing was applied to analyse RNA ligands bound to
Salmonella Hfq, one of the key players in sRNA-mediated regulation. A bioinformatics-based
work flow that was developed for the analysis and visualization of the deep sequencing data was
presented. The identification of novel sRNAs in Salmonella as well as more than 700 mRNAs
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bound to Hfq showed that this approach is capable of identifying sRNAs specific to certain bacteria
and of limiting the mRNA input-set for target prediction programs. In furture, incorporation of a
cross-linking step and digestion of RNA regions that are not covered by Hfq could narrow down
the regions that are actually bound by Hfq. This could help to define Hfq consensus binding sites
which could in turn be incorporated into target-prediction algorithms. Although this approach is
limited to bacteria where Hfq or any other RNA binding proteins are known, it could be helpful to
unravel the post-transcriptional regulons of a wide range of bacteria.
In Helicobacter pylori neither Hfq nor any sRNAs were previously known and the bioinformatics-
based approach which was presented in the last part of this thesis identified only a few sRNAs in this
organism. In contrast, a high-throughput ‘RNA-seq’ approach of total H. pylori RNA revealed many
additional sRNA candidates including antisense transcripts to ORFs in Helicobacter. Among >30
sRNAs which have been verified on Northern blots, a homologue of the ubiquitous 6S RNA and its
associated pRNAs were identified. Moreover, differential analysis of primary and processed RNA
species facilitated the identification of≈ 800 transcription start sites of mRNAs across the H. pylori
genome. Besides a refinement of the functional annotation of the H. pylori and related genomes, this
approach should facilitate the global transcriptome analysis of mixed pathogen-host populations as
it avoids the problem of cross-hybridization observed in microarray experiments. Furthermore, ini-
tial studies suggested the use of high-throughput sequencing for transcription-profiling (Mortazavi
et al., 2008; Yoder-Himes et al., 2009). Ongoing improvements of next-generation sequencing
methods including generation of more sequences per run as well as longer average read lengths
will allow to cover longer transcripts and sequencing of diverse growth conditions. In addition,
the development of single-molecule sequencing technologies (Pacific Biosiences and Heliscope of
Helicos) will avoid a potential bias introduced during cDNA construction in the PCR amplification
or adapter ligation step and allow a more precise transcription profiling.
Current high-throughput sequencing approaches indicate the demand for appropriate databases to
store sequence data as well as analysis and visualization tools. Especially the manual annotation
of TSS is feasible only for small genome sizes and, hence, algorithms for an automatic recogni-
tion of enrichment patterns could be very helpful. Deep sequencing in combination with proper
analysis tools will then allow a fast and effective way to improve genome annotation based on ac-
tual transcription, global promoter maps, as well as the identification of novel transcripts including
regulatory RNAs.
CHAPTER 8
MATERIAL AND METHODS
8.1. Material
Chemicals used in this study were purchased from Merck (Darmstadt), Roth (Karlsruhe) and Sigma
(Mu¨nchen). The following tables list all labware (Table 8.1), instruments (Table 8.2), enzymes,
proteins, and size markers (Table 8.3), and commercially available systems (Table 8.4) that were
used throughout this study.
Table 8.1: Labware and Manufacturer.
Labware Manufacturer
CampyGenTM Oxoid, Basingstoke, Hampshire, England
Corex II centrifuge tubes Krackeler Scientific, Albany NY, USA
Gene Pulser/MicroPulser Cuvettes, 1 mm BioRad, Mu¨nchen
Horizontal Electrophoresis Systems Peqlab, Erlangen
PerfectBlue Mini S, M, L
Hybond-XL Membrane for Nucleic Acid GE Healthcare, Mu¨nchen
Transfer
Glass Beads, 0.1 mm Roth, Karlsruhe
Imaging Plates BAS-IP MS 2325, 2340 Fujifilm, Du¨sseldorf
Imaging Plates Cassettes BAS 2325, 2340 Fujifilm, Du¨sseldorf
Inoculation Loops 10 µl VWR, Darmstadt
L-shape Bacteriology Loops VWR, Darmstadt
MicroSpin G-25, G-50 Columns GE Healthcare, Mu¨nchen
Nucleic Acid Sequencing Unit #SG-400-20 CBS Scientific, Del Mar CA, USA
Phase Lock GelTM (PLG) Tubes VWR, Darmstadt
Pipetman P10, P20, P200, P1000 Gilson, Bad Camberg
Pipetboy acu Integra Biosciences, Fernwald
PolyScreen PVDF Transfer Membrane PerkinElmer, Waltham MA, USA
Protein A Sepharose Beads Sigma-Aldrich, Taufkirchen
Reagent and Centrifuge Tubes 15, 50 ml Sarstedt, Nu¨mbrecht
Safe-Lock Tubes 1.5 ml, 2.0 ml Eppendorf, Wesseling-Berzdorf
Semi-dry Electroblotter SEDEC M Peqlab, Erlangen
Semi-micro Cuvettes Sarstedt, Nu¨mbrecht
Serological Pipets 5 ml, 10 ml, 25 ml Corning, Wiesbaden
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Labware Manufacturer
Tank Electroblotter PerfectBlue Web S, M Peqlab, Erlangen
Thermo-Tubes 0.2 ml Abigene, Hamburg
Ventilation Cap Tubes 13 ml Sarstedt, Nu¨mbrecht
Vertical Electrophoresis Systems Peqlab, Erlangen
PerfectBlue Twin S, L
Sterile filters (0.2 µm pore size) Whatman, Dassel
Table 8.2: Instruments.
Instrument Manufacturer
Analytical Balances TE64, TE601 Sartorius, Go¨ttingen
BD FACSCantoTM Flow Cytometer BD Biosciences, Franklin Lakes NJ, USA
Bio-Link BLX 254 UV-Crosslinker Peqlab, Erlangen
Centrifuge 5415R, 5810R Eppendorf, Wesseling-Berzdorf
Centrifuge RC5C Plus (Rotor: SS-34) Thermo Scientific, Langenselbold
DNA Engine Thermal Cycler BioRad, Mu¨nchen
E. coli Pulser Bio-Rad, Mu¨nchen
Electrophoresis Power Supplies EV 232, Consort, Turnhout, Belgium
EV202, E802
Eraser for Imaging Plates Raytest, Straubenhardt
Gel Documentation System Gel Doc 2000 Biorad, Mu¨nchen
Gel Dryer Model 583 Biorad, Mu¨nchen
GenePix 4000A scanner Molecular Devices, Sunnyvale CA, USA
Hybridization Oven Compact-Line OV4 Biometra, Go¨ttingen
Imaging System LAS-3000 Fujifilm, Du¨sseldorf
Incubator Innovens Category 1 Jouan, Unterhaching
Incubator Shaker Innova 44 New Brunswick Scientific, Nu¨rtingen
MultiTempIII Thermostatic Circulator Amersham Biosciences, Freiburg
Refrigerated Incubator Shaker C24KC New Brunswick Scientific, Nu¨rtingen
Spectrophotometer NanoDrop ND-1000 Peqlab, Erlangen
Thermomixer comfort Eppendorf, Wesseling-Berzdorf
Phosphoimager FLA-3000 Fujifilm, Du¨sseldorf
Ultrospec 10 photometer Amersham Biosciences, Freiburg
Vacuum Concentrator RC10.22 Jouan, Unterhaching
Vortex-Genie 2 Scientific Industries, Bohemia NY, USA
7900HT-RealTime-PCR System Applied Biosystems, Foster City CA, USA
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Table 8.3: Enzymes, proteins, and size markers.
Enzyme/Protein/Size marker Manufacturer
Albumin Fraktion V Roth, Karlsruhe
AvrII (4 u/µl) New England Biolabs, Frankfurt a.M.
BfrBI/Mph1103I (NsiI, 10 u/µl) Fermentas, St. Leon-Rot
BseRI (4 u/µl) New England Biolabs, Frankfurt a.M.
Calf Intestine Alkaline Phosphatase (CIAP, 1 u/µl) Fermentas, St. Leon-Rot
Calf Intestine Alkaline Phosphatase (CIP, 10 u/µl) New England Biolabs, Frankfurt a.M.
Deoxyribonuclease I (DNase I, 1 u/µl) Fermentas, St. Leon-Rot
DpnI (20 u/µl) New England Biolabs, Frankfurt a.M.
ECL Anti-Mouse IgG (sheep), HPR-conjugated GE Healthcare, Mu¨nchen
ECL Anti-Rabbit IgG (donkey), HPR-conjugated GE Healthcare, Mu¨nchen
GeneRuler 1kb DNA Ladder Fermentas, St. Leon-Rot
Hfq (purified S. typhimurium protein) Sittka et al., 2007
Lysozyme Roth, Karlsruhe
Monoclonal Anti-FLAG M2 Antibody (mouse) Sigma-Aldrich, Taufkirchen
Monoclonal Anti-GFP antibodies Roche, Mannheim
(Clones 7.1, 13.1; mouse)
NheI (10 u/µl) Fermentas, St. Leon-Rot
pUC Mix Marker, 8 Fermentas, St. Leon-Rot
pUC19 DNA/MspI (HpaII) Marker, 23 Fermentas, St. Leon-Rot
Pfu DNA Polymerase (2.5 u/µl) Fermentas, St. Leon-Rot
Phusion High-Fidelity DNA Polymerase (2 u/µl) New England Biolabs, Frankfurt a.M.
Polyclonal Anti-GroEL antiserum (rabbit), Sigma-Aldrich, Taufkirchen
Peroxidase conjugated
Prestained Protein Marker Broad Range New England Biolabs, Frankfurt a.M.
Ribonuclease H (RNase H, 5 u/µl) New England Biolabs, Frankfurt a.M.
Ribonuclease T1 (RNase T1, 1 u/µl) Ambion, Austin TX, USA
Ribonuclease T2 (RNase T2, 20 u/µl) Invitrogen, Karlsruhe
Ribonuclease III (RNase III, 1.3 u/µl) New England Biolabs, Frankfurt a.M.
RNA ladder Low Range, High Range Fermentas, St. Leon-Rot
SpeI (10 u/µl) New England Biolabs, Frankfurt a.M.
Shrimp Alkaline Phosphatase (SAP, 1 u/µl) Fermentas, St. Leon-Rot
StratasScript Reverse Transcriptase Stratagene, Cedar Creek TX, USA
SUPERase-In RNase Inhibitor (20 u/µl) Ambion, Austin TX, USA
T4 DNA Ligase (5 Weiss u/µl) Fermentas, St. Leon-Rot
T4 Polynucleotide Kinase (PNK, 10 u/µl) Fermentas, St. Leon-Rot
T4 Polynucleotide Kinase (PNK, 10 u/µl) New England Biolabs, Frankfurt a.M
T4 RNA Ligase (20 u/µl) New England Biolabs, Frankfurt a.M.
Taq DNA polymerase (5 u/µl) New England Biolabs, Frankfurt a.M.
Tobacco Acid Pyrophosphatase (TAP, 10 u/µl) Epicentre, Madison WI, USA
TerminatorTM 5’-Phosphate-Dependent Exonuclease Epicentre, Madison WI, USA
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Enzyme/Protein/Size marker Manufacturer
(TEX, 10 u/µl)
XbaI (10 u/µl) Fermentas, St. Leon-Rot
XhoI (20 u/µl) New England Biolabs, Frankfurt a.M.
α-OppA polyclonal antibody (rabbit) K. Igarashi, Chiba University, Japan
Table 8.4: Commercially available systems.
System Application Manufacturer
CycleReaderTM DNA
Sequencing Kit
Sequencing ladders Fermentas, St. Leon-Rot
Gel Loading Buffer II RNA sample loading buffer Ambion, Austin TX, USA
GlycoBlueTM DNA/RNA precipitation Ambion, Austin TX, USA
MAXIscript T7 Kit In vitro transcription for RNA used
in EMSA, structure probing
Ambion, Austin TX, USA
MEGAscript T7 Kit In vitro transcription for riboprobe
synthesis
Ambion, Austin TX, USA
NucleoBond PC100 Plasmid isolation (large-scale) Macherey-Nagel, Du¨ren
NucleoSpin Extract II DNA purification Macherey-Nagel, Du¨ren
NucleoSpin Plasmid
QuickPure
Plasmid isolation (small-scale) Macherey-Nagel, Du¨ren
PageBlue Protein Staining
Solution
Protein staining Fermentas, St. Leon-Rot
Puresystem In vitro translation Cosmo Bio Co., Tokyo, Japan
Protein Loading Buffer
Pack
Protein sample loading buffer Fermentas, St. Leon-Rot
QuantitectTM SYBR Green
RT-PCR Kit
Real time PCR Qiagen, Hilden
Rapid-hybTM Buffer Northern blot hybridization Amersham Biosciences, Freiburg
Rediprime II DNA Labeling
System
DNA probe synthesis GE Healthcare, Mu¨nchen
Roti-Free Western blot stripping Roth, Karlsruhe
Roti-Hybriquick Northern blot hybridization Roth, Karlsruhe
Stains-All RNA staining Sigma-Aldrich, Mu¨nchen
SuperScriptII Reverse
Transcriptase
cDNA synthesis Invitrogen, Karlsruhe
SuperScriptIII Reverse
Transcriptase
cDNA synthesis Invitrogen, Karlsruhe
SV Total RNA Isolation
System
DNA-free total RNA isolation Promega, Madison WI, USA
TOPO TA Cloning Kit Cloning of Taq PCR products Invitrogen, Karlsruhe
TRIzol Reagent total RNA isolation Invitrogen, Karlsruhe
continued on next page
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System Application Manufacturer
Western Lightning
Chemiluminescence
Reagent
Western blot detection Perkin Elmer, Weiterstadt
6×Sample Loading Buffer DNA loading buffer Fermentas, St. Leon-Rot
8.2. General Methods
This section describes general methods that were applied throughout the whole study. Standard
methods which are not described in this section were performed as described in Sambrook & Russell
(2001), or according to manufacturers’ instructions.
8.2.1. Bacterial cell culture
All materials used throughout this study were autoclaved for 20 minutes (min) at 121°C and 1 bar
before use. Where necessary, solutions were sterilized by filtration and glassware by heating to
180°C for a minimum of three hours (h), respectively.
8.2.1.1. Media
If not stated otherwise, bacteria were grown in Lennox-broth (L-broth) or on Lennox agar plates.
Lennox broth:
1 % (w/v) tryptone
0.5 % (w/v) yeast extract
85.6 mM sodium chloride
Lennox agar:
as L-broth but supplemented with 1.2 % (w/v) agar.
Growth was carried out at 37°C with an agitation of 220 rotations per minute (rpm) under normal
aeration. Cultures were either inoculated from single colony grown overnight at 37°C or were
diluted 1/100 into fresh medium from overnight cultures that were inoculated from freshly grown
single colonies into 3 ml L-broth.
For inducible PBAD promoters, cultures were supplemented with 0.2 % (w/v) L-arabinose.
The following antibiotica were used throughout this study:
Kanamycin: 50 µg/ml
Ampicillin: 50 or 100 µg/ml for low- or high-copy plasmids, respectively
Chloramphenicol: 20 or 30 µg/ml for low- or high-copy plasmids, respectively
Streptomycin: 90 µg/ml
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8.2.1.2. Preparation of electrocompetent Salmonella cells
For preparation of electrocompetent Salmonella, cells were inoculated either from single colony or
1/100 from overnight cultures in fresh medium. The cultures were grown at 37°C, 220 rpm until
the suspensions reached an OD600 of 0.5. Cells were washed three times in ice-cold sterile water,
resuspended in 50µl ice-cold sterile water, and subjected to electroporation (1.8 kV, 25µF, and
200Ω). Following transformation, cells were resuspended in 1 ml SOC medium prior to plating.
Recovery was carried out for 60 min at 37°C, 220 rpm before selection on L-broth agar plates with
the appropriate antibiotics.
SOC medium
2 % (w/v) tryptone
0.5 % yeast extract
85.6 mM NaCl
2.5 mM KCl
10 mM MgCl2
20 mM glucose
8.2.1.3. Transformation of chemically competent E. coli cells
1 µl of a ligation reaction or 0.5µl plasmid (concentration≈ 10-100 ng/µl) was mixed with 20µl of
chemically competent E. coli TOP10 or TOP10 F’, respectively (Invitrogen). After pre-incubation
for 30 min on ice, cells were subjected to a heat shock for 30 seconds (s) at 42°C. Cells were chilled
for 1 min on ice and resuspended in 100 µl SOC medium. Recovery was carried out for 60 min at
37°C, 220 rpm before selection on L-broth agar plates with the appropriate antibiotics.
8.2.1.4. Growth curves
For growth curve determination, 30 ml L-broth, supplemented with the appropriate antibiotic, were
inoculated from overnight culture to an optical density OD600 of 0.04. Growth was carried out at
37°C, 220 rpm. The OD600 was measured in time intervals of 45 min over a time period of 630
min.
8.2.2. Mutant construction in S. typhimurium and E. coli
8.2.2.1. One-step inactivation of chromosomal genes
Chromosomal mutagenesis of S. typhimurium SL1344 followed the procedure described by
Datsenko & Wanner (2000) for E. coli with a few modifications. The wild-type Salmonella strain
carrying plasmid pKD46 was grown in L-broth supplemented with ampicillin and 0.2 % L-arabinose
at 28°C to an OD600 of 0.5 (25 ml culture per transformation). Cells were collected by centrifu-
gation (20 min, 4,000 rpm), washed three times with ice-cold water, and dissolved in 50 µl ice-
cold water. Polymerase chain reaction (PCR) products of marker genes, e. g., chloramphenicol or
kanamycin resistance cassettes, (50 µl standard reactions) were DpnI-treated for 3 h at 37°C, and
purified on agarose gels, followed by purification on Macherey-Nagel spin columns (NucleoSpin
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Extract II). One-fifth of the 25 µl column eluate (in water) was used for transformation. 50 µl of
competent cells were mixed with the purified PCR product in a chilled cuvette (0.1-cm electrode
gap) and electroporated (18 kV/cm). Subsequently, 1 ml of pre-warmed SOC medium was added,
and cells were recovered by incubation for 1 h at 37°C before selection on L-broth agar plates with
the appropriate antibiotics. All mutations were moved to a fresh SL1344 background by phage P22
transduction.
8.2.2.2. Resistance removal following chromosomal one-step inactivation
For removal of resistance genes of mutant Salmonella the strain was transformed with the FLP
recombinase-expressing, temperature sensitive helper plasmid pCP20 (Datsenko & Wanner, 2000)
and transformants were selected at 28°C on plates containing ampicillin. Transformants were struck
on three fresh plates, one containing no antibiotic, one containing ampicillin (as a control for re-
moval of the pCP20 helper plasmid), and one containing chloramphenicol or kanamycin (as a con-
trol for removal of the chromosomal resistance cassette). Transformants grown overnight exclu-
sively on plate containing no antibiotic were used for further experiments.
8.2.2.3. P22 transduction
P22 lysates were prepared from soft agar plate lysates of donor strains using P22 phage HT/105-1
by standard procedure (Sternberg & Maurer, 1991). 100 µl of an overnight culture of the donor
strain were mixed with 3 ml TOP agar and poured on a pre-warmed L-broth plate.
TOP agar:
1 % (w/v) tryptone
1 % (w/v) agar
10 mM MgSO4
5 mM CaCl2
86 mM NaCl
100 µl of a P22 phage lysate were spread on the TOP agar surface followed by overnight incubation
at 37°C. TOP agar was collected from the plate and resuspended in 5 ml L-broth containing 10
mM magnesium sulfate and 5 mM calcium chloride. Upon addition of 400 µl chloroform, the
suspension was vigorously vortexed and incubated overnight at 4°C. After centrifugation (10 min,
4,000 rpm) the supernatant was transferred into a glass tube and 400 µl chloroform were added to
the phage lysate. Storage was performed at 4°C.
For transduction, 100 µl of a culture of the acceptor strain grown from single colony to an OD600
of 1 were mixed with 1, 10, and 100 µl of the phage lysate and incubated for 15 min at room
temperature. To stop the transduction, 100 µl of a 20 mM EGTA solution were added to 100
µl of the mixture. The entire 200 µl sample was plated on pre-warmed L-plates containing the
appropriate antibiotic. Incubation was carried out for up to 3 days at 37°C. Transformants were
verified by PCR.
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8.2.3. Nucleic acids techniques
The concentrations of all nucleic acid solutions (DNA as well as RNA) were determined by mea-
surements using a NanoDrop machine. For purification of PCR products or plasmid mini-preps the
NucleoSpin Extract II and the NucleoSpin Plasmid QuickPure kits, respectively, from Macherey-
Nagel were used. The standard methods of in vitro amplification of DNA by PCR and the ligation
of DNA fragments were carried out as described in Sambrook & Russell (2001).
8.2.3.1. Agarose gel electrophoresis
Agarose gels were used to separate DNA fragments. For gel preparation, agarose was dissolved in
concentrations of 0.8 to 2 % (w/v) in 1×TAE buffer.
50×TAE buffer:
242 g Tris base
57.1 ml acetic acid
100 ml 0.5 M EDTA
Adjust pH to 8.5, add H2O to a final volume of 1 l.
At a gel solution temperature of 50-60°C, ethidium bromide was added to a final concentration of
40µg/ 100 ml. Prior to loading, five volumes of sample were mixed with one volume of 6×sample
loading buffer. Gels were run in 1×TAE buffer at 100 V for about 30-60 min (according to fragment
size).
8.2.3.2. Polyacrylamide gel electrophoresis (PAGE)
Polyacrylamide (PAA) gels were used to separate RNA fragments of different size. For gel prepa-
ration, 40 % PAA solution was used. Native and denaturing gels were run in the presence of 0.5×
and 1×TBE buffer, respectively.
10×TBE buffer:
0.89 M Tris Base
0.89 M boric acid
20 mM EDTA pH 8.0
Add H2O to a final volume of 1 l.
Denaturing PAGE: For denaturing gels (the native structure of RNA molecules is destroyed), the
gels are supplemented with urea to a final concentration of 8.3 M for Northern blot gels or 7 M for
sequencing gels, respectively.
5 % PAA gel solution:
125 ml 40 % PAA solution (19:1 acrylamide/bisacrylamide)
500 g urea
100 ml 10×TBE
Add H2O to a final volume of 1 l.
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All gel equipment was cleaned with 70 % ethanol before use (glass plates, spacer, combs etc.). Poly-
merization was initiated by addition of 1/100 volume of ammonium persulfate (APS) and 1/1000
volume of N,N,N,N,-Tetramethylethylendiamin (TEMED). Prior to loading, the RNA samples were
denatured for 5 min at 100°C in sample loading buffer and subsequently chilled on ice for 5 min.
2×RPA loading buffer:
98 % (v/v) Formamid
2 mM EDTA, pH 8.0
0.02 % (w/v) Xylene Cyanole
0.02 % (w/v) Bromophenol Blue
Gel runs were performed in the presence of 1×TBE at 300 V at room temperature for about 2 to 3
h (according to the size of the RNA species to detect).
Native PAGE:
Native polyacrylamide gel electrophoresis was performed in the presence of 0.5×TBE at 300 V.
Native PAGE was used to analyse preformed RNA-protein complexes. To avoid heating, the gel
apparatus was connected to a water cooling system. Complexes were loaded in native sample
loading buffer.
5×native sample buffer
50 % glycerol
0.2 % (w/v) Bromphenol Blue
0.5×TBE buffer
8.2.4. Protein techniques
8.2.4.1. Preparation of whole cell protein fraction
After the appropriate incubation, bacteria samples were taken (a total amount of 0.5 to 1 OD600).
After centrifugation for 2 min at 13,000 rpm at 4°C the supernatant was discarded and the cell pellet
resuspended in 1× sample loading buffer to a final concentration of 0.01 OD/µl buffer. The sample
was denatured by heating at 95°C for 5 min and was subsequently chilled on ice.
8.2.4.2. Preparation of periplasmic fractions
The periplasmic protein fraction was extracted following the cold osmotic shock procedure de-
scribed by Neu & Heppel (1965). At the appropriate OD600, cells were harvested by centrifugation
for 30 min at 4000 rpm at 4°C. The pellet was resuspended at room temperature in ‘shock buffer’.
Shock buffer:
30 mM Tris-HCl pH 8.0
20 % sucrose
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EDTA (pH 8.0) was added to a final concentration of 1 mM. Cells were incubated for 10 min at room
temperature with occasional shaking. Subsequently, cells were collected by centrifugation (30 min,
4,000 rpm) at 4°C, and the pellet was resuspended in 10 ml ice-cold 5 mM MgSO4. After incu-
bation for 10 min with occasional shaking in an ice-water bath, the suspension was centrifuged as
mentioned above. The supernatant was the cold osmotic shock-fluid. For denaturation, 4× sample
loading buffer was added and samples heated for 5 min at 95°C.
8.2.4.3. One-dimensional SDS PAGE
For denaturing separation of proteins, samples were loaded on 10 % to 15 % SDS PAGE (according
to the size of the proteins to be analysed). Gel solutions for the separation and the stacking gel were
prepared as follows:
PAA gel for separation gel 10 % 12 % 15 %
1 M Tris base pH 8.8 3.75 ml 3.75 ml 3.75 ml
40 % PAA solution 2.5 ml 3 ml 3.75 ml
(37.5:1 acrylamide/bisacrylamide)
H2O 3.75 ml 3.25 ml 2.5 ml
10 % SDS 100 µl 100 µl 100 µl
10 % APS 75 µl 75 µl 75 µl
TEMED 7.5 µl 7.5 µl 7.5 µl
PAA gel for stacking gel
1 M Tris base pH 6.8 1.25 ml
40 % PAA solution 1 ml
(37.5:1 acrylamide/bisacrylamide)
H2O 7.485 ml
10 % SDS 100 µl
10 % APS 150 µl
TEMED 15 µl
10× running buffer:
250 mM Tris
1.92 M glycine
1 % SDS
All gel equipment was cleaned with 70 % ethanol before use (glass plates, spacer, combs etc.).
Polymerization was initiated by addition of 10 % APS and TEMED (see above) to the separation
and stacking gel, respectively. Gels were run for 1 h at 80 V (stacking gel) and for 2-6 h at ≈ 150
V (according to gel size and molecular weight of proteins to be detected). Gels were stained using
PageBlue staining solution.
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8.2.4.4. Two-dimensional SDS PAGE
Sample preparation from Salmonella cultures, analysis by high-resolution two-dimensional elec-
trophoresis, protein staining, and peptide mass fingerprinting were performed at the Max-Planck-
Institute for Infection Biology (Berlin, Germany) protein analysis core facility1 according to previ-
ously published standard protocols (Doherty et al., 1998; Jungblut & Seifert, 1990; Klose & Kobalz,
1995).
8.2.4.5. Western blot
1×Transfer buffer:
25 mM Tris base
192 mM glycine
20 % methanol
TBST20 buffer:
20 mM Tris base
150 mM NaCl
0.1 % Tween 20
Whole-cell protein samples corresponding to 0.01 or 0.05 OD600 culture volume were separated via
SDS-PAGE as described above. PVDF membranes were activated by incubation in methanol (90 s),
H2O (5 min), and transfer buffer (5 min), consecutively. Gels were blotted either for 60 min at 100
V at 4°C in a cable tank blotter or for 2 h at 2 mA/ cm2 membrane in a semi-dry blotter onto PVDF
membrane in transfer buffer. After rinsing in 1×TBST20 buffer, membranes were blocked for 1 h in
10 % dry milk in TBST20. Hybridization was carried out as follows: appropriate primary antisera or
antibodies were diluted in 3 % BSA, TBST20 and blots hybridized for 1 h at room temperature under
agitation, followed by five 6 min wash-steps in TBST20. Subsequently, the blots were hybridized
with the α-rabbit-horseradish peroxidase (HRP) or α-mouse-HRP conjugated secondary antibodies
(1:5,000 in 3 % BSA in TBST20) for 1 h at room temperature. The final wash steps were performed
6× for 10 min in TBST20. Blots were developed using Western Lightning Reagent in a Fuji LAS-
3000 CCD campera.
8.2.5. RNA techniques
Throughout this study, three different methods for isolation of total RNA from E. coli,
S. typhimurium or H. pylori were used. RNA was always kept on ice and stored at -20°C.
8.2.5.1. RNA preparation with TRIzol
Bacterial cultures corresponding to 4 OD600 were spun for 2 min at 11,000 rpm at 4°C. After
discarding the supernatant, the bacterial pellet was dissolved in 1 ml TRIzol Reagent. The mixture
was transferred to 2 ml Phase lock tubes (heavy) and upon addition of 400µl chloroform, the
samples were mixed by shaking and centrifuged for 12 min at 15 °C at 13,000 rpm. The supernatant
1 http://info.mpiib-berlin.mpg.de/jungblut/
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was transferred to a fresh reaction tube and the nucleic acids were precipitated by addition of 0.7
volumes of 2-propanol. Precipitation was carried out either overnight or at least for 1 h at -20°C.
Nucleic acids were pelleted by centrifugation for 30 min at 13,000 rpm at 4°C. After a wash step
with 350 µl of 75 % ethanol and additional centrifugation for 10 min, the supernatant was discarded,
the pellets air-dried, and subsequently dissolved in H2O or 2× RNA loading buffer.
8.2.5.2. RNA isolation using the SV40 Total RNA Isolation System (Promega)
RNA was isolated using the Promega SV total RNA purification kit as described at the Institute for
Food Research (Norwich, UK)2 website and in Kelly et al. (2004). Two OD600 of a bacterial culture
were mixed with 0.2 volume of stop-mix (ethanol:phenol 95:5 v/v). After snap-freezing in liquid
nitrogen the samples were subsequently thawed on ice. Bacteria were spun for 2 min at 13,000
rpm at 4°C. After resuspension in 100 µl H2O containing 50 mg/ml lysozyme the samples were
incubated for 4 min at room temperature. Upon addition of 75 µl of lysis reagent, the samples were
mixed and 350 µl RNA dilution buffer was added. The samples were heated for 3 min at 70°C,
followed by a 10 min centrifugation step at 13,000 rpm at room temperature. The supernatant was
transferred to a new tube, mixed with 200 µl 95 % ethanol and the mixture loaded on a spin column
provided with the kit. After centrifugation for 1 min at maximum speed the eluate was discarded
and the column washed with 600µl wash buffer. After an additional centrifugation step, 50µl of a
DNase mix (5µl 90 mM MnCl2, 40µl DNase core buffer and 5µl DNase I; all provided with the
kit) were applied to the membrane and incubation carried out for 15 min at room temperature. Upon
addition of 200µl DNase stop mix the columns were centrifuged for 1 min at 13,000 rpm. Following
two wash steps with 600 and 250µl wash buffer, respectively, (the second centrifugation was carried
out for 2 min) the column was transferred to a sterile Eppendorf tube and 100µl RNase-free water
was added. After incubation for 1 min at room temperature, RNA was eluted by centrifugation for
2 min at 13,000 rpm.
8.2.5.3. Isolation of total RNA by sucrose shock and hot phenol
RNA preparation using hot phenol was first described in Aiba et al. (1981). In this study, cells
were lysed using a ‘sucrose shock’ method followed by hot phenol extraction of RNA as described
in Mattatall & Sanderson (1996). 10 OD600 of bacterial culture were mixed with 0.2 volume of
stop-mix (ethanol:phenol 95:5 v/v) and incubated for 10 min on ice. Bacteria were pelleted by
centrifugation for 20 min at 4,000 rpm at 4°C. The pellet was snap frozen in liquid nitrogen and
stored at -80°C until RNA preparation.
Following resuspension of the pellet in 12 ml extraction buffer, 10% SDS solution was added to a
final concentration of 1%.
Extraction buffer:
10 mM sodium acetate, pH 4.8
0.15 M sucrose
Cells were vigorously vortexed in 50 ml Falcon tubes; upon addition of 13 ml preheated (65°C)
phenol the samples were transferred to a 65°C water bath and incubated for 5 min with short inter-
2 www.ifr.ac.uk/safety/microarrays/protocols.html
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vals of vortexing. After 30 min centrifugation in Corex tubes at 8,000 rpm at 4°C the upper phase
was transferred to a new 50 ml Falcon tube and a second phenol extraction (13 ml Phenol, vortexing
at room temperature) was carried out. After centrifugation in a Corex tube (see above) the upper
phase was transferred to a fresh Corex tube and 12 ml chloroform were added to the sample. After
30 min centrifugation at 8,000 rpm at 4°C the upper phase was transferred into a fresh Corex tube
and RNA was precipitated by addition of 2.5 volumes of a Ethanol:sodium acetate mixture (30:1
v/v, pH 6.5). The nucleic acids were precipitated overnight at -20°C. The samples were collected
by centrifugation for 30 min at 8,000 rpm at 4°C. After aspiration of the supernatant, the pellet was
washed with 4 ml 75% ethanol. Following subsequent centrifugation for 10 min at 8,000 rpm and
4°C, the supernatant was discarded and the pellets air dried. Samples were dissolved in water and
subjected to DNase I treatment (see below).
8.2.5.4. DNase I digestion
Following resuspension in H2O, RNA samples were treated with 1 u of DNase I per µg of RNA
for 30 min at 37°C in the presence of RNase inhibitor. Prior to addition of DNase I reaction buffer
and enzymes, the RNA was denatured at 65°C for 8 min and subsequently cooled on ice for 5
min. After DNase I digestion, the RNA was isolated by phenol:chloroform:isoamylalcohol (P:C:I)
extraction. One volume dissolved RNA was mixed with one volume P:C:I (25:24:1 v/v) in 2 ml
Phase lock (heavy) tubes. Following mixing for 15 s by vigorous shaking, samples were spun for
15 min at 13,000 rpm at 15°C. The aqueous (upper) phase was mixed with 2.5 volumes of 30:1
(v/v) EtOH:3M sodium acetate (pH 6.5) mixture and RNA was precipitated overnight at -20°C.
After centrifugation for 30 min at 13,000 rpm and 4°C, the supernatant was discarded and the pellet
was washed with 350µl 75 % ethanol. After additional centrifugation for 10 min at 13,000 rpm
and 4°C, the supernatant was discarded and the pellet was air-dried. Finally the RNA pellet was
resuspended in H2O.
8.2.5.5. Generation of radioactively labelled DNA oligo nucleotides for RNA detection
For labelling of DNA oligonucleotides, 10 pmol of the oligonucleotide was incubated in a 10µl
reaction volume with 25µCi of 32P-γ-ATP in the presence of 1 u T4 polynucleotide kinase
(PNK, New England Biolabs) for 1 h at 37°C. Unincorporated nucleotides were removed using
MicroSpinTM G-25 columns.
8.2.5.6. Northern blot
To detect mRNAs or sRNAs, 5 to 20µg RNA were separated on 5-10% denaturing (8.3 M urea)
PAA gels. After a 1 h transfer to Hybond-XL membranes in a tankblotter at 50 V and 4°C in the
presence of 1× TBE (see Section 8.2.3.2), the RNA was cross-linked to the membrane on a UV-
table (302 nm) for 4 min or with 120 kJ in a UV-crosslinker (Bio-Link BLX 254, λ=254 nm). After
prehybridization for 1 h in 15 ml Rapid-hyb buffer or 20 ml Roti-Hybri-Quick buffer at 42°C, the
radioactive labelled probe (2-5 pmol) was added. After a period of 1 to 12 h of hybridization at 42
°C the membrane was rinsed with 5× SCC, followed by three wash steps at 42°C with SSC (20 min
5× SCC, 15 min 1× SCC, and 15 min 0.5× SCC). All SSC buffers were supplemented with 0.1%
SDS.
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20× SSC buffer:
3 M sodium chloride
0.3 M sodium citrate
8.2.5.7. Rapid amplification of cDNA ends (5´ RACE)
Mapping of transcriptional start sites using 5’ RACE followed the protocol described in Argaman
et al. (2001). Primary transcripts in bacteria carry a 5’ triphosphate, which can be hydrolyzed by
tobacco acid pyrophosphatase (TAP) specifically between the α- and β-phosphate groups. Via the
resulting 5’ monophosphate, these RNAs can be subsequently ligated to the 3’ hydroxyl group of an
RNA oligonucleotide, followed by reverse transcription with a gene-specific deoxyoligonucleotide
and subsequent PCR amplification using a 5’-adapter specific primer and a nested gene-specific
primer. TAP treatment is expected to yield a specific or at least strongly enhanced signal for pri-
mary transcripts in the amplification step as compared to untreated RNA samples. However, 5’ ends
resulting from processing (retaining a 5’-monophosphate) will also be amplified and can be ana-
lyzed in parallel.
In detail, 12 µg of total RNA was adjusted to a volume of 87.5 µl by adding the required volume of
H2O. 10 µl of 10×TAP buffer and 0.5 µl SUPERase-In RNase inhibitor were added and samples
split into two reactions of 49 µl each. Following treatment of one reaction with 10 units tobacco
acid pyrophosphatase (TAP) for 30 min at 37°C, 300 pmol of RNA-linker A4 (encoding a BseRI
restriction sit) was added to both reactions. Following organic extraction and ethanol precipitation,
RNA was dissolved in 13.5 µl H2O, denatured for 5 min at 90°C and chilled on ice for 5 min.
The RNA-linker ligation was performed overnight at 17°C in presence of 40 units T4 RNA lig-
ase, 1×RNA ligase buffer, 10% v/v DMSO (final concentration) and 20 units SUPERase-In RNase
Inhibitor. Following P:C:I extraction and ethanol precipitation, 2 µg linker-ligated RNA was con-
verted to cDNA using 100 pmol random hexamer primers and the Superscript III (200 units) reverse
transcription kit in a 20 µl reaction. 10 min incubation at 25°C was carried out before addition of the
reverse transcriptase, followed by four subsequent 15 min incubation steps at 42°C, 50°C, 55°C and
60°C. After heat inactivation of the reverse transcriptase for 5 min at 85°C, samples were treated
with 1 unit RNaseH (New England Biolabs) at 37°C for 20 min.
1 µl of the cDNA samples was subsequently used as template in standard Taq polymerase PCR
reactions using the sense primer JVO-0367, which anneals to the RNA-linker sequence, and an
antisense primer that anneals within the gene of interest. (For GFP fusion cloning, the antisense
primer binds to the N-terminal coding region of the gene of interest and carries an in-frame NheI
site.) Following visualization on 3% agarose gels, PCR products enriched in TAP treated samples
(indicating primary transcripts) were excised, purified, and sequenced after TOPO cloning.
8.2.5.8. In vitro transcription and 5’ end labelling of RNA
In vitro transcription was performed using the MEGAscript T7 kit, followed by DNase I diges-
tion (1 unit) for 15 min at 37°C. Following extraction with P:C:I (25:24:1 v/v), unincorporated
nucleotides were removed from the aqueous phase using MicroSpinTM G-25 columns. The RNA
was precipitated from the eluate by addition of 2.5 volumes of 30:1 EtOH:3M sodium acetate (pH
6.5) mixture and incubation overnight at -20°C. After centrifugation for 30 min at 13,000 rpm and
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4°C the supernatant was discarded and the pellet washed with 350µl 75 % ethanol. After additional
centrifugation for 10 min at 13,000 rpm and 4°C, the supernatant was again discarded and the pel-
let air-dried. Finally, the RNA pellet was resuspended in H2O. RNA integrity was checked on a
denaturing PAA gel and visualized with Stains-All.
20 pmol RNA was dephosphorylated with 10 u of calf intestine alkaline phosphatase (CIP) in a
20µl reaction at 37°C for 1 h. Following phenol extraction, the RNA was precipitated overnight
with ethanol:sodium acetate (30:1 v/v) and 20µg GlycoBlue. The dephosphorylated RNA was
5’ end-labelled with 32P-γ-ATP (20µCi), using 1 u of T4 polynucleotide kinase (PNK) for 30 min
at 37°C in a 20µl reaction. Unincorporated nucleotides were removed using MicroSpinTM G-25
columns, followed by purification of the labelled RNA on a denaturing gel (6% PAA/ 8.3 M urea).
Upon visualization of the labelled RNA by exposure on a phosphorimager, the RNA was cut from
the gel and eluted with RNA elution buffer at 4°C overnight, followed by P:C:I extraction and
ethanol precipitation as before.
RNA elution buffer:
0.1 M sodium acetate
0.1% SDS
10 mM EDTA, pH 8.0
8.3. Methods: Multiple targeting of ABC transporter mRNAs by
GcvB sRNA
8.3.1. Bacterial strains and oligonucleotides
Bacterial strains are listed in Table 10.1 in the Appendix. The gcvB deletion strains of Salmonella
(JVS-0236) and E. coli (JVS-6081) were constructed using the λ red protocol (Datsenko & Wanner,
2000) as described in Section 8.2.2.1 by replacing residues 17-176 with a kanamycin marker gene,
PCR amplified with primer JVO-0133/-0134 and JVO-0131/-0132, respectively. Mutants were ver-
ified by PCR with primers JVO-0135/-0136 or JVO-0137/-0138, respectively. The Salmonella
∆gcvB/∆hfq strain (JVS-0617) was constructed by P22 transduction of ∆hfq::CmR (JVS-0255)
into strain JVS-0236. Marker genes were removed with FLP recombinase (Datsenko & Wanner,
2000) as described in Section 8.2.2.2.
DNA oligonucleotides used for cloning, PCR amplification of T7 templates, for toeprinting assays,
and as hybridization probes are listed in the Appendix in Table 10.3.
8.3.2. Media and growth conditions
Cells were grown aerobically at 37°C in Lennox broth or M9 minimal medium supplemented with
0.4 % glucose. When required, antibiotics were added at 92 µg/µl streptomycin, 100 µg/ml ampi-
cillin, 50 µg/ml kanamycin, and 20 µg/ml chloramphenicol.
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Table 8.5: Construction of GcvB RNA mutant plasmids.
Plasmid Name Template Oligo 1 Oligo 2 Deletion of position
pJL03-15 pgcvB∆R1 pTP05 JVO-0746 JVO-0745 66 - 89
pJL16-10 pgcvB∆R2 pTP05 JVO-0895 JVO-0896 136 - 144
pJL05-16 pgcvB5’∆ pTP05 JVO-0743 JVO-0744 1 - 91
pJL01-1 pgcvB3’∆ pTP05 JVO-0619 JVO-0742 135 - 206 and region downstream of
gcvB terminator
pJL22 pLgcvB∆R1 pTP09 JVO-0746 JVO-0745 66 - 89
pJL23 pLgcvB∆R2 pTP09 JVO-0895 JVO-0896 136 - 144
pJL29-4 pLgcvB5’∆ pTP09 JVO-0744 PLlacO-C 1 - 91
8.3.3. Plasmids
Plasmids are listed in Table 10.2 in the Appendix. Details of their construction and insert sequences
are given in Tables 8.5-8.7.
8.3.3.1. sRNA plasmid construction
Control plasmid pTP11 was obtained by replacing the ColE1 origin of control plasmid pJV300
with the p15A origin of pZA31-luc via SpeI/AvrII cloning. pTP11 expresses a ≈ 50 nt nonsense
transcript derived from the rrnB terminator. The low copy control vector pTP24 was constructed
by replacing the ColE1 origin of pJV968-1 with the p15A origin of pTP05 by XhoI/AvrII cloning;
it carries a neutral, 1.5 kb internal lacZ fragment.
The ColE1-based plasmid, pTP02, expressing Salmonella gcvB from its own promoter, was ob-
tained by cloning a gcvB PCR fragment (primers JVO-0137/-0138) into the XhoI/XbaI sites of
plasmid pZE12-luc. JVO-0137 binds 292 nt upstream of the +1 site of gcvB; JVO-0138 binds 116
nt downstream of the gcvB terminator. Since the pTP02 is lethal in Salmonella, the ColE1 origin
was replaced with p15A as described above for pTP11. This yielded plasmid pTP05 (pgcvB).
To express gcvB from the PLlacO promoter (plasmid pJV846-11, ColE1 origin), the GcvB gene
was amplified using primers JVO-0237 (binds to the +1 site of gcvB) and JVO-0138 and inserted
into pZE12-luc by blunt-end/XbaI cloning as described in Urban & Vogel (2007). Subsequently,
the ColE1 origin of pJV846-11 was replaced by p15A as above (see pTP11), yielding pTP09
(pPL gcvB).
GcvB mutant plasmids were constructed via PCR amplification from the original plasmids pTP05
or pTP09 using Phusion Polymerase, DpnI digestion of template plasmid, and self-ligation of pu-
rified PCR products. Primers and templates used for each mutant plasmid are listed in Table 8.5.
Sequences of the mutant inserts are given in Table 8.6.
The gcvB3’∆T mutant plasmid (pJL13-12) was constructed by ligation of XhoI digested PCR prod-
ucts of pJV752-1 using oligos JVO-0619/ pZE-B and of pTP05 using primers JVO-0892/pZE-A.
This plasmid contained only part of the modified terminator. PCR amplification with primers JVO-
0619/-0892 on plasmid template pJL13-12, followed by self-ligation of the PCR product, gave
plasmid pgcvB3’∆T (pJL17-6).
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Table 8.6: Inserts of GcvB mutant plasmids. Red letters indicate the gcvB wild-type sequence, deleted
parts of the individual GcvB mutants are marked in blue, and the modified terminator/inserted nucleotides
for the 3’ deletion mutants are shown in green. Black bold letters indicate the XbaI site for cloning.
Name Plasmid Insert from +1 to end of gcvB terminator Positions
deleted as
compared to
wild-type gcvB
pgcvB
pPLgcvB
pTP05
pTP09
acttcctgagccggaacgaaaagttttatcggaatgcgtgttctg
atgggcttttggcttacggttgtgatgttgtgttgttgtgtttgc
aattggtctgcgattcagaccacggtagcgagactaccctttttc
acttcctgtacatttaccctgtctgtccatagtgattaatgtagc
accgccatattgcggtgcttttttttgtataacaaacggttagtt
ttccagagccaccatctctttcacgtcagtacgattgatctgctg
tttgttgccattagcgtctttatacgaaatcataccggtatcgtt
atcggTCTAGA
none
pgcvB∆R1
pPLgcvB∆R1
pJL03-15
pJL22
acttcctgagccggaacgaaaagttttatcggaatgcgtgttctg
atgggcttttggcttacggttgtgatgttgtgttgttgtgtttgc
aattggtctgcgattcagaccacggtagcgagactaccctttttc
acttcctgtacatttaccctgtctgtccatagtgattaatgtagc
accgccatattgcggtgcttttttttgtataacaaacggttagtt
ttccagagccaccatctctttcacgtcagtacgattgatctgctg
tttgttgccattagcgtctttatacgaaatcataccggtatcgtt
atcggTCTAGA
66 - 89
pgcvB∆R2
pPLgcvB∆R2
pJL16-10
pJL23
acttcctgagccggaacgaaaagttttatcggaatgcgtgttctg
atgggcttttggcttacggttgtgatgttgtgttgttgtgtttgc
aattggtctgcgattcagaccacggtagcgagactaccctttttc
acttcctgtacatttaccctgtctgtccatagtgattaatgtagc
accgccatattgcggtgcttttttttgtataacaaacggttagtt
ttccagagccaccatctctttcacgtcagtacgattgatctgctg
tttgttgccattagcgtctttatacgaaatcataccggtatcgtt
atcggTCTAGA
136 - 144
pgcvB5’∆
pPLgcvB5’∆
pJL05-16
pJL29-4
acttcctgagccggaacgaaaagttttatcggaatgcgtgttctg
atgggcttttggcttacggttgtgatgttgtgttgttgtgtttgc
aattggtctgcgattcagaccacggtagcgagactaccctttttc
acttcctgtacatttaccctgtctgtccatagtgattaatgtagc
accgccatattgcggtgcttttttttgtataacaaacggttagtt
ttccagagccaccatctctttcacgtcagtacgattgatctgctg
tttgttgccattagcgtctttatacgaaatcataccggtatcgtt
atcggTCTAGA
1 - 91
pgcvB3’∆ pJL01-1 acttcctgagccggaacgaaaagttttatcggaatgcgtgttctg
atgggcttttggcttacggttgtgatgttgtgttgttgtgtttgc
aattggtctgcgattcagaccacggtagcgagactaccctttttc
acttcctgtacatttaccctgtctgtccatagtgattaatgtagc
accgccatattgcggtgcttttttttgtataacaaacggttagtt
ttccagagccaccatctctttcacgtcagtacgattgatctgctg
tttgttgccattagcgtctttatacgaaatcataccggtatcgtt
atcggcTCTAGA
135 - 206 and
region
downstream of
gcvB
terminator
pgcvB3’∆T pJL17-6 acttcctgagccggaacgaaaagttttatcggaatgcgtgttctg
atgggcttttggcttacggttgtgatgttgtgttgttgtgtttgc
aattggtctgcgattcagaccacggtagcggaaacgctaccgttt
tttttcTCTAGA
135 - 206;
modification in
terminator
starts at
position 121
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Table 8.7: Inserts of GFP-fusion plasmids. Salmonella gene sequences are capitalized, in which black
letters correspond to 5’ UTR parts and red letters to ORF parts. BfrBI sites of pXG-10 and NheI sites that
were used for cloning are highlighted in bold in magenta and green, respectively. The C/A-rich element of
gltI is marked in blue.
GFP fusion Insert
dppA::gfp ATGAGGGGCATTTTATGGAGAATCCGCACTGCAACTCAGTCGATTATGCGAACGGAATCC
CCACCTCTCACTACTGACCTGACCAGGTAAAAAACAAAAAAGGCCGGGCGGTAAAAGCCT
TTGCAAAGGGCAAAACAACATACATCACAATTGGAGCAGAAGAATGAGTATTTCCTTGAA
GAAGTCAGGGATGgctagc
oppA::gfp ATCGACGAAAGGCGATCGAACGAATCGTCAGAATAAATAAAGTCGGTGATAGCAAAAGCA
GTGACAGACCTGGCAGTACACCACCAGTGCTGCACAGGAACCCTGACGGGATTAAACAGG
CTGGTAAAAACCAGTAATTATAATGAGTGGAGTACAAACACAATGTCTAACATCACGAAA
AAAAGTTTGATTGCAGCGGGAATACTCACTGCtagc
livJ::gfp GAGTATGCTGCTAAAGCACGGGTAGCTAGCCAATAATCGAAATAAAGTGCTGAACAATAA
CACCACAACACACGTAACAACCAGAATAATGGGGATTATCAGGATGAATATGAAGGGTAA
AACGTTATTGGCAGGATGTATCGCtagc
livK::gfp atgcatATCTATAGCGAAAAGCAGAATATTATCTTTTCTTAATAGACTGAAAAATAGAGA
TTTTAATCTTATTATGCTTTAAATGCTGCGCTAACTCATTAATGAGTCAGTAAAAAGCGC
ACCATTTATAAAAAGTACAGTCTGCTTTTTAACCAGCAAAAAACAAAACATATAACATCA
CGAATGGGGATACAGGCACATGAAACGGAAAGCGAAAACAATAATCGCAGGGATTGTTGC
tagc
argT::gfp AGGACAATATTGCAACGTTTTATTAACAAATTTAACGTCGAATCGTTTTGCTGACGTGAA
AATGGCATAAGACCTGCATGAAAAAGTCTGCAAACACACAACGCCACGTAAAACATAAGA
AAATGACGCCACTTGAGGGGTATGTATGAAGAAGACCGTTCTCGCTTTGTCTTTGCTGAT
AGGTCTGGGCGCtagc
STM4351::gfp atgcatATCAGAATAGCACCCTGCGCCAAAAAAAGAATAGCACGGTGACCACAACATCCA
ATTGATATCAGGGATCAAGATGAAAAAAAAACTTATTGTCATGCTGTTAGCGCtagc
gltI::gfp ATAACACTGCACGCGCAAGTTGCAGGCAATAACAACATCACAATAGCTATCAATGCGTCG
ACGGCGCAGATGATAAAGGAGTTGGATATGCAATTACGTAAGCTAACCACAGCAATGCTG
GTCATGGGACTGTCTGCtagc
gltI∆CA::gfp ATAACACTGCACGCGCAAGCTATCAATGCGTCGACGGCGCAGATGATAAAGGAGTTGGAT
ATGCAATTACGTAAGCTAACCACAGCAATGCTGGTCATGGGACTGTCTGCtagc
ompR::gfp atgcatGCTTTTTTAAGAATACACGCTTACAAATTGTTGCGAACCTTTGGGAGTACAAAC
AATGCAAGAGAACTACAAGATTCTGGTGGTCGATGACGACATGCGCCTGCGTGCGCTGCT
GGAACGTTATCTCACCGAACAAGGCTTCCAGGTTCGAAGCGTCGCTagc
ompRCA::gfp atgcatGCTTTTTTAAGAATAGTTGCAGGCAATAACAACATCACAATACACGCTTACAAA
TTGTTGCGAACCTTTGGGAGTACAAACAATGCAAGAGAACTACAAGATTCTGGTGGTCGA
TGACGACATGCGCCTGCGTGCGCTGCTGGAACGTTATCTCACCGAACAAGGCTTCCAGGT
TCGAAGCGTCGCTagc
8.3.3.2. Fusion plasmid construction
Translational GFP fusions to GcvB target mRNAs were constructed as described in Urban & Vogel
(2007). For dppA, oppA, gltI, livJ, and argT from Salmonella SL1344, promoters were confirmed
or mapped by 5’ RACE as described in Section 8.2.5.7; BseRI/NheI digested 5’RACE cDNA frag-
ments were cloned into the BsgI/NheI-digested fusion plasmid pXG-20. The livK and STM4351
fusions were cloned in vector pXG-10. The insert sequences of all GFP fusions are given in Ta-
ble 8.7. Details for GFP plasmid construction are listed in Table 8.8.
To construct fusion gltI∆CA::gfp (pJL45-3), bp -71 to -44 relative to gltI AUG were deleted from
the gltI::gfp fusion plasmid by PCR amplification of pJL24-1 using oligos JVO-1973/-1974 and
Phusion Polymerase, DpnI digestion, and self-ligation of purified PCR product. The deleted 27 bp
C/A-rich element was inserted in the ompR::gfp fusion (pJU-63) at position -42 according to the
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dppA dppA::gfp pJL19-1 pXG-20 JVO-0367 ×
JVO-0424
BseRI/
NheI
yes/+ -165 -163 30 193 10 28 +
oppA oppA::gfp pJL18-1 pXG-20 JVO-0367 ×
JVO-0656
BseRI/
NheI
yes/- -511
(-266,
-171)c
-162 50 212 17 26 ++
gltI d gltI::gfp pJL24-1 pXG-20 JVO-0367 ×
JVO-0427
BseRI/
NheI
yes/- -149 -87 50 137 17 22 +++ ATG wrongly
annotated in
Salmonella
livJ d livJ::gfp pJL20-1 pXG-20 JVO-0367 ×
JVO-0728
BseRI/
NheI
yes/- -104 -103 41 144 14 23 +++ ATG wrongly
annotated in
Salmonella
livK livK::gfp pJL31-24 pXG-10 JVO-1271 ×
JVO-0800
BfrBI/
NheI
no
product
-195/
-170
-193 41 234 14 23 -
argT argT::gfp pJL27-2 pXG-20 JVO-0367 ×
JVO-0796
BseRI/
NheI
yes/+ -60 -145 47 192 16 22 -
STM4351 STM4351::gfp pTP28 pXG-10 JVO-0731 ×
JVO-0732
BfrBI/
NheI
noe/- - -73 32 105 11 17 -
a Promoter in E. coli based on EcoCyc www.ecocyc.org annotation.
b Signal peptide predicted with SignalP 3.0 server (http://www.cbs.dtu.dk/services/SignalP/); (Bendtsen et al., 2004).
c Promoters 2 and 3 of oppA from (Igarashi et al., 1997).
d Positions and amino acid numbers are given according to the start codon that was determined by toeprinting (gltI) and sequence alignment with homologous genes from other
bacteria (livJ).
e The 5’ end of STM4351 was mapped at position -65.
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ompR AUG to yield ompRCA::gfp (pJL50-11). This plasmid was constructed by PCR amplification
of pJU-63 using oligos JVO-2154/-2155, followed by self-ligation of the purified PCR-product.
8.3.4. RNA and protein detection
RNA preparation and Northern analysis followed previously published protocols (Urban & Vogel,
2007) and as described in Section 8.2.5. GcvB RNAs were detected with 5’ end-labelled oligos
(see figure legends), and 5S rRNA or gfp fusion mRNAs with oligos JVO-0322 or JVO-0155,
respectively.
OppA protein was detected on Western Blot using a polyclonal OppA antibody kindly provided by
K. Igarashi (Chiba University, Japan) according to the protocol described in Section 8.2.4 and Sittka
et al. (2007). GFP fusion and GroEL proteins were detected as described in Urban & Vogel (2007).
Periplasmic proteins were prepared from Salmonella cultured to an OD600 of 2 as previously pub-
lished in Sittka et al. (2007) and described in Section 8.2.4.2, and analysed by high-resolution 2D
electrophoresis, protein staining, and peptide mass fingerprinting at the Max-Planck-Institute for In-
fection Biology (Berlin, Germany) protein analysis core facility3 according to previously published
standard protocols.
8.3.5. Colony fluorescence imaging
E. coli carrying gfp fusion plasmids were grown overnight on LB plates supplemented with the
appropriate antibiotics. Colonies were photographed using a CCD camera after 2 s excitation at
460 nm with a 510 nm emission filter in a FUJI LAS-3000 image analyser.
8.3.6. T7 transcription, purification and 5’ end labelling of RNA
DNA templates carrying a T7 promoter sequence for in vitro transcription were generated by PCR.
Primers and sequences of the T7 transcripts are given in Tables 8.9 and 8.10. T7 templates of gfp
fusion mRNAs were amplified from plasmids using a sense primer that adds a T7 promoter to the
+1 site of the 5’UTR, and antisense oligo pZE-T1, which binds 122 nt downstream of the gfp stop
codon. These transcripts end with the rrnB terminator of the fusion plasmids. RNA was in vitro
transcribed and quality-checked as previously published in Sittka et al. (2007) and described in
Section 8.2.5.8. The protocol for 5’ end labelling of RNA is published in Papenfort et al. (2006)
and also described in Section 8.2.5.8.
8.3.7. Gel mobility shift assays
GcvB/dppA leader and GcvB/oppA leader binding assays were performed in 1× structure buffer
(provided with RNase T1) in a total reaction volume of 10 µl as follows. 5’ end-labelled GcvB
RNA (≈ 5 nM final concentration in binding reaction) and 1 µg of yeast RNA (Ambion) were
incubated in the presence of unlabelled dppA or oppA leader (final concentrations are given in the
figure legends) at 37°C for 15 min. Prior to gel loading, the binding reactions were mixed with 3 µl
3 http://info.mpiib-berlin.mpg.de/jungblut/
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Table 8.9: Details of RNAs used for in vitro work. .
In vitro
synthesized RNA
fragments
Oligosa Template 5’ part to
ATG [nt]b
3’ part from
ATG [nt]b
Size [nt]
GcvB WT JVO-0941/
JVO-0942
pTP05 - - 201
GcvB ∆R1 JVO-0941/
JVO-0942
pJL3-15/ pJL-22 - - 177
GcvB ∆R2 JVO-0941/
JVO-0942
pJL16-10/ pJL-23 - - 192
GcvB 3’∆ JVO-0941/
JVO-0742
pTP05 - - 134
MicA JVO-0937/
JVO-0938
pKP6-21 - - 73
dppA leader JVO-1034/
JVO-1035
genomic DNA SL1344 - 163 + 72 236
oppA leader JVO-1037/
JVO-1038
genomic DNA SL1344 - 162 + 57 219
gltI leader JVO-1039/
JVO-1040
genomic DNA SL1344 - 87 + 74 161
livJ leader JVO-1065/
JVO-1066
genomic DNA SL1344 -103 (- 109) + 66 (+ 60) 169
livK leader JVO-1063/
JVO-1064
genomic DNA SL1344 - 193 + 58 251
STM4351 leader JVO-1067/
JVO-1068
genomic DNA SL1344 - 73 + 85 158
argT leader JVO-1060/
JVO-1061
genomic DNA SL1344 - 145 + 58 236
ompA leader JVO-1768/
JVO-1769
genomic DNA SL1344 - 133 + 38 171
gfp leader JVO-1048/
JVO-1049
pXG-1 (pJV859-8) - 47 + 70 117
gltI::gfp JVO-1039/
pZE-T1
pJL24-1 - 87 + 887 974
gltI∆CA::gfp JVO-1039/
pZE-T1
pJL45-3 - 60 + 887 947
gltIM2::gfp JVO-1039/
pZE-T1
pJL56-2 - 87 + 887 974
ompR::gfp JVO-2233/
pZE-T1
pJU-63 - 55 + 941 996
ompRCA::gfp JVO-2234/
pZE-T1
pJL50-11 - 82 + 941 1023
cycA leader JVO-1274/
JVO-1042
genomic DNA SL1344 - 79 + 82 161
cycA 10th::gfp
leader
JVO-1274/
JVO-1976
pJL83-2 - 79 + 92 171
a Oligos that were used for amplification of T7 template.
b Only for mRNAs.
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of native loading buffer and electrophoresed on native 6% polyacrylamide gels in 0.5× TBE buffer
at 300 V at 4°C for 3 h (see Section 8.2.3.2). Gels were dried, and analysed on X-ray films. Gel
shifts with labelled dppA/oppA leader and unlabelled GcvB RNA were done in the same way.
10× Structure buffer:
100 mM Tris, pH 7.0
1 M KCl
100 mM MgCl2
Table 8.10: Sequences of T7 transcripts used for in vitro work (cf. Table 8.9).
Red letters indicate ORFs in the T7 transcripts and start codons are shown in bold. Lower-case
letters correspond to the gfp coding region and the gfp stop-codon UAA is shown in black bold
letters. NheI (GCTAGC) and XbaI (TCTAGA) sites of the template plasmids are highlighted in
green. The C/A-rich element of gltI is marked in magenta, whereas dark blue letters indicate the
plasmid-borne rrnB terminator.
T7 RNA Sequence
GcvB WT ACUUCCUGAGCCGGAACGAAAAGUUUUAUCGGAAUGCGUGUUCUGAUGGGCUUUUGGCUUACGGUUGUGA
UGUUGUGUUGUUGUGUUUGCAAUUGGUCUGCGAUUCAGACCACGGUAGCGAGACUACCCUUUUUCACUUC
CUGUACAUUUACCCUGUCUGUCCAUAGUGAUUAAUGUAGCACCGCCAUAUUGCGGUGCUUU
GcvB∆R1 ACUUCCUGAGCCGGAACGAAAAGUUUUAUCGGAAUGCGUGUUCUGAUGGGCUUUUGGCUUACGGUCAAUU
GGUCUGCGAUUCAGACCACGGUAGCGAGACUACCCUUUUUCACUUCCUGUACAUUUACCCUGUCUGUCCA
UAGUGAUUAAUGUAGCACCGCCAUAUUGCGGUGCUUU
GcvB∆R2 ACUUCCUGAGCCGGAACGAAAAGUUUUAUCGGAAUGCGUGUUCUGAUGGGCUUUUGGCUUACGGUUGUGA
UGUUGUGUUGUUGUGUUUGCAAUUGGUCUGCGAUUCAGACCACGGUAGCGAGACUACCCUUUUUCACAUU
UACCCUGUCUGUCCAUAGUGAUUAAUGUAGCACCGCCAUAUUGCGGUGCUUU
GcvB∆3’end ACUUCCUGAGCCGGAACGAAAAGUUUUAUCGGAAUGCGUGUUCUGAUGGGCUUUUGGCUUACGGUUGUGA
UGUUGUGUUGUUGUGUUUGCAAUUGGUCUGCGAUUCAGACCACGGUAGCGAGACUACCCUUUUU
MicA GAAAGACGCGCAUUUGUUAUCAUCAUCCCUGUUUUCAGCGAUGAAAUUUUGGCCACUCCGUGAGUGGCCU
UUU
dppA leader AUGAGGGGCAUUUUAUGGAGAAUCCGCACUGCAACUCAGUCGAUUAUGCGAACGGAAUCCCCACCUCUCA
CUACUGACCUGACCAGGUAAAAAACAAAAAAGGCCGGGCGGUAAAAGCCUUUGCAAAGGGCAAAACAACA
UACAUCACAAUUGGAGCAGAAGAAUGAGUAUUUCCUUGAAGAAGUCAGGGAUGCUGAAGCUUGGUUUGAG
CCUGGUGGCCAUGACCGUUGCAGCAA
oppA leader AUCGACGAAAGGCGAUCGAACGAAUCGUCAGAAUAAAUAAAGUCGGUGAUAGCAAAAGCAGUGACAGACC
UGGCAGUACACCACCAGUGCUGCACAGGAACCCUGACGGGAUUAAACAGGCUGGUAAAAACCAGUAAUUA
UAAUGAGUGGAGUACAAACACAAUGUCUAACAUCACGAAAAAAAGUUUGAUUGCAGCGGGAAUACUCACU
GCGCUCAUC
gltI leader AUAACACUGCACGCGCAAGUUGCAGGCAAUAACAACAUCACAAUAGCUAUCAAUGCGUCGACGGCGCAGA
UGAUAAAGGAGUUGGAUAUGCAAUUACGUAAGCUAACCACAGCAAUGCUGGUCAUGGGACUGUCUGCGGG
CCUUGCGCACGCAGAAGAUGG
livJ leader GAGUAUGCUGCUAAAGCACGGGUAGCUAGCCAAUAAUCGAAAUAAAGUGCUGAACAAUAACACCACAACA
CACGUAACAACCAGAAUAAUGGGGAUUAUCAGGAUGAAUAUGAAGGGUAAAACGUUAUUGGCAGGAUGUA
UCGCCCUGUCAUUAAGCCAUAUGGCAUUC
livK leader AUCUAUAGCGAAAAGCAGAAUAUUAUCUUUUCUUAAUAGACUGAAAAAUAGAGAUUUUAAUCUUAUUAUG
CUUUAAAUGCUGCGCUAACUCAUUAAUGAGUCAGUAAAAAGCGCACCAUUUAUAAAAAGUACAGUCUGCU
UUUUAACCAGCAAAAAACAAAACAUAUAACAUCACGAAUGGGGAUACAGGCACAUGAAACGGAAAGCGAA
AACAAUAAUCGCAGGGAUUGUUGCAUUAGCAGUCUCGCAGG
STM4351 leader AUCAGAAUAGCACCCUGCGCCAAAAAAAGAAUAGCACGGUGACCACAACAUCCAAUUGAUAUCAGGGAUC
AAGAUGAAAAAAAAACUUAUUGUCAUGCUGUUAGCCAGCCUCUCCGUUCACGCCGCUUCCGUUUCCGCCA
GAACAUUACAUUUUGGCA
continued on next page
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T7 RNA Sequence
argT leader AGGACAAUAUUGCAACGUUUUAUUAACAAAUUUAACGUCGAAUCGUUUUGCUGACGUGAAAAUGGCAUAA
GACCUGCAUGAAAAAGUCUGCAAACACACAACGCCACGUAAAACAUAAGAAAAUGACGCCACUUGAGGGG
UAUGUAUGAAGAAGACCGUUCUCGCUUUGUCUUUGCUGAUAGGUCUGGGCGCGACGGCGGCCAGUUACGC
CGCGCUCCCGCAAACGGUUCGUAUUG
ompA leader GCCAGGGGTGCTCAGCATAAGCCGTAGATATCGGTAGAGTAACTATTGAGCAGATCCCCCGGTGAAGGAT
TTAACCGTGTTATCTCGTTGGAGATATTCATGGCGTATTTTGGATGATAACGAGGCGCAAAAAAUGAAAA
AGACAGCTATCGCGATTGCAGTGGCACTGGC
gfp leader AUCAGCAGGACGCACUGACCGAAUUCAUUAAAGAGGAGAAAGGUACCAUGGCUAGCAAAGGAGAAGAACU
UUUCACUGGAGUUGUCCCAAUUCUUGUUGAAUUAGAUGGUGAUGUUA
gltI::gfp AUAACACUGCACGCGCAAGUUGCAGGCAAUAACAACAUCACAAUAGCUAUCAAUGCGUCGACGGCGCAGA
UGAUAAAGGAGUUGGAUAUGCAAUUACGUAAGCUAACCACAGCAAUGCUGGUCAUGGGACUGUCUGcuag
caaaggagaagaacuuuucacuggaguugucccaauucuuguugaauuagauggugauguuaaugggcac
aaauuuucugucaguggagagggugaaggugaugcuacauacggaaagcuuacccuuaaauuuauuugca
cuacuggaaaacuaccuguuccauggccaacacuugucacuacuuugaccuaugguguucaaugcuuuuc
ccguuauccggaucauaugaaacggcaugacuuuuucaagagugccaugcccgaagguuauguacaggaa
cgcacuauaucuuucaaagaugacgggaacuacaagacgcgugcugaagucaaguuugaaggugauaccc
uuguuaaucguaucgaguuaaaagguauugauuuuaaagaagauggaaacauucucggacacaaacucga
guacaacuauaacucacacaauguauacaucacggcagacaaacaaaagaauggaaucaaagcuaacuuc
aaaauucgccacaacauugaagauggauccguucaacuagcagaccauuaucaacaaaauacuccaauug
gcgauggcccuguccuuuuaccagacaaccauuaccugucgacacaaucugcccuuucgaaagaucccaa
cgaaaagcgugaccacaugguccuucuugaguuuguaacugcugcugggauuacacauggcauggaugag
cucuacaaaTAAugaauucgagcauuuaaaucuagaggcaucaaauaaaacgaaaggcucagucgaaaga
cugggccuuucguuuuaucuguuguuugucggugaacgcucuccugaguaggacaaauccgccg
gltI∆CA::gfp AUAACACUGCACGCGCAAGCUAUCAAUGCGUCGACGGCGCAGAUGAUAAAGGAGUUGGAUAUGCAAUUAC
GUAAGCUAACCACAGCAAUGCUGGUCAUGGGACUGUCUGcuagcaaaggagaAgaacuuuucacuggagu
ugucccaauucuuguugaauuagauggugauguuaaugggcacaaauuuucugucaguggagagggugaa
ggugaugcuacauacggaaagcuuacccuuaaauuuauuugcacuacuggaaaacuaccuguuccauggc
caacacuugucacuacuuugaccuaugguguucaaugcuuuucccguuauccggaucauaugaaacggca
ugacuuuuucaagagugccaugcccgaagguuauguacaggaacgcacuauaucuuucaaagaugacggg
aacuacaagacgcgugcugaagucaaguuugaaggugauacccuuguuaaucguaucgaguuaaaaggua
uugauuuuaaagaagauggaaacauucucggacacaaacucgaguacaacuauaacucacacaauguaua
caucacggcagacaaacaaaagaauggaaucaaagcuaacuucaaaauucgccacaacauugaagaugga
uccguucaacuagcagaccauuaucaacaaaauacuccaauuggcgauggcccuguccuuuuaccagaca
accauuaccugucgacacaaucugcccuuucgaaagaucccaacgaaaagcgugaccacaugguccuucu
ugaguuuguaacugcugcugggauuacacauggcauggaugagcucuacaaaTAAugaauucgagcauuu
aaaucuagaggcaucaaauaaaacgaaaggcucagucgaaagacugggccuuucguuuuaucuguuguuu
gucggugaacgcucuccugaguaggacaaauccgccg
gltIM2::gfp AUAACACUGCACGCGCAAGUUGCAGGCAAUAACAACAUCACAAUAGCUAUGAAUCCGUCGACGGCGCAGA
UGAUAAAGGAGUUGGAUAUGCAAUUACGUAAGCUAACCACAGCAAUGCUGGUCAUGGGACUGUCUGcuag
caaaggagaagaacuuuucacuggaguugucccaauucuuguugaauuagauggugauguuaaugggcac
aaauuuucugucaguggagagggugaaggugaugcuacauacggaaagcuuacccuuaaauuuauuugca
cuacuggaaaacuaccuguuccauggccaacacuugucacuacuuugaccuaugguguucaaugcuuuuc
ccguuauccggaucauaugaaacggcaugacuuuuucaagagugccaugcccgaagguuauguacaggaa
cgcacuauaucuuucaaagaugacgggaacuacaagacgcgugcugaagucaaguuugaaggugauaccc
uuguuaaucguaucgaguuaaaagguauugauuuuaaagaagauggaaacauucucggacacaaacucga
guacaacuauaacucacacaauguauacaucacggcagacaaacaaaagaauggaaucaaagcuaacuuc
aaaauucgccacaacauugaagauggauccguucaacuagcagaccauuaucaacaaaauacuccaauug
gcgauggcccuguccuuuuaccagacaaccauuaccugucgacacaaucugcccuuucgaaagaucccaa
cgaaaagcgugaccacaugguccuucuugaguuuguaacugcugcugggauuacacauggcauggaugag
cucuacaaaTAAugaauucgagcauuuaaaucuagaggcaucaaauaaaacgaaaggcucagucgaaaga
cugggccuuucguuuuaucuguuguuugucggugaacgcucuccugaguaggacaaauccgccg
continued on next page
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T7 RNA Sequence
ompR::gfp GCUUUUUUAAGAAUACACGCUUACAAAUUGUUGCGAACCUUUGGGAGUACAAACAAUGCAAGAGAACUAC
AAGAUUCUGGUGGUCGAUGACGACAUGCGCCUGCGUGCGCUGCUGGAACGUUAUCUCACCGAACAAGGCU
UCCAGGUUCGAAGCGUCGCUagcaaaggagaagaacuuuucacuggaguugucccaauucuuguugaauu
agauggugauguuaaugggcacaaauuuucugucaguggagagggugaaggugaugcuacauacggaaag
cuuacccuuaaauuuauuugcacuacuggaaaacuaccuguuccauggccaacacuugucacuacuuuga
ccuaugguguucaaugcuuuucccguuauccggaucauaugaaacggcaugacuuuuucaagagugccau
gcccgaagguuauguacaggaacgcacuauaucuuucaaagaugacgggaacuacaagacgcgugcugaa
gucaaguuugaaggugauacccuuguuaaucguaucgaguuaaaagguauugauuuuaaagaagauggaa
acauucucggacacaaacucgaguacaacuauaacucacacaauguauacaucacggcagacaaacaaaa
gaauggaaucaaagcuaacuucaaaauucgccacaacauugaagauggauccguucaacuagcagaccau
uaucaacaaaauacuccaauuggcgauggcccuguccuuuuaccagacaaccauuaccugucgacacaau
cugcccuuucgaaagaucccaacgaaaagcgugaccacaugguccuucuugaguuuguaacugcugcugg
gauuacacauggcauggaugagcucuacaaaTAAugaauucgagcauuuaaaucuagaggcaucaaauaa
aacgaaaggcucagucgaaagacugggccuuucguuuuaucuguuguuugucggugaacgcucuccugag
uaggacaaauccgccg
ompRCA::gfp GCUUUUUUAAGAAUAGUUGCAGGCAAUAACAACAUCACAAUACACGCUUACAAAUUGUUGCGAACCUUUG
GGAGUACAAACAAUGCAAGAGAACUACAAGAUUCUGGUGGUCGAUGACGACAUGCGCCUGCGUGCGCUGC
UGGAACGUUAUCUCACCGAACAAGGCUUCCAGGUUCGAAGCGUCGCUagcaaaggagaagaacuuuucac
uggaguugucccaauucuuguugaauuagauggugauguuaaugggcacaaauuuucugucaguggagag
ggugaaggugaugcuacauacggaaagcuuacccuuaaauuuauuugcacuacuggaaaacuaccuguuc
cauggccaacacuugucacuacuuugaccuaugguguucaaugcuuuucccguuauccggaucauaugaa
acggcaugacuuuuucaagagugccaugcccgaagguuauguacaggaacgcacuauaucuuucaaagau
gacgggaacuacaagacgcgugcugaagucaaguuugaaggugauacccuuguuaaucguaucgaguuaa
aagguauugauuuuaaagaagauggaaacauucucggacacaaacucgaguacaacuauaacucacacaa
uguauacaucacggcagacaaacaaaagaauggaaucaaagcuaacuucaaaauucgccacaacauugaa
gauggauccguucaacuagcagaccauuaucaacaaaauacuccaauuggcgauggcccuguccuuuuac
cagacaaccauuaccugucgacacaaucugcccuuucgaaagaucccaacgaaaagcgugaccacauggu
ccuucuugaguuuguaacugcugcugggauuacacauggcauggaugagcucuacaaaTAAugaauucga
gcauuuaaaucuagaggcaucaaauaaaacgaaaggcucagucgaaagacugggccuuucguuuuaucug
uuguuugucggugaacgcucuccugaguaggacaaauccgccg
cycA leader GUCCUGAUAACAGGAUCGUCGUAUCAUAGACCAAAGGCCGUAGAGCCCGCACAACACAGACAGGUACAGG
AAGAAAAACAUGGUAGAUCAGGUAAAAGUCGCAGCCGACGAACAGGCUCCGGCUGAACAGUCGCUACGGC
GCAAUCUUACAAACCGUCAUA
cycA 10th::gfp
leader
GUCCUGAUAACAGGAUCGUCGUAUCAUAGACCAAAGGCCGUAGAGCCCGCACAACACAGACAGGUACAGG
AAGAAAAACAUGGUAGAUCAGGUAAAAGUCGCAGCCGACgctagcaaaggagaagaacuuuucacuggag
uugucccaauucuuguugaauuagaugguga
8.3.8. In vitro structure mapping and footprinting
Secondary structure probing and mapping of RNA complexes was conducted on 5’-end-labelled
RNA (≈0.1 pmol) in 10 µl reactions. RNA was denatured for 1 min at 95°C and chilled on ice
for 5 min, upon which 1 µg yeast RNA and 10×structure buffer were added. Concentrations of
unlabelled sRNA/mRNA leader added to the reactions are given in the figure legends. Following
incubation for 10 min at 37°C, 2 µl of a fresh solution of lead(II) acetate (25 mM) or 2 µl of RNase
T1 (0.01 u/µl) or 2 µl RNase T2 (0.02 u/µl) were added and incubated for 2, 3 or 5 min at 37°C,
respectively. RNase III cleavage reactions contained 1 mM DTT and 1.3 unit enzyme, and were
incubated for 6 min at 37 °C.
Reactions were stopped with 5 µl of 0.1 M EDTA, precipitated, and dissolved in Gel Loading Buffer
II (Ambion), or by direct addition of 12 µl loading buffer on ice. RNase T1 ladders were obtained
by incubating labelled RNA (≈0.2 pmol) in 1× sequencing buffer (provided with RNase T1) for 1
min at 95°C. Subsequently, 1 µl RNase T1 (0.1 u/µl) was added and incubation continued at 37°C
for 5 min. OH ladders were generated by 5 min incubation of 0.2 pmol labelled RNA in alkaline
hydrolysis buffer (provided with RNase T1) at 95°C. Reactions were stopped with 12 µl loading
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buffer. Samples were denatured for 3 min at 95°C prior to separation on 6% polyacrylamide/7M
urea sequencing gels in 1X TBE. Gels were dried and analysed using a PhosphorImager (FLA-3000
Series) and AIDA software (Raytest, Germany).
8.3.9. 30S ribosome toeprints
Toeprinting reactions were carried out as described (Hartz et al., 1988; Udekwu et al., 2005) with a
few modifications. 0.2 pmol of an unlabelled dppA mRNA fragment (236 nt, T7 template amplified
with JVO-1034/-1035), and 0.6 pmol of 5’end labelled primer JVO-1035 complementary to the
dppA coding region were annealed. For inhibition analysis, 0.2, 0.6, 1 and 2 pmol of GcvB RNA
or 1 pmol control RNA (MicA) or GcvB mutant RNAs were added. Nucleic acids were denatured
in annealing buffer (10 mM Tris-acetate pH 7.6, 1 mM DTT, 100 mM potassium acetate) for 1
min at 95 °C and chilled on ice for 5 min, upon which Mg2+ acetate and all dNTPs were added
to final concentrations of 10 mM and 0.5 mM, respectively. All subsequent incubation steps were
at 37 °C. After 5 min incubation, 2 pmol of 30S ribosomal subunit (provided by Knud Nierhaus,
Max Planck Institute for Molecular Genetics, Berlin, Germany; pre-activated for 20 min prior to the
assay) were added. Following incubation for 5 min, uncharged tRNAfMet (10 pmol) was added, and
incubations continued for 15 min. Reverse transcription was carried out by addition of 100 units of
Superscript II and incubation for 20 min. cDNA synthesis was terminated with 100 µl stop buffer.
Following phenol-chloroform extraction, alkaline hydolysis of template RNA at 90°C, and ethanol
precipitation, cDNA was dissolved in 10 µl of loading buffer II (Ambion). Toeprint analysis on
gltI 5’ RNA (161 nt, T7 template amplified with primers JVO-1039/-1040) was performed using
5’ end-labelled primer JVO-1775. See figure legend for final concentrations of other components.
Sequencing ladders were generated with CycleReaderTM DNA Sequencing Kit according to the
manufacturer’s protocol on the same DNA template as used for T7 transcription and the same 5’-
end-labelled primer as in the toeprinting reactions. cDNAs and sequence ladders were separated on
a 6% polyacrylamide/ 7M urea gel. Autoradiograms of dried gels were obtained as above.
Stop buffer:
50 mM Tris-HCl pH 7.5
0.1% SDS
10 mM EDTA
8.3.10. In vitro translation assays
Translation reactions were carried out using Puresystem according to the manufacturer’s instruc-
tions. 10 µl (Figs. 3.16B and D) or 20 µl (Fig. 3.17C) reactions contained, in addition to 70S
ribosomes, mRNA template, Hfq and - where applicable - GcvB RNAs (see figure legends for final
concentrations). Hfq dilutions were prepared in 1× dilution buffer.
1× Dilution buffer:
1× structure buffer
1% glycerol
0.1% Triton-X-100
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Tables 8.9 and 8.10 list the details of DNA fragments used for T7 transcription. Before addition of
puresystem mix, RNA was denatured for 1 min at 90°C and chilled on ice for 5 min. Hfq was mixed
with mRNA (and sRNA), and pre-incubated for 10 min at 37°C. Puresystem mix was added and
incubation continued at 37°C for the time given in the figure legend. Reactions were stopped with 4
vol of ice-cold acetone, kept on ice for 15 min, and proteins collected by centrifugation (10,000 g,
10 min, 4°C). Proteins were quantified by Western blot analysis with a monoclonal GFP antibody
as previously published in Urban & Vogel (2007) and described in Section 8.2.4.5.
8.3.11. Quantitative RT-PCR
10 ml of a Salmonella culture grown to an OD600 of 0.4 (4 OD600 in total) were harvested, treated
with 1/5 volume of stop solution (95% EtOH; 5% water-saturated phenol), snap-frozen in liquid
nitrogen, and stored at -80°C until RNA extraction. RNA was isolated using the Promega SV
total RNA purification kit as described in Section 8.2.5.2. RNA concentrations were determined
on a Nanodrop machine. The relative amount of target mRNAs was determined by q-PCR us-
ing QuantitectTM SYBR Green RT-PCR Kit following manufacturer’s instructions (Qiagen) in a
7900HT-RealTime-PCR System. For each reaction (25 µL final volume) 1 µl of RNA sample (100
ng / reaction) were mixed with 0.25 µl of primer pairs (0.5µM final) and 12.5 µl of SYBR Green
mix. For coupled cDNA synthesis and target gene amplification 0.25 µl of Quantitect RT mix was
added. Each sample was assayed in triplicate for each run. Control RNA from wild-type cells was
used to construct a standard curve for all inspected genes. Reaction conditions were: 30 min 50°C,
15 min 95°C, and 45 cycles at 94°C for 20 s, 60°C for 40 s, and 72°C for 40 s. Specific primer pairs
for Salmonella dppA (JVO-1254/1255), oppA (JVO-1256/1257), gltI (JVO-1381/1382), livJ (JVO-
1628/1629), livK (JVO-2326/2327), argT (JVO-2328/2329), and STM4351 (JVO-2330/2331) were
designed using the PRIMER EXPRESSTM software (Applied Biosystems). The rpoA gene (JVO-
1340/1341) was used as an internal standard.
8.4. Methods: GcvB RNA, a global regulator of genes involved in
amino acid metabolism
8.4.1. Strains, plasmids, and oligonucleotides
The Salmonella enterica serovar Typhimurium and Escherichia coli strains used in this section are
listed in Table 10.1 in the Appendix. The complete list of DNA oligonucleotides used for cloning
and as probes in hybridization is provided in Table 10.4 in the Appendix.
8.4.2. Plasmids
Plasmids that were used or constructed in this section are listed in Table 10.2 in the Appendix.
Details of their construction, and insert sequences are given in Tables 8.11-8.14.
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Table 8.11: Construction of additional GcvB RNA mutant plasmids.
Plasmid Name Template Oligo 1 Oligo 2 Deletion of position
pKP30-1 pBAD-GcvB∆R2 pKP1-1 JVO-0895 JVO-0896 136 - 144
pJL36-5 pPLgcvB∆R1&∆R2 pJL22 JVO-0895 JVO-0896 66 - 89, 136 - 144
pJL57-1 pPLgcvB5’∆&∆R2 pJL29-4 JVO-0895 JVO-0896 1 - 91, 136 - 144
pJL65-3 pPLgcvB∆SL2 pTP09 JVO-2856 JVO-2857 92 - 113
pJL66-12 pPLgcvB∆SL2&∆SL3 pTP09 JVO-2856 JVO-2858 92 - 134
pFS127-2 pPLgcvBSL1, SL4 & SL5 pTP09 JVO-0745 JVO-0895 66 - 144
pFS129-2 pPLgcvBSL4 & SL5 pTP09 PLlacO-D JVO-0895 1 - 144
pFS130-1 pPLgcvBR2, SL4 & SL5 pTP09 PLlacO-D JVO-2989 1 - 134
pFS131-1 pgcvB∆R1& 3’∆T pJL17-6 JVO-0745 JVO-0746 66 - 89, 135 - 206, and
region downstream of gcvB
terminator
pJL73-14 pPLgcvBSL1 & SL5 pTP09 JVO-0745 JVO-2986 66 - 177
pJL79-16 pPLgcvBM2, R2, SL4 & SL5 pFS130-1 JVO-3327 JVO-3328 1- 134, G143→C, C158→G
pJL78-11 pPLgcvB5’∆12nt, SL1 & SL5 pJL73-14 PLlacO-D JVO-2990 1 - 12, 66 - 177
pJL77-3 pgcvB5’∆12nt,∆R1 & 3’∆T pFS131-1 JVO-0743 JVO-2990 1 - 12, 66 - 89, 135 - 206,
and region downstream of
gcvB terminator
pJL85-4 pgcvB∆PL pTP09 JVO-3355 JVO-1396 (-1) - (-35)
pSP9-1 pPLgcvBSL1 & SL5, C3 pJL73-14 JVO-3466 JVO-3467 T3→C, 66 - 177
pSP11-1 pPLgcvBSL1 & SL5, C8 pJL73-14 JVO-3464 JVO-3465 G8→C, 66 - 177
pSP10-1 pPLgcvBSL1 & SL5, G11 pJL73-14 JVO-3468 JVO-3469 C11→G, 66 - 177
8.4.2.1. sRNA plasmid construction
Plasmid pBAD-GcvB (pKP1-1) was constructed similarly as described for pBAD-RybB in Papen-
fort et al. (2006) but using primers JVO-0897 and pZE-XbaI for insert amplification on pTP05
which carries the Salmonella gcvB locus (292 bp upstream of the +1 site to 116 bp downstream
of the terminator). Similarly, plasmid pJL3-15 and primers JVO-0897 and pZE-XbaI were used
for amplification of the gcvB∆R1 allele which was cloned under the control of the pBAD promoter
analogous to pKP1-1 resulting in plasmid pKP2-6 (pBAD-GcvB∆R1). Plasmid pKP30-1 (pBAD-
GcvB∆R2) was constructed by PCR amplification from plasmid pKP1-1 using Phusion Polymerase
and primer pair JVO-0895/JVO-0896, DpnI digestion of template plasmid, and self-ligation of pu-
rified PCR product.
GcvB mutant plasmids were constructed via PCR amplification from the original plasmids using
Phusion Polymerase, DpnI digestion of template plasmid, and self-ligation of purified PCR prod-
ucts. Primers and templates used for each mutant plasmid are listed in Table 8.11. Sequences of the
mutant inserts are given in Table 8.12.
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Table 8.12: Inserts of new GcvB mutant plasmids.
Black letters indicate the gcvB wild-type sequence, deleted parts of the individual GcvB mutants
are marked in red, and the modified terminator/inserted nucleotides for the 3’ deletion mutants are
shown in green. Single nucleotide exchanges are indicated in blue uppercase letters.
Name Plasmid Insert from +1 to end of gcvB terminator Positions
deleted as
compared to
wild-type
gcvB
pPLgcvB pTP09 acttcctgagccggaacgaaaagttttatcggaatgcgtgttctg
atgggcttttggcttacggttgtgatgttgtgttgttgtgtttgc
aattggtctgcgattcagaccacggtagcgagactaccctttttc
acttcctgtacatttaccctgtctgtccatagtgattaatgtagc
accgccatattgcggtgctttttttt
none
pPLgcvB∆R1 pJL22 acttcctgagccggaacgaaaagttttatcggaatgcgtgttctg
atgggcttttggcttacggttgtgatgttgtgttgttgtgtttgc
aattggtctgcgattcagaccacggtagcgagactaccctttttc
acttcctgtacatttaccctgtctgtccatagtgattaatgtagc
accgccatattgcggtgctttttttt
66 - 89
pPLgcvB∆R2 pJL23 acttcctgagccggaacgaaaagttttatcggaatgcgtgttctg
atgggcttttggcttacggttgtgatgttgtgttgttgtgtttgc
aattggtctgcgattcagaccacggtagcgagactaccctttttc
acttcctgtacatttaccctgtctgtccatagtgattaatgtagc
accgccatattgcggtgctttttttt
136 - 144
pPLgcvB5’∆ pJL29-4 acttcctgagccggaacgaaaagttttatcggaatgcgtgttctg
atgggcttttggcttacggttgtgatgttgtgttgttgtgtttgc
aattggtctgcgattcagaccacggtagcgagactaccctttttc
acttcctgtacatttaccctgtctgtccatagtgattaatgtagc
accgccatattgcggtgctttttttt
1 - 91
pgcvB3’∆T pJL17-6 acttcctgagccggaacgaaaagttttatcggaatgcgtgttctg
atgggcttttggcttacggttgtgatgttgtgttgttgtgtttgc
aattggtctgcgattcagaccacggtagcggaaacgctaccgttt
tttttc
135 - 206;
modification
in terminator
starts at
position 121
pPLgcvB∆R1&∆R2 pJL36-5 acttcctgagccggaacgaaaagttttatcggaatgcgtgttctg
atgggcttttggcttacggttgtgatgttgtgttgttgtgtttgc
aattggtctgcgattcagaccacggtagcgagactaccctttttc
acttcctgtacatttaccctgtctgtccatagtgattaatgtagc
accgccatattgcggtgctttttttt
66 - 89,
136 - 144
pPLgcvB5’∆&∆R2 pJL57-1 acttcctgagccggaacgaaaagttttatcggaatgcgtgttctg
atgggcttttggcttacggttgtgatgttgtgttgttgtgtttgc
aattggtctgcgattcagaccacggtagcgagactaccctttttc
acttcctgtacatttaccctgtctgtccatagtgattaatgtagc
accgccatattgcggtgctttttttt
1 - 91,
136 - 144
pPLgcvB∆SL2 pJL65-3 acttcctgagccggaacgaaaagttttatcggaatgcgtgttctg
atgggcttttggcttacggttgtgatgttgtgttgttgtgtttgc
aattggtctgcgattcagaccacggtagcgagactaccctttttc
acttcctgtacatttaccctgtctgtccatagtgattaatgtagc
accgccatattgcggtgctttttttt
92 - 113
pPLgcvB∆SL2&∆SL3 pJL66-12 acttcctgagccggaacgaaaagttttatcggaatgcgtgttctg
atgggcttttggcttacggttgtgatgttgtgttgttgtgtttgc
aattggtctgcgattcagaccacggtagcgagactaccctttttc
acttcctgtacatttaccctgtctgtccatagtgattaatgtagc
accgccatattgcggtgctttttttt
92 - 134
continued on next page
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Name Plasmid Insert from +1 to end of gcvB terminator Positions
deleted as
compared to
wild-type
gcvB
pPLgcvBSL1, SL4 & SL5 pFS127-2 acttcctgagccggaacgaaaagttttatcggaatgcgtgttctg
atgggcttttggcttacggttgtgatgttgtgttgttgtgtttgc
aattggtctgcgattcagaccacggtagcgagactaccctttttc
acttcctgtacatttaccctgtctgtccatagtgattaatgtagc
accgccatattgcggtgctttttttt
66 - 44
pPLgcvBSL4 & SL5 pFS129-2 acttcctgagccggaacgaaaagttttatcggaatgcgtgttctg
atgggcttttggcttacggttgtgatgttgtgttgttgtgtttgc
aattggtctgcgattcagaccacggtagcgagactaccctttttc
acttcctgtacatttaccctgtctgtccatagtgattaatgtagc
accgccatattgcggtgctttttttt
1 - 144
pPLgcvBR2, SL4 & SL5 pFS130-1 acttcctgagccggaacgaaaagttttatcggaatgcgtgttctg
atgggcttttggcttacggttgtgatgttgtgttgttgtgtttgc
aattggtctgcgattcagaccacggtagcgagactaccctttttc
acttcctgtacatttaccctgtctgtccatagtgattaatgtagc
accgccatattgcggtgctttttttt
1 - 134
pgcvB∆R1& 3’∆T pFS131-1 acttcctgagccggaacgaaaagttttatcggaatgcgtgttctg
atgggcttttggcttacggttgtgatgttgtgttgttgtgtttgc
aattggtctgcgattcagaccacggtagcggaaacgctaccgttt
tttttc
66 - 89,
135 - 206;
modification
in terminator
starts at
position 121
pPLgcvBSL1 & SL5 pJL73-14 acttcctgagccggaacgaaaagttttatcggaatgcgtgttctg
atgggcttttggcttacggttgtgatgttgtgttgttgtgtttgc
aattggtctgcgattcagaccacggtagcgagactaccctttttc
acttcctgtacatttaccctgtctgtccatagtgattaatgtagc
accgccatattgcggtgctttttttt
66 - 177
pPLgcvBM2, R2, SL4 & SL5 pJL79-16 acttcctgagccggaacgaaaagttttatcggaatgcgtgttctg
atgggcttttggcttacggttgtgatgttgtgttgttgtgtttgc
aattggtctgcgattcagaccacggtagcgagactaccctttttc
acttcctCtacatttaccctgtGtgtccatagtgattaatgtagc
accgccatattgcggtgctttttttt
1 - 134,
G143→C,
C158→G
pPLgcvB5’∆12nt, SL1 & SL5 pJL78-11 acttcctgagccggaacgaaaagttttatcggaatgcgtgttctg
atgggcttttggcttacggttgtgatgttgtgttgttgtgtttgc
aattggtctgcgattcagaccacggtagcgagactaccctttttc
acttcctgtacatttaccctgtctgtccatagtgattaatgtagc
accgccatattgcggtgctttttttt
1 - 12,
66 - 177
pgcvB5’∆12nt,∆R1 & 3’∆T pJL77-3 acttcctgagccggaacgaaaagttttatcggaatgcgtgttctg
atgggcttttggcttacggttgtgatgttgtgttgttgtgtttgc
aattggtctgcgattcagaccacggtagcggaaacgctaccgttt
tttttc
1 - 12,
66 - 89,
135 - 206;
modification
in terminator
starts at
position 121
pPLgcvBSL1 & SL5, C3 pSP9-1 acCtcctgagccggaacgaaaagttttatcggaatgcgtgttctg
atgggcttttggcttacggttgtgatgttgtgttgttgtgtttgc
aattggtctgcgattcagaccacggtagcgagactaccctttttc
acttcctgtacatttaccctgtctgtccatagtgattaatgtagc
accgccatattgcggtgctttttttt
T3→C,
66 - 177
pPLgcvBSL1 & SL5, C8 pSP11-1 acttcctCagccggaacgaaaagttttatcggaatgcgtgttctg
atgggcttttggcttacggttgtgatgttgtgttgttgtgtttgc
aattggtctgcgattcagaccacggtagcgagactaccctttttc
acttcctgtacatttaccctgtctgtccatagtgattaatgtagc
accgccatattgcggtgctttttttt
G8→C,
66 - 177
continued on next page
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Name Plasmid Insert from +1 to end of gcvB terminator Positions
deleted as
compared to
wild-type
gcvB
pPLgcvBSL1 & SL5, G11 pSP10-1 acttcctgagGcggaacgaaaagttttatcggaatgcgtgttctg
atgggcttttggcttacggttgtgatgttgtgttgttgtgtttgc
aattggtctgcgattcagaccacggtagcgagactaccctttttc
acttcctgtacatttaccctgtctgtccatagtgattaatgtagc
accgccatattgcggtgctttttttt
C11→G,
66 - 177
8.4.2.2. Construction of GFP-reporter plasmids
Translational GFP fusions to GcvB target mRNAs were constructed as described in Urban & Vo-
gel (2007). For cycA, the promoter was mapped by 5’ RACE as described in Section 8.2.5.7; the
BseRI/NheI-digested cDNA product was cloned into the BsgI/NheI-digested fusion plasmid pXG-
20. All other fusions were cloned into vector pXG-10. The details for GFP plasmid construction
are listed in Table 8.13, and the inserts of all GFP fusions are listed in Table 8.14.
A shortened cycA::gfp fusion to the 10th amino acid was constructed by PCR amplification from the
original plasmid pJL30-14 using Phusion polymerase and oligos JVO-3330 and JVO-0323, DpnI
digestion of template plasmid, NheI digestion, and self-ligation of purified PCR products. This
resulted in plasmid pJL83-2.
8.4.2.3. Transcriptomic experiments
RNA extraction and data generation were carried out with SALSA microarrays as described in
Papenfort et al. (2006). RNA was isolated using the Promega SV total RNA purification kit
as described in Section 8.2.5.2. The microarrays used in this study include PCR products of
all the genes present in the sequenced S. typhimurium strain LT2. In addition, 229 genes spe-
cific to S. typhimurium strain SL1344 were added. Details of all the amplicons can be found
at http://www.ifr.ac.uk/Safety/MolMicro/pubs.html. The experimental design involves the use of
Salmonella enterica serovar Typhimurium genomic DNA as the co-hybridized control for one chan-
nel on all microarrays. This method has the advantage of allowing the direct comparison of mul-
tiple samples. Total RNA and chromosomal DNA were labelled by random priming according to
the protocols described at the IFR (Institute of Food Research, Norwich) website4. Briefly, 16µg
RNA were reverse transcribed and labelled with Cy3-conjugated dCTP (Pharmacia) using 200 units
of StrataScript and random octamers (Invitrogen). Chromosomal DNA (400 ng) was labelled with
Cy5-dCTP using the Klenow fragment. After labelling, each Cy3-labelled cDNA sample was com-
bined with Cy5-labelled chromosomal DNA and hybridized to a microarray overnight at 65ºC.
After hybridization, slides were washed and scanned using a GenePix 4000A scanner. Fluorescent
spots and the local background intensities were identified and quantified using Bluefuse software
(BlueGnome, Oxford). To compensate for unequal dye incorporation, data centring to zero was
performed for each block (one block being defined as the group of spots printed by the same pin).
Microarray data were analysed using GeneSpring 7.3 (Agilent) and genes were considered to be
differentially expressed if they displayed ≥2-fold changes in all replicates and were statistically
significantly different.
4 www.ifr.ac.uk/safety/microarrays/protocols.html
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Table 8.13: Details of new GFP-fusion plasmids construction.
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cycA cycA::gfp pJL30-14 pXG-20 JVO-0367 × JVO-1275 BseRI/NheI Yes/ - - -79 +57 136 19 maybe Tat +++
ydgR (tppB) ydgR::gfp pJL70-9 pXG-10 JVO-2850 × JVO-2851 BfrBI/NheI - -98 -96 +45 141 15 no +
ygjU (sstT)c ygjU::gfp pFS133-3 pXG-10 JVO-2971 × JVO-3087 BfrBI/NheI - - -81 +21 102 7 no +
yaeC yaeC::gfp pFM27-1 pXG-30 JVO-2058 × JVO-2059 BfrBI/NheI - operon
metNIQ
-41 +36 77 12 21 ++
gdhA gdhA:gfp pJL69-5 pXG-10 JVO-2806 × JVO-2807 BfrBI/NheI - -63 -64 +33 97 11 no +
asdc asd::gfp pFS116-1 pXG-10 JVO-2969 × JVO-2970 BfrBI/NheI - - -101 +27 128 9 no weak
lrp lrp::gfp pFS103-3 pXG-10 JVO-2800 × JVO-2801 BfrBI/NheI - -267 -225 +45 270 15 no +
ilvC ilvC::gfp pJL68-1 pXG-10 JVO-2804 × JVO-2805 BfrBI/NheI - -58 -68 +33 101 11 no +
iciA (argP) iciA::gfp pFS121-1 pXG-10 JVO-2973 × JVO-2874 BfrBI/NheI - -23 -27 +36 63 12 no +
brnQd brnQ::gfp pFS105-3 pXG-10 JVO-2842 × JVO-2843 BfrBI/NheI - - -174 +30 204 10 26 +
ilvE ilvE::gfp pSP25-7 pXG-10 JVO-3388 × JVO-3389 BfrBI/NheI - -96 -94 +36 130 12 no ++
thrL thrL::gfp pSP20-1 pXG-10 JVO-3378 × JVO-3379 BfrBI/NheI - -42 -42 +57 99 19 no ++
ybdH ybdH::gfp pSP21-2 pXG-10 JVO-3380 × JVO-3381 BfrBI/NheI - - -71 +30 101 10 no weak
ndk ndk::gfp pFS115-2 pXG-10 JVO-2965 × JVO-2808 BfrBI/NheI -34 - -35 +39 74 13 no +
serA serA::gfp pFS117-1 pXG-10 JVO-2967 × JVO-2968 BfrBI/NheI - -139/ -46 -51 +30 81 10 no +
a Promoter in E. coli based on EcoCyc www.ecocyc.org annotation.
b Signal peptide predicted with SignalP 3.0 server (http://www.cbs.dtu.dk/services/SignalP/); (Bendtsen et al., 2004).
c Promoter taken from Hfq-CoIP 454 data (Sittka et al., 2008).
d Promoter taken from Ohnishi et al. (1988).
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Table 8.14: Inserts of new GFP-fusion plasmids. Salmonella gene sequences are capitalized, in which
black letters correspond to 5’ UTR parts and red letters to ORF parts. BfrBI sites of pXG-10 and NheI sites
that were used for cloning are highlighted in bold in magenta and green, respectively.
GFP fusion Insert
cycA::gfp GTCCTGATAACAGGATCGTCGTATCATAGACCAAAGGCCGTAGAGCCCGCACAACACAGA
CAGGTACAGGAAGAAAAACATGGTAGATCAGGTAAAAGTCGCAGCCGACGAACAGGCTCC
GGCTGAACAGTCGCTAgctagc
cycA 10th::gfp GTCCTGATAACAGGATCGTCGTATCATAGACCAAAGGCCGTAGAGCCCGCACAACACAGA
CAGGTACAGGAAGAAAAACATGGTAGATCAGGTAAAAGTCGCAGCCGACgctagc
ydgR::gfp atgcatGCCGTTTCCCCTCCAATATAACAATCGGACGGATGAGTCTGACTCATCACGCGC
CAGACAATCCCTGTTAATACGGGGCGTAAAAAAGAGGTAAAAGTGTCTACTGCAAACAAA
AAACCAACTGAAAGCGTCAGTTTGAACgctagc
ygjU::gfp atgcatGCAAACACTTTGTTACATCCTGAAAGATGCGCCGTAAGAGCGTGCAGGGGATGA
CCAGCAACACAATACAAGGAATATGAAATGGCTACGCAACGAGCATCAgctagc
yaeC::gfp atgcatTAACGTTAAACACAACACAAATACTCATTAAGGAAATAACGATGGCGTTCAAAT
TCAAAACCTTTGCGGCAGTGGGTgctagc
gdhA::gfp atgcatGCAAATACATATTCTGATAAAACGCAAATACAACCACATTAATATATAAGAGGT
TTTTATATCTATGGATCAGACATGTTCTCTGGAATCGTTCCTCgctagc
asd::gfp atgcatTTAATTTCACTTGCGACTTTGGCTGCTTTTTGTATGGTGAAGGATGCGCCACAG
ATACTGGCGCGCATACACAGCACATCTCTTTGCAGGAAAAAAACGCTATGAAAAATGTTG
GTTTTATCGGCTGGgctagc
lrp::gfp atgcatGTAAATACCATGTTTACCGGGCTAGTGAAATCTACGCATGGCGTGGACAGACGC
CATTCGTGATGTCGATAGCTGCCGCGAGGCAACGGTCTTCTCACCATAGACCAGGCATTG
CGCGCCGTTAATCCCTCTGGGTTTCGGTCTATCGTGATGGGCAGCGACTCTGAACAGTGA
TGTGAGTAGAGTCAGGCAGGAGTAGGGAAGGAATACAGAGAGACAATAATAATGGTAGAT
AGCAAGAAGCGCCCTGGCAAAGATCTCGACCGTATCgctagc
ilvC::gfp atgcatATTCGCACAGATAGCAATCTGTAAACCGAACAATAAGCGCGACACACAACATCA
CGGAGTACACCATCATGGCTAACTACTTTAATACACTGAATCTGCGCgctagc
iciA::gfp atgcatAAAAAATAACAGGAGCATGACACAACAATGAAACGTCCGGACTACAGAACACTA
CAGGCGCTGgctagc
brnQ::gfp atgcatTCAGGTGCTGTCATTACGACTGCATTTGCGCGGTAAATCGAAAAACAATTCTTC
GCCGCATCGGTCCGGGAGCTTTTCCCGCTGAAATTGATAAAAAACGCCGCTTTATAATCC
TCCGGGAAAGGCAAAAATTTTAATGTTTACAACATCACCATCCACAGGCAGTAAGACTTT
ATGACCCATCAGTTAAAATCGCGCGATATCgctagc
ilvE::gfp atgcatAGTTAAGTAAACTGGTAGATGTTGCGCATGTCGCGATCTGCCAGAGCGCTGCCA
CATCACAACAAATCCGCGCCTGAGCGCAAAAGGAAGAAAAATGACGACGAAAAAAGCTGA
TTATATTTGGTTCAATgctagc
thrL::gfp atgcatATACAAGACAGACAAATAAAAATGACAGAGTACACAACATCCATGAACCGCATC
AGCACCACCACCATTACCACCATCACCATTACCACAGGTAACGGTgctagc
ybdH::gfp atgcatATTTGGCAATCAAGACGTTTAGATGTCTAAATATAATAACAACGGTGAGAAGAC
CCTAAGGACAACACAACATGAACCACACTGAGATCCGCGTCGTTACCgctagc
ndk::gfp atgcatCTGACATAACAACAGAACATATTTCAGAGGTAAACATGGCTATTGAACGGACTT
TTTCCATCATTAAACCCAACgctagc
serA::gfp atgcatGATGCAAATCCACACACAACATCAGATGGCAAAAAAGACAGGATCGGGGAAATG
GCAAAGGTATCGCTGGAGAAAGATAAAgctagc
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8.4.3. RNA and protein detection
RNA preparation and Northern analysis as well as GFP fusion and GroEL protein detection were
performed as described in Sections 8.2.5 and 8.3.4. Colony fluorescence imaging was carried out
as described in Section 8.3.5.
For FACS analysis, E. coli strains carrying gfp fusion plasmids were grown to stationary phase in 3
ml liquid cultures (inoculated from single colonies) in LB medium (supplemented with the appro-
priate antibiotics). After 14 h, bacteria from 1 ml culture volume were harvested by centrifugation
for 2 min at 8,000 rpm and 4°C. After removal of supernatants, bacteria were resuspended in 500µl
2% PFA (paraformaldehyde) in 1×PBS buffer (pH 7.4) for fixation and stored for up to five days in
the dark at 4°C until FACS analysis. Prior to FACS measurements, samples were diluted 1:250 in
1×PBS buffer.
10× PBS (phosphate-buffered saline) buffer, pH 7.4:
137 mM NaCl
2.7 mM KCl
4.3 mM Na2HPO4*2 H20
1.4 mM KH2PO4
To determine reporter activities of single cells, a BD FACSCantoTM Flow Cytometer equipped
with a blue excitation source (air-cooled, 20 mW solid state 488 nm laser) was used to measure
forward angle light scatter (FSC), side scatter (SSC), and the fluorescence of the cells (FITC). The
instrument settings were in logarithmic mode: FSC-H: 516, SSC-A: 626; FITC-A (GFP): 753. GFP
fluorescence intensity was measured for 30,000 events (maximum threshold of 10,000 events/sec).
All FACS analyses were done in duplicates. Data analysis was carried out using FCS Express
software, version 3 (De Novo Software).
8.4.4. In vitro structure probing and 30S ribosome toeprinting
DNA templates carrying a T7 promoter sequence for in vitro transcription were generated by
PCR. Primers and sequences of the T7 transcripts are included in Tables 8.9 and 8.10 in Sec-
tion 8.3.6. RNA was in vitro transcribed, quality-checked and labelled at the 5’ end as described in
Section 8.2.5.8. Secondary structure probing and mapping of RNA complexes was conducted on
5’-end-labelled RNA as described in Section 8.3.8.
Toeprinting reactions were carried out as described in Section 8.3.9. Specifically, 0.2 pmol of an
unlabelled cycA 10th::gfp mRNA fragment (171 nt, T7 template amplified with JVO-1274/-1976)
and 0.5 pmol of 5’end labelled primer JVO-1976 complementary to the gfp coding region were
annealed. For inhibition analysis, 0.2, 1 and 2 pmol of GcvB RNA or 2 pmol control RNA (MicA)
or GcvB mutant RNAs were added.
8.4.5. Motif detection using MEME and MAST
The gfp fusion sequences of the seven old targets (dppA, oppA, livJ, livK, argT, STM4351, and gltI,
see Table 8.7) and seven new targets from the microarray analysis (ydgR, ygjU, yaeC, gdhA, asd,
182 CHAPTER 8. Material and Methods
lrp, and cycA, see Table 8.14) were used as input sequences for MEME5 motif identification (Bailey
et al., 2006). The following parameters were defined: number of different motifs: 10; minimum
number of sites: 8; maximum number of sites: 14; minimum motif width: 6; maximum motif
width: 25.
The position-specific weight matrix for the C/A-rich GcvB target derived from the MEME search
was then used as input for MAST6 (Bailey & Gribskov, 1998) searches in a database composed of
the 5’ regions (-70 to +30 according to the start codon) of all annotated Salmonella ORFs. These
were extracted as a multi-Fasta file from the Salmonella typhimurium LT2 genome sequence and
annotation (NC 003197) using own unpublished Perl7 scripts.
8.4.6. Prediction of sRNA-target mRNA duplexes
GcvB-target mRNA complexes were predicted with RNAhybrid (Rehmsmeier et al., 2004). 5’
regions (-70/+30 nt of annotated start codon) of 246 Salmonella LT2 genes, where the C/A motif
was predicted by MAST searches, were used as target sequence input. An extended GcvB region
R1 (TTGGCTTACGGTTGTGATGTTGTGTTGTTGTGTTTGCAATTGGTCTGCG) was used as
miRNA input. Two sets of interactions were predicted: one without limitations for bulge/internal
loops and another where these loops were restricted to a length of one nucleotide. Interactions that
have no helix with at least nine subsequent base-pairs were sorted out manually from the prediction
lists. Furthermore, target interactions were predicted for the GcvB R1 sequence with the -70/+30
regions of all Salmonella mRNAs.
8.5. Methods: Hfq-coIP in Salmonella
8.5.1. Bacterial strains, growth, and oligodeoxynucleotides
The Salmonella enterica serovar Typhimurium strains used in this section are listed in Table 10.1 in
the Appendix. The complete list of DNA oligonucleotides used as hybridization probes is provided
in Table 10.9 in the Appendix. For early stationary phase (ESP) cultures, 30 ml L-broth in a 100
ml flask was inoculated 1/100 from overnight cultures and incubated at 37°C, 220 rpm to an optical
density of 2.
8.5.2. RNA isolation and Northern blot analysis
RNA was prepared by hot phenol extraction as described in Mattatall & Sanderson (1996) and
Section 8.2.5.3, followed by DNase I treatment. After separation on 5% polyacrylamide (PAA)
gels containing 8.3 M Urea, RNA was transferred onto Hybond-XL membrane. 5 or 10 µg RNA
was loaded per sample. For detection of new transcripts γ32P-ATP end-labelled oligodeoxyribonu-
cleotides were used (see Table 10.9 in the Appendix).
5 meme.sdsc.edu/meme4_1/cgi-bin/meme.cgi
6 meme.sdsc.edu/meme4_1/cgi-bin/mast.cgi
7 www.perl.org
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8.5.3. Hfq co-immunoprecipitation, cDNA synthesis and high-throughput pyrosequenc-
ing (HTPS)
Strains SL1344 and JVS-1338 (hfqFLAG) were grown in L-broth under normal aeration at 37°C
to early stationary phase. Co-immunoprecipitation was carried out using the protocol published
in Pfeiffer et al. (2007). For pyrosequencing, samples of two independent pull down experiments
were used. cDNA cloning and pyrosequencing was performed as described for the identification
of eukaryotic microRNA (Berezikov et al., 2006) but omitting size-fractionation of RNA prior to
cDNA synthesis. The cDNA libraries were constructed by vertis Biotechnology AG8 and sequenced
at the Max Planck Institute for Molecular Genetics in Berlin, Germany.
8.5.4. Hardware and software used for 454 sequencing analysis
This following programming languages, programs, tools, and existing methods were used for the
analysis of 454 sequencing data:
8.5.4.1. Development environment and programming language
The operating system Fedora9 GNU/Linux core 8 with kernel 2.6.x was used during the analysis of
454 sequencing data. Programs were run on a computer with an Intel(R) Pentium(R) M processor
2.0 GHz and 2 GB RAM.
Scripts for analysis of 454 data were programmed in Perl10(Practical Extraction and Report Lan-
guage). Perl is both a very simple and a high-level language suited especially for string handling,
pattern recognition in data and texts, and rapid prototyping. It allows easy programming solutions
for data evaluations with far less programming effort than in C or Java because, e. g., Perl automat-
ically manages the memory allocation. Perl v.5.8.8 was used for the implementation of all analysis
programs of this thesis because of its above mentioned strengths in the evaluation of data files.
8.5.4.2. Tools
BLAST11 (Basic Local Alignment Search Tool) provides a method for rapid searching in nucleotide
and protein databases (Altschul et al., 1990). Here, blastn (for standard nucleotide-nucleotide
BLAST) of the WU-BLAST12 package was used for mapping of 454 reads. The BLAST algorithm
uses an indexed table or dictionary of short subsequences called words for both the query sequence
and the database to find similar sequences. It localizes rapidly initial exact matches to the query
words by simply looking up a particular word in the database dictionary. With these initial matches
serving as starting points for longer alignments a final gapped and scored alignment is generated in
several steps.
8 http://www.vertis-biotech.com/
9 fedoraproject.org
10 http://www.perl.com
11 http://www.ncbi.nlm.nih.gov/BLAST/
12 http://blast.wustl.edu/
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Patscan13 is a pattern matcher which searches protein or nucleotide sequence archives for instances
of a pattern which is provided as input (Dsouza et al., 1997). Patscan was used for 5’ end linker and
polyA tail identification during the clipping step.
The Integrated Genome Browser14 (IGB, pronounced ig-bee) is an application intended for vi-
sualization and exploration of genomes and corresponding annotations from multiple data sources.
The IGB is also a part of the open source GenoViz15 project. Links to all documentation and Java
source code for IGB, including the most recent version of this document, can be found on the
homepage of the GenoViz project. The IGB can work with three distinct types of data: annotations,
graphs, and genomic sequences. Annotations indicate the known or suspected locations of features
such as mRNAs, rRNAs, promoter regions, pseudogenes, and so forth. Annotation data can be
directly loaded from files. The IGB was chosen for visualization of mapped 454 reads, as it is able
to display graphs. Graphs indicate scores or other numeric values as a function of genomic position
and can be displayed as some form of plot (x,y-plot, bar plot, etc.).
8.5.5. Analysis and visualization of pyrosequencing results
A detailed description of the developed analysis tools, the analysis workflow and visualization of
pyrosequencing results is given in Section 5.1.2.
In brief, after 5’end linker and polyA-tail clipping from the initial pyrosequencing results, all in-
serts ≥18 nt of the Hfq-coIP and coIP-Ctr libraries were separately mapped to the Salmonella LT2
genome (NC 003197.fna) using WU-BLAST. From the resulting BLAST positions one graph for
each strand of the Salmonella chromosome was calculated, where the number of cDNA hits for
each nucleotide position was plotted. To compare the graphs of the Hfq-coIP and coIP-Ctr, the
graphs were normalized to number of mapped reads. Following upload of the Salmonella genome
sequence and annotation (NC 003197.fna and NC 003197.gff), the two graphs for each library were
loaded into the Integrated Genome Browser (IGB) of Affymetrix (version 4.56).
8.6. Methods: Deep sequencing reveals the primary transcriptome of
Helicobacter pylori
8.6.1. Bacterial strains and oligodeoxynucleotides
Throughout the whole study, Helicobacter pylori strain 26695 was used. H. pylori strain 26695
(CIP 106780) was purchased from the Collection of the ‘Institut Pasteur’ (CIP).
The complete lists of DNA oligonucleotides used as hybridization probes or for 5’ RACE analysis
are provided in Tables 10.14 and 10.15 in the Appendix.
13 http://www-unix.mcs.anl.gov/compbio/PatScan/HTML/patscan.html
14 http://www.affymetrix.com/partners_programs/programs/developer/tools/
igbsource_terms.affx
15 http://genoviz.sourceforge.net/
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8.6.2. Biocomputational prediction of sRNAs
A bioinformatics-based approach similar to Chen et al. (2002) and Argaman et al. (2001) was
taken for the prediction of novel sRNA candidates in Helicobacter pylori 26695 (see Section 2.3.3).
First, all intergenic regions ≥ 60 nt were extracted from the genome sequence based on the anno-
tations specified in the H. pylori 26695 Genbank file NC000915.gb that can be downloaded from
NCBI16. Intergenic regions are defined as regions where no gene is annotated on either of the two
strands. The resulting list of 636 intergenic regions ≥ 60 in H. pylori 26695 was then scanned for
orphan promoter/ terminator pairs. Rho-independent transcription terminators were predicted like
in Chen et al. (2002) using the RNAMotif (Macke et al., 2001) descriptor file specified in Lesnik
et al. (2001). From the resulting list of 109 predicted terminators with energy scores between -1.03
and -9.66, only terminators with a threshold value less than -3.0 were considered for further analy-
sis. A less sringent threshold compared to Chen et al. (2002) was used, as it was unclear whether
Helicobacter Rho-independent terminators are as stable as those from E. coli. Thus, the terminator
predictions ended up with a list of 56 possible terminators.
From this list, all terminators that are close to flanking genes so that either this terminator belongs
to the flanking gene or the space to the flanking gene is not long enough to harbour a promoter
sequence were removed. This resulted in 29 predicted terminators. For promoter predictions, only
regulatory elements were used that were described for the H. pylori σ80 (RpoD) family of promoter
signals (Vanet et al., 2000) which is related to σ70 from E. coli. Promoters were predicted by
pattern searches with PatScan (Dsouza et al., 1997). Only promoter/ terminator pairs on the same
strand and correct orientation within 40 - 400 nt were considered as putative sRNA candidates. No
appropriate promoter could be predicted for eleven terminators. After removal of six putative,
non-annotated ORFs using ORF finder17 and blastx from the list of 18 promoter/terminator
pairs, a search for conservation of the remaining 12 sRNA candidates in the H. pylori strain J99
was conducted. This restrictive search led to a final list of six sRNA candidates (Table 10.10 in the
Appendix) that were selected for experimental verification, whereof one is HP26695 specific. The
alignments for sRNA candidates of H. pylori 26695 and J99 can be found in Figures 10.7 to 10.11
in the Appendix.
8.6.3. Helicobacter growth
Bacteria were grown on columbia agar plates supplemented with 7% laked horse blood and the
Dent selective supplement (Oxoid, Basingstoke, Hampshire, England) for 24 to 48 hours at 37°C
in anaerobic jars under microaerobic conditions (10% CO2, 6% O2) generated by CampyGen bags.
For liquid cultures, plate-grown bacteria were harvested and resuspended to a final OD600 of 0.08
in a flask containing 25 mL of Brain Heart Infusion (BHI) medium, supplemented with 10% foetal
calf serum (FCS) and Dent selective supplement. A starter culture was prepared by incubating the
flasks at 37°C, under microaerobic atmosphere and agitation at 120 rpm to an OD600 of 1.5.
16 http://www.ncbi.nlm.nih.gov/
17 http://www.ncbi.nlm.nih.gov/gorf/gorf.html
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8.6.3.1. Acid stress.
Cells from the starter culture were diluted to an OD600 of 0.08 in three flasks containing fresh BHI
medium, supplemented with 10% foetal calf serum (FCS) and Dent’s antibiotics, and then incubated
for 15 h at 37°C in jars under microaerobic conditions. After 15 hours of growth, one flask was
used to estimate the volume of HCl (3,7%) required to lower the pH to 5.5. Then, the estimated
volume of HCl or sterilized H20 was added to the acid stress flask and the control flask, respectively.
Both flasks were incubated for 30 more minutes, at 37°C, under microaerobic conditions. After
incubaction, bacterial growth was stopped by adding 3 mL stop solution (95% ethanol/5% phenol)
to 25 mL of bacterial culture. Cells were harvested and centrifuged for 10 minutes at 3,000 rpm and
4°C. Then, the supernatant was removed and pellets were stored at -80°C.
8.6.3.2. Co-infection with human cells.
Huh7 and AGS cell lines were cultivated in flasks containing Dulbecco’s Modified Eagle’s Medium
(DMEM) or Ham’s medium, respectively, at 37°C, in a humidified atmosphere of 5% CO2, 95% air.
Before the co-infection experiment, the medium was removed from the flasks, cells were washed
with PBS, and fresh Ham’s medium was added in both flasks containing AGS and Huh7 adherent
cells, and in one more flask containing no cells (plastic control). Then AGS, Huh7 and control
flasks were inoculated with a H. pylori suspension from 48 h plate-grown cultures, at a multiplicity
of infection (MOI) of 240, and incubated at 37°C for 7 h. To collect bacteria adherent to host
cells, first cells were removed from plastic substrate by using a cell scraper. Then, stop solution
was added to each flask, and the whole suspension (composed of supernatant bacteria and released
cell-adherent bacteria) was harvested, centrifuged at 4°C, for 10 minutes at 3.000 rpm, and pellets
were stored at -80°C.
8.6.4. RNA extraction, Northern blot analysis, and 5’ RACE analysis
Frozen pellets from acid stress and co-infection experiments were thawed on ice and resuspended in
lysis solution containing 800 µl of 0.5 mg/mL lysozyme in TE buffer (pH 8.0), and 80µl 10% SDS.
Bacterial cells lysis was done by placing the samples in a water bath for 1-2 minutes at 64°C. Total
RNA was then extracted from the lysates by using the hot-phenol method described in Blomberg
et al. (1990).
For Northern Blot analysis, 3 to 20 µg RNA was loaded per sample. After separation on 6% poly-
acrylamide (PAA) gels containing 8.3 M urea, RNA was transferred onto Hybond-XL membranes,
and membranes were hybridized with γ32P-ATP end-labelled oligodeoxyribonucleotides probes
listed in Table 10.14 in the Appendix.
5’ RACE analysis of Helicobacter genes was done following previously published protocols (Arga-
man et al., 2001; Urban & Vogel, 2007) and as described in Section 8.2.5.7. Gene specific antisense
oligos that were used for 5’ end mapping are listed in Table 10.15 in the Appendix.
8.6.5. Depletion of processed RNAs and construction of cDNA libraries
Total RNA from Helicobacter was first treated with DNase I. For depletion of processed transcripts,
7 µg of Helicobacter RNA were incubated for 60 min at 30°C with TerminatorTM 5’-Phosphate-
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Dependent Exonuclease (TEX) or in buffer alone. Following P:C:I extraction, RNAs were precip-
itated overnight by addition of 2.5 volumes of an ethanol:sodium acetate (pH 5.2) mixture (30:1
v/v). Afterwards, RNAs were treated with TAP (tobacco acid pyrophosphatase) for one hour at
37°C to generate 5’-mono-phosphates for linker ligation, followed by an additional P:C:I extraction
and ethanol precipitation step.
cDNA cloning and 454 pyrosequencing was performed as described for the identification of eukary-
otic microRNA (Berezikov et al., 2006) but omitting size-fractionation of RNA prior to cDNA syn-
thesis. All cDNA libraries were constructed by vertis Biotechnology AG18. In brief, equal amounts
of -/+ TEX treated RNA were poly(A)-tailed using poly(A) polymerase, followed by ligation of
an RNA adapter to the 5’-phosphate of the small RNAs. First-strand cDNA synthesis was then
performed using an oligo(dT)-adapter primer and M-MLV-RNaseH− reverse transcriptase. Incuba-
tion temperatures were 42°C for 20 min, ramp to 55°C followed by 55°C for 5 min. The resulting
cDNAs were then PCR-amplified to 20-30 ng/µl using a high fidelity DNA polymerase. Each
library contains a specific 4-mer barcode sequence which is attached to the 5’-end of the cDNAs.
Helicobacter cDNA libraries were prepared for -/+ TEX treated RNA samples from five growth
conditions: culture in BHI media to mid-log phase (C-/+ libraries), and following 30 min acid
stress (AS-/+); growth in cell culture flasks in the absence (PL-/+) or presence of two eukaryotic
cell types, i. e. AGS human gastric epithelia cells (AGS-/+) as an infection model and Huh7 cells
(Huh7-/+) as negative control.
8.6.6. 454 sequencing and read mapping
In total, 2.15 million reads were sequenced for the acid stress libaries and 1.79 million reads for
the infection libraries. This resulted in 220,000-530,000 cDNAs per library (a total of≈ 3.7 million
cDNAs, see Table 8.15) on a Roche FLX sequencer. The cDNA libraries were sequenced at the
Max-Planck-Institute for Molecular Genetics in Berlin, Germany, and in collaboration with Roche
Diagnostics GmbH in Penzberg, Germany.
First 5’end linker sequences were clipped using the Perl script clip linker.pl, which was
developed for the analysis of the Hfq-coIP libraries described in Section 5.1.2. Afterwards, 5’-linker
clipped reads were mapped to the Helicobacter pylori 26695 genome using the program segemehl
which is based on an error-tolerant suffix array method (Hoffmann et al., 2009, submitted). For this
mapping method, clipping of tailing sequences is not necessary as they will be removed during
the mapping step. However, for very short sequences the polyA tail often leads to mapping errors.
Therefore, a filtering step was introduced which removed all sequences with an A-content of more
than 70% (see Table 8.15). For these sequences, the polyA tail was clipped separately. Of the
clipped reads, all sequences ≥12 nt were mapped again with segemehl. This procedure allowed
mapping of also very short sequences of at least 12 nucleotides.
For each library, the mapped read length distribution (see Figure 6.9 in Section 6.1.3) was calculated
for all mapped reads using a modified version of the Perl script lengths statistics.pl
described in Section 5.1.2. The modified script recognizes the tabular mapping output generated by
segemehl instead of the tabular BLAST output generated by WU-Blast.
18 http://www.vertis-biotech.com/
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Table 8.15: Mapping statistics of ten Heliobacter cDNA libraries.
cDNA
Library
Total
number of
5’end
clipped
sequences
Sequences
removed by
dustbin
filter
(>70%
‘A’s)
< 12 nt
in
dustbin
≥12 nt in
dustbin for
remapping
No match Total
number of
mapped
reads
Percent
mapped
reads
[%]
Mapped
locations
Total
number of
uniquely
mapped
reads
Percent
uniquely
mapped
reads
[%]
Mapped
nucleotides
C - 528373 25952 7515 18437 75887 444971 84,2 793725 114505 25.7 24387787
C + 528169 34403 14984 19419 90256 422929 80,1 618441 257645 60.9 27799949
AS - 427455 24055 8265 15790 63905 355285 83,1 518099 220089 61.9 26336292
AS + 540133 37263 18019 19244 108420 413694 76,6 546118 311267 75.2 27419459
PL - 268841 15781 5130 10651 61007 202704 75,4 319243 98682 48.7 14177628
PL + 315309 14680 6602 8078 57063 251644 79,8 377525 153904 61.2 18783183
AGS - 280713 22972 4547 18245 93029 183137 65,2 293503 85227 46.5 13337457
AGS + 223705 21794 5280 16214 78116 140309 62,7 204815 90533 64.5 9996795
Huh7 - 266621 9795 865 8930 66904 198852 74,6 326304 84105 42.3 27012137
Huh7 + 308759 12259 657 11602 100704 207398 67,2 326898 107017 51.6 27601375
SUM 3688078 218954 71864 146610 795291 2820923 76,5 4324671 1522974 54.0 216852062
CHAPTER 9
REFERENCES
Aarons, S., Abbas, A., Adams, C., Fenton, A. & O’Gara, F. (2000). A regulatory RNA (PrrB RNA)
modulates expression of secondary metabolite genes in Pseudomonas fluorescens F113. J. Bacteriol.,
182(14), 3913–3919.
Abouhamad, W. N., Manson, M., Gibson, M. M. & Higgins, C. F. (1991). Peptide transport and chemotaxis
in Escherichia coli and Salmonella typhimurium: characterization of the dipeptide permease (Dpp)
and the dipeptide-binding protein. Mol. Microbiol., 5(5), 1035–1047.
Afonyushkin, T., Vecerek, B., Moll, I., Bla¨si, U. & Kaberdin, V. R (2005). Both RNase E and RNase III
control the stability of sodB mRNA upon translational inhibition by the small regulatory RNA RyhB.
Nucleic Acids Res., 33(5), 1678–1689.
Aiba, H. (2007). Mechanism of RNA silencing by Hfq-binding small RNAs. Curr. Opin. Microbiol., 10(2),
134–139.
Aiba, H., Adhya, S. & de Crombrugghe, B. (1981). Evidence for two functional gal promoters in intact
Escherichia coli cells. J. Biol. Chem., 256(22), 11905–11910.
Akada, J. K., Shirai, M., Takeuchi, H., Tsuda, M. & Nakazawa, T. (2000). Identification of the urease
operon in Helicobacter pylori and its control by mRNA decay in response to pH. Mol. Microbiol.,
36(5), 1071–1084.
Alix, E. & Blanc-Potard, A. (2009). Hydrophobic peptides: novel regulators within bacterial membrane.
Mol. Microbiol., 72(1), 5–11.
Alkan, C., Karakoc¸, E., Nadeau, J. H., Sahinalp, S. C. & Zhang, K. (2006). RNA-RNA interaction
prediction and antisense RNA target search. J. Comput. Biol., 13(2), 267–282.
Alm, R. A., Ling, L. S., Moir, D. T., King, B. L., Brown, E. D., Doig, P. C., Smith, D. R., Noonan, B.,
Guild, B. C., deJonge, B. L., Carmel, G., Tummino, P. J., Caruso, A., Uria-Nickelsen, M.,
Mills, D. M., Ives, C., Gibson, R., Merberg, D., Mills, S. D., Jiang, Q., Taylor, D. E., Vovis, G. F. &
Trust, T. J. (1999). Genomic-sequence comparison of two unrelated isolates of the human gastric
pathogen Helicobacter pylori. Nature, 397(6715), 176–180.
Altier, C., Suyemoto, M. & Lawhon, S. D. (2000). Regulation of Salmonella enterica Serovar Typhimurium
invasion genes by csrA. Infect. Immun., 68(12), 6790–6797.
Altier, C., Suyemoto, M., Ruiz, A. I., Burnham, K. D. & Maurer, R. (2000). Characterization of two novel
regulatory genes affecting Salmonella invasion gene expression. Mol. Microbiol., 35(3), 635–646.
Altschul, S.F., Gish, W., Miller, W., Myers, E.W. & Lipman, D.J. (1990). Basic local alignment search tool.
J. Mol. Biol., 215, 403–410.
Altuvia, S. (2007). Identification of bacterial small non-coding RNAs: experimental approaches. Curr.
Opin. Microbiol., 10(3), 257–261.
Altuvia, S., Weinstein-Fischer, D., Zhang, A., Postow, L. & Storz, G. (1997). A small, stable RNA induced
by oxidative stress: role as a pleiotropic regulator and antimutator. Cell, 90(1), 43–53.
190 CHAPTER 9. References
Altuvia, S., Zhang, A., Argaman, L., Tiwari, A. & Storz, G. (1998). The Escherichia coli OxyS regulatory
RNA represses fhlA translation by blocking ribosome binding. EMBO J., 17(20), 6069–6075.
Anantharaman, V., Koonin, E. V. & Aravind, L. (2002). Comparative genomics and evolution of proteins
involved in RNA metabolism. Nucleic Acids Res., 30(7), 1427–1464.
Ando, Y., Asari, S., Suzuma, S., Yamane, K. & Nakamura, K. (2002). Expression of a small RNA, BS203
RNA, from the yocI-yocJ intergenic region of Bacillus subtilis genome. FEMS Microbiol. Lett.,
207(1), 29–33.
Andre´, G., Even, S., Putzer, H., P.Burguie`re, Croux, C., Danchin, A., Martin-Verstraete, I. & Soutourina, O.
(2008). S-box and T-box riboswitches and antisense RNA control a sulfur metabolic operon of
Clostridium acetobutylicum. Nucleic Acids Res., 36(18), 5955–5969.
Ansong, C., Yoon, H., Porwollik, S., Mottaz-Brewer, H., Petritis, B. O., Jaitly, N., Adkins, J. N.,
McClelland, M., Heffron, F. & Smith, R. D. (2009). Global systems-level analysis of Hfq and SmpB
deletion mutants in Salmonella: implications for virulence and global protein translation. PLoS ONE,
4(3), e4809.
Antal, M., Bordeau, V., Douchin, V. & Felden, B. (2005). A small bacterial RNA regulates a putative ABC
transporter. J. Biol. Chem., 280(9), 7901–7908.
Aravin, A., Gaidatzis, D., Pfeffer, S., Lagos-Quintana, M., Landgraf, P., Iovino, N., Morris, P.,
Brownstein, M. J., Kuramochi-Miyagawa, S., Nakano, T., Chien, M., Russo, J. J., Ju, J., Sheridan, R.,
Sander, C., Zavolan, M. & Tuschl, T. (2006). A novel class of small RNAs bind to MILI protein in
mouse testes. Nature, 442(7099), 203–207.
Argaman, L. & Altuvia, S. (2000). fhlA repression by OxyS RNA: kissing complex formation at two sites
results in a stable antisense-target RNA complex. J. Mol. Biol., 300(5), 1101–1112.
Argaman, L., Hershberg, R., Vogel, J., Bejerano, G., Wagner, E. G., Margalit, H. & Altuvia, S. (2001).
Novel small RNA-encoding genes in the intergenic regions of Escherichia coli. Curr. Biol., 11(12),
941–950.
Arluison, V., Hohng, S., Roy, R., Pellegrini, O., Re´gnier, P. & Ha, T. (2007). Spectroscopic observation of
RNA chaperone activities of Hfq in post-transcriptional regulation by a small non-coding RNA.
Nucleic Acids Res., 35(3), 999–1006.
Arluison, V., Mutyam, S. K., Mura, C., Marco, S. & Sukhodolets, M. V. (2007). Sm-like protein Hfq:
location of the ATP-binding site and the effect of ATP on Hfq–RNA complexes. Protein Sci., 16(9),
1830–1841.
Arraiano, C. M. & Maquat, L. E. (2003). Post-transcriptional control of gene expression: effectors of
mRNA decay. Mol. Microbiol., 49(1), 267–276.
Axmann, I. M., Kensche, P., Vogel, J., Kohl, S., Herzel, H. & Hess, W. R. (2005). Identification of
cyanobacterial non-coding RNAs by comparative genome analysis. Genome Biol, 6(9), R73.
Azam, T. A., Iwata, A., Nishimura, A., Ueda, S. & Ishihama, A. (1999). Growth phase-dependent variation
in protein composition of the Escherichia coli nucleoid. J. Bacteriol., 181(20), 6361–6370.
Babitzke, P. & Romeo, T. (2007). CsrB sRNA family: sequestration of RNA-binding regulatory proteins.
Curr. Opin. Microbiol., 10(2), 156–163.
Bailey, T. L. & Gribskov, M. (1998). Combining evidence using p-values: application to sequence
homology searches. Bioinformatics, 14(1), 48–54.
Bailey, T. L., Williams, N., Misleh, C. & Li, W. W. (2006). MEME: discovering and analyzing DNA and
protein sequence motifs. Nucleic Acids Res., 34(Web Server issue), W369–W373.
Bang, I., Frye, J. G., McClelland, M., Velayudhan, J. & Fang, F. C. (2005). Alternative sigma factor
interactions in Salmonella: sigma and sigma promote antioxidant defences by enhancing sigma levels.
Mol. Microbiol., 56(3), 811–823.
191
Barrick, J. E., Sudarsan, N., Weinberg, Z., Ruzzo, W. L. & Breaker, R. R. (2005). 6S RNA is a widespread
regulator of eubacterial RNA polymerase that resembles an open promoter. RNA, 11(5), 774–784.
Baumeister, R., Flache, P., Melefors, O., von Gabain, A. & Hillen, W. (1991). Lack of a 5’ non-coding
region in Tn1721 encoded tetR mRNA is associated with a low efficiency of translation and a short
half-life in Escherichia coli. Nucleic Acids Res., 19(17), 4595–4600.
Beier, D., Spohn, G., Rappuoli, R. & Scarlato, V. (1997). Identification and characterization of an operon of
Helicobacter pylori that is involved in motility and stress adaptation. J. Bacteriol., 179(15),
4676–4683.
Beier, D., Spohn, G., Rappuoli, R. & Scarlato, V. (1998). Functional analysis of the Helicobacter pylori
principal sigma subunit of RNA polymerase reveals that the spacer region is important for efficient
transcription. Mol. Microbiol., 30(1), 121–134.
Beitzinger, M., Peters, L., Zhu, J. Y., Kremmer, E. & Meister, G. (2007). Identification of human microRNA
targets from isolated argonaute protein complexes. RNA Biol., 4(2), 76–84.
Bendtsen, J. D., Nielsen, H., von Heijne, G. & Brunak, S. (2004). Improved prediction of signal peptides:
SignalP 3.0. J. Mol. Biol., 340(4), 783–795.
Berezikov, E., Thuemmler, F., van Laake, L. W., Kondova, I., Bontrop, R., Cuppen, E. & Plasterk, R. H. A.
(2006). Diversity of microRNAs in human and chimpanzee brain. Nat. Genet., 38(12), 1375–1377.
Bernhart, S. H., Tafer, H., Mu¨ckstein, U., Flamm, C., Stadler, P. F. & Hofacker, I. L. (2006). Partition
function and base pairing probabilities of RNA heterodimers. Algorithms Mol. Biol., 1(1), 3.
Bernstein, E., Caudy, A. A., Hammond, S. M. & Hannon, G. J. (2001). Role for a bidentate ribonuclease in
the initiation step of RNA interference. Nature, 409(6818), 363–366.
Beuzo´n, C. R., Marque´s, S. & Casadesu´s, J. (1999). Repression of IS200 transposase synthesis by RNA
secondary structures. Nucleic Acids Res., 27(18), 3690–3695.
Beyer, D., Skripkin, E., Wadzack, J. & Nierhaus, K. H. (1994). How the ribosome moves along the mRNA
during protein synthesis. J. Biol. Chem., 269(48), 30713–30717.
Blaser, M. J. (1998). Helicobacter pylori and gastric diseases. BMJ, 316(7143), 1507–1510.
Blattner, F. R., Plunkett, G., Bloch, C. A., Perna, N. T., Burland, V., Riley, M., Collado-Vides, J.,
Glasner, J. D., Rode, C. K., Mayhew, G. F., Gregor, J., Davis, N. W., Kirkpatrick, H. A.,
Goeden, M. A., Rose, D. J., Mau, B. & Shao, Y. (1997). The complete genome sequence of
Escherichia coli K-12. Science, 277(5331), 1453–1474.
Blomberg, P., Wagner, E. G. & Nordstro¨m, K. (1990). Control of replication of plasmid R1: the duplex
between the antisense RNA, CopA, and its target, CopT, is processed specifically in vivo and in vitro
by RNase III. EMBO J., 9(7), 2331–2340.
Bohn, C., Rigoulay, C. & Bouloc, P. (2007). No detectable effect of RNA-binding protein Hfq absence in
Staphylococcus aureus. BMC Microbiol., 7, 10.
Boisset, S., Geissmann, T., Huntzinger, E., Fechter, P., Bendridi, N., Possedko, M., Chevalier, C.,
Helfer, A. C., Benito, Y., Jacquier, A., Gaspin, C., Vandenesch, F. & Romby, P. (2007).
Staphylococcus aureus RNA III coordinately represses the synthesis of virulence factors and the
transcription regulator Rot by an antisense mechanism. Genes Dev., 21(11), 1353–1366.
Boneca, I. G., de Reuse, H., Epinat, J., Pupin, M., Labigne, A. & Moszer, I. (2003). A revised annotation
and comparative analysis of Helicobacter pylori genomes. Nucleic Acids Res., 31(6), 1704–1714.
Boni, I. V., Isaeva, D. M., Musychenko, M. L. & Tzareva, N. V. (1991). Ribosome-messenger recognition:
mRNA target sites for ribosomal protein S1. Nucleic Acids Res., 19(1), 155–162.
Bossi, L. & Figueroa-Bossi, N. (2007). A small RNA downregulates LamB maltoporin in Salmonella. Mol.
Microbiol., 65(3), 799–810.
192 CHAPTER 9. References
Bossi, L., Maloriol, D. & Figueroa-Bossi, N. (2008). Porin biogenesis activates the sigma(E) response in
Salmonella hfq mutants. Biochimie, 90(10), 1539–1544.
Bouvier, M., Sharma, C. M., Mika, F., .Nierhaus, K. H & Vogel, J. (2008). Small RNA binding to 5’ mRNA
coding region inhibits translational initiation. Mol. Cell, 32(6), 827–837.
Brantl, S. (2007). Regulatory mechanisms employed by cis-encoded antisense RNAs. Curr. Opin.
Microbiol., 10(2), 102–109.
Brennan, R. G. & Link, T. M. (2007). Hfq structure, function and ligand binding. Curr. Opin. Microbiol.,
10(2), 125–133.
Brennecke, J., Stark, A., Russell, R. B. & Cohen, S. M. (2005). Principles of microRNA-target recognition.
PLoS Biol., 3(3), e85.
Brock, J. E., Pourshahian, S., Giliberti, J., Limbach, P. A. & Janssen, G. R. (2008). Ribosomes bind
leaderless mRNA in Escherichia coli through recognition of their 5’-terminal AUG. RNA, 14(10),
2159–2169.
Brown, J. W. (1999). The Ribonuclease P Database. Nucleic Acids Res., 27(1), 314.
Brown, L. & Elliott, T. (1996). Efficient translation of the RpoS sigma factor in Salmonella typhimurium
requires host factor I, an RNA-binding protein encoded by the hfq gene. J. Bacteriol., 178(13),
3763–3770.
Brownlee, G. G. (1971). Sequence of 6S RNA of E. coli. Nat. New Biol., 229(5), 147–149.
Busch, A., Richter, A. S. & Backofen, R. (2008). IntaRNA: efficient prediction of bacterial sRNA targets
incorporating target site accessibility and seed regions. Bioinformatics, 24(24), 2849–2856.
Carpousis, A. J. (2002). The Escherichia coli RNA degradosome: structure, function and relationship in
other ribonucleolytic multienzyme complexes. Biochem. Soc. Trans., 30(2), 150–155.
Carpousis, A. J., Houwe, G. Van, Ehretsmann, C. & Krisch, H. M. (1994). Copurification of E. coli RNase E
and PNPase: evidence for a specific association between two enzymes important in RNA processing
and degradation. Cell, 76(5), 889–900.
Carpousis, A. J., Vanzo, N. F. & Raynal, L. C. (1999). mRNA degradation. A tale of poly(A) and
multiprotein machines. Trends Genet., 15(1), 24–28.
Carter, R. J., Dubchak, I. & Holbrook, S. R. (2001). A computational approach to identify genes for
functional RNAs in genomic sequences. Nucleic Acids Res., 29(19), 3928–3938.
Cavanagh, A. T., Klocko, A. D., Liu, X. & Wassarman, K. M. (2008). Promoter specificity for 6S RNA
regulation of transcription is determined by core promoter sequences and competition for region 4.2 of
σ70. Mol. Microbiol., 67(6), 1242–1256.
Chant, E. L. & Summers, D. K. (2007). Indole signalling contributes to the stable maintenance of
Escherichia coli multicopy plasmids. Mol. Microbiol., 63(1), 35–43.
Chen, S., Lesnik, E. A., Hall, T. A., Sampath, R., Griffey, R. H., Ecker, D. J. & Blyn, L. B. (2002). A
bioinformatics based approach to discover small RNA genes in the Escherichia coli genome.
Biosystems, 65(2-3), 157–177.
Chen, S., Zhang, A., Blyn, L. B. & Storz, G. (2004). MicC, a second small-RNA regulator of Omp protein
expression in Escherichia coli. J. Bacteriol., 186(20), 6689–6697.
Chevalier, C., Geissmann, T., Helfer, A. & Romby, P. (2009). Probing mRNA Structure and sRNA-mRNA
Interactions in Bacteria Using Enzymes and Lead(II). Methods Mol. Biol., 540, 215–232.
Christiansen, J. K., Nielsen, J. S., Ebersbach., T., Valentin-Hansen, P., Søgaard-Andersen, L. &
Kallipolitis, B. H. (2006). Identification of small Hfq-binding RNAs in Listeria monocytogenes. RNA,
12(7), 1383–1396.
193
Cloonan, N., Forrest, A. R. R., Kolle, G., Gardiner, B. B. A., Faulkner, G. J., Brown, M. K., Taylor, D. F.,
Steptoe, A. L., Wani, S., Bethel, G., Robertson, A. J., Perkins, A. C., Bruce, S. J., Lee, C. C.,
Ranade, S. S., Peckham, H. E., Manning, J. M., McKernan, K. J. & .Grimmond, S. M (2008). Stem
cell transcriptome profiling via massive-scale mRNA sequencing. Nat. Methods, 5(7), 613–619.
Collins, J. A., Irnov, I., Baker, S. & Winkler, W. C. (2007). Mechanism of mRNA destabilization by the
glmS ribozyme. Genes Dev., 21(24), 3356–3368.
Corpet, F. (1988). Multiple sequence alignment with hierarchical clustering. Nucleic Acids Res., 16(22),
10881–10890.
Cosloy, S. D. (1973). D-serine transport system in Escherichia coli K-12. J. Bacteriol., 114(2), 679–684.
Cromie, M. J., Shi, Y., Latifi, T. & Groisman, E. A. (2006). An RNA sensor for intracellular Mg2+. Cell,
125(1), 71–84.
Darfeuille, F., Unoson, C., Vogel, J. & Wagner, E. G. H. (2007). An antisense RNA inhibits translation by
competing with standby ribosomes. Mol. Cell, 26(3), 381–392.
Davis, B. M., Quinones, M., Pratt, J., Ding, Y. & Waldor, M. K. (2005). Characterization of the small
untranslated RNA RyhB and its regulon in Vibrio cholerae. J. Bacteriol., 187(12), 4005–4014.
de Hoon, M. J. L., Makita, Y., Nakai, K. & Miyano, S. (2005). Prediction of transcriptional terminators in
Bacillus subtilis and related species. PLoS Comput. Biol., 1(3), e25.
De Lay, N. & Gottesman, S. (2009). The Crp-activated small noncoding regulatory RNA CyaR (RyeE)
links nutritional status to group behavior. J. Bacteriol., 191(2), 461–476.
Deana, A. & Belasco, J. G. (2005). Lost in translation: the influence of ribosomes on bacterial mRNA
decay. Genes Dev., 19(21), 2526–2533.
Deiwick, J., Nikolaus, T., Erdogan, S. & Hensel, M. (1999). Environmental regulation of Salmonella
pathogenicity island 2 gene expression. Mol. Microbiol., 31(6), 1759–1773.
del Val, C., Rivas, E., Torres-Quesada, O., N.Toro & Jime´nez-Zurdo, J. I. (2007). Identification of
differentially expressed small non-coding RNAs in the legume endosymbiont Sinorhizobium meliloti
by comparative genomics. Mol. Microbiol., 66(5), 1080–1091.
Delany, I., G.Spohn, Pacheco, A. F., Ieva, R., Alaimo, C., Rappuoli, R. & Scarlato, V. (2002).
Autoregulation of Helicobacter pylori Fur revealed by functional analysis of the iron-binding site.
Mol. Microbiol., 46(4), 1107–1122.
Delany, I., Pacheco, A. B., Spohn, G., Rappuoli, R. & Scarlato, V. (2001). Iron-dependent transcription of
the frpB gene of Helicobacter pylori is controlled by the Fur repressor protein. J. Bacteriol., 183(16),
4932–4937.
Delany, I., Spohn, G., Rappuoli, R. & Scarlato, V. (2001). The Fur repressor controls transcription of
iron-activated and -repressed genes in Helicobacter pylori. Mol. Microbiol., 42(5), 1297–1309.
Delany, I., Spohn, G., Rappuoli, R. & Scarlato, V. (2002). Growth phase-dependent regulation of target
gene promoters for binding of the essential orphan response regulator HP1043 of Helicobacter pylori.
J. Bacteriol., 184(17), 4800–4810.
Delcher, A. L., Harmon, D., Kasif, S., White, O. & Salzberg, S. L. (1999). Improved microbial gene
identification with GLIMMER. Nucleic Acids Res., 27(23), 4636–4641.
Du¨hring, U., Axmann, I. M., Hess, W. R. & Wilde, A. (2006). An internal antisense RNA regulates
expression of the photosynthesis gene isiA. Proc. Nat. Acad. Sci. U.S.A., 103(18), 7054–7058.
Dietz, P., Gerlach, G. & Beier, D. (2002). Identification of target genes regulated by the two-component
system HP166-HP165 of Helicobacter pylori. J. Bacteriol., 184(2), 350–362.
194 CHAPTER 9. References
Ding, Y., Davis, B. M. & Waldor, M. K. (2004). Hfq is essential for Vibrio cholerae virulence and
downregulates sigma expression. Mol. Microbiol., 53(1), 345–354.
Dobrindt, U., Hochhut, B., Hentschel, U. & Hacker, J. (2004). Genomic islands in pathogenic and
environmental microorganisms. Nat. Rev. Microbiol., 2(5), 414–424.
Doherty, N. S., Littman, B. H., Reilly, K., Swindell, A. C., Buss, J. M. & Anderson, N. L. (1998). Analysis
of changes in acute-phase plasma proteins in an acute inflammatory response and in rheumatoid
arthritis using two-dimensional gel electrophoresis. Electrophoresis, 19(2), 355–363.
Douchin, V., Bohn, C. & Bouloc, P. (2006). Down-regulation of porins by a small RNA bypasses the
essentiality of the regulated intramembrane proteolysis protease RseP in Escherichia coli.
J. Biol. Chem., 281(18), 12253–12259.
Dsouza, M., Larsen, N. & Overbeek, R. (1997). Searching for patterns in genomic data. Trends Genet.,
13(12), 497–498.
Dunn, B. E., Vakil, N. B., Schneider, B. G., Miller, M. M., Zitzer, J. B., Peutz, T. & Phadnis, S. H. (1997).
Localization of Helicobacter pylori urease and heat shock protein in human gastric biopsies. Infect.
Immun., 65(4), 1181–1188.
Ebeling, S., Ku¨ndig, C. & Hennecke, H. (1991). Discovery of a rhizobial RNA that is essential for
symbiotic root nodule development. J. Bacteriol., 173(20), 6373–6382.
Elbashir, S. M., Lendeckel, W. & Tuschl, T. (2001). RNA interference is mediated by 21- and 22-nucleotide
RNAs. Genes Dev., 15(2), 188–200.
Ender, C., Krek, A., Friedla¨nder, M. R., Beitzinger, M., Weinmann, L., Chen, W., Pfeffer, S.,
Rajewsky, N. & Meister, G. (2008). A human snoRNA with microRNA-like functions. Mol. Cell,
32(4), 519–528.
Ermolaeva, M. D., Khalak, H. G., White, O., Smith, H. O. & Salzberg, S. L. (2000). Prediction of
transcription terminators in bacterial genomes. J. Mol. Biol., 301(1), 27–33.
Ernst, F. D., Stoof, J., Horrevoets, W. M., Kuipers, E. J., Kusters, J. G. & van Vliet, A. H. M. (2006). NikR
mediates nickel-responsive transcriptional repression of the Helicobacter pylori outer membrane
proteins FecA3 (HP1400) and FrpB4 (HP1512). Infect. Immun., 74(12), 6821–6828.
Even, S., Pellegrini, O., Zig, L., Labas, V., Vinh, J., Bre´chemmier-Baey, D. & Putzer, H. (2005).
Ribonucleases J1 and J2: two novel endoribonucleases in B. subtilis with functional homology to
E. coli RNase E. Nucleic Acids Res., 33(7), 2141–2152.
Fang, F. C., Libby, S. J., Buchmeier, N. A., Loewen, P. C., Switala, J., Harwood, J. & Guiney, D. G. (1992).
The alternative sigma factor katF (rpoS) regulates Salmonella virulence. Proc. Nat. Acad. Sci. U.S.A.,
89(24), 11978–11982.
Fantappie`, L., Metruccio, M. M. E., Seib, K. L., Oriente, F., Cartocci, E., Ferlicca, F., Giuliani, M. M.,
Scarlato, V. & Delany, I. (2009). The RNA chaperone Hfq is involved in the stress response and
virulence in Neisseria meningitidis and is a pleiotropic regulator of protein expression. Infect. Immun.
Figueroa-Bossi, N., Lemire, S., Maloriol, D., Balbontı´n, R., Casadesu´s, J. & Bossi, L. (2006). Loss of Hfq
activates the σE-dependent envelope stress response in Salmonella enterica. Mol. Microbiol., 62(3),
838–852.
Folichon, M., Allemand, F., Re´gnier, P. & Hajnsdorf, E. (2005). Stimulation of poly(A) synthesis by
Escherichia coli poly(A)polymerase I is correlated with Hfq binding to poly(A) tails. FEBS J., 272(2),
454–463.
Folichon, M., Arluison, V., Pellegrini, O., Huntzinger, E., Re´gnier, P. & Hajnsdorf, E. (2003). The poly(A)
binding protein Hfq protects RNA from RNase E and exoribonucleolytic degradation. Nucleic Acids
Res., 31(24), 7302–7310.
195
Forsyth, M. H., Cao, P., Garcia, P. P., Hall, J. D. & Cover, T. L. (2002). Genome-wide transcriptional
profiling in a histidine kinase mutant of Helicobacter pylori identifies members of a regulon.
J. Bacteriol., 184(16), 4630–4635.
Fortune, D. R., Suyemoto, M. & Altier, C. (2006). Identification of CsrC and characterization of its role in
epithelial cell invasion in Salmonella enterica serovar Typhimurium. Infect. Immun., 74(1), 331–339.
Fozo, E. M., Hemm, M. R. & Storz, G. (2008). Small toxic proteins and the antisense RNAs that repress
them. Microbiol. Mol. Biol. Rev., 72(4), 579–89.
Fozo, E. M., Kawano, M., Fontaine, F., Kaya, Y., Mendieta, K. S., Jones, K. L., Ocampo, A., Rudd, K. E. &
Storz, G. (2008). Repression of small toxic protein synthesis by the Sib and OhsC small RNAs. Mol.
Microbiol., 70(5), 1076–1093.
Franze de Fernandez, M. T., Eoyang, L. & August, J. T. (1968). Factor fraction required for the synthesis of
bacteriophage Qβ-RNA. Nature, 219(5154), 588–590.
Franze de Fernandez, M. T., Hayward, W. S. & August, J. T. (1972). Bacterial proteins required for
replication of phage Q ribonucleic acid. Pruification and properties of host factor I, a ribonucleic
acid-binding protein. J. Biol. Chem., 247(3), 824–831.
Frias-Lopez, J., Shi, Y., Tyson, G. W., Coleman, M. L., Schuster, S. C., Chisholm, S. W. & Delong, E. F.
(2008). Microbial community gene expression in ocean surface waters. Proc. Nat. Acad. Sci. U.S.A.,
105(10), 3805–3810.
Fujita, Y., Yamaguchi, K., Kamegaya, T., Sato, H., Semura, K., Mutoh, K., Kashimoto, T., Ohori, H. &
Mukai, T. (2005). A novel mechanism of autolysis in Helicobacter pylori: possible involvement of
peptidergic substances. Helicobacter, 10(6), 567–576.
Geisinger, E., Adhikari, R. P., Jin, R., Ross, H. F. & Novick, R. P. (2006). Inhibition of rot translation by
RNAIII, a key feature of agr function. Mol. Microbiol., 61(4), 1038–1048.
Geissmann, T. A. & Touati, D. (2004). Hfq, a new chaperoning role: binding to messenger RNA determines
access for small RNA regulator. EMBO J., 23(2), 396–405.
Gerdes, K., Gultyaev, A. P., Franch, T., Pedersen, K. & Mikkelsen, N. D. (1997). Antisense RNA-regulated
programmed cell death. Annu. Rev. Genet., 31, 1–31.
Gerdes, K., Thisted, T. & Martinussen, J. (1990). Mechanism of post-segregational killing by the hok/sok
system of plasmid R1: sok antisense RNA regulates formation of a hok mRNA species correlated with
killing of plasmid-free cells. Mol. Microbiol., 4(11), 1807–1818.
Gildehaus, N., Neusser, T., Wurm, R. & Wagner, R. (2007). Studies on the function of the riboregulator 6S
RNA from E. coli: RNA polymerase binding, inhibition of in vitro transcription and synthesis of
RNA-directed de novo transcripts. Nucleic Acids Res., 35(6), 1885–1896.
Girard, A., Sachidanandam, R., Hannon, G. J. & Carmell, M. A. (2006). A germline-specific class of small
RNAs binds mammalian Piwi proteins. Nature, 442(7099), 199–202.
Gottesman, S. (2004). The small RNA regulators of Escherichia coli: roles and mechanisms. Annu. Rev.
Microbiol., 58, 303–328.
Gressmann, H., Linz, B., Ghai, R., Pleissner, K., Schlapbach, R., Yamaoka, Y., Kraft, C., Suerbaum, S.,
Meyer, T. F. & Achtman, M. (2005). Gain and loss of multiple genes during the evolution of
Helicobacter pylori. PLoS Genet., 1(4), e43.
Griffin, B. (1971). Separation of 32P-labelled ribonucleic acid components. The use of
polyethylenimine-cellulose (TLC) as a second dimension in separating oligoribonucleotides of 4.5 S
and 5 S from E. coli. FEBS Lett., 15(3), 165–168.
Griffiths-Jones, S., Moxon, S., Marshall, M., Khanna, A., Eddy, S. R. & Bateman, A. (2005). Rfam:
annotating non-coding RNAs in complete genomes. Nucleic Acids Res., 33(Database issue),
D121–D124.
196 CHAPTER 9. References
Grimson, A., Farh, K. K., Johnston, W. K., Garrett-Engele, P., Lim, L. P. & Bartel, D. P. (2007). MicroRNA
targeting specificity in mammals: determinants beyond seed pairing. Mol. Cell, 27(1), 91–105.
Grundy, F. J. & Henkin, T. M. (2006). From ribosome to riboswitch: control of gene expression in bacteria
by RNA structural rearrangements. Crit. Rev. Biochem. Mol. Biol., 41(6), 329–338.
Guillier, M. & Gottesman, S. (2006). Remodelling of the Escherichia coli outer membrane by two small
regulatory RNAs. Mol. Microbiol., 59(1), 231–247.
Guillier, M. & Gottesman, S. (2008). The 5’ end of two redundant sRNAs is involved in the regulation of
multiple targets, including their own regulator. Nucleic Acids Res., 36(21), 6781–6794.
Guillier, M., Gottesman, S. & Storz, G. (2006). Modulating the outer membrane with small RNAs. Genes
Dev., 20(17), 2338–2348.
Guisbert, E., Rhodius, V. A., Ahuja, N., Witkin, E. & Gross, C. A. (2007). Hfq modulates the σE-mediated
envelope stress response and the σ32-mediated cytoplasmic stress response in Escherichia coli.
J. Bacteriol., 189(5), 1963–1973.
Guzman, L. M., Belin, D., Carson, M. J. & Beckwith, J. (1995). Tight regulation, modulation, and
high-level expression by vectors containing the arabinose PBAD promoter. J. Bacteriol., 177(14),
4121–4130.
Hajnsdorf, E., Braun, F., Haugel-Nielsen, J. & Re´gnier, P. (1995). Polyadenylylation destabilizes the rpsO
mRNA of Escherichia coli. Proc. Nat. Acad. Sci. U.S.A., 92(9), 3973–3977.
Hajnsdorf, E. & Re´gnier, P. (2000). Host factor Hfq of Escherichia coli stimulates elongation of poly(A)
tails by poly(A) polymerase I. Proc. Nat. Acad. Sci. U.S.A., 97(4), 1501–1505.
Halfmann, A., Kova´cs, M., Hakenbeck, R. & Bru¨ckner, R. (2007). Identification of the genes directly
controlled by the response regulator CiaR in Streptococcus pneumoniae: five out of 15 promoters drive
expression of small non-coding RNAs. Mol. Microbiol., 66(1), 110–126.
Haney, S. A., Platko, J. V., Oxender, D. L. & Calvo, J. M. (1992). Lrp, a leucine-responsive protein,
regulates branched-chain amino acid transport genes in Escherichia coli. J. Bacteriol., 174(1),
108–115.
Hartz, D., McPheeters, D. S., Traut, R. & Gold, L. (1988). Extension inhibition analysis of translation
initiation complexes. Methods Enzymol, 164, 419–425.
Heeb, S., Blumer, C. & Haas, D. (2002). Regulatory RNA as mediator in GacA/RsmA-dependent global
control of exoproduct formation in Pseudomonas fluorescens CHA0. J. Bacteriol., 184(4), 1046–1056.
Heidrich, N., Moll, I. & Brantl, S. (2007). In vitro analysis of the interaction between the small RNA SR1
and its primary target ahrC mRNA. Nucleic Acids Res., 35(13), 4331–4346.
Hemm, M. R., Paul, B. J., Schneider, T. D., Storz, G. & Rudd, K. E. (2008). Small membrane proteins found
by comparative genomics and ribosome binding site models. Mol. Microbiol., 70(6), 1487–1501.
Hershberg, R., Altuvia, S. & Margalit, H. (2003). A survey of small RNA-encoding genes in Escherichia
coli. Nucleic Acids Res., 31(7), 1813–1820.
Higgins, C. F. & Hardie, M. M. (1983). Periplasmic protein associated with the oligopeptide permeases of
Salmonella typhimurium and Escherichia coli. J. Bacteriol., 155(3), 1434–1438.
Hindley, J. (1967). Fractionation of 32P-labelled ribonucleic acids on polyacrylamide gels and their
characterization by fingerprinting. J. Mol. Biol., 30(1), 125–136.
Hoffmann, S., Otto, C., Kurtz, S., Sharma, C. M., Khaitovich, P., Vogel, J., Stadler, P. F. & Hackermu¨ller, J.
(2009). Fast mapping of short sequences with mismatches, insertions and deletions using index
structures. (submitted).
197
Hoiseth, S. K. & Stocker, B. A. (1981). Aromatic-dependent Salmonella typhimurium are non-virulent and
effective as live vaccines. Nature, 291(5812), 238–239.
Hosie, A. H. & Poole, P. S. (2001). Bacterial ABC transporters of amino acids. Res. Microbiol., 152(3-4),
259–270.
Hsu, L. M., Zagorski, J., Wang, Z. & Fournier, M. J. (1985). Escherichia coli 6S RNA gene is part of a
dual-function transcription unit. J. Bacteriol., 161(3), 1162–1170.
Hu¨ttenhofer, A. (2005). Experimental RNomics: A Global Approach to Identify Non-coding RNAs in
Model Organisms. In Handbook of RNA Biochemistry (Hartmann, R., Bindereif, A., Scho¨n, A. &
Westhof, E., eds), pp. 643–654.
Hu¨ttenhofer, A., Brosius, J. & Bachellerie, J. P. (2002). RNomics: identification and function of small,
non-messenger RNAs. Curr. Opin. Chem. Biol., 6(6), 835–843.
Hu¨ttenhofer, A., Kiefmann, M., Meier-Ewert, S., O’Brien, J., Lehrach, H., Bachellerie, J. P. & Brosius, J.
(2001). RNomics: an experimental approach that identifies 201 candidates for novel, small,
non-messenger RNAs in mouse. EMBO J., 20(11), 2943–2953.
Hu¨ttenhofer, A. & Noller, H. F. (1994). Footprinting mRNA-ribosome complexes with chemical probes.
EMBO J., 13(16), 3892–3901.
Hu¨ttenhofer, A. & Vogel, J. (2006). Experimental approaches to identify non-coding RNAs. Nucleic Acids
Res., 34(2), 635–646.
Hu, Z., Zhang, A., Storz, G., Gottesman, S. & Leppla, S. H. (2006). An antibody-based microarray assay
for small RNA detection. Nucleic Acids Res., 34(7), e52.
Huang, C., Wolfgang, M. C., Withey, J., Koomey, M. & Friedman, D. I. (2000). Charged tmRNA but not
tmRNA-mediated proteolysis is essential for Neisseria gonorrhoeae viability. EMBO J., 19(5),
1098–1107.
Hung, S., Baldi, P. & Hatfield, G. Wesley (2002). Global gene expression profiling in Escherichia coli K12.
The effects of leucine-responsive regulatory protein. J. Biol. Chem., 277(43), 40309–40323.
Huntzinger, E., Boisset, S., Saveanu, C., Benito, Y., Geissmann, T., Namane, A., Lina, G., Etienne, J.,
Ehresmann, B., Ehresmann, C., Jacquier, A., Vandenesch, F. & Romby, P. (2005). Staphylococcus
aureus RNA III and the endoribonuclease III coordinately regulate spa gene expression. EMBO J.,
24(4), 824–835.
Igarashi, K., Saisho, T., Yuguchi, M. & Kashiwagi, K. (1997). Molecular mechanism of polyamine
stimulation of the synthesis of oligopeptide-binding protein. J. Biol. Chem., 272(7), 4058–4064.
Ikemura, T. & Dahlberg, J. E. (1973). Small ribonucleic acids of Escherichia coli. I. Characterization by
polyacrylamide gel electrophoresis and fingerprint analysis. J. Biol. Chem., 248(14), 5024–5032.
Ikemura, T. & Dahlberg, J. E. (1973). Small ribonucleic acids of Escherichia coli. II. Noncoordinate
accumulation during stringent control. J. Biol. Chem., 248(14), 5033–5041.
Inada, M. & Guthrie, C. (2004). Identification of Lhp1p-associated RNAs by microarray analysis in
Saccharomyces cerevisiae reveals association with coding and noncoding RNAs.
Proc. Nat. Acad. Sci. U.S.A., 101(2), 434–439.
Janssen, S., Reeder, J. & Giegerich, R. (2008). Shape based indexing for faster search of RNA family
databases. BMC Bioinformatics, 9, 131.
Janzon, L., Lo¨fdahl, S. & Arvidson, S. (1989). Identification and nucleotide sequence of the delta-lysin
gene, hld, adjacent to the accessory gene regulator (agr) of Staphylococcus aureus. Mol. Gen. Genet.,
219(3), 480–485.
198 CHAPTER 9. References
Johansen, J., Eriksen, M., Kallipolitis, B. & Valentin-Hansen, P. (2008). Down-regulation of outer
membrane proteins by noncoding RNAs: unraveling the cAMP-CRP- and σE-dependent CyaR-ompX
regulatory case. J. Mol. Biol., 383(1), 1–9.
Johansen, J., Rasmussen, A. Aamann, Overgaard, M. & Valentin-Hansen, P. (2006). Conserved small
non-coding RNAs that belong to the σE regulon: role in down-regulation of outer membrane proteins.
J. Mol. Biol., 364(1), 1–8.
Johansson, J., Mandin, P., Renzoni, A., Chiaruttini, C., Springer, M. & Cossart, P. (2002). An RNA
thermosensor controls expression of virulence genes in Listeria monocytogenes. Cell, 110(5),
551–561.
Jones, A. C., Logan, R. P., Foynes, S., Cockayne, A., Wren, B. W. & Penn, C. W. (1997). A flagellar sheath
protein of Helicobacter pylori is identical to HpaA, a putative N-acetylneuraminyllactose-binding
hemagglutinin, but is not an adhesin for AGS cells. J. Bacteriol., 179(17), 5643–5647.
Julio, S. M., Heithoff, D. M. & Mahan, M. J. (2000). ssrA (tmRNA) plays a role in Salmonella enterica
serovar Typhimurium pathogenesis. J. Bacteriol., 182(6), 1558–1563.
Jungblut, P. R. & Seifert, R. (1990). Analysis by high-resolution two-dimensional electrophoresis of
differentiation-dependent alterations in cytosolic protein pattern of HL-60 leukemic cells. J. Biochem.
Biophys. Methods, 21(1), 47–58.
Kaberdina, A. C., Szaflarski, W., Nierhaus, K. H. & Moll, I. (2009). An unexpected type of ribosomes
induced by kasugamycin: a look into ancestral times of protein synthesis? Mol. Cell, 33(2), 227–236.
Kajitani, M., Kato, A., Wada, A., Inokuchi, Y. & Ishihama, A. (1994). Regulation of the Escherichia coli
hfq gene encoding the host factor for phage Qβ . J. Bacteriol., 176(2), 531–534.
Kalamorz, F., Reichenbach, B., Ma¨rz, W., Rak, B. & Go¨rke, B. (2007). Feedback control of
glucosamine-6-phosphate synthase GlmS expression depends on the small RNA GlmZ and involves
the novel protein YhbJ in Escherichia coli. Mol Microbiol, 65(6), 1518–1533.
Karzai, A. W., Susskind, M. M. & Sauer, R. T. (1999). SmpB, a unique RNA-binding protein essential for
the peptide-tagging activity of SsrA (tmRNA). EMBO J., 18(13), 3793–3799.
Kawamoto, H., Koide, Y., Morita, T. & Aiba, H. (2006). Base-pairing requirement for RNA silencing by a
bacterial small RNA and acceleration of duplex formation by Hfq. Mol. Microbiol., 61(4), 1013–1022.
Kawano, M., Aravind, L. & Storz, G. (2007). An antisense RNA controls synthesis of an SOS-induced
toxin evolved from an antitoxin. Mol. Microbiol., 64(3), 738–754.
Kawano, M., Reynolds, A. A., Miranda-Rios, J. & Storz, G. (2005). Detection of 5’- and 3’-UTR-derived
small RNAs and cis-encoded antisense RNAs in Escherichia coli. Nucleic Acids Res., 33(3),
1040–1050.
Kawano, M., Storz, G., Rao, B. S., Rosner, J. L. & Martin, R. G. (2005). Detection of low-level promoter
activity within open reading frame sequences of Escherichia coli. Nucleic Acids Res., 33(19),
6268–6276.
Kelly, A., Goldberg, M. D., Carroll, R. K., Danino, V., Hinton, J. C. D. & Dorman, C. J. (2004). A global
role for Fis in the transcriptional control of metabolism and type III secretion in Salmonella enterica
serovar Typhimurium. Microbiology, 150(Pt 7), 2037–2053.
Kim, K. & Lee, Y. (2004). Regulation of 6S RNA biogenesis by switching utilization of both sigma factors
and endoribonucleases. Nucleic Acids Res., 32(20), 6057–6068.
Kingsford, C. L., Ayanbule, K. & L.Salzberg, S. (2007). Rapid, accurate, computational discovery of
Rho-independent transcription terminators illuminates their relationship to DNA uptake. Genome Biol,
8(2), R22.
199
Klose, J. & Kobalz, U. (1995). Two-dimensional electrophoresis of proteins: an updated protocol and
implications for a functional analysis of the genome. Electrophoresis, 16(6), 1034–1059.
Komarova, A. V., Tchufistova, L. S., Dreyfus, M. & Boni, I. V. (2005). AU-rich sequences within 5’
untranslated leaders enhance translation and stabilize mRNA in Escherichia coli. J. Bacteriol., 187(4),
1344–1349.
Krek, A., Gru¨n, D., Poy, M. N., Wolf, R., Rosenberg, L., Epstein, E. J., MacMenamin, P., da Piedade, I.,
Gunsalus, K. C., Stoffel, M. & Rajewsky, N. (2005). Combinatorial microRNA target predictions.
Nat. Genet., 37(5), 495–500.
Lagos-Quintana, M., Rauhut, R., Lendeckel, W. & Tuschl, T. (2001). Identification of novel genes coding
for small expressed RNAs. Science, 294(5543), 853–858.
Landt, S. G., Abeliuk, E., McGrath, P. T., Lesley, J. A., McAdams, H. H. & Shapiro, L. (2008). Small
non-coding RNAs in Caulobacter crescentus. Mol. Microbiol., 68(3), 600–614.
Lau, N. C., Lim, L. P., Weinstein, E. G. & Bartel, D. P. (2001). An abundant class of tiny RNAs with
probable regulatory roles in Caenorhabditis elegans. Science, 294(5543), 858–862.
Lease, R. A. & Belfort, M. (2000). A trans-acting RNA as a control switch in Escherichia coli: DsrA
modulates function by forming alternative structures. Proc. Nat. Acad. Sci. U.S.A., 97(18), 9919–9924.
Lease, R. A., Cusick, M. E. & Belfort, M. (1998). Riboregulation in Escherichia coli: DsrA RNA acts by
RNA:RNA interactions at multiple loci. Proc. Nat. Acad. Sci. U.S.A., 95(21), 12456–12461.
Lease, R. A., Smith, D., McDonough, K. & Belfort, M. (2004). The small noncoding DsrA RNA is an acid
resistance regulator in Escherichia coli. J. Bacteriol., 186(18), 6179–6185.
Lease, R. A. & Woodson, S. A. (2004). Cycling of the Sm-like protein Hfq on the DsrA small regulatory
RNA. J. Mol. Biol., 344(5), 1211–1223.
Lee, C. A. & Falkow, S. (1990). The ability of Salmonella to enter mammalian cells is affected by bacterial
growth state. Proc. Nat. Acad. Sci. U.S.A., 87(11), 4304–4308.
Lee, R. C. & Ambros, V. (2001). An extensive class of small RNAs in Caenorhabditis elegans. Science,
294(5543), 862–864.
Lee, T. & Feig, A. L. (2008). The RNA binding protein Hfq interacts specifically with tRNAs. RNA, 14(3),
514–523.
Lee, W. K., An, Y. S., Kim, K. H., Kim, S. H., Song, J. Y., Ryu, B. D., Choi, Y. J., Yoon, Y. H., Baik, S. C.,
Rhee, K. H. & Cho, M. J. (1997). Construction of a Helicobacter pylori-Escherichia coli shuttle
vector for gene transfer in Helicobacter pylori. Appl. Environ. Microbiol., 63(12), 4866–4871.
Lenz, D. H., Miller, M. B., Zhu, J., Kulkarni, R. V. & Bassler, B. L. (2005). CsrA and three redundant small
RNAs regulate quorum sensing in Vibrio cholerae. Mol. Microbiol., 58(4), 1186–1202.
Lenz, D. H., Mok, K. C., Lilley, B. N., Kulkarni, R. V., Wingreen, N. S. & Bassler, B. L. (2004). The small
RNA chaperone Hfq and multiple small RNAs control quorum sensing in Vibrio harveyi and Vibrio
cholerae. Cell, 118(1), 69–82.
Lesnik, E. A., Sampath, R., Levene, H. B., Henderson, T. J., McNeil, J. A. & Ecker, D. J. (2001). Prediction
of rho-independent transcriptional terminators in Escherichia coli. Nucleic Acids Res., 29(17),
3583–3594.
Leying, H., Suerbaum, S., Geis, G. & Haas, R. (1992). Cloning and genetic characterization of a
Helicobacter pylori flagellin gene. Mol. Microbiol., 6(19), 2863–2874.
Lister, R., O’Malley, R. C., Tonti-Filippini, J., Gregory, B. D., Berry, C. C., Millar, A. H. & Ecker, J. R.
(2008). Highly integrated single-base resolution maps of the epigenome in Arabidopsis. Cell, 133(3),
523–536.
200 CHAPTER 9. References
Liu, J. M., Livny, J., Lawrence, M. S., Kimball, M. D., Waldor, M. K. & Camilli, A. (2009). Experimental
discovery of sRNAs in Vibrio cholerae by direct cloning, 5S/tRNA depletion and parallel sequencing.
Nucleic Acids Res., 10.1093, 1–10.
Liu, M. Y., Gui, G., Wei, B., Preston, J. F., Oakford, L., Yu¨ksel, U., Giedroc, D. P. & Romeo, T. (1997). The
RNA molecule CsrB binds to the global regulatory protein CsrA and antagonizes its activity in
Escherichia coli. J. Biol. Chem., 272(28), 17502–17510.
Liu, Y., Cui, Y., Mukherjee, A. & Chatterjee, A. K. (1998). Characterization of a novel RNA regulator of
Erwinia carotovora ssp. carotovora that controls production of extracellular enzymes and secondary
metabolites. Mol. Microbiol., 29(1), 219–234.
Livny, J., Brencic, A., Lory, S. & Waldor, M. K. (2006). Identification of 17 Pseudomonas aeruginosa
sRNAs and prediction of sRNA-encoding genes in 10 diverse pathogens using the bioinformatic tool
sRNAPredict2. Nucleic Acids Res., 34(12), 3484–3493.
Livny, J., Fogel, M. A., Davis, B. M. & Waldor, M. K. (2005). sRNAPredict: an integrative computational
approach to identify sRNAs in bacterial genomes. Nucleic Acids Res., 33(13), 4096–4105.
Livny, J., Teonadi, H., Livny, M. & Waldor, M. K. (2008). High-throughput, kingdom-wide prediction and
annotation of bacterial non-coding RNAs. PLoS ONE, 3(9), e3197.
Livny, J. & Waldor, M. K. (2007). Identification of small RNAs in diverse bacterial species. Curr. Opin.
Microbiol., 10(2), 96–101.
Lorenz, C., von Pelchrzim, F. & Schroeder, R. (2006). Genomic systematic evolution of ligands by
exponential enrichment (Genomic SELEX) for the identification of protein-binding RNAs
independent of their expression levels. Nat. Protoc., 1(5), 2204–2212.
Lu, C., Tej, S. S., Luo, S., Haudenschild, C. D., Meyers, B. C. & Green, P. J. (2005). Elucidation of the
small RNA component of the transcriptome. Science, 309(5740), 1567–1569.
Lutz, R. & Bujard, H. (1997). Independent and tight regulation of transcriptional units in Escherichia coli
via the LacR/O, the TetR/O and AraC/I1-I2 regulatory elements. Nucleic Acids Res., 25(6),
1203–1210.
Lynn, S. P., Gardner, J. F. & Reznikoff, W. S. (1982). Attenuation regulation in the thr operon of
Escherichia coli K-12: molecular cloning and transcription of the controlling region. J. Bacteriol.,
152(1), 363–371.
Ma, W., Cui, Y., Liu, Y., Dumenyo, C. K., Mukherjee, A. & Chatterjee, A. K. (2001). Molecular
characterization of global regulatory RNA species that control pathogenicity factors in Erwinia
amylovora and Erwinia herbicola pv. gypsophilae. J. Bacteriol., 183(6), 1870–1880.
Macke, T. J., Ecker, D. J., Gutell, R. R., Gautheret, D., Case, D. A. & Sampath, R. (2001). RNAMotif, an
RNA secondary structure definition and search algorithm. Nucleic Acids Res., 29(22), 4724–4735.
Majdalani, N., Chen, S., Murrow, J., John, K. St & Gottesman, S. (2001). Regulation of RpoS by a novel
small RNA: the characterization of RprA. Mol. Microbiol., 39(5), 1382–1394.
Majdalani, N., Cunning, C., Sledjeski, D., Elliott, T. & Gottesman, S. (1998). DsrA RNA regulates
translation of RpoS message by an anti-antisense mechanism, independent of its action as an
antisilencer of transcription. Proc. Nat. Acad. Sci. U.S.A., 95(21), 12462–12467.
Majdalani, N., Hernandez, D. & Gottesman, S. (2002). Regulation and mode of action of the second small
RNA activator of RpoS translation, RprA. Mol. Microbiol., 46(3), 813–826.
Majdalani, N., Vanderpool, C. K. & Gottesman, S. (2005). Bacterial small RNA regulators. Crit. Rev.
Biochem. Mol. Biol., 40(2), 93–113.
Maki, K., Uno, K., Morita, T. & Aiba, H. (2008). RNA, but not protein partners, is directly responsible for
translational silencing by a bacterial Hfq-binding small RNA. Proc. Nat. Acad. Sci. U.S.A., 105(30),
10332–10337.
201
Mandal, M. & Breaker, R. R. (2004). Gene regulation by riboswitches. Nat. Rev. Mol. Cell Biol., 5(6),
451–463.
Mandin, P., Repoila, F., Vergassola, M., Geissmann, T. & Cossart, P. (2007). Identification of new
noncoding RNAs in Listeria monocytogenes and prediction of mRNA targets. Nucleic Acids Res.,
35(3), 962–974.
Mao, C., Evans, C., Jensen, R. V. & Sobral, B. W. (2008). Identification of new genes in Sinorhizobium
meliloti using the Genome Sequencer FLX system. BMC Microbiol., 8, 72.
Marcus, E. A. & Scott, D. R. (2001). Cell lysis is responsible for the appearance of extracellular urease in
Helicobacter pylori. Helicobacter, 6(2), 93–99.
Margulies, M., Egholm, M., Altman, W. E., Attiya, S., Bader, J. S., Bemben, L. A., Berka, J.,
Braverman, M. S., Chen, Y., Chen, Z., Dewell, S. B., Du, L., Fierro, J. M., Gomes, X. V.,
Godwin, B. C., He, W., Helgesen, S., Ho, C. H., Ho, C. H., Irzyk, G. P., Jando, S. C., Alenquer, M.
L. I., Jarvie, T. P., Jirage, K. B., Kim, J., Knight, J. R., Lanza, J. R., Leamon, J. H., Lefkowitz, S. M.,
Lei, M., Li, J., Lohman, K. L., Lu, H., Makhijani, V. B., McDade, K. E., McKenna, M. P.,
Myers, E. W., Nickerson, E., Nobile, J. R., Plant, R., Puc, B. P., Ronan, M. T., Roth, G. T.,
Sarkis, G. J., Simons, J. F., Simpson, J. W., Srinivasan, M., Tartaro, K. R., Tomasz, A., Vogt, K. A.,
Volkmer, G. A., Wang, S. H., Wang, Y., Weiner, M. P., Yu, P., Begley, R. F. & Rothberg, J. M. (2005).
Genome sequencing in microfabricated high-density picolitre reactors. Nature, 437(7057), 376–380.
Mariner, P. D., Walters, R. D., Espinoza, C. A., Drullinger, L. F., Wagner, S. D., Kugel, J. F. &
Goodrich, J. A. (2008). Human Alu RNA is a modular transacting repressor of mRNA transcription
during heat shock. Mol. Cell, 29(4), 499–509.
Marker, C., Zemann, A., Terho¨rst, T., Kiefmann, M., Kastenmayer, J. P., Green, P., Bachellerie, J. P.,
Brosius, J. & Hu¨ttenhofer, A. (2002). Experimental RNomics: identification of 140 candidates for
small non-messenger RNAs in the plant Arabidopsis thaliana. Curr. Biol., 12(23), 2002–2013.
Martin-Farmer, J. & Janssen, G. R. (1999). A downstream CA repeat sequence increases translation from
leadered and unleadered mRNA in Escherichia coli. Mol. Microbiol., 31(4), 1025–1038.
Maruyama, K., Sato, N. & Ohta, N. (1999). Conservation of structure and cold-regulation of RNA-binding
proteins in cyanobacteria: probable convergent evolution with eukaryotic glycine-rich RNA-binding
proteins. Nucleic Acids Res., 27(9), 2029–2036.
Masse´, E., Escorcia, F. E. & Gottesman, S. (2003). Coupled degradation of a small regulatory RNA and its
mRNA targets in Escherichia coli. Genes Dev., 17(19), 2374–2383.
Masse´, E. & Gottesman, S. (2002). A small RNA regulates the expression of genes involved in iron
metabolism in Escherichia coli. Proc. Nat. Acad. Sci. U.S.A., 99(7), 4620–4625.
Masse´, E., Vanderpool, C. K. & Gottesman, S. (2005). Effect of RyhB small RNA on global iron use in
Escherichia coli. J. Bacteriol., 187(20), 6962–6971.
Mathews, D. H., Disney, M. D., Childs, J. L., Schroeder, S. J., Zuker, M. & Turner, D. H. (2004).
Incorporating chemical modification constraints into a dynamic programming algorithm for prediction
of RNA secondary structure. Proc. Nat. Acad. Sci. U.S.A., 101(19), 7287–7292.
Mattatall, N. R. & Sanderson, K. E. (1996). Salmonella typhimurium LT2 possesses three distinct 23S
rRNA intervening sequences. J. Bacteriol., 178(8), 2272–2278.
Datsenko, K. A. & Wanner, B. L. (2000). One-step inactivation of chromosomal genes in Escherichia coli
K-12 using PCR products. Proc. Nat. Acad. Sci. U.S.A., 97(12), 6640–6645.
Wassarman, K. M., Repoila, F., Rosenow, C., Storz, G. & Gottesman, S. (2001). Identification of novel
small RNAs using comparative genomics and microarrays. Genes Dev., 15(13), 1637–1651.
McArthur, S. D., Pulvermacher, S. C. & Stauffer, G. V. (2006). The Yersinia pestis gcvB gene encodes two
small regulatory RNA molecules. BMC Microbiol., 6, 52.
202 CHAPTER 9. References
McClelland, M., Sanderson, K. E., Spieth, J., Clifton, S. W., Latreille, P., Courtney, L., Porwollik, S., Ali, J.,
Dante, M., Du, F., Hou, S., Layman, D., Leonard, S., Nguyen, C., Scott, K., Holmes, A., Grewal, N.,
Mulvaney, E., Ryan, E., Sun, H., Florea, L., Miller, W., Stoneking, T., Nhan, M., Waterston, R. &
Wilson, R. K. (2001). Complete genome sequence of Salmonella enterica serovar Typhimurium LT2.
Nature, 413(6858), 852–856.
McGowan, C. C., Necheva, A. S., Forsyth, M. H., Cover, T. L. & Blaser, M. J. (2003). Promoter analysis of
Helicobacter pylori genes with enhanced expression at low pH. Mol. Microbiol., 48(5), 1225–1239.
Mu¨ckstein, U., Tafer, H., Hackermu¨ller, J., Bernhart, S. H., Stadler, P. F. & Hofacker, I. L (2006).
Thermodynamics of RNA-RNA binding. Bioinformatics, 22(10), 1177–1182.
Meibom, K. L., Forslund, A., Kuoppa, K., Alkhuder, K., Dubail, I., Dupuis, M., Forsberg, A. & Charbit, A.
(2009). Hfq, a novel pleiotropic regulator of virulence-associated genes in Francisella tularensis.
Infect. Immun.
Mika, F., Sharma, C. M., Bouvier, M., Papenfort, K. & Vogel, J. (2009). Small RNA binding to 5’ mRNA
coding region inhibits translational initiation. (Submitted).
Mikulecky, P. J., Kaw, M. K., Brescia, C. C., Takach, J. C., Sledjeski, D. D. & Feig, A. L. (2004).
Escherichia coli Hfq has distinct interaction surfaces for DsrA, rpoS and poly(A) RNAs. Nat. Struct.
Mol. Biol., 11(12), 1206–1214.
Mironov, A. S., Gusarov, I., Rafikov, R., Lopez, L. Errais, Shatalin, K., Kreneva, R. A., Perumov, D. A. &
Nudler, E. (2002). Sensing small molecules by nascent RNA: a mechanism to control transcription in
bacteria. Cell, 111(5), 747–756.
Mitarai, N., Andersson, A. M. C., Krishna, S., Semsey, S. & Sneppen, K. (2007). Efficient degradation and
expression prioritization with small RNAs. Phys. Biol., 4(3), 164–171.
Mizuno, T., Chou, M. Y. & Inouye, M. (1984). A unique mechanism regulating gene expression:
translational inhibition by a complementary RNA transcript (micRNA). Proc. Nat. Acad. Sci. U.S.A.,
81(7), 1966–1970.
Mu¨ller, S., Fo¨rster, J. & Beier, D. (2006). Repeated sequence motifs in the Helicobacter pylori P1408
promoter do not affect its transcription. Microbiol. Res., 161(3), 212–221.
Møller, T., Franch, T., P.Højrup, Keene, D. R., Ba¨chinger, H. P., Brennan, R. G. & Valentin-Hansen, P.
(2002). Hfq: a bacterial Sm-like protein that mediates RNA-RNA interaction. Mol. Cell, 9(1), 23–30.
Mohanty, B. K., Maples, V. F. & Kushner, S. R. (2004). The Sm-like protein Hfq regulates polyadenylation
dependent mRNA decay in Escherichia coli. Mol. Microbiol., 54(4), 905–920.
Moll, I., Grill, S., Gualerzi, C. O. & Bla¨si, U. (2002). Leaderless mRNAs in bacteria: surprises in ribosomal
recruitment and translational control. Mol. Microbiol., 43(1), 239–246.
Moll, I., Hirokawa, G., Kiel, M. C., Kaji, A. & Bla¨si, U. (2004). Translation initiation with 70S ribosomes:
an alternative pathway for leaderless mRNAs. Nucleic Acids Res., 32(11), 3354–3363.
Moll, I., Leitsch, D., Steinhauser, T. & Bla¨si, U. (2003). RNA chaperone activity of the Sm-like Hfq
protein. EMBO Rep., 4(3), 284–289.
Møller, T., Franch, T., Udesen, C., Gerdes, K. & Valentin-Hansen, P. (2002). Spot 42 RNA mediates
discoordinate expression of the E. coli galactose operon. Genes Dev., 16(13), 1696–1706.
Molna´r, A., Schwach, F., Studholme, D. J., Thuenemann, E. C. & Baulcombe, D. C. (2007). miRNAs
control gene expression in the single-cell alga Chlamydomonas reinhardtii. Nature, 447(7148),
1126–1129.
Morita, T., Maki, K. & Aiba, H. (2005). RNase E-based ribonucleoprotein complexes: mechanical basis of
mRNA destabilization mediated by bacterial noncoding RNAs. Genes Dev., 19(18), 2176–2186.
203
Morita, T., Mochizuki, Y. & Aiba, H. (2006). Translational repression is sufficient for gene silencing by
bacterial small noncoding RNAs in the absence of mRNA destruction. Proc. Nat. Acad. Sci. U.S.A.,
103(13), 4858–4863.
Mortazavi, A., Williams, B. A., McCue, K., Schaeffer, L. & Wold, B. (2008). Mapping and quantifying
mammalian transcriptomes by RNA-Seq. Nat. Methods, 5(7), 621–628.
Muffler, A., Fischer, D. & Hengge-Aronis, R. (1996). The RNA-binding protein HF-I, known as a host
factor for phage Qβ RNA replication, is essential for rpoS translation in Escherichia coli. Genes Dev.,
10(9), 1143–1151.
Murakawa, G. J. & Nierlich, D. P. (1989). Mapping the lacZ ribosome binding site by RNA footprinting.
Biochemistry, 28(20), 8067–8072.
Nagalakshmi, U., Wang, Z., Waern, K., Shou, C., Raha, D., Gerstein, M. & Snyder, M. (2008). The
transcriptional landscape of the yeast genome defined by RNA sequencing. Science, 320(5881),
1344–1349.
Nakao, H., Watanabe, H., Nakayama, S. & Takeda, T. (1995). yst gene expression in Yersinia enterocolitica
is positively regulated by a chromosomal region that is highly homologous to Escherichia coli host
factor 1 gene (hfq). Mol. Microbiol., 18(5), 859–865.
Neu, H. C. & Heppel, L. A. (1965). The release of enzymes from Escherichia coli by osmotic shock and
during the formation of spheroplasts. J. Biol. Chem., 240(9), 3685–3692.
Nicholson, A. W. (1999). Function, mechanism and regulation of bacterial ribonucleases. FEMS Microbiol.
Rev., 23(3), 371–390.
Nielsen, J. S., Bøggild, A., Andersen, C. B. F., Nielsen, G., Boysen, A., Brodersen, D. E. &
Valentin-Hansen, P. (2007). An Hfq-like protein in archaea: crystal structure and functional
characterization of the Sm protein from Methanococcus jannaschii. RNA, 13(12), 2213–2223.
Nikulin, A., Stolboushkina, E., Perederina, A., Vassilieva, I., Blaesi, U., Moll, I., Kachalova, G.,
Yokoyama, S., Vassylyev, D., Garber, M. & Nikonov, S. (2005). Structure of Pseudomonas aeruginosa
Hfq protein. Acta Crystallogr. D. Biol. Crystallogr., 61(Pt 2), 141–146.
Novick, R. P., Ross, H. F., Projan, S. J., Kornblum, J., Kreiswirth, B. & Moghazeh, S. (1993). Synthesis of
staphylococcal virulence factors is controlled by a regulatory RNA molecule. EMBO J., 12(10),
3967–3975.
Ochsner, U. A., .Wilderman, P. J, Vasil, A. I. & Vasil, M. L. (2002). GeneChip expression analysis of the
iron starvation response in Pseudomonas aeruginosa: identification of novel pyoverdine biosynthesis
genes. Mol. Microbiol., 45(5), 1277–1287.
Odenbreit, S., Till, M., Hofreuter, D., Faller, G. & Haas, R. (1999). Genetic and functional characterization
of the alpAB gene locus essential for the adhesion of Helicobacter pylori to human gastric tissue. Mol.
Microbiol., 31(5), 1537–1548.
Oh, J. D., Kling-Ba¨ckhed, H., Giannakis, M., Xu, J., Fulton, R. S., Fulton, L. A., Cordum, H. S., Wang, C.,
Elliott, G., Edwards, J., Mardis, E. R., Engstrand, L. G. & Gordon, J. I. (2006). The complete genome
sequence of a chronic atrophic gastritis Helicobacter pylori strain: evolution during disease
progression. Proc. Nat. Acad. Sci. U.S.A., 103(26), 9999–10004.
O’Hara, E. B., Chekanova, J. A., Ingle, C. A., Kushner, Z. R., Peters, E. & Kushner, S. R. (1995).
Polyadenylylation helps regulate mRNA decay in Escherichia coli. Proc. Nat. Acad. Sci. U.S.A.,
92(6), 1807–1811.
Ohnishi, K., Hasegawa, A., Matsubara, K., Date, T., Okada, T. & Kiritani, K. (1988). Cloning and
nucleotide sequence of the brnQ gene, the structural gene for a membrane-associated component of
the LIV-II transport system for branched-chain amino acids in Salmonella typhimurium. Jpn. J. Genet.,
63(4), 343–357.
204 CHAPTER 9. References
Opdyke, J. A., Kang, J. & Storz, G. (2004). GadY, a small-RNA regulator of acid response genes in
Escherichia coli. J. Bacteriol., 186(20), 6698–6705.
Ow, M. C., Perwez, T. & Kushner, S. R. (2003). RNase G of Escherichia coli exhibits only limited
functional overlap with its essential homologue, RNase E. Mol. Microbiol., 49(3), 607–622.
Padalon-Brauch, G., Hershberg, R., Elgrably-Weiss, M., Baruch, K., Rosenshine, I., Margalit, H. &
Altuvia, S. (2008). Small RNAs encoded within genetic islands of Salmonella typhimurium show
host-induced expression and role in virulence. Nucleic Acids Res., 36(6), 1913–1927.
Papenfort, K., Pfeiffer, V., F.Mika, S.Lucchini, Hinton, J. C D & Vogel, J. (2006). σE-dependent small
RNAs of Salmonella respond to membrane stress by accelerating global omp mRNA decay. Mol.
Microbiol., 62(6), 1674–1688.
Papenfort, K., Pfeiffer, V., Lucchini, S., Sonawane, A., Hinton, J. C. D. & Vogel, J. (2008). Systematic
deletion of Salmonella small RNA genes identifies CyaR, a conserved CRP-dependent riboregulator of
OmpX synthesis. Mol. Microbiol., 68(4), 890–906.
Papenfort, K. & Vogel, J. (2009). Multiple target regulation by small noncoding RNAs rewires gene
expression at the post-transcriptional level. Res. Microbiol., in press.
Pesci, E. C. & Pickett, C. L. (1994). Genetic organization and enzymatic activity of a superoxide dismutase
from the microaerophilic human pathogen, Helicobacter pylori. Gene, 143(1), 111–116.
Petersen, L., Larsen, T. S., Ussery, D. W., On, S. L. W. & Krogh, A. (2003). RpoD promoters in
Campylobacter jejuni exhibit a strong periodic signal instead of a -35 box. J. Mol. Biol., 326(5),
1361–1372.
Pfeiffer, V., Sittka, A., Tomer, R., Tedin, K., Brinkmann, V. & Vogel, J. (2007). A small non-coding RNA of
the invasion gene island (SPI-1) represses outer membrane protein synthesis from the Salmonella core
genome. Mol. Microbiol., 66(5), 1174–1191.
Pflock, M., Bathon, M., Scha¨r, J., Mu¨ller, S., Mollenkopf, H., Meyer, T. F. & Beier, D. (2007). The orphan
response regulator HP1021 of Helicobacter pylori regulates transcription of a gene cluster presumably
involved in acetone metabolism. J. Bacteriol., 189(6), 2339–2349.
Pflock, M., Dietz, P., Scha¨r, J. & Beier, D. (2004). Genetic evidence for histidine kinase HP165 being an
acid sensor of Helicobacter pylori. FEMS Microbiol. Lett., 234(1), 51–61.
Pflock, M., Finsterer, N., Joseph, B., Mollenkopf, H., Meyer, T. F. & Beier, D. (2006). Characterization of
the ArsRS regulon of Helicobacter pylori, involved in acid adaptation. J. Bacteriol., 188(10),
3449–3462.
Pflock, M., Kennard, S., Delany, I., Scarlato, V. & Beier, D. (2005). Acid-induced activation of the urease
promoters is mediated directly by the ArsRS two-component system of Helicobacter pylori. Infect.
Immun., 73(10), 6437–6445.
Phadnis, S. H., Parlow, M. H., Levy, M., Ilver, D., Caulkins, C. M., Connors, J. B. & Dunn, B. E. (1996).
Surface localization of Helicobacter pylori urease and a heat shock protein homolog requires bacterial
autolysis. Infect. Immun., 64(3), 905–912.
Pichon, C. & Felden, B. (2003). Intergenic sequence inspector: searching and identifying bacterial RNAs.
Bioinformatics, 19(13), 1707–1709.
Pichon, C. & Felden, B. (2005). Small RNA genes expressed from Staphylococcus aureus genomic and
pathogenicity islands with specific expression among pathogenic strains. Proc. Nat. Acad. Sci. U.S.A.,
102(40), 14249–14254.
Pichon, C. & Felden, B. (2007). Proteins that interact with bacterial small RNA regulators. FEMS
Microbiol. Rev., 31(5), 614–625.
205
Pichon, C. & Felden, B. (2008). Small RNA gene identification and mRNA target predictions in bacteria.
Bioinformatics, 24(24), 2807–2813.
Platt, T. & Yanofsky, C. (1975). An intercistronic region and ribosome-binding site in bacterial messenger
RNA. Proc. Nat. Acad. Sci. U.S.A., 72(6), 2399–2403.
Pa´nek, J., Bobek, J., Mikulı´k, K., Basler, M. & Vohradsky´, J. (2008). Biocomputational prediction of small
non-coding RNAs in Streptomyces. BMC Genomics, 9, 217.
Porwollik, S. & McClelland, M. (2003). Lateral gene transfer in Salmonella. Microbes Infect., 5(11),
977–989.
Porwollik, S., Noonan, B. & O’Toole, P. W. (1999). Molecular characterization of a flagellar export locus of
Helicobacter pylori. Infect. Immun., 67(5), 2060–2070.
Pre´vost, K., Salvail, H., Desnoyers, G., Jacques, J., Phaneuf, E. & Masse´, E. (2007). The small RNA RyhB
activates the translation of shiA mRNA encoding a permease of shikimate, a compound involved in
siderophore synthesis. Mol. Microbiol., 64(5), 1260–1273.
Pulvermacher, S. C., Stauffer, L. T. & Stauffer, G. V. (2009). Role of the sRNA GcvB in regulation of cycA
in Escherichia coli. Microbiology, 155(Pt 1), 106–114.
Pulvermacher, S. C., Stauffer, L. T. & Stauffer, G. V. (2009). The small RNA GcvB regulates sstT mRNA
expression in Escherichia coli. J. Bacteriol., 191(1), 238–248.
Rajewsky, N. (2006). microRNA target predictions in animals. Nat. Genet., 38 Suppl, S8–13.
Rajkowitsch, L. & Schroeder, R. (2007). Dissecting RNA chaperone activity. RNA, 13(12), 2053–2060.
Rasmussen, A. A., Eriksen, M., Gilany, K., Udesen, C., Franch, T., Petersen, C. & Valentin-Hansen, P.
(2005). Regulation of ompA mRNA stability: the role of a small regulatory RNA in growth
phase-dependent control. Mol. Microbiol., 58(5), 1421–1429.
Reeder, J. & Giegerich, R. (2005). Consensus shapes: an alternative to the Sankoff algorithm for RNA
consensus structure prediction. Bioinformatics, 21(17), 3516–3523.
Regalia, M., Rosenblad, M. A. & Samuelsson, T. (2002). Prediction of signal recognition particle RNA
genes. Nucleic Acids Res., 30(15), 3368–3377.
Rehmsmeier, M., Steffen, P., Hochsmann, M. & Giegerich, R. (2004). Fast and effective prediction of
microRNA/target duplexes. RNA, 10(10), 1507–1517.
Reichenbach, B., Maes, A., Kalamorz, F., Hajnsdorf, E. & Go¨rke, B. (2008). The small RNA GlmY acts
upstream of the sRNA GlmZ in the activation of glmS expression and is subject to regulation by
polyadenylation in Escherichia coli. Nucleic Acids Res., 36(8), 2570–2580.
Repoila, F. & Gottesman, S. (2001). Signal transduction cascade for regulation of RpoS: temperature
regulation of DsrA. J. Bacteriol., 183(13), 4012–4023.
Re´gnier, P. & Arraiano, C. M. (2000). Degradation of mRNA in bacteria: emergence of ubiquitous features.
Bioessays, 22(3), 235–244.
Re´gnier, P. & Grunberg-Manago, M. (1990). RNase III cleavages in non-coding leaders of Escherichia coli
transcripts control mRNA stability and genetic expression. Biochimie, 72(11), 825–834.
Rijk, Peter De, Wuyts, Jan & Wachter, Rupert De (2003). RnaViz 2: an improved representation of RNA
secondary structure. Bioinformatics, 19(2), 299–300.
Rivas, E. & Eddy, S. R. (2001). Noncoding RNA gene detection using comparative sequence analysis. BMC
Bioinformatics, 2, 8.
Rivas, E., Klein, R. J., Jones, T. A. & Eddy, S. R. (2001). Computational identification of noncoding RNAs
in E. coli by comparative genomics. Curr. Biol., 11(17), 1369–1373.
206 CHAPTER 9. References
Robbins, J. C. & Oxender, D. L. (1973). Transport systems for alanine, serine, and glycine in Escherichia
coli K-12. J. Bacteriol., 116(1), 12–18.
Robertson, G. T. & Roop, R. M. (1999). The Brucella abortus host factor I (HF-I) protein contributes to
stress resistance during stationary phase and is a major determinant of virulence in mice. Mol.
Microbiol., 34(4), 690–700.
Romeo, T. (1998). Global regulation by the small RNA-binding protein CsrA and the non-coding RNA
molecule CsrB. Mol. Microbiol., 29(6), 1321–1330.
Ruby, J. G., Jan, C., Player, C., Axtell, M. J., Lee, W., Nusbaum, C., Ge, H. & Bartel, D. P. (2006).
Large-scale sequencing reveals 21U-RNAs and additional microRNAs and endogenous siRNAs in
C. elegans. Cell, 127(6), 1193–1207.
Russell, R. R. (1972). Mapping of a D-cycloserine resistance locus in Escherichia coli K-12. J. Bacteriol.,
111(2), 622–624.
Saetrom, P., Sneve, R., Kristiansen, K. I., Snøve, O., Gru¨nfeld, T., Rognes, T. & Seeberg, E. (2005).
Predicting non-coding RNA genes in Escherichia coli with boosted genetic programming. Nucleic
Acids Res., 33(10), 3263–3270.
Said, N., Rieder, R., Hurwitz, R., Deckert, J., Urlaub, H. & Vogel, J. (2009). In vivo expression and
purification of aptamer-tagged small RNA regulators. (Submitted).
Salzberg, S. L., Delcher, A. L., Kasif, S. & White, O. (1998). Microbial gene identification using
interpolated Markov models. Nucleic Acids Res., 26(2), 544–548.
Sambrook, J. & Russell, D.W. (2001). Molecular cloning: A laboratory manual. Cold Spring Harbor
Laboratory Press, Cold Spring Harbor, New York, USA, 3rd edition.
Santos, J. M., Drider, D., Marujo, P. E., Lopez, P. & Arraiano, C. M. (1997). Determinant role of E. coli
RNase III in the decay of both specific and heterologous mRNAs. FEMS Microbiol. Lett., 157(1),
31–38.
Sarkar, N. (1997). Polyadenylation of mRNA in prokaryotes. Annu. Rev. Biochem., 66, 173–197.
Sauter, C., Basquin, J. & Suck, D. (2003). Sm-like proteins in Eubacteria: the crystal structure of the Hfq
protein from Escherichia coli. Nucleic Acids Res., 31(14), 4091–4098.
Scheibe, M., Bonin, S., Hajnsdorf, E., Betat, H. & Mo¨rl, M. (2007). Hfq stimulates the activity of the
CCA-adding enzyme. BMC Mol. Biol., 8, 92.
Schmitz, A., Josenhans, C. & Suerbaum, S. (1997). Cloning and characterization of the Helicobacter pylori
flbA gene, which codes for a membrane protein involved in coordinated expression of flagellar genes.
J. Bacteriol., 179(4), 987–997.
Schumacher, M. A., Pearson, R. F., Møller, T., Valentin-Hansen, P. & Brennan, R. G. (2002). Structures of
the pleiotropic translational regulator Hfq and an Hfq-RNA complex: a bacterial Sm-like protein.
EMBO J, 21(13), 3546–3556.
Selinger, D. W., Cheung, K. J., Mei, R., Johansson, E. M., Richmond, C. S., Blattner, F. R.,
Lockhart, D. J. & Church, G. M. (2000). RNA expression analysis using a 30 base pair resolution
Escherichia coli genome array. Nat. Biotechnol., 18(12), 1262–1268.
Sharma, A. K. & Payne, S. M. (2006). Induction of expression of hfq by DksA is essential for Shigella
flexneri virulence. Mol. Microbiol., 62(2), 469–479.
Sharma, C. M., Darfeuille, F., Plantinga, T. H. & Vogel, J. (2007). A small RNA regulates multiple ABC
transporter mRNAs by targeting C/A-rich elements inside and upstream of ribosome-binding sites.
Genes Dev., 21(21), 2804–2817.
Shirai, M., Fujinaga, R., Akada, J. K. & Nakazawa, T. (1999). Activation of Helicobacter pylori ureA
promoter by a hybrid Escherichia coli-H. pylori rpoD gene in E. coli. Gene, 239(2), 351–359.
207
Silvaggi, J. M., Perkins, J. B. & Losick, R. (2005). Small untranslated RNA antitoxin in Bacillus subtilis.
J. Bacteriol., 187(19), 6641–6650.
Silvaggi, J. M., Perkins, J. B. & Losick, R. (2006). Genes for small, noncoding RNAs under sporulation
control in Bacillus subtilis. J. Bacteriol., 188(2), 532–541.
Simons, R. W. & Kleckner, N. (1983). Translational control of IS10 transposition. Cell, 34(2), 683–691.
Singer, B. S., Shtatland, T., Brown, D. & Gold, L. (1997). Libraries for genomic SELEX. Nucleic Acids
Res., 25(4), 781–786.
Sittka, A., Pfeiffer, V., Tedin, K. & J.Vogel (2007). The RNA chaperone Hfq is essential for the virulence of
Salmonella typhimurium. Mol. Microbiol., 63(1), 193–217.
Sittka, A., Sharma, C. M., Rolle, K. & Vogel, J. (2009). Deep sequencing of Salmonella RNA associated
with heterologous Hfq proteins in vivo reveals small RNAs as a major target class and identifies RNA
processing phenotypes. RNA Biology, 6(3), 1–10.
Sittka, A., S.Lucchini, Papenfort, K., Sharma, C. M., Rolle, K., Binnewies, T. T., Hinton, J. C. D. &
Vogel, J. (2008). Deep sequencing analysis of small noncoding RNA and mRNA targets of the global
post-transcriptional regulator, Hfq. PLoS Genet., 4(8), e1000163.
Sittka, A. & Vogel, J. (2008). A glimpse at the evolution of virulence control. Cell Host Microbe, 4(4),
310–312.
Sledjeski, D. & Gottesman, S. (1995). A small RNA acts as an antisilencer of the H-NS-silenced rcsA gene
of Escherichia coli. Proc. Nat. Acad. Sci. U.S.A., 92(6), 2003–2007.
Sledjeski, D. D., Gupta, A. & Gottesman, S. (1996). The small RNA, DsrA, is essential for the low
temperature expression of RpoS during exponential growth in Escherichia coli. EMBO J., 15(15),
3993–4000.
Song, M., Kim, H., Kim, E. Y., Shin, M., Lee, H. C., Hong, Y., Rhee, J. H., Yoon, H., Ryu, S., Lim, S. &
Choy, H. E. (2004). ppGpp-dependent stationary phase induction of genes on Salmonella
pathogenicity island 1. J. Biol. Chem., 279(33), 34183–34190.
Song, T., Mika, F., Lindmark, B., Liu, Z., Schild, S., Bishop, A., Zhu, J., Camilli, A., Johansson, J.,
J.Vogel & Wai, S. N. (2008). A new Vibrio cholerae sRNA modulates colonization and affects release
of outer membrane vesicles. Mol. Microbiol., 70(1), 100–111.
Sonnleitner, E., Hagens, S., Rosenau, F., Wilhelm, S., Habel, A., Ja¨ger, K. & Bla¨si, U. (2003). Reduced
virulence of a hfq mutant of Pseudomonas aeruginosa O1. Microb. Pathog., 35(5), 217–228.
Sonnleitner, E., Schuster, M., Sorger-Domenigg, T., Greenberg, E. P. & U.Bla¨si (2006). Hfq-dependent
alterations of the transcriptome profile and effects on quorum sensing in Pseudomonas aeruginosa.
Mol. Microbiol., 59(5), 1542–1558.
Sonnleitner, E., Sorger-Domenigg, Th., Madej, M. J., Findeiss, S., Hackermu¨ller, J., A.Hu¨ttenhofer,
Stadler, P. F., Bla¨si, U. & Moll, I. (2008). Detection of small RNAs in Pseudomonas aeruginosa by
RNomics and structure-based bioinformatic tools. Microbiology, 154(Pt 10), 3175–3187.
Soppa, J., Straub, J., Brenneis, Ma., Jellen-Ritter, A., Heyer, R., Fischer, S., Granzow, M., Voss, B.,
Hess, W. R., Tjaden, B. & Marchfelder, A. (2009). Small RNAs of the halophilic archaeon Haloferax
volcanii. Biochem. Soc. Trans., 37(Pt 1), 133–136.
Spohn, G., Beier, D., Rappuoli, R. & Scarlato, V. (1997). Transcriptional analysis of the divergent cagAB
genes encoded by the pathogenicity island of Helicobacter pylori. Mol. Microbiol., 26(2), 361–372.
Spohn, G. & Scarlato, V. (1999). Motility of Helicobacter pylori is coordinately regulated by the
transcriptional activator FlgR, an NtrC homolog. J. Bacteriol., 181(2), 593–599.
Spohn, G. & Scarlato, V. (1999). The autoregulatory HspR repressor protein governs chaperone gene
transcription in Helicobacter pylori. Mol. Microbiol., 34(4), 663–674.
208 CHAPTER 9. References
Stauffer, L. T. & Stauffer, G. V. (2005). GcvA interacts with both the alpha and sigma subunits of RNA
polymerase to activate the Escherichia coli gcvB gene and the gcvTHP operon. FEMS Microbiol. Lett.,
242(2), 333–338.
¨Ostberg, Y., Bunikis, I., Bergstro¨m, S. & Johansson, J. (2004). The etiological agent of Lyme disease,
Borrelia burgdorferi, appears to contain only a few small RNA molecules. J. Bacteriol., 186(24),
8472–8477.
Steffen, P., Voss, B., Rehmsmeier, M., Reeder, J. & Giegerich, R. (2006). RNAshapes: an integrated RNA
analysis package based on abstract shapes. Bioinformatics, 22(4), 500–503.
Steglich, C., Futschik, M. E., Lindell, D., Voss, B., Chisholm, S. W. & Hess, W. R. (2008). The challenge of
regulation in a minimal photoautotroph: non-coding RNAs in Prochlorococcus. PLoS Genet., 4(8),
e1000173.
Steitz, J. A. & Jakes, K. (1975). How ribosomes select initiator regions in mRNA: base pair formation
between the 3’ terminus of 16S rRNA and the mRNA during initiation of protein synthesis in
Escherichia coli. Proc. Nat. Acad. Sci. U.S.A., 72(12), 4734–4738.
Sternberg, N. L. & Maurer, R. (1991). Bacteriophage-mediated generalized transduction in Escherichia coli
and Salmonella typhimurium. Methods Enzymol, 204, 18–43.
Stork, M., Lorenzo, M. Di, Welch, T. J. & Crosa, J. H. (2007). Transcription termination within the iron
transport-biosynthesis operon of Vibrio anguillarum requires an antisense RNA. J. Bacteriol., 189(9),
3479–3488.
Storz, G. (2002). An expanding universe of noncoding RNAs. Science, 296(5571), 1260–1263.
Storz, G., Altuvia, S. & Wassarman, K. M. (2005). An abundance of RNA regulators. Annu. Rev. Biochem.,
74, 199–217.
Storz, G., Opdyke, J. A. & Zhang, A. (2004). Controlling mRNA stability and translation with small,
noncoding RNAs. Curr. Opin. Microbiol., 7(2), 140–144.
Stougaard, P., Molin, S. & Nordstro¨m, K. (1981). RNAs involved in copy-number control and
incompatibility of plasmid R1. Proc. Nat. Acad. Sci. U.S.A., 78(10), 6008–6012.
Straub, J., Brenneis, M., Jellen-Ritter, A., Heyer, R., Soppa, J. & Marchfelder, A. (2009). Small RNAs in
haloarchaea: Identification, differential expression and biological function. RNA Biol., 6(3).
Suerbaum, S., Thiberge, J. M., Kansau, I., Ferrero, R. L. & Labigne, A. (1994). Helicobacter pylori
hspA-hspB heat-shock gene cluster: nucleotide sequence, expression, putative function and
immunogenicity. Mol. Microbiol., 14(5), 959–974.
Sukhodolets, M. V. & Garges, S. (2003). Interaction of Escherichia coli RNA polymerase with the
ribosomal protein S1 and the Sm-like ATPase Hfq. Biochemistry, 42(26), 8022–8034.
Sultan, M., Schulz, M. H., Richard, H., Magen, A., Klingenhoff, A., Scherf, M., Seifert, M., Borodina, T.,
Soldatov, A., Parkhomchuk, D., Schmidt, D., O’Keeffe, S., Haas, S., Vingron, M., Lehrach, H. &
Yaspo, M. (2008). A global view of gene activity and alternative splicing by deep sequencing of the
human transcriptome. Science, 321(5891), 956–960.
Sun, X., Zhulin, I. & Wartell, R. M. (2002). Predicted structure and phyletic distribution of the
RNA-binding protein Hfq. Nucleic Acids Res., 30(17), 3662–3671.
Suzuma, S., Asari, S., Bunai, K., Yoshino, K., Ando, Y., Kakeshita, H., Fujita, M., Nakamura, K. &
Yamane, K. (2002). Identification and characterization of novel small RNAs in the aspS-yrvM
intergenic region of the Bacillus subtilis genome. Microbiology, 148(Pt 8), 2591–2598.
Svoboda, P. (2007). Off-targeting and other non-specific effects of RNAi experiments in mammalian cells.
Curr. Opin. Mol. Ther., 9(3), 248–257.
209
Swiercz, J. P., Hindra, Bobek, J., Bobek, J., Haiser, H. J., Berardo, C. Di, Tjaden, B. & Elliot, M. . (2008).
Small non-coding RNAs in Streptomyces coelicolor. Nucleic Acids Res., 36(22), 7240–7251.
Tafer, H. & Hofacker, I. L. (2008). RNAplex: a fast tool for RNA-RNA interaction search. Bioinformatics,
24(22), 2657–2663.
Tang, T., Bachellerie, J., Rozhdestvensky, T., Bortolin, M., Huber, H., Drungowski, M., Elge, T.,
Brosius, J. & Hu¨ttenhofer, A. (2002). Identification of 86 candidates for small non-messenger RNAs
from the archaeon Archaeoglobus fulgidus. Proc. Nat. Acad. Sci. U.S.A., 99(11), 7536–7541.
Tang, T., Polacek, N., Zywicki, M., Huber, H., Brugger, K., Garrett, R., Bachellerie, J. P. & Hu¨ttenhofer, A.
(2005). Identification of novel non-coding RNAs as potential antisense regulators in the archaeon
Sulfolobus solfataricus. Mol. Microbiol., 55(2), 469–481.
Tenenbaum, S. A., Lager, P. J., Carson, C. C. & Keene, J. D. (2002). Ribonomics: identifying mRNA
subsets in mRNP complexes using antibodies to RNA-binding proteins and genomic arrays. Methods,
26(2), 191–198.
Tjaden, B. (2008). TargetRNA: a tool for predicting targets of small RNA action in bacteria. Nucleic Acids
Res., 36(Web Server issue), W109–W113.
Tjaden, B., Goodwin, S. S., Opdyke, J. A., Guillier, M., Fu, D. X., Gottesman, S. & Storz, G. (2006). Target
prediction for small, noncoding RNAs in bacteria. Nucleic Acids Res., 34(9), 2791–2802.
Tjaden, B., Saxena, R. M., Stolyar, S., Haynor, D. R., Kolker, E. & Rosenow, C. (2002). Transcriptome
analysis of Escherichia coli using high-density oligonucleotide probe arrays. Nucleic Acids Res.,
30(17), 3732–3738.
Tomb, J. F., White, O., Kerlavage, A. R., Clayton, R. A., Sutton, G. G., Fleischmann, R. D.,
Ketchum, K. A., Klenk, H. P., Gill, S., Dougherty, B. A., Nelson, K., Quackenbush, J., Zhou, L.,
Kirkness, E. F., Peterson, S., Loftus, B., Richardson, D., Dodson, R., Khalak, H. G., Glodek, A.,
McKenney, K., Fitzegerald, L. M., Lee, N., Adams, M. D., Hickey, E. K., Berg, D. E., Gocayne, J. D.,
Utterback, T. R., Peterson, J. D., Kelley, J. M., Cotton, M. D., Weidman, J. M., Fujii, C., Bowman, C.,
Watthey, L., Wallin, E., Hayes, W. S., Borodovsky, M., Karp, P. D., Smith, H. O., Fraser, C. M. &
Venter, J. C. (1997). The complete genome sequence of the gastric pathogen Helicobacter pylori.
Nature, 388(6642), 539–547.
Tomizawa, J., Itoh, T., Selzer, G. & Som, T. (1981). Inhibition of ColE1 RNA primer formation by a
plasmid-specified small RNA. Proc. Nat. Acad. Sci. U.S.A., 78(3), 1421–1425.
Tramonti, A., De Canio, M. & De Biase, D. (2008). GadX/GadW-dependent regulation of the Escherichia
coli acid fitness island: transcriptional control at the gadY-gadW divergent promoters and identification
of four novel 42 bp GadX/GadW-specific binding sites. Mol. Microbiol., 70(4), 965–982.
Trotochaud, A. E. & Wassarman, K. M. (2004). 6S RNA function enhances long-term cell survival.
J. Bacteriol., 186(15), 4978–4985.
Trotochaud, A. E. & Wassarman, K. M. (2005). A highly conserved 6S RNA structure is required for
regulation of transcription. Nat. Struct. Mol. Biol., 12(4), 313–319.
Tsui, H. C., Leung, H. C. & Winkler, M. E. (1994). Characterization of broadly pleiotropic phenotypes
caused by an hfq insertion mutation in Escherichia coli K-12. Mol. Microbiol., 13(1), 35–49.
Udagawa, T., Shimizu, Y. & Ueda, T. (2004). Evidence for the translation initiation of leaderless mRNAs by
the intact 70 S ribosome without its dissociation into subunits in eubacteria. J. Biol. Chem., 279(10),
8539–8546.
Udekwu, K. I., Darfeuille, F., Vogel, J., Reimega˚rd, J., Holmqvist, E. & Wagner, E. G. H. (2005).
Hfq-dependent regulation of OmpA synthesis is mediated by an antisense RNA. Genes Dev., 19(19),
2355–2366.
210 CHAPTER 9. References
Ulbrandt, N. D., Newitt, J. A. & Bernstein, H. D. (1997). The E. coli signal recognition particle is required
for the insertion of a subset of inner membrane proteins. Cell, 88(2), 187–196.
Ulve´, V. M., Sevin, E. W., Che´ron, A. & Barloy-Hubler, F. (2007). Identification of chromosomal
alpha-proteobacterial small RNAs by comparative genome analysis and detection in Sinorhizobium
meliloti strain 1021. BMC Genomics, 8, 467.
Urban, J. H., Papenfort, K., J.Thomsen, .Schmitz, R. A & Vogel, J. (2007). A conserved small RNA
promotes discoordinate expression of the glmUS operon mRNA to activate GlmS synthesis.
J. Mol. Biol., 373(3), 521–528.
Urban, J. H. & Vogel, J. (2007). Translational control and target recognition by Escherichia coli small
RNAs in vivo. Nucleic Acids Res., 35(3), 1018–1037.
Urban, J. H. & Vogel, J. (2008). Two seemingly homologous noncoding RNAs act hierarchically to activate
glmS mRNA translation. PLoS Biol, 6(3), e64.
Urbanowski, M. L., Stauffer, L. T. & Stauffer, G. V. (2000). The gcvB gene encodes a small untranslated
RNA involved in expression of the dipeptide and oligopeptide transport systems in Escherichia coli.
Mol. Microbiol., 37(4), 856–868.
Uzzau, S., Figueroa-Bossi, N., Rubino, S. & Bossi, L. (2001). Epitope tagging of chromosomal genes in
Salmonella. Proc. Nat. Acad. Sci. U.S.A., 98(26), 15264–15269.
Valentin-Hansen, P., Eriksen, M. & Udesen, C. (2004). The bacterial Sm-like protein Hfq: a key player in
RNA transactions. Mol. Microbiol., 51(6), 1525–1533.
Valverde, C., Heeb, S., Keel, C. & Haas, D. (2003). RsmY, a small regulatory RNA, is required in concert
with RsmZ for GacA-dependent expression of biocontrol traits in Pseudomonas fluorescens CHA0.
Mol. Microbiol., 50(4), 1361–1379.
Valverde, C., Lindell, M., Wagner, E. G. H. & Haas, D. (2004). A repeated GGA motif is critical for the
activity and stability of the riboregulator RsmY of Pseudomonas fluorescens. J. Biol. Chem., 279(24),
25066–25074.
Valverde, C., Livny, J., Schlu¨ter, J., Reinkensmeier, J., Becker, A. & Parisi, G. (2008). Prediction of
Sinorhizobium meliloti sRNA genes and experimental detection in strain 2011. BMC Genomics, 9,
416.
Vanderpool, C. K. & Gottesman, S. (2004). Involvement of a novel transcriptional activator and small RNA
in post-transcriptional regulation of the glucose phosphoenolpyruvate phosphotransferase system.
Mol. Microbiol., 54(4), 1076–1089.
Vanet, A. & Labigne, A. (1998). Evidence for specific secretion rather than autolysis in the release of some
Helicobacter pylori proteins. Infect. Immun., 66(3), 1023–1027.
Vanet, A., Marsan, L., Labigne, A. & Sagot, M. F. (2000). Inferring regulatory elements from a whole
genome. An analysis of Helicobacter pylori σ80 family of promoter signals. J. Mol. Biol., 297(2),
335–353.
Vecerek, B., Moll, I. & Bla¨si, U. (2005). Translational autocontrol of the Escherichia coli hfq RNA
chaperone gene. RNA, 11(6), 976–984.
Vecerek, B., Moll, I. & Bla¨si, U. (2007). Control of Fur synthesis by the non-coding RNA RyhB and
iron-responsive decoding. EMBO J., 26(4), 965–975.
Viegas, S. C. & Arraiano, C. M. (2008). Regulating the regulators: How ribonucleases dictate the rules in
the control of small non-coding RNAs. RNA Biol., 5(4), 230–243.
Viegas, S. C., Pfeiffer, V., Sittka, A., Silva, I. J., Vogel, J. & Arraiano, C. M. (2007). Characterization of the
role of ribonucleases in Salmonella small RNA decay. Nucleic Acids Res., 35(22), 7651–7664.
211
Vogel, J., Argaman, L., Wagner, E. G. H. & Altuvia, S. (2004). The small RNA IstR inhibits synthesis of an
SOS-induced toxic peptide. Curr. Biol., 14(24), 2271–2276.
Vogel, J., Bartels, V., Tang, T. H., Churakov, G., Slagter-Ja¨ger, J. G., Hu¨ttenhofer, A. & Wagner, E. G. H.
(2003). RNomics in Escherichia coli detects new sRNA species and indicates parallel transcriptional
output in bacteria. Nucleic Acids Res., 31(22), 6435–6443.
Vogel, J. & Papenfort, K. (2006). Small non-coding RNAs and the bacterial outer membrane. Curr. Opin.
Microbiol., 9(6), 605–611.
Vogel, J. & Sharma, C. M. (2005). How to find small non-coding RNAs in bacteria. Biol. Chem., 386(12),
1219–1238.
Vogel, J. & Wagner, E. G. H. (2007). Target identification of small noncoding RNAs in bacteria. Curr.
Opin. Microbiol., 10(3), 262–270.
Vytvytska, O., Moll, I., Kaberdin, V. R., von Gabain, A. & Bla¨si, U. (2000). Hfq (HF1) stimulates ompA
mRNA decay by interfering with ribosome binding. Genes Dev., 14(9), 1109–1118.
Wadler, C. S. & Vanderpool, C. K. (2007). A dual function for a bacterial small RNA: SgrS performs base
pairing-dependent regulation and encodes a functional polypeptide. Proc. Nat. Acad. Sci. U.S.A.,
104(51), 20454–20459.
Wagner, E.G. & Darfeuille, F. (2006). Small Regulatory RNAs in Bacteria. In Small RNAs: Analysis and
regulatory functions (Nellen, W. & Hamann, C., eds), pp. 1–29.
Wagner, E. G. H., Altuvia, S. & Romby, P. (2002). Antisense RNAs in bacteria and their genetic elements.
Adv. Genet., 46, 361–398.
Waldminghaus, T., Fippinger, A., Alfsmann, J. & Narberhaus, F. (2005). RNA thermometers are common in
alpha- and gamma-proteobacteria. Biol. Chem., 386(12), 1279–1286.
Waldminghaus, T., Heidrich, N., Brantl, S. & Narberhaus, F. (2007). FourU: a novel type of RNA
thermometer in Salmonella. Mol. Microbiol., 65(2), 413–424.
Walz, A., Pirrotta, V. & Ineichen, K. (1976). Lambda repressor regulates the switch between PR and Prm
promoters. Nature, 262(5570), 665–669.
Wang, Z., Gerstein, M. & Snyder, M. (2009). RNA-Seq: a revolutionary tool for transcriptomics. Nat. Rev.
Genet., 10(1), 57–63.
Wang, Z. & Wang, G. (2004). APD: the Antimicrobial Peptide Database. Nucleic Acids Res., 32(Database
issue), D590–D592.
Wargel, R. J., Hadur, C. A. & Neuhaus, F. C. (1971). Mechanism of D-cycloserine action: transport mutants
for D-alanine, D-cycloserine, and glycine. J. Bacteriol., 105(3), 1028–1035.
Washietl, S. & Hofacker, I. L. (2004). Consensus folding of aligned sequences as a new measure for the
detection of functional RNAs by comparative genomics. J. Mol. Biol., 342(1), 19–30.
Washietl, S., Hofacker, I. L. & Stadler, P. F. (2005). Fast and reliable prediction of noncoding RNAs.
Proc. Nat. Acad. Sci. U.S.A., 102(7), 2454–2459.
Washio, T., Sasayama, J. & Tomita, M. (1998). Analysis of complete genomes suggests that many
prokaryotes do not rely on hairpin formation in transcription termination. Nucleic Acids Res., 26(23),
5456–5463.
Wassarman, K.M., Repoila, F., Rosenow, C., Storz, G. & Gottesman, S. (2001). Identification of novel small
RNAs using comparative genomics and microarrays. Genes Dev., 15(13), 1637–1651.
Wassarman, K. M. (2007). 6S RNA: a regulator of transcription. Mol. Microbiol., 65(6), 1425–1431.
Wassarman, K. M. & Saecker, R. M. (2006). Synthesis-mediated release of a small RNA inhibitor of RNA
polymerase. Science, 314(5805), 1601–1603.
212 CHAPTER 9. References
Wassarman, K. M. & Storz, G. (2000). 6S RNA regulates E. coli RNA polymerase activity. Cell, 101(6),
613–623.
Wassarman, K. M., Zhang, A. & Storz, G. (1999). Small RNAs in Escherichia coli. Trends Microbiol., 7(1),
37–45.
Watanabe, T., Sugiura, M. & Sugita, M. (1997). A novel small stable RNA, 6Sa RNA, from the
cyanobacterium Synechococcus sp. strain PCC6301. FEBS Lett., 416(3), 302–306.
Waters, Lauren S & Storz, Gisela (2009). Regulatory RNAs in bacteria. Cell, 136(4), 615–628.
Weber, A. P. M., Weber, K. L., Carr, K., Wilkerson, C. & Ohlrogge, J. B. (2007). Sampling the Arabidopsis
transcriptome with massively parallel pyrosequencing. Plant Physiol., 144(1), 32–42.
Weilbacher, T., Suzuki, K., Dubey, A. K., Wang, X., Gudapaty, S., Morozov, I., Baker, C. S., Georgellis, D.,
Babitzke, P. & Romeo, T. (2003). A novel sRNA component of the carbon storage regulatory system
of Escherichia coli. Mol. Microbiol., 48(3), 657–670.
Weinberg, Z., Barrick, J. E., Yao, Z., Roth, A., Kim, J. N., Gore, J., Wang, J. X., Lee, E. R., Block, K. F.,
Sudarsan, N., Neph, S., Tompa, M., Ruzzo, W. L. & Breaker, R. R. (2007). Identification of 22
candidate structured RNAs in bacteria using the CMfinder comparative genomics pipeline. Nucleic
Acids Res., 35(14), 4809–4819.
Wen, Y., Feng, J., Scott, D. R., Marcus, E. A. & Sachs, G. (2007). The HP0165-HP0166 two-component
system (ArsRS) regulates acid-induced expression of HP1186 α-carbonic anhydrase in Helicobacter
pylori by activating the pH-dependent promoter. J. Bacteriol., 189(6), 2426–2434.
Wilderman, P. J., Sowa, N. A., FitzGerald, D. J., FitzGerald, P. C., Gottesman, S., Ochsner, U. A. &
Vasil, M. L. (2004). Identification of tandem duplicate regulatory small RNAs in Pseudomonas
aeruginosa involved in iron homeostasis. Proc. Nat. Acad. Sci. U.S.A., 101(26), 9792–9797.
Wilhelm, B. T., Marguerat, S., Watt, S., Schubert, F., Wood, V., Goodhead, I., Penkett, C. J., Rogers, J. &
Ba¨hler, J. (2008). Dynamic repertoire of a eukaryotic transcriptome surveyed at single-nucleotide
resolution. Nature, 453(7199), 1239–1243.
Will, S., Reiche, K., Hofacker, I. L., Stadler, P. F. & Backofen, R. (2007). Inferring noncoding RNA families
and classes by means of genome-scale structure-based clustering. PLoS Comput. Biol., 3(4), e65.
Williams, K. P. & Bartel, D. P. (1996). Phylogenetic analysis of tmRNA secondary structure. RNA, 2(12),
1306–1310.
Willins, D. A., Ryan, C. W., Platko, J. V. & Calvo, J. M. (1991). Characterization of Lrp, and Escherichia
coli regulatory protein that mediates a global response to leucine. J. Biol. Chem., 266(17),
10768–10774.
Willkomm, D. K., Minnerup, J., Hu¨ttenhofer, A. & Hartmann, R. K. (2005). Experimental RNomics in
Aquifex aeolicus: identification of small non-coding RNAs and the putative 6S RNA homolog.
Nucleic Acids Res., 33(6), 1949–1960.
Wilson, J. W., Ott, C. M., zu Bentrup, K. Ho¨ner, Ramamurthy, R., Quick, L., Porwollik, S., Cheng, P.,
McClelland, M., Tsaprailis, G., Radabaugh, T., Hunt, A., Fernandez, D., Richter, E., Shah, M.,
Kilcoyne, M., Joshi, L., Nelman-Gonzalez, M., Hing, S., Parra, M., Dumars, P., Norwood, K.,
Bober, R., Devich, J., Ruggles, A., Goulart, C., Rupert, M., Stodieck, L., Stafford, P., Catella, L.,
Schurr, M. J., Buchanan, K., Morici, L., McCracken, J., Allen, P., Baker-Coleman, C., Hammond, T.,
Vogel, J., Nelson, R., Pierson, D. L., Stefanyshyn-Piper, H. M. & Nickerson, C. A. (2007). Space
flight alters bacterial gene expression and virulence and reveals a role for global regulator Hfq.
Proc. Nat. Acad. Sci. U.S.A., 104(41), 16299–16304.
Wilusz, C. J. & Wilusz, J. (2005). Eukaryotic Lsm proteins: lessons from bacteria. Nat. Struct. Mol. Biol.,
12(12), 1031–1036.
213
Windbichler, N., von Pelchrzim, F., Mayer, O., Csaszar, E. & Schroeder, R. (2008). Isolation of small
RNA-binding proteins from E. coli: evidence for frequent interaction of RNAs with RNA polymerase.
RNA Biol., 5(1), 30–40.
Winkler, W. C., Nahvi, A., Roth, A., Collins, J. A. & Breaker, R. R. (2004). Control of gene expression by a
natural metabolite-responsive ribozyme. Nature, 428(6980), 281–286.
Xiao, B., Li, W., Guo, G., Li, B., Liu, Z., Jia, K., Guo, Y., Mao, X. & Zou, Q. (2009). Identification of small
noncoding RNAs in Helicobacter pylori by a bioinformatics-based approach. Curr. Microbiol., 58(3),
258–263.
Xiao, B., Li, W., Guo, G., Li, B., Liu, Z., Tang, B., Mao, X. & Zou, Q. (2009). Screening and identification
of natural antisense transcripts in Helicobacter pylori by a novel approach based on RNase I protection
assay. Mol. Biol. Rep., 36(7), 1853–1858.
Xu, F. & Cohen, S. N. (1995). RNA degradation in Escherichia coli regulated by 3’ adenylation and 5’
phosphorylation. Nature, 374(6518), 180–183.
Yachie, N., Numata, K., Saito, R., Kanai, A. & Tomita, M. (2006). Prediction of non-coding and antisense
RNA genes in Escherichia coli with Gapped Markov Model. Gene, 372, 171–181.
Yamanaka, K., Fang, L. & Inouye, M. (1998). The CspA family in Escherichia coli: multiple gene
duplication for stress adaptation. Mol. Microbiol., 27(2), 247–255.
Yassour, M., Kaplan, T., Fraser, H. B., Levin, J. Z., Pfiffner, J., Adiconis, X., Schroth, G., Luo, S.,
Khrebtukova, I., Gnirke, A., Nusbaum, C., Thompson, D., Friedman, N. & Regev, A. (2009). Ab initio
construction of a eukaryotic transcriptome by massively parallel mRNA sequencing.
Proc. Nat. Acad. Sci. U.S.A., 106(9), 3264–3269.
Yoder-Himes, D. R., Chain, P. S G, Zhu, Y., Wurtzel, O., Rubin, E. M., Tiedje, James M & Sorek, R. (2009).
Mapping the Burkholderia cenocepacia niche response via high-throughput sequencing.
Proc. Nat. Acad. Sci. U.S.A., 106(10), 3976–3981.
Yuan, G., Kla¨mbt, C., Bachellerie, J., Brosius, J. & Hu¨ttenhofer, A. (2003). RNomics in Drosophila
melanogaster: identification of 66 candidates for novel non-messenger RNAs. Nucleic Acids Res.,
31(10), 2495–2507.
Yusupova, G., Jenner, L., Rees, B., Moras, D. & Yusupov, M. (2006). Structural basis for messenger RNA
movement on the ribosome. Nature, 444(7117), 391–394.
Yusupova, G. Z., Yusupov, M. M., Cate, J. H. & Noller, H. F. (2001). The path of messenger RNA through
the ribosome. Cell, 106(2), 233–241.
Zhang, A., Altuvia, S., Tiwari, A., Argaman, L., Hengge-Aronis, R. & Storz, G. (1998). The OxyS
regulatory RNA represses rpoS translation and binds the Hfq (HF-I) protein. EMBO J., 17(20),
6061–6068.
Zhang, A., Wassarman, K. M., Ortega, J., Steven, A. C. & Storz, G. (2002). The Sm-like Hfq protein
increases OxyS RNA interaction with target mRNAs. Mol. Cell, 9(1), 11–22.
Zhang, A., Wassarman, K. M., Rosenow, C., Tjaden, B. C., Storz, G. & Gottesman, S. (2003). Global
analysis of small RNA and mRNA targets of Hfq. Mol. Microbiol., 50(4), 1111–1124.
Zhang, Y., Sun, S., Wu, T., Wang, J., Liu, C., Chen, L., Zhu, X., Zhao, Y., Zhang, Z., Shi, B., Lu, H. &
Chen, R. (2006). Identifying Hfq-binding small RNA targets in Escherichia coli. Biochem. Biophys.
Res. Commun., 343(3), 950–955.
Zhang, Y., Zhang, Z., Ling, L., Shi, B. & Chen, R. (2004). Conservation analysis of small RNA genes in
Escherichia coli. Bioinformatics, 20(5), 599–603.
Zhao, T., Li, G., Mi, S., Li, S., Hannon, G. J., Wang, X. & Qi, Y. (2007). A complex system of small RNAs
in the unicellular green alga Chlamydomonas reinhardtii. Genes Dev., 21(10), 1190–1203.
Ziolkowska, K., Derreumaux, P., Folichon, M., Pellegrini, O., Re´gnier, P., Boni, I. V. & Hajnsdorf, E.
(2006). Hfq variant with altered RNA binding functions. Nucleic Acids Res., 34(2), 709–720.
Zuker, M. (2003). Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids
Res., 31(13), 3406–3415.
CHAPTER 10
APPENDICES
The following Table 10.1 lists the bacterial strains that were used in Chapters 3, 4, and 5 of this
thesis.
Table 10.1: Bacterial strains.
Strain Relevant markers/ genotype Reference/ source
S. typhimurium
SL1344 StrR hisG rpsL xyl Hoiseth & Stocker,
1981, provided by D.
Bumann, MPI-IB Berlin
JVS-0255 SL1344 ∆hfq::CmR Sittka et al., 2007
JVS-0236 SL1344 ∆gcvB::KmR this study
JVS-0617 SL1344 ∆gcvB/∆hfq this study
JVS-1338 SL1344 hfqFlag Pfeiffer et al., 2007
E. coli
TOP10 mcrA ∆(mrr-hsdRMS-mcrBC) Φ80lacZ∆M15 ∆lacX74
deoR recA1 araD139 ∆(ara-leu)7697 galU galK rpsL
endA1 nupG
Invitrogen
TOP10 F’ F´lacIq Tn10 (TetR) mcrA ∆(mrr-hsdRMS-mcrBC)
Φ80lacZ ∆M15 ∆lacX74 deoR recA1 araD139
∆(ara-leu)7697 galU galK rpsL endA1 nupG
Invitrogen
JVS-6081 TOP10 ∆gcvB::KmR this study
Plasmids that were used or constructed in Chapters 3 and 4 of this thesis are listed in the following
Table 10.2.
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Table 10.2: Plasmids that were used or constructed in Chapters 3 and 4 of this thesis.
Name Synonym Relevant Comment Origin/ Reference
fragment marker
pKD3 Template for mutant construction;
carries chloramphenicol cassette
oriRγ/
AmpR
Datsenko &
Wanner, 2000
pKD4 Template for mutant construction;
carries kanamycin cassette
oriRγ/
AmpR
Datsenko &
Wanner, 2000
pKD46 ParaB-γ-β-exo Temperature sensitive λ red
recombinase expression plasmid
oriR101/
AmpR
Datsenko &
Wanner, 2000
pCP20 Temperature sensitive FLP
recombinase expression plasmid
oriR101/
AmpR,
CmR
Datsenko &
Wanner, 2000
pJV300 ColE1 control plasmid, based on
pZE12-luc, -1 site of PLlacO
promoter religated to second
position of XbaI site (destroyed),
yields ≈ 50 nt nonsense transcript
derived from rrnB terminator
ColE1/
AmpR
Sittka et al.,
2007
pJV968-1 ‘lacZ’ ColE control plasmid, carries 1.5
kb internal lacZ fragment
ColE1/
AmpR
Vogel et al.,
2004
pJV846-11 PLlacO gcvB Salmonella SL1344 gcvB
high-copy expression plasmid,
gcvB is controlled by the
constitutive PLlacO promoter
ColE1/
AmpR
Sharma et al.,
2007
pZE12-luc luc General expression plasmid ColE1/
AmpR
Lutz &
Bujard, 1997
pTP11 control plasmid Control plasmid based on pJV300,
ColE1 origin replaced by p15A
origin
p15A/
AmpR
Sharma et al.,
2007
pTP24 control plasmid ’lacZ’ Low copy control plasmid, based
on pJV968-1; ColE1 origin
replaced by p15A origin
p15A/
AmpR
Sharma et al.,
2007
pTP02 PgcvB-gcvB Salmonella SL1344 gcvB
high-copy expression plasmid,
gcvB is controlled by its own
promoter
ColE1/
AmpR
Sharma et al.,
2007
pTP05 pgcvB PgcvB-gcvB Salmonella SL1344 gcvB mid-copy
expression plasmid, gcvB is
controlled by its own promoter
p15A/
AmpR
Sharma et al.,
2007
pTP09 pPL gcvB PLlacO-gcvB Salmonella SL1344 gcvB mid-copy
expression plasmid, gcvB is
controlled by the constitutive
PLlacO promoter
p15A/
AmpR
Sharma et al.,
2007
pJL03-15 pgcvB∆R1 Pwt-gcvB∆R1 Salmonella SL1344 gcvB∆R1
(deletion of position 66 - 89)
mid-copy expression plasmid,
gcvB∆R1 is controlled by its own
promoter
p15A/
AmpR
Sharma et al.,
2007
pJL16-10 pgcvB∆R2 Pwt-gcvB∆R2 Salmonella SL1344 gcvB∆R2
(deletion of position 136 - 144)
mid-copy expression plasmid,
gcvB∆R1 is controlled by its own
promoter
p15A/
AmpR
Sharma et al.,
2007
pJL05-16 pgcvB5’∆ Pwt-gcvB5’∆ Salmonella SL1344 gcvB5’∆
(deletion of position 1 - 91)
mid-copy expression plasmid,
gcvB5’∆ is controlled by its own
promoter
p15A/
AmpR
Sharma et al.,
2007
continued on next page
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fragment marker
pJL01-1 pgcvB3’∆ Pwt-gcvB3’∆ Salmonella SL1344 gcvB3’∆
(deletion of position 135 - 206)
mid-copy expression plasmid,
gcvB3’∆ is controlled by its own
promoter
p15A/
AmpR
Sharma et al.,
2007
pJL17-6 pgcvB3’∆T Pwt-gcvB3’∆T Salmonella SL1344 gcvB3’∆T
(deletion of bp 135 - 206 and
stabilized terminator) mid-copy
expression plasmid, gcvB3’∆T is
controlled by its own promoter
p15A/
AmpR
Sharma et al.,
2007
pJL22 pPLgcvB∆R1 PLlacO-gcvB∆R1 Salmonella SL1344 gcvB∆R1
(deletion of position 66 - 89)
mid-copy expression plasmid,
gcvB∆R1 is controlled by the
constitutive PLlacO promoter
p15A/
AmpR
Sharma et al.,
2007
pJL23 pPLgcvB∆R2 PLlacO-gcvB∆R2 Salmonella SL1344 gcvB∆R2
(deletion of position 136 - 144)
mid-copy expression plasmid,
gcvB∆R2 is controlled by the
constitutive PLlacO promoter
p15A/
AmpR
Sharma et al.,
2007
pJL29-4 pPLgcvB5’∆ PLlacO -gcvB5’∆ Salmonella SL1344 gcvB5’∆
(deletion of position 1 - 91)
mid-copy expression plasmid,
gcvB5’∆ is controlled by the
constitutive PLlacO promoter
p15A/
AmpR
Sharma et al.,
2007
pJL13-12 pgcvB3’∆T’ Pwt-gcvB3’∆T’ Salmonella SL1344 gcvB3’∆T
(deletion of bp 135-206 and
mutated SL3) mid-copy expression
plasmid, gcvB3’∆T’ is controlled
by its own promoter
p15A/
AmpR
Sharma et al.,
2007
pJV752-1 pZE12-luc with modified p15A
origin (no XbaI site)
p15A/
AmpR
J. Vogel,
unpublished
pXG-0
(pJU-004)
no gfp luc non-fluorescent control plasmid, no
gfp
pSC101*/
CmR
Urban &
Vogel, 2007
pXG-1
(pJV859-8)
gfp PLtetO-gfp Fluorescent GFP control plasmid,
constitutively expresses full-length
gfp
pSC101*/
CmR
Urban &
Vogel, 2007
pXG-10 PLtetO-lacZ::gfp standard plasmid for directional
cloning of a target mRNA as
N-translational fusion to GFP
pSC101*/
CmR
Urban &
Vogel, 2007
pXG-20 PLtetO-lacZ::gfp plasmid for RACE gfp fusion
cloning
pSC101*/
CmR
Urban &
Vogel, 2007
pJL18-1 dppA::gfp PLtetO-dppA::gfp Salmonella dppA translational GFP
fusion plasmid
pSC101*/
CmR
Sharma et al.,
2007
pJL19-1 oppA::gfp PLtetO-oppA::gfp Salmonella oppA translational GFP
fusion plasmid
pSC101*/
CmR
Sharma et al.,
2007
pJL24-1 gltI::gfp PLtetO-gltI::gfp Salmonella gltI translational GFP
fusion plasmid
pSC101*/
CmR
Sharma et al.,
2007
pJL20-1 livJ::gfp PLtetOlivJ::gfp Salmonella livJ translational GFP
fusion plasmid
pSC101*/
CmR
Sharma et al.,
2007
pJL31-24 livK::gfp PLtetO-livK::gfp Salmonella livK translational GFP
fusion plasmid
pSC101*/
CmR
Sharma et al.,
2007
pJL27-2 argT::gfp PLtetO-argT::gfp Salmonella argT translational GFP
fusion plasmid
pSC101*/
CmR
Sharma et al.,
2007
pTP28 STM4351::gfp PLtetO-
STM4351::gfp
Salmonella STM4351 translational
GFP fusion plasmid
pSC101*/
CmR
Sharma et al.,
2007
pJU-63 ompR::gfp PLtetO-ompR::gfp E. coli ompR fused to gfp at aa 35 pSC101*/
CmR
Urban &
Vogel, 2007
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pJL45-3 gltI∆CA::gfp PLtetO-
gltI∆CA::gfp
Salmonella gltI::gfp fusion plasmid
with deletion of CA-rich region
from 5’UTR of gltI
pSC101*/
CmR
Sharma et al.,
2007
pJL50-11 ompRCA::gfp PLtetO-
ompRCA::gfp
E. coli ompR ::gfp with insertion of
CA-rich element from Salmonella
gltI 5’UTR
pSC101*/
CmR
Sharma et al.,
2007
pJL56-2 gltIM2::gfp PLtetO-
gltIM2::gfp
Salmonella gltI::gfp fusion plasmid
with two mutations to disrupt
stem-loop structure in 5’UTR of
gltI
pSC101*/
CmR
Sharma et al.,
2007
pFS133-3 ygjU::gfp PLtetO-ygjU::gfp Salmonella ygjU (sstT)
translational GFP fusion plasmid
pSC101*/
CmR
this study
pFM27-1 yaeC::gfp PLtetO-yaeC::gfp Salmonella yaeC translational GFP
fusion plasmid
pSC101*/
CmR
F. Mika,
unpublished
pJL69-5 gdhA::gfp PLtetO-gdhA::gfp Salmonella gdhA translational GFP
fusion plasmid
pSC101*/
CmR
this study
pFS116-1 asd::gfp PLtetO-asd::gfp Salmonella asd translational GFP
fusion plasmid
pSC101*/
CmR
this study
pFS103-3 lrp::gfp PLtetO-lrp::gfp Salmonella lrp translational GFP
fusion plasmid
pSC101*/
CmR
this study
pJL68-1 ilvC::gfp PLtetO-ilvC::gfp Salmonella ilvC translational GFP
fusion plasmid
pSC101*/
CmR
this study
pFS121-1 ciA::gfp PLtetO-iciA::gfp Salmonella iciA translational GFP
fusion plasmid
pSC101*/
CmR
this study
pFS105-3 brnQ::gfp PLtetO-brnQ::gfp Salmonella brnQ translational GFP
fusion plasmid
pSC101*/
CmR
this study
pSP25-7 ilvE::gfp PLtetO-ilvE::gfp Salmonella ilvE translational GFP
fusion plasmid
pSC101*/
CmR
this study
pSP20-1 thrL::gfp PLtetO-thrL::gfp Salmonella thrL translational GFP
fusion plasmid
pSC101*/
CmR
this study
pSP21-2 ybdH::gfp PLtetO-ybdH::gfp Salmonella ybdH translational GFP
fusion plasmid
pSC101*/
CmR
this study
pFS115-2 ndk::gfp PLtetO-ndk::gfp Salmonella ndk translational GFP
fusion plasmid
pSC101*/
CmR
this study
pFS117-1 serA::gfp PLtetO-serA::gfp Salmonella serA translational GFP
fusion plasmid
pSC101*/
CmR
this study
pJL30-14 cycA::gfp PLtetO-cycA::gfp Salmonella cycA translational GFP
fusion plasmid to 19th amino acid
pSC101*/
CmR
this study
pJL83-2 cycA 10th::gfp PLtetO-
cycA10th::gfp
Salmonella cycA translational GFP
fusion plasmid to 10th amino acid
pSC101*/
CmR
this study
pJL70-9 ydgR ::gfp PLtetO-ydgR::gfp Salmonella ydgR (tppB)
translational GFP fusion plasmid
pSC101*/
CmR
this study
pKP6-21 PBAD-micA Salmonella MicA expression
plasmid, micA is under control of
PBAD promoter
pBR322/
AmpR
Papenfort et
al.,
unpublished
pKP8-35 control plasmid pBAD control plasmid, expresses
≈ 50 nt nonsense RNA derived
from rrnB terminator
pBR322/
AmpR
Papenfort
et al., 2006
pKP1-1 pBAD-GcvB PBAD-gcvB GcvB expression plasmid, gcvB is
controlled by the plasmid-borne
PBAD promoter
pBR322/
AmpR
this study
pKP2-6 pBAD-GcvB∆R1 PBAD-gcvB∆R1 GcvB ∆R1 (deletion of position 66
- 89) expression plasmid,
gcvB∆R1is controlled by the
plasmid-borne PBAD promoter
pBR322/
AmpR
this study
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pKP30-1 pBAD-GcvB∆R2 PBAD-gcvB∆R2 GcvB∆R2 (deletion of position 136
- 144) expression plasmid,
gcvB∆R2 is controlled by the
plasmid-borne PBAD promoter
pBR322/
AmpR
this study
pJL36-5 pPL-
gcvB∆R1&∆R2
PLlacO-
gcvB∆R1&∆R2
Salmonella SL1344
gcvB∆R1&∆R2 (deletion of
position 66 - 89 and 136 - 144)
mid-copy expression plasmid,
gcvB∆R1&∆R2 is controlled by
the constitutive PLlacO promoter
p15A/
AmpR
this study
pJL57-1 pPL-
gcvB5’∆&∆R2
PLlacO-
gcvB5’∆&∆R2
Salmonella SL1344
gcvB5’∆&∆R2 (deletion of
position 1 - 91 and 136 - 144)
mid-copy expression plasmid,
gcvB5’∆&∆R2 is controlled by the
constitutive PLlacO promoter
p15A/
AmpR
this study
pJL65-3 pPLgcvB∆SL2 PLlacO-gcvB∆SL2 Salmonella SL1344 gcvB∆SL2
(deletion of position 92 - 113)
mid-copy expression plasmid,
gcvB∆SL2 is controlled by the
constitutive PLlacO promoter
p15A/
AmpR
this study
pJL66-12 pPL-
gcvB∆SL2&∆SL3
PLlacO-
gcvB∆SL2&∆SL3
Salmonella SL1344
gcvB∆SL2&∆SL3 (deletion of
position 92 - 134) mid-copy
expression plasmid,
gcvB∆SL2&∆SL3 is controlled by
the constitutive PLlacO promoter
p15A/
AmpR
this study
pFS127-2 pPL-
gcvBSL1, SL4 & SL5
PLlacO-
gcvBSL1, SL4 & SL5
Salmonella SL1344
gcvBSL1, SL4 & SL5 (deletion of
position 66 - 144) mid-copy
expression plasmid,
gcvBSL1, SL4 & SL5 is controlled by
the constitutive PLlacO promoter
p15A/
AmpR
this study
pFS129-2 pPLgcvBSL4 & SL5 PLlacO-
gcvBSL4 & SL5
Salmonella SL1344 gcvBSL4 & SL5
(deletion of position 1 - 144)
mid-copy expression plasmid,
gcvBSL4 & SL5 is controlled by the
constitutive PLlacOpromoter
p15A/
AmpR
this study
pFS130-1 pPL-
gcvBR2, SL4 & SL5
PLlacO-
gcvBR2, SL4 & SL5
Salmonella SL1344
gcvBR2, SL4 & SL5 (deletion of
position 1 - 134) mid-copy
expression plasmid,
gcvBR2, SL4 & SL5 is controlled by
the constitutive PLlacO promoter
p15A/
AmpR
this study
pFS131-1 pgcvB∆R1& 3’∆T Pwt-
gcvB∆R1& 3’∆T
Salmonella SL1344
gcvB∆R1& 3’∆T (66 - 89, deletion
of bp 135 - 206 and stabilized
terminator) mid-copy expression
plasmid, gcvB∆R1& 3’∆T is
controlled its own promoter
p15A/
AmpR
this study
pJL73-14 pPLgcvBSL1 & SL5 PLlacO-
gcvBSL1 & SL5
Salmonella SL1344 gcvBSL1 & SL5
(deletion of position 66 - 177 )
mid-copy expression plasmid,
gcvBSL1 & SL5 is controlled by the
constitutive PLlacO promoter
p15A/
AmpR
this study
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pJL79-16 pPLgcvBM2, R2,
SL4 & SL5
PLlacO-
gcvBM2, R2,
SL4 & SL5
Salmonella SL1344
gcvBM2, R2, SL4 & SL5 (deletion of
position 1- 134, G143→C,
C158→G) mid-copy expression
plasmid, gcvBM2, R2, SL4 & SL5 is
controlled by the constitutive
PLlacO promoter
p15A/
AmpR
this study
pJL78-11 pPLgcvB5’∆12nt,
SL1 & SL5
PLlacO-
gcvB5’∆12nt,
SL1 & SL5
Salmonella SL1344
gcvB5’∆12nt, SL1 & SL5 (deletion of
position 1 - 12, 66 - 177) mid-copy
expression plasmid,
gcvB5’∆12nt, SL1 & SL5 is controlled
by the constitutive PLlacO promoter
p15A/
AmpR
this study
pJL77-3 pgcvB5’∆12nt,
∆R1 & 3’∆T
Pwt-gcvB5’∆12nt,
∆R1 & 3’∆T
Salmonella SL1344
gcvB5’∆12nt,∆R1 & 3’∆T (1 - 12, 66
- 89, deletion of bp 135 - 206 and
stabilized terminator) mid-copy
expression plasmid,
gcvB5’∆12nt,∆R1 & 3’∆T is
controlled its own promoter
p15A/
AmpR
this study
pJL85-4 pgcvB∆PL gcvB∆PL Salmonella SL1344 gcvB∆PL
(deletion of position (-1) - (-35))
mid-copy expression plasmid,
gcvB∆PL has a deletion of the
constitutive PLlacO promoter
p15A/
AmpR
this study
pSP9-1 pPL-
gcvBSL1 & SL5, C3
PLlacO-
gcvBSL1 & SL5, C3
Salmonella SL1344
gcvBSL1 & SL5, C3 (deletion of
position 66 - 177, single nucleotide
exchange T3→C) mid-copy
expression plasmid,
gcvBSL1 & SL5, C3 is controlled by
the constitutive PLlacO promoter
p15A/
AmpR
this study
pSP11-1 pPL-
gcvBSL1 & SL5, C8
PLlacO-
gcvBSL1 & SL5, C8
Salmonella SL1344
gcvBSL1 & SL5, C8 (deletion of
position 66 - 177, single nucleotide
exchange G8→C) mid-copy
expression plasmid,
gcvBSL1 & SL5, C8 is controlled by
the constitutive PLlacO promoter
p15A/
AmpR
this study
pSP10-1 pPL-
gcvBSL1 & SL5, G11
PLlacO-
gcvBSL1 & SL5, G11
Salmonella SL1344
gcvBSL1 & SL5, G11 (deletion of
position 66 - 177, single nucleotide
exchange C11→G) mid-copy
expression plasmid,
gcvBSL1 & SL5, G11 is controlled by
the constitutive PLlacO promoter
p15A/
AmpR
this study
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This section contains supplementary Figures and Tables to Chapter 3.
Table 10.3: DNA oligonucleotides used in this study.
Sequences are given in 5’→ 3’ direction and 5’P denotes a 5’-mono-phosphate.
Name Sequence Used for
pZE-T1 CGGCGGATTTGTCCTACT T7 template
PLlacO-C 5’ P-GTGCTCAGTATCTTGTTATCCG sRNA cloning
pZE-B GGCGTATCTCTTCATAGCCTTAT sRNA cloning
pZE-A GTGCCACCTGACGTCTAAGA sRNA cloning
JVO-0076 GAAGTATTACAGGTTGTTGGTG Knockout construction
JVO-0077 GCATCATAACGGTCAAACA Knockout construction
JVO-0131 TTCTACCAGCAAATACCTATAGTGGCGGCACTTCCTGAGCC
GGAAGTGTAGGCTGGAGCTGCTTC
Knockout construction
JVO-0132 TCGCGATCGCAAGGTAAAAAAAAGCACCGCAATTAGGCGGT
GCTAGGTCCATATGAATATCCTCCTTAG
Knockout construction
JVO-0133 TTCTACCAGCAAATACCTATAGTGGCGGCACTTCCTGAGCC
GGAAGTGTAGGCTGGAGCTGCTTC
Knockout construction
JVO-0134 TAACCGTTTGTTATACAAAAAAAAGCACCGCAATATGGCGG
TGCTAGGTCCATATGAATATCCTCCTTAG
Knockout construction
JVO-0135 GTTTTTCTCGAGCGGTCAGCAGGAGTGAA Knockout construction
JVO-0136 GTTTTTTCTAGACATCGTCTCTGACGGCA Knockout construction
JVO-0137 GTTTTTCTCGAGCGGCGGAACAGTTTTA Knockout construction, sRNA
cloning
JVO-0138 GTTTTTTCTAGACCGATAACGATACCGGTAT Knockout construction, sRNA
cloning
JVO-0155 CCGTATGTAGCATCACCTTC Northern blot probe
JVO-0237 ACTTCCTGAGCCGGAAC sRNA cloning
JVO-0322 CTACGGCGTTTCACTTCTGAGTTC Northern blot probe
JVO-0367 ACTGACATGGAGGAGGGA GFP fusion cloning
JVO-0424 GTTTTTGCTAGCCATCCCTGACTTCTTCAAG GFP fusion cloning
JVO-0427 GTTTTTGCTAGCAGACAGTCCCATGAC GFP fusion cloning
JVO-0619 CTCTAGAGGCATCAAATAAAAC sRNA cloning
JVO-0656 GTTTTGCTAGCAGTGAGTATTCCCGCTG GFP fusion cloning
JVO-0728 GTTTTTGCTAGCGATACATCCTGCCAATAAC GFP fusion cloning
JVO-0731 GTTTTATGCATCAGAATAGCACCCTGCG GFP fusion cloning
JVO-0732 GTTTTTGCTAGCTAACAGCATGACAATAAGTTTT GFP fusion cloning
JVO-0742 5’ P-AAAAAAGGGTAGTCTCGCTAC sRNA cloning, T7 template
JVO-0743 5’ P-GCCGCCACTATAGGTATT sRNA cloning
JVO-0744 5’ P-ATTGGTCTGCGATTCAGA sRNA cloning
JVO-0745 5’ P-ACCGTAAGCCAAAAGC sRNA cloning
JVO-0746 5’ P-CAATTGGTCTGCGATTC sRNA cloning
JVO-0749 TTCGTTCCGGCTCAGGA Northern blot probe
JVO-0750 AATCACTATGGACAGACAGGGTA Northern blot probe
JVO-0796 GTTTTTGCTAGCGCCCAGACCTATCAGCAA GFP fusion cloning
JVO-0800 GTTTTTGCTAGCAACAATCCCTGCGATTATT GFP fusion cloning
JVO-0892 5’ P-AAAAAAAACGGTAGCGTTTCCGCTACCGTGGTCTGA sRNA cloning
JVO-0895 5’ P-ACATTTACCCTGTCTGTCC sRNA cloning
JVO-0896 5’ P-GAAAAAGGGTAGTCTCGC sRNA cloning
JVO-0937 GTTTTTTTTAATACGACTCACTATAGGAAAGACGCGCATTT T7 template
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JVO-0938 AAAGGCCACTCACGG T7 template
JVO-0941 GTTTTTTTTAATACGACTCACTATAGGACTTCCTGAGCCGG T7 template
JVO-0942 AAAGCACCGCAATATG T7 template
JVO-1034 GTTTTTTTTAATACGACTCACTATAGGATGAGGGGCATTTTATG T7 template
JVO-1035 TTGCTGCAACGGTCAT T7 template, toeprinting
JVO-1037 GTTTTTTTTAATACGACTCACTATAGGATCGACGAAAGGCGAT T7 template
JVO-1038 GATGAGCGCAGTGAGTATT T7 template
JVO-1039 GTTTTTTTTAATACGACTCACTATAGGATAACACTGCACGCGC T7 template
JVO-1040 CCATCTTCTGCGTGC T7 template
JVO-1048 GTTTTTTTTAATACGACTCACTATAGGATCAGCAGGACGCACT T7 template
JVO-1049 TAACATCACCATCTAATTCAAC T7 template
JVO-1060 GTTTTTTTTAATACGACTCACTATAGGAGGACAATATTGCAAC
GTT
T7 template
JVO-1061 CAATACGAACCGTTTGC T7 template
JVO-1062 GTTTTTTTTAATACGACTCACTATAGGCATTAATGAGTCAGTA
AAAAGC
T7 template
JVO-1063 GTTTTTTTTAATACGACTCACTATAGGATCTATAGCGAAAAGC
AGAATA
T7 template
JVO-1064 CCTGCGAGACTGCTAAT T7 template
JVO-1065 GTTTTTTTTAATACGACTCACTATAGGAGTATGCTGCTAAAGC
AC
T7 template
JVO-1066 GAATGCCATATGGCTTAAT T7 template
JVO-1067 GTTTTTTTTAATACGACTCACTATAGGATCAGAATAGCACCCT
GC
T7 template
JVO-1068 TGCCAAAATGTAATGTTCTG T7 template
JVO-1117 TCAGCCATTTTGTGCGCTT qRT-PCR
JVO-1118 TTCAGGATCGACAACGCCTT qRT-PCR
JVO-1254 CCGACAAGCAAACGTTGGTAC qRT-PCR
JVO-1255 TCACGGCTGACGTTCGATT qRT-PCR
JVO-1256 TGCCGGATCTGATTAGCGA qRT-PCR
JVO-1257 TGGCTAAATCGGCAAGGAAC qRT-PCR
JVO-1271 GTTTTATGCATATCTATAGCGAAAAGCAGAATA GFP fusion cloning
JVO-1340 CGCCTGGTAGATATCGAGCAA qRT-PCR
JVO-1341 AATACGGCGCAGTGCGTTA qRT-PCR
JVO-1381 GGACGCGACTGCTGACTAAAA qRT-PCR
JVO-1382 AGAATTTCAGAGGTCGTCCCG qRT-PCR
JVO-1628 CGGAAATCGCCAAATACCTG qRT-PCR
JVO-1629 CACGCCGAACTCAAATCCTT qRT-PCR
JVO-1775 ATCTTCTGCGTGCGCAA toeprinting
JVO-1973 5’ P-TGCGCGTGCAGTGTTAT GFP fusion cloning
JVO-1974 5’ P-AGCTATCAATGCGTCGACG GFP fusion cloning
JVO-2154 5’ P-AACAACATCACAATACACGCTTACAAATTGTTGC GFP fusion cloning
JVO-2155 ATTGCCTGCAACTATTCTTAAAAAAGCATGCATGT GFP fusion cloning
JVO-2233 GTTTTTTTTAATACGACTCACTATAGGCTTTTTTAAGAATACA
CGCTTACA
T7 template
JVO-2234 GTTTTTTTTAATACGACTCACTATAGGCTTTTTTAAGAATAGT
TGCAGG
T7 template
JVO-2326 AGTACATTATGCGTACCGCCG qRT-PCR
JVO-2327 AATGATAGCGATGCGCTGC qRT-PCR
JVO-2328 TGGAATCGCTGAAAGGCAAG qRT-PCR
JVO-2329 GCCACCACATCCACACCTTTA qRT-PCR
JVO-2330 ATGCAAGCGGAGTGCTCATT qRT-PCR
JVO-2331 TCATATCCATACCGGCGATCA qRT-PCR
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G T A C GA AC T TA AT G CC G TCT CCAG AAAT C T GC GCACTTC T GCCGGAA CG AG TT GTTCTGA CTTTTGG C T TG GT GTG A T
G T C GA AC T TA T G CC G A CT CCAG AAAT C T GC CACTTC T GCCGGAA CG AG TT GTTCTG CTTTTGG C T TG GT GTG A T
G T A C GA C T TA AT G CC TCT CCAG AAAT C T GC GCACTTC T GCCGGAA CG AG TT GTTCTG CTTTTGG C T TG GT GTG A T
G T A C GA C T TA AT G CC TCT CCAG AAAT C T GC GCACTTC T GCCGGAA CG AG TT TTCTG CTTTTGG C T TG GT GTG A T
G T C GA C T TA AT G CC G TCT CCAG AAAT C T GC GCACTTC T GCCGGAA CG AG TT GTTC CTTTTGG C T TG GT GTG A T
G T C GA T TA T G CC TCT CCAG AAAT C T GC GCACTTC T GCCGGAA CG AG TT GTTC A CTTTTGG C T TG GT GTG A T
G A C GA C T TA AT G CC G AT CCAG AAAT C T GC GCACTTC GCCGGAA CG AGT T GT CTGA T CTTTTGG C T TG GT GTGA AAT
G T A C GA C T TA T G CC G AT CCAG AAAT C T GC GCACTTC GCCGGAA CG AG T C GA CTTTTGG C T TG GT GTGA AATT
G A C GA C T TA AT G CC G AT CCAG AAAT C T GC CACTTC T GCCGGAA CG AGT T CT CTTTTGG C T TG GT GTGA A TT
G A C GA C T TA T G CC G AT T CCAG AAAT C T GC ACTTC T GCCGGAA CG AGT G CTGA T CTTTTGG C T TG GT GTGA A TT
G T A C GA AC T TA AT G CC A C CCAG AA T C C GC C C GCC GAA CG G T TG C T GG C T G GT G GA AA T
G T A C GA AC T TA T G CC T G A C CCAG AA T C C C C C GCC GAA CG G T T TG C TTGG C T G GT G GA AA T
T A A T A T T G A T AG AAAT T T C G A TT GTTCT T CT TT C T TGA ATT
G T A AT C T A AG C T CGC GC T C T G A T TT T GA T C TT C T T A ATT
G A A A A C T TCT A CGC GCA T C T G G T T GTT GA T C C T TGA ATT
G T A C G A T T TCT C T CGC GCA T C T G C G T TT TT GA T T T T A ATT
G CTG G T C AC A A C A CTA C TTTTC A TTA TGTCTG C AT ATT T AGC TGC T TT T A A
G CTG G T C AC A A C A GCTA C TTTTC A TTA TGTCTG C AT ATT T AGC TGC T TT C T C A
G CTG G T C AC A A C A GCTA C T TTTTC A TTA TGTCTG C AT ATT T AGC TGC T TT C T T C A
G CTG G T C AC A A C A GCTA C T TTTTC A TTA TGTCTG C AT ATT T AGC TGC T TT C T T C A
G CTG T C AC A C A GCTA C TTTTC A TTA TGTCTG C AT ATT T AGC GC T TT C T C
G C GGG T C AC A A C A GCTA C TTTTC A TTA TGTCTG C AT ATT T AGC GC T TT C C A
G CTGG A T C A A A C A GCTA CT T TTTTC A TTA TGTCTG C AT ATT T AGC T GC T TT TC TA T C
G C GG A T C A A C A GCTA CT T TTTTC A TTA TGTCTG C AT ATT T AGC TGC T TT C A T C
G CTGG A C A C A GCTA CT T TTTTC A TTA TGTCTG C AT ATT T GC TGC T TT C TA C
G CTG T A C A CTA C T TTC A TTA TGTCTG C A ATT T AGC TGC T TT C TA T C
G G T AC A GC CT C T TT A TGTCTG C A ATT T AGC T GC T T T T C
G G T AC A C A CT C T TT A TGTCTG C A ATT T C T GC T T T A C A
G CT GG A AC A A A C A G TA CT TTTC TA T AA T T G AT T T T T A T C
G GGG A C AC A A T T TTT TA T AA T T T T GC T GC T T TC TA T A
G TGGG A C AC A A T T TTTTC TA T A T T A C T GC T T T T T A
G TGGG A C AC A A A T T TT TA A T T T GC TGC T T TC A T A
1 100 180
ST T G G AG -T A C A G G- G C -GA - AAA -TT ATCGGAATGCGT TGGG ------ ACGGTTG AT T T G--
CR T T G T G AG - A A C A G G- GA C -GA - AAA -TT ATCGGAATGCGT GTGGG ------ ACGGTTG AT T T G--
EC T GC G AGC-T A C A G G- G C -GA - AAA -TT ATCGGAATGCGT GTGAA ------ ACGGTTG AT T T G--
SF T GC G AGC-T A C A G G- G C -GA - AAA -TT ATCGGAATGCGTA GTGAA ------ ACGGTTG AT T T G--
KP T T GC G AG -T A C A G G- G C -GA - AGA CTT TTTGGAATGCGT CATCAAG ------ ACGGTTG AT T T G--
KO T T GCT T G AGC-T A C A G G- G C -GA - AAG CTT TTTGGAATGCGT CA CAAG ------ ACGGTTG AT T T G--
YP A C GC A AG - ACG T A G G- C CCCTA - AAA AGG TTGGTATCCCAG A AA G ------ -----TG -- G G--
SM C GC T G AG - GCG C A G G- G CC-GG - AAA GGAG G-GGTGTCGAGGACG C TGAA ------ ------G -- --
PL G C AT A AG - ACA T C G G- GC C -AA - AAA GAA CAG-----CTTAACG ATGAAA ------ -----TG -- G --
EW G C GG T A AG - G A C A T A- GCA C -GG - AAA GCGGAGGG------GT AC GG G ------ ------G -- T T TT
VC T A G CTA- C GA AG AAT T T A C G AA GG-CG T - GCTT ATT --------------CCT TAAAT AA A ------ -------A TT C C CG
VV T A T A A - A AG AT ATT T T A CC G AA GC-TA T - GCTT ATT --------------C T TAAAT AA ------ -------A TT C C CG
HD T G TAT A A A T T AGT T C GG GAA A T- TACGTTGTAC TAAAGGGA T A ATAGTTTAGTG TATT-----CGT TTAA G A AAATCCAT ATTTCAAA TTAAG A T --
MS T GTTTCGA A A C AC TCA CTCCTT TCC-CC A A A C G- A T AAT ATTA GCAATTCCT T- C-----------A AAA GT T A --------- -----A--TTAAG A T T --
PM C GCTTC T A A A A GA CCAC CTT TTTC-CCT A A G - - A T AAT ATT -GTAATTCCT A-C G----------- AA GT T GGA--------- -----A-----AG A T --
AS C TC A A AT T C AGT CCGC G TTTCTT- TT C A A - - A T AAT A T -GTAATTCCT AA G-----------A AA GT GAA C---------T -----TAGTTAAG A T T --
181 300 355
ST -- C AT------- - AG C CG G --G- GA ------ C---CT ---- C ------ C C AGTG -A--A GT CATA-------------T C G ATA CAAACGGTT
CR -- C AT------- - AG C CG G --G- A ------ C---CT ---- C ------ C C AGTG -A--A GT CCTA-------------T C AC T -CAGACG TG
EC -- C AT------- - AG C TG G --A- A ------ C--- T ---- C ------ C C AGTG -A--A GT CTAA-------------T C AC T GCGA CG GA
SF -- C AT------- - AG C TG G --A- A ------ C--- T ---- C ------ C C AGTG -A--A GT CTAA-------------T C AC T GCGA CG GA
KP -- TTTT------- G AG CCTG G --A- A ------ C---CC ---- C ------ C C AGTG TA--A GT AACG-------------C- C GC T TTTACTG CTT
KO -- C TT------- G GG C TG G --G- A ------ C---CC ---- C ------ C C AGTG TA--A GT ACTG-------------C- C GC TGCTAAAAA CA
YP -- T- ------- G CAGAC T G --T- A ------ GCT T ---- C ------ C C AGTG TT--A GC TTATT ------------TG C A C T-- TT GAG
SM -- C CG ------- T CGGAC TG G --T- G ------ G-- T ---- C ------ C C AGTG TT--A GC AAAAC------------T C GC TG CGG TA TGG
PL -- -G -------AA CGGACCCT G --TC A ------ G-- T ---- C ------ C C AGTG TT--T AAT AG---------------T C GG A AGG--- GTG
EW TT CTTC------- TGCAGATGTG G --G- GT ------ C----C A ---- C ------ C T AAGTG TTTTA GT AAA--------------T C G- T CGA TT ACG
VC AAA TC A TTAGGTAG- TTCT C CC-CGTT--TTGT AGTTATCC GCCACAAAA AAAT T AT--TT G A ----- ----- TT CT-T ------------GG T A C GCATTTT AG TCC
VV TAT TC A TTAGGTAGA TTCT CGT GTT--TTGTC A --CTCC GTGACAAAA CTAT T AT--TT G A ----- ----- GTTA CTAT ------------AG T A C GCG AATATG TC
HD -G A C -------ACTAG T G A AGTT A T ------ ----CA ---- -----T A T TG TT T----------------A CTAA ------------T A- C G AC TAA TTT AA TAT
MS -- TC A -------AC GA GCA A------CTTA------GT ACT A A----- TT---T A AAT T GGG TC---------G AAT TCTT GT----------GA T A C T AGA ATTAA
PM -- T A -------AC AA A-G A------CTTATCTTAAGT ACT A ---- TTATTT AG --CT T GG-------------- TA A TCTA -C----------GA T A C GT CGAT CTAAC
AS -- T T -------AC AA A A ATTAATCCTTCTATTTAAT ACT A A------ TTA----CT AAT T AGG T-----------ATTG GCTTAAACTCCAAAAAAG T A A G- AAT CTATC
ATTA TTTTT T AT AT A A T T TTG CTA A T T T TGTTGTGTTTGCA
ATTA TTTTT T AT AT A A T T TTG CTA A T T T TGTTGTGTTTGCA
ATTA TTTTT T AT AT A A T T TTG CTA A T T T TGTTGTGTTTGCA
ATTA TTTTT T AT AT A A T T TTG CTA A T T T TGTTGTGTTTGCA
ATTA TTTTT T AT AT A A T T TTG CTA A T T T TGTTGTGTTTGCA
ATTA TTTTT T AT AT A A T T TTG CTA A T T T TGTTGTGTTTGCA
ATTA TTTTT T AT AT A A T T TTG CTA A T T TGTTGTGTTTGCA
ATTA TTTTT T AT AT A A T T TTG CTA A T T T TGTTGTGTTTGCA
ATTA TTTTT T AT AT A A T T TTG CTA A T T T TGTTGTGTTTGCA
ATTA TTTTT T AT AT A A T T TTG CTA A T T T TGTTGTGTTTGC
ATTA TTTTT T AT AT A A T T TTG CTA A T T T TGTTGTGTTTGCA
ATTA TTTTT T AT AT A A T T TTG CTA A T T T TGTTGTGTTTGCA
ATTA TTTTT T AT AT A A T T TTG CTA AAT T T TGTTGTGTTTGCA
ATTA TTTTT T AT AT A A T T TTG TA A T T T TGTTGTGTTTGCA
ATTA TTTTT T AT AT A A T T TTG CTA A T T T TGTTGTGTTTGCA
ATTA TTTTT T AT AT A A T T TTG CTA A T T T TGTTGTGTTTGCA
T GT ACTTCCTGTA T CC T ACCGC GG G TTTTTT
T GT ACTTCCTGTA T CC T ACCGC GG G TTTTTT
T GT ACTTCCTGTA T CC T ACCGC GG G TTTTTT
T GT ACTTCCTGTA T CC T ACCGC GG G TTTTTT
T GT ACTTCCTGTA T CC T ACCGC GG G TTTTTT
T GT ACTTCCTGTA T CC T ACCGC GG G TTTTTT
T GT ACTTCCTGTA T CC T ACCG GG G TTTTTT
T GT ACTTCCTGTA T CC T ACCGC GG G TTTTTT
T GT ACTTCCTGTA T CC T ACCGC GG G TTTTTT
T GT ACTTCCTGTA T CC T ACCGC GG G TTTTTT
T ACTTCCTGTA T CC T ACCGC GG G TTTTTT
T GT ACTTCCTGTA T CC T ACCGC GG G TTTTTT
T GT ACTTCCTGTA T CC T ACCGC GG G TTTTTT
T GT ACTTCCTGTA T CC T ACCGC GG G TTTTTT
T GT ACTTCCTGTA T CC T ACCGC GG G TTTTTT
T GT ACTTCCTGTA T CC T ACCGC GG G TTTTTT
Figure 10.1: Multiple alignment of gcvB genes in different eubacteria. To identify gcvB homologues in diverse γ-proteobacteria, BLAST searches for the
divergently encoded GcvA protein were carried out. The GcvA upstream regions corresponding to the genomic location of gcvB in E. coli and Salmonella were
extracted, and transcriptional terminators of possible gcvB genes were predicted by RNAmotif as described in Chen et al. (2002). Based on sequence conservation
and the assumption that the gcvB location is conserved, GcvB homologues could be identified in a wide range of eubacteria: ST: Salmonella typhimurium, CR:
Citrobacter rodentium, EC: Escherichia coli, SF: Shigella flexneri, KP: Klebsiella pneumoniae, KO: Klebsiella oxytoca, YP: Yersinia pestis, SM: Serratia
marcescens, PL: Photorhabdus luminescens, EW: Erwinia carotovora, VC: Vibrio cholerae, VV: Vibrio vulnificus, HD: Haemophilus ducreyi, MS: Mannheimia
succiniciproducens, PM: Pasteurella multocida, AS: Actinobacillus succinogenes. Promoter elements of gcvA and gcvB genes are marked by black boxes; the
transcriptional start sites are indicated by arrows. The stem-loop of the gcvB transcriptional terminator is indicated by two arrows. The two highly conserved
regions, consensus R1 and R2, that are present in all GcvB homologues are highlighted by yellow boxes.
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1 100
ST_dppA GAG G A T TGG G AAT C CAC GCA CTC GT G TTATGCG A C- AA C CCC CCTCT ACTAC G CC TG CAG A A A AA
EC_dppA CGAG G A T TGG G GAT C CAC G CACTGA TGTT ATT G T C- CA C CCC CCTCAT AACGT G CC CG C G CA A A AA
YP_dppA TGA GA C CA G --- CAAAA GGGGGCCTG AT ATTTT ATCT TA C TCA TCCTG ATCCC GTGT TC AC G CC A - GG A
EW_dppA A A T GGCC AC ACC AATTGA T CGA T G C G TC CG T G C CT GT TT T A CCG T T T -
PL_dppA T T CT TG ATGA CTGTT AGA C TT C G C GTT TT A A G A G TG AAA T AA AAA C G - G
101 200
ST_dppA A GCCGG GGTA -A C CTTT CA AG ----A A T T-- G -- GT T T G AG G
EC_dppA A G CAG AGC CA CC CA T CA AG T---TA A A T-- G T -- CGT T T AG G
YP_dppA TCCAT G ACTA AA AT TATA AGTC CGTAT C C TAA C CG- CG T T G G A G
EW_dppA GTA G A TT GT G - G - A ----- -T CAC -- T T G A A C G T T A
PL_dppA T T T A CA -- T - A TC --TGT T - -- TGC A C C T CT G G G A
201
ST_dppA A
EC_dppA A
YP_dppA A A
EW_dppA G
PL_dppA T A
5'-...A A A A ...-3' EC
AAC ACA ACAUCACAAUU C GA
UUG UGU UGUAGUGUUGGC UUCG UUU
3'-...G A G U...-5' EC GcvB
5'- ...C A C ...- 3' YP
AACACA CAUCACCAU AU CA AAGCG
UUGUGU GUAGUGGUG UGUUUC GU UUCGU
3'- ...U U G G U A...-5' YP GcvB
5'-...G C U U C A U ...-3' EW
AGUAGG G GGG AUAGC A CACAACAUCA C AC AU CA AAGUA
UCGUCU U UUU UAUCG U GUGUUGUAGU G UG UG UUC GU UUCGU
3'-...U G U U U U U G G U G...-5' EW GcvB
5'-...C C A A U A A ...-3' PL
UGUA AU ACAACAUCACAA U GC AGAA
ACGU UG UGUUGUAGUGUU GU UU CG UUUU
3'-...A U G G U G C...-5' PL GcvB
dppA
dppA
dppA
dppA
AT G C TTT A C G T A A C A A G A C T A AC GT AA AA
A G C TTT A C G T TTA A A A G A T A AC G G AA AA
AT G T TTT A C C T G AGA G A C T A G G AA C
AT C G TC A C T C TT GA G CA GA A AA CA G TTAAT A A TT A CAG GT T A AACG
T C T TTT C T G T TTA GA G CAAGA A AA CA TT AT A C A TAA ACA T TA A CG
AG C G A G C C A ACA CA G A A TC GAA T A G
AG T C G C A G C A ACA CA A TC GAA A T A G
CAG T G C C C A AC CA G A TC GA A A A G
C T C C GG G GCG TA T C C C A CA G A- A C G AT AAG
CAG T C GG G GCG T T G C C A ACA A G AA A A T AA A A A
G
G
G
G A G T A C
G A G T A C
G A G T A C
G A G T A C
G A G T A C
G A A G G A A AACA CA TC A T AA A T CT A C G
G A A G G A A AACA CA TC A T AA A T CT A C G
G A A G G A A AACA CA TC A T AA A T CT A C G
G A A G G A A AACA CA TC A T AA A A T CT A C G
G A A G G A A AACA CA TC A T AA A T CT A C G
T
T
T
T
T
GAG
G
GGAG ATG
GGAG ATG
GGAG ATG
GGAG ATG
GGAG ATG
UG
G GAG A
AUG
GGAG
G AUG
AUG
G AG
A
B
Figure 10.2: Alignment of dppA leaders. (A) Alignment of dppA leaders of diverse enterobacteria indicates
conservation of the GcvB interaction site. ST: Salmonella typhimurium, EC: Escherichia coli, YP: Yersinia
pestis, EW: Erwinia carotovora, PL: Photorhabdus luminescens. Shine-Dalgarno and start codon (ATG)
are indicated in red bold letters. (B) Mapped GcvB interaction site for Salmonella and predicted interaction
sites are highlighted in blue and grey, respectively.
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1 100
ST_oppA AT C -- A GCG T ACG A GT C AAT A AAA CG-G GA AGCAAA - AGT AC GA---- ---GC G AC CCA CA G
EC_oppA AT CA--T A GTG T TC G A AC C AAT A AAA CG-G GA AGTAA TA C AT AGTAA ACAGC GAAA GTCT CGAGC
YP_oppA GT TT -- T CTA TT CC TCG CA AC A A CACC A G GAGGTT T CC G T C T -- ----CC GGT ACG AAA--
PL_oppA AG CTGT T GAT AAA A T GA A C TT T AAAAG GT C GAGA CC T A ACAA C T - ------T T TA G AG G
EW_oppA A TG GC AGC G T T TG GTT TC G T CC ---C T GT G G G AGTCG C T AATC C
101 200
ST_oppA C GCACAG A G C-G G ATTAAACA G G A A C GT AT TATAATG G AC A C -C T T G A GTT
EC_oppA C G GCAG G T AATCCG G ATTA ACA TG G T A C GT AT TATAATG G- CC A C C C G G GTT
YP_oppA --- TTAGA TA GTT AA TGAGT T C T C GGGCAATAC T A A A AC T T AC C G G TC
PL_oppA --G A TCC C T T CT GGC C G A A GTCT G TG A A T -- G AG T CA G A G G C
EW_oppA T C C CA G A T C C AAT G CTGG A C A C C -- ----- T C CT A
201 225
ST_oppA GA A G GA AC A
EC_oppA G A A T GCG TC G
YP_oppA CA A A T G AGC T
PL_oppA C A T AGC C G
EW_oppA G G A T G
5'-...A A C...-3' EC
AAA ACA AC CAACAUCAC
UUU UGUUGUUG GUUGUAGUG
3'-...G G U U...-5' EC GcvB
5'-... C A A A C A...-3' YP
UA AUAUA AC ACC AC U ACAAAG
CGU UGUGU UGUA UGG UG G UGUUUC
3'-...A U G G...-5' YP GcvB
5'-... A...-3' EW
AAAAUA ACAC ACAUCACAACUA
UUUUUUUAU G UUGUG UGUAGUGUUGGU
3'-...G C U U G...-5' EW GcvB
5'-... A A...-3' PL
UAAACACAACG
AC GUUUGUGUUGU
3'-...A A...- 5' PL GcvB
oppA
oppA
oppA
oppA
C A G A A CG A A TC AG AA GT T T A GC G A CTG A T A C GT
C A A CG T A TC AG AA GT T T TA CG A G A A CTG A C
C G A A G A A C TAG AAA T AC T T TA CG TA GG T G T C A A C
C A A A A T A C G TAG T A C A T A T C GC A A AT G T CT T G T C GT
A G A CG A TAA T G T TAA CT GT AC ATT CTA C CT GGGA AT G T TG AAT G A T GT
T GA CC T A G G CT A A CA A T T A A C A TC A AA
T T G CC G C CT TA CA A T A A A A AC A TC A A
T A C T AGG T G CT C T A A TA T T A A AC A TC A A A A
T A A CC T ATT G CGT G CT A A A GAC A T A T T A A A A AA A A A
T T A G C T ATT AGG CGT A A C TA CA GAC A ATTA A A A AC A TC A AA AA
T TG C G A TC CT
TA G C G T GCT
T T C GCT C G T
TA T T C A A C GCT
A G T C CGCTA ATC GC
G G A T C
G G A T C
G G A T C
G G A T C
G G A T C
C G T A A A A ACA AC A A A
C G T A A A A ACA AC A A A
C G T A A A A ACA AC A A A
C G T A A A A ACA AC A A A
C G T A A A A ACA AC A A A
T C G T GC
T C G T GC
T C G T GC
T C G T GC
T C G T GC
GGAG ATG
GGAG ATG
GGAG ATG
GGAG ATG
GGAG ATG
AUG
GGA G
G AU
G A
GAG U G
A
UG
A
B
Figure 10.3: Alignment of oppA leaders. (A) Alignment of oppA leaders of diverse enterobacteria indicates
conservation of the GcvB interaction site. ST: Salmonella typhimurium, EC: Escherichia coli, YP: Yersinia
pestis, EW: Erwinia carotovora, PL: Photorhabdus luminescens. Shine-Dalgarno and start codon (ATG)
are indicated in red bold letters. (B) Mapped GcvB interaction site for Salmonella and predicted interaction
sites are highlighted in blue and grey, respectively.
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1 100
ST_gltI T AC T GCGC C GCA --- ---- C AA A CT A G G G CG G C G T --- -
EC_gltI C AC T AA A C CG A AC C C AA CG GT CA G G TCTTA C G A --- -
YP_gltI TAA A G G TT A AT CG TT T G CC - GTG T CAC A TA GC A A A GC CC
EW_gltI G TGTT AC G A A C G C C TT C TA TGG- T T G G AC G G T A T TT G AGC GC A AC
PL_gltI T A AA GATCC A TT A A C A T G AG --G T CA A A GCAA AT G C T AT -
101 158
ST_gltI T A G AA CA C G CA G A C T T G CC T G
EC_gltI T A CT CA C C CGCC G CG C TT C A AC G A
YP_gltI T G G TGC A T AGCA G A AAGTA C G T
EW_gltI G A T C A TC T T C CTG C CA T CA C
PL_gltI GT T A TA A C A T A T C G G GG CT CTCAA
5'-...A G A C G...-3' EC
AGUUGCAGAC AUAACAACACA ACA UCACAAC
UUAACGUUUG UGUUGUUGUGU UGU AGUGUUG
3'-...G G...-5' EC GcvB
5'-...U A...-3' YP
CACAACAUUA
GUGUUGUAGU
3'-...U G...-5' YP GcvB
5'-...U A U C...- 3' PL
UGCAAACACAACAUCGCAA CG A AGCCA
ACGUUUGUGUUGUAGUGUU GU U UCGGU
3'-...A G G U U...-5' PL GcvB
two alternative sites are predicted for Erwinia:
5'-...C C U A G C A...-3' EW
AGC G UAUAAC AUUGCAGC AC A AGC AAAGG
UCG U GUGUUG UAGUGUUG UG U UCG UUUUC
3'-...A U U G G G...-5' EW GcvB
5'-...U U C U U...-3' EW
AACG GACA CA UAACC UA GGUUA
UUGU UUGU GU GUUGG GU UCGGU
3'-...U G A U U...-5' EW GcvB
gltI
gltI
gltI
gltI
gltI
A AC GC AC AAGT TG AG AT AAC A A T AC T G T A T C TC A CG A A G T GG T
A AC GC AC T AAGT TG AGA AT AAC A ACA A T AC G T T C T ACG A A G T GG T
CA G C TT A T AAGAA T C A A A A T T TT T AC ACAT A A G AAAC CA GG
A CAA A TT AAG T A G A A A A C T A T TG C TA A C A C AACG CA G
A CAAC GC A T T GA AA A A ACA A ACT TTG AC ACATC ACG A C CA T T
AA CT C GCAA GC G T T G TG GC G G T GC
AA AC GC GCAA C CT T GC G G T GC
AAA G A T GC T T G C G T G ATG G GT GC
AAA G ACT GC T T CA G T CT G A GC G G GC
A G CT G T T C A G G T CT G ATG G G G
A A C A C A AA TT A
A A C A C A AA TT A
A A C A C A AA TT A
A A C A C A AA TT A
A A C A C A AA TT A
C T CGT AA A T T G C
C T CGT AA A T T G C
C T CGT AA A T T G C
C T CGT AA A T T G C
C T CGT AA A T T G C
AGGA G AT
AGGA G AT
AGGA G AT
AGGA G AT
AGGA G AT
G
G
G
G
G
A
B
Figure 10.4: Alignment of gltI leaders. (A) Alignment of gltI leaders of diverse enterobacteria indicates
conservation of the GcvB interaction site. ST: Salmonella typhimurium, EC: Escherichia coli, YP: Yersinia
pestis, EW: Erwinia carotovora, PL: Photorhabdus luminescens. Shine-Dalgarno and start codon (ATG)
are indicated in red bold letters. (B) Mapped GcvB interaction site for Salmonella and predicted interaction
sites are highlighted in blue and grey, respectively.
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1 100
ST_livK TAG-- ------C A AA A TT CTT C AC G A A C TT TT TGCT T G TG C
EC_livK T A-- ------AT A A T A TT CTG C C AC GG A A C CT TT C A A TG CC C
YP_livK T GCTTGT C T G CT C G G T - C A A AG CT T G T A
EW_livK T GA AGG G G G CT C G AT -CC A C T TAAT - GC T
PL_livK G C TTG T A T TA G G TA AC A- AT T TT CT TCAGTGA
101 200
ST_livK G G C A T A G - C C T TAA TA T CTT TT C GC A AC A T- A TCAC CAG
EC_livK C GAC A GCA G AG AT AAA A T ATT T T TA AC G AC CA TCAC TTTT
YP_livK T AC T A C T GT - TG T A - C --- -AC C GCATGT T CA G ---- ATTC-
EW_livK CT AC T-A G T C G-G TGG G AGG G --- - TTT GGC -----AT T C TA G ---- TAA A-A
PL_livK CA AG C C GTT TCC T G- A T-- GG T TAAA --- - T TT G C -- C -AC- TA ACT
201 248
ST_livK -C C CGG A G- -- AA AA C AT G
EC_livK - CT CGG AT G- -- TA CA C ATG
YP_livK -CGG T A C AA GTGT GC G T G
EW_livK - - T C GTAA GTAT GC GATG T G
PL_livK T A A C T GC AT A C
5'-...A A A...-3' EC
AAACA AGCAACACAACAUCACGA
UUUGU UUGUUGUGUUGUAGUGUU
3'-...G G G...-5' EC GcvB
5'-...A A G G U A U...-3' YP
CAAACACAAC A CAU U UCACAA G CAGA
GUUUGUGUUG U GUG G GGUGUU C GUUU
3'-...C A U U G U...-5' YP GcvB
5'-...G C G A...-3' EW
GCAAUAUC AUAAU ACAG
UGUUGUAG UGUUG UGUU
3'-...G G C...-5' EW GcvB
5'-...G A A A...-3' PL
GUAAACACAAU A UUA GACCA
CGUUUGUGUUG U AGU UUGGU
3'-...A G G...-5' PL GcvB
livK
livK
livK
livK
AT A G GC A T TT AG A G TT A A TAAAT C CGCTAA T A
AT A C T C A T TT G G TT G A AT A C AAAT C CGCTAA
T T A TTG T TTGC C A AA C T T G A AA G T T A G AAAAAT A A T CAA G TAA T A
T C T A TTG T TTGC C A AA C T T A A AA G T A G AAA AT A CTAA AA C CTAA
A A C T A TTG T TT C AA T C TT A A AA TT T A AAAAAT A CT AT AA T A
TTAAT A T G A AA C G AC A T A AA G AGTC TAA A A AAA AAA T G AT ATA G
TTAAT A G AAAC AGT C A AA GA AGTC GT AA ACA AAA AAA G AT AT G
TTA T TTA G A AAA TAC A TA A C A A A TCA AAA ACA A AA T G -T A G
TT T TTA A AAA AG A TA CA GTCA GT A A T G -T A
AA AT A G C A TA A A C GA A GTAAA ACA A AAA A A T -- A A
A AGC AC GCA G T T
A GC AC GCA G A T
T A AG GT GC G TGTA
AA T AG GT TGTA
AA T AGCAG GT AC GCA TGTA T
CT A AG AT A TTAAT T GAAAAATA TTA T C
CT A AG AT A TTAAT T GAAAAATA TTA T C
CT A AG AT A TTAAT T GAAAAATA TTA T C
CT A AG AT A TTAAT T GAAAAATA TTA T C
CT A AG AT A TTAAT T GAAAAATA TTA T C
A T A C G C CA A AC A A
A T A C G C CA A AC A A
A T A C G C CA A AC A A
A T A C G C CA A AC A A
A T A C G C CA A AC A A
AAA A AAA T T GG T GC
AAA A AAA T T GG T GC
AAA A AAA T T GG T GC
AAA A AAA T T GG T GC
AAA A AAA T T GG T GC
G GGG
G GGG
G GGG
G GGG
G GGG
ATG
ATG
ATG
ATG
ATG
A
B
Figure 10.5: Alignment of livK leaders. (A) Alignment of livK leaders of diverse enterobacteria indicates
conservation of the GcvB interaction site. ST: Salmonella typhimurium, EC: Escherichia coli, YP: Yersinia
pestis, EW: Erwinia carotovora, PL: Photorhabdus luminescens. Shine-Dalgarno and start codon (ATG)
are indicated in red bold letters. (B) Mapped GcvB interaction site for Salmonella and predicted interaction
sites are highlighted in blue and grey, respectively.
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1 100
ST_livJ T T T C T T
EC_livJ T TG T T T C
101 144
ST_livJ T G T
EC_livJ G
5'-...C C A A...-3' EC
AACAU ACAACAC ACGU AUAACC
UUGUG UGUUGUG UGUA UGUUGG
3'-...U U U G C...-5' EC GcvB
livJ
GAGTATGCTG CTAAAGCACG GGTAG A CA AA CGA AATAAAGTGC TGAA AA AA CA CACAACA CACGTAA AA CCAGAA AAT TT TC
GAGTATGCTG CTAAAGCACG GGTAG A CA AA CGA AATAAAGTGC TGAA AA AA CA CACAACA CACGTAA AA CCAGAA AAT TT TC
AGG AA A T AAGGGTAA A CGTTA TG GCAGGATGTA TCGC
AGG AA A T AAGGGTAA A CGTTA TG GCAGGATGTA TCGC
GGGGA
GGGGA
ATG
ATG
C GC A C C A
C A A A C G
A
C A C
1 100
ST_argT T T TT G T
EC_argT T T GT T T G G
101 193
ST_argT G C GT G TG - G T G G G G
EC_argT T C G TTTT T T G T G C T
5'-...C A...-3' EC
UGCAAACACA CAACACAAUA CACAAC
ACGUUUGUGU GUUGUGUUGU GUGUUG
3'-...A U A G...-5' EC GcvB
argT
AGGACAATA TGCAACGT T TATTAACA A TTTAACGT G AAT T TG TG CGT AA ATGGCATAA GACCTGCATG AAA AG CTG CAAACACACA
AGGACAATA TGCAACGT T TATTAACA A TTTAACGT G AAT T TG TG CGT AA ATGGCATAA GACCTGCATG AAA AG CTG CAAACACACA
AC C A A AACATAA A AA A CACTTG TATGT A AGAAG C T TCTCGCT TG TCTTTG T T GGTCT C C
AC C A A AACATAA A AA A CACTTG TATGT A AGAAG C T TCTCGCT TG TCTTTG T T GGTCT C C
AGGG ATG
AGGG ATG
A C CG C A A A
A C AC C C
C A A CGC G A C C A A G
A A AC A CC A C A C C A
A
B
Figure 10.6: Alignment of livJ and argT leaders. (A, B) Alignment of livJ and argT leaders of Salmonella
and E. coli indicates conservation of the GcvB interaction site. ST: Salmonella typhimurium, EC: Es-
cherichia coli. Shine-Dalgarno and start codon (ATG) are indicated in red bold letters. Mapped GcvB
interaction site for Salmonella and predicted interaction sites are highlighted in blue and grey, respectively.
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This section contains a supplementary Table to Chapter 4.
Table 10.4: DNA oligonucleotides used in this study.
Sequences are given in 5’→ 3’ direction and 5’P denotes a 5’-mono-phosphate.
Name Sequence Used for
JVO-0367 ACTGACATGGAGGAGGGA GFP fusion cloning
JVO-1275 GTTTTGCTAGCTAGCGACTGTTCAGCCG GFP fusion cloning
JVO-2850 GTTTTTATGCATGCCGTTTCCCCTCCAAT GFP fusion cloning
JVO-2851 GTTTTTGCTAGCGTTCAAACTGACGCTTTCAGTT GFP fusion cloning
JVO-2971 GTTTTTATGCATGCAAACACTTTGTTACATCCTG GFP fusion cloning
JVO-3087 GTTTTTGCTAGCTGATGCTCGTTGCGTAGC GFP fusion cloning
JVO-2058 GTTTTTATGCATTAACGTTAAACACAACACAAAT GFP fusion cloning
JVO-2059 GTTTTTGCTAGCACCCACTGCCGCA GFP fusion cloning
JVO-2806 GTTTTATGCATGCAAATACATATTCTGATAAAACG GFP fusion cloning
JVO-2807 GTTTTTGCTAGCGAGGAACGATTCCAGAGAAC GFP fusion cloning
JVO-2969 GTTTTTATGCATTTAATTTCACTTGCGACTTTG GFP fusion cloning
JVO-2970 GTTTTTGCTAGCCCAGCCGATAAAACCAAC GFP fusion cloning
JVO-2800 GTTTTATGCATGGAAGAAAAAACTGTGTTATGTATGT GFP fusion cloning
JVO-2801 GTTTTTGCTAGCGATACGGTCGAGATCTTTGC GFP fusion cloning
JVO-2804 GTTTTATGCATATTCGCACAGATAGCAATCTG GFP fusion cloning
JVO-2805 GTTTTTGCTAGCGCGCAGATTCAGTGTATTAAAG GFP fusion cloning
JVO-2973 GTTTTTATGCATAAAAAATAACAGGAGCATGACAC GFP fusion cloning
JVO-2874 GTTTTTGCTAGCCAGCGCCTGTAGTGTTCTG GFP fusion cloning
JVO-2842 GTTTTTATGCATTCAGGTGCTGTCATTACGAC GFP fusion cloning
JVO-2843 GTTTTTGCTAGCGATATCGCGCGATTTTAACT GFP fusion cloning
JVO-3388 GTTTTTATGCATAGTTAAGTAAACTGGTAGATGTTGC GFP fusion cloning
JVO-3389 GTTTTTGCTAGCATTGAACCAAATATAATCAGCTTT GFP fusion cloning
JVO-3378 GTTTTTATGCATATACAAGACAGACAAATAAAAATGAC GFP fusion cloning
JVO-3379 GTTTTTGCTAGCACCGTTACCTGTGGTAATGG GFP fusion cloning
JVO-3380 GTTTTTATGCATATTTGGCAATCAAGACGTT GFP fusion cloning
JVO-3381 GTTTTTGCTAGCGGTAACGACGCGGATCT GFP fusion cloning
JVO-2965 GTTTTTATGCATCTGACATAACAACAGAACATATTTCA GFP fusion cloning
JVO-2808 GTTTTTGCTAGCGTTGGGTTTAATGATGGAAAAAG GFP fusion cloning
JVO-2967 GTTTTTATGCATTTCATCTGCTATTTCCCGC GFP fusion cloning
JVO-2968 GTTTTTGCTAGCTTTATCTTTCTCCAGCGATACCT GFP fusion cloning
JVO-3330 TTTTTGCTAGCGTCGGCTGCGACTTTTA GFP fusion cloning
JVO-0323 CCCTTTGCTAGCAAAGGAGAAGAACTTTTCACTG GFP fusion cloning
JVO-0749 TTCGTTCCGGCTCAGGA Northern blot probe
JVO-0750 AATCACTATGGACAGACAGGGTA Northern blot probe
JVO-0322 CTACGGCGTTTCACTTCTGAGTTC Northern blot probe
JVO-0897 5’P-ACTTCCTGAGCCGGAAC sRNA cloning
PZE-XbaI TCGTTTTATTTGATGCCTCTAGA sRNA cloning
PLlaco-D GTGCTCAGTATCTTGTTATCCG sRNA cloning
JVO-0895 5’P-ACATTTACCCTGTCTGTCC sRNA cloning
JVO-0896 5’P-GAAAAAGGGTAGTCTCGC sRNA cloning
JVO-2856 5’P-TGCAAACACAACAACACAA sRNA cloning
JVO-2857 GGTAGCGAGACTACCCTTTT sRNA cloning
JVO-2858 CACTTCCTGTACATTTACCCTG sRNA cloning
continued on next page
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Name Sequence Used for
JVO-0745 5’P-ACCGTAAGCCAAAAGC sRNA cloning
JVO-2989 5’P-CACTTCCTGTACATTTACCCTG sRNA cloning
JVO-0746 5’P-CAATTGGTCTGCGATTC sRNA cloning
JVO-2986 AGCACCGCCATATTGC sRNA cloning
JVO-3327 ACTTCCTCTACATTTACCCTGTGTGTCCATAGTGATTAATGTAG
CAC
sRNA cloning
JVO-3328 ATGGACACACAGGGTAAATGTAGAGGAAGTGGTGCTCAGTAT
CT
sRNA cloning
JVO-2990 5’P-GGAACGAAAAGTTTTATCGG sRNA cloning
JVO-0743 5’P-GCCGCCACTATAGGTATT sRNA cloning
JVO-3355 TTGTTATCCGCTCACAATTC sRNA cloning
JVO-1396 5’P-ACTTCCTGAGCCGGAAC sRNA cloning
JVO-3466 AGCACACCTCCTGAGCCGGAACG sRNA cloning
JVO-3467 CTCAGGAGGTGTGCTCAGTATCTTGTTATCC sRNA cloning
JVO-3464 ACTTCCTCAGCCGGAACGAAAAGTTT sRNA cloning
JVO-3465 TCCGGCTGAGGAAGTGTGCTCAGTATCTTGT sRNA cloning
JVO-3468 TCCTGAGGCGGAACGAAAAGTTTTATCG sRNA cloning
JVO-3469 CGTTCCGCCTCAGGAAGTGTGCTCAGTATCT sRNA cloning
JVO-0941 GTTTTTTTTAATACGACTCACTATAGGACTTCCTGAGCCGG T7 template
JVO-0942 AAAGCACCGCAATATG T7 template
JVO-0742 5’P-AAAAAAGGGTAGTCTCGCTAC T7 template
JVO-0937 GTTTTTTTTAATACGACTCACTATAGGAAAGACGCGCATTT T7 template
JVO-0938 AAAGGCCACTCACGG T7 template
JVO-1274 GTTTTTTTTAATACGACTCACTATAGGTCCTGATAACAGGATC
GT
T7 template
JVO-1042 TATGACGGTTTGTAAGATTG T7 template
JVO-1976 TCACCATCTAATTCAACAAGAATTG T7 template, toeprinting
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10.3. Appendix to Chapter 5
This section contains supplementary Tables to Chapter 5.
Table 10.5: Salmonella rRNAs, tRNAa, and housekeeping RNAS listed in the annotation file
LT2 rRNA tRNA hkRNAs.txt.
Product Name Start End Strand Length GeneID Locus Locus tag Links
16S ribosomal RNA 289189 290732 + 1544 1251767 rrsH STM0249 -
Ile tRNA 290800 290873 + 74 1251768 ileV STM0250 -
Asx tRNA 290986 291058 + 73 1251769 alaV STM0251 -
23S ribosomal RNA 291244 294336 + 3093 1251770 rrlH STM0252 -
5S ribosomal RNA 294519 294640 + 122 1251771 rrfH STM0253 -
Val tRNA 294838 294911 + 74 1251772 aspU STM0254 -
Sec tRNA 304277 304350 + 74 1251783 aspV STM0265 -
Thr tRNA 368806 368878 + 73 1251842 thrW STM0323 -
4.5S ribosomal RNA 524424 524539 + 116 1251987 ffs SRP STM0467 SRP -
Arg tRNA 613567 613640 + 74 1252073 argU STM0553 -
- 617984 618056 + 73 2673761 - STM05559.T1 -
Gln tRNA 738011 738082 - 72 1252193 glnX STM0673 -
Gln tRNA 738129 738200 - 72 1252194 glnV STM0674 -
Xaa tRNA 738250 738323 - 74 1252195 metU STM0675 -
Gln tRNA 738342 738413 - 72 1252196 glnW STM0676 -
Gln tRNA 738452 738523 - 72 1252197 glnU STM0677 -
Leu tRNA 738550 738631 - 82 1252198 leuW STM0678 -
Met tRNA 738643 738716 - 74 1252199 metT STM0679 -
Lys tRNA 818775 818847 + 73 1252271 lysT STM0751 -
Val tRNA 818982 819054 + 73 1252272 valT STM0752 -
Lys tRNA 819061 819133 + 73 1252273 lysW STM0753 -
Lys tRNA 819186 819258 + 73 1252274 lysY STM0754 -
Lys tRNA 819396 819468 + 73 1252275 lysZ STM0755 -
Ser tRNA 1027441 1027525 - 85 1252468 serW STM0949 -
Ser tRNA 1175321 1175405 + 85 1252604 serT STM1086 -
Ser tRNA 1224743 1224827 - 85 1252652 serX STM1134 -
Xaa tRNA 1333209 1333282 + 74 1252765 - STM1247 -
Xaa tRNA 1345647 1345720 + 74 1252780 - STM1262 -
Val tRNA 1501640 1501713 - 74 1252941 valW STM1423 -
Val tRNA 1501727 1501800 - 74 1252942 valV STM1424 -
Tyr tRNA 1852570 1852651 + 82 1253276 tyrT STM1757 -
Tyr tRNA 1852859 1852940 + 82 1253278 tyrV STM1759 -
Leu tRNA 2035366 2035449 - 84 1253463 leuZ STM1942 -
Cys tRNA 2035464 2035534 - 71 1253464 cysT STM1943 -
Gly tRNA 2035590 2035662 - 73 1253465 glyW STM1944 -
Ser tRNA 2082177 2082263 - 87 1253521 serU STM2000 -
Asn tRNA 2083250 2083322 + 73 1253523 asnT STM2002 -
Asn tRNA 2084220 2084292 + 73 1253525 asnT STM2004 -
Asn tRNA 2094165 2094237 - 73 1253533 asnW STM2012 -
Asn tRNA 2095995 2096067 + 73 1253535 asnU STM2014 -
Pro tRNA 2330749 2330822 + 74 1253751 tRNAPro2 STM2229 -
Arg tRNA 2505822 2505893 + 72 1253916 argW STM2394 -
Ala tRNA 2528939 2529011 - 73 1253933 alaX STM2411 -
Ala tRNA 2529057 2529129 - 73 1253934 alaW STM2412 -
Val tRNA 2531835 2531907 + 73 1253938 valU STM2416 -
Val tRNA 2531956 2532028 + 73 1253939 valX STM2417 -
Val tRNA 2532073 2532145 + 73 1253940 valY STM2418 -
Lys tRNA 2532153 2532225 + 73 1253941 lysV STM2419 -
Xaa tRNA 2761647 2761720 - 74 1254138 - STM2615
5S ribosomal RNA 2796440 2796561 - 122 1254179 rrfG STM2656 -
23S ribosomal RNA 2796755 2799764 - 3010 1254180 rrlG STM2657 -
Sec tRNA 2799958 2800030 - 73 1254181 gltW STM2658 -
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16S ribosomal RNA 2800118 2801660 - 1543 1254182 rrsG STM2659 -
regulatory RNA 2843947 2844309 + 363 1254216 tmRNA STM2693 tmRNA -
Arg tRNA 2969928 2970001 - 74 1254344 - STM2821 -
Arg tRNA 2970198 2970271 - 74 1254345 - STM2822 -
Arg tRNA 2970337 2970410 - 74 1254346 - STM2823 -
Arg tRNA 2970476 2970549 - 74 1254347 - STM2824 -
Ser tRNA 2970556 2970645 - 90 1254348 - STM2825 -
Met tRNA 3141064 3141137 + 74 1254512 metZ STM2989 -
Met tRNA 3141170 3141243 + 74 1254513 metW STM2990 -
Gly tRNA 3197425 3197495 - 71 1254560 glyU STM3037 -
Phe tRNA 3276146 3276218 + 73 1254639 pheV STM3116 -
Ile tRNA 3379004 3379076 + 73 1254736 ileX STM3213 -
regulatory RNA 3414805 3415177 - 377 1254769 rnpB STM3246 RNaseP -
Met tRNA 3458506 3458579 - 74 1254812 metY STM3289 -
Leu tRNA 3461755 3461838 - 84 1254815 leuU STM3292 -
5S ribosomal RNA 3566622 3566743 - 122 1254916 rrfF STM3393 -
Thr tRNA 3566784 3566856 - 73 1254917 thrV STM3394 -
5S ribosomal RNA 3566867 3566988 - 122 1254918 rrfD STM3395 -
23S ribosomal RNA 3567078 3570071 - 2994 1254919 rrlD STM3396 -
Gln tRNA 3570307 3570379 - 73 1254920 - STM3397 -
16S ribosomal RNA 3570463 3572006 - 1544 1254921 rrsD STM3398 -
Pro tRNA 3820412 3820485 - 74 1255158 proK STM3634 -
Sec tRNA 3948576 3948666 + 91 1255275 selC STM3751 -
16S ribosomal RNA 4100132 4101675 + 1544 1255416 rrsC STM3889 -
Trp tRNA 4101759 4101831 + 73 1255417 gltU STM3890 -
23S ribosomal RNA 4102028 4105021 + 2994 1255418 rrlC STM3891 -
5S ribosomal RNA 4105111 4105230 + 120 1255420 rrfC STM3894 -
Sec tRNA 4105283 4105362 + 80 1255421 aspT STM3895 -
Xaa tRNA 4105368 4105440 + 73 1255422 trpT STM3896 -
Arg tRNA 4140908 4140981 + 74 1255457 argX STM3931 -
His tRNA 4141039 4141111 + 73 1255458 hisR STM3932 -
Leu tRNA 4141135 4141218 + 84 1255459 leuT STM3933 -
Pro tRNA 4141264 4141337 + 74 1255460 proM STM3934 -
16S ribosomal RNA 4196059 4197600 + 1542 1255514 rrsA STM3988 -
Ile tRNA 4197670 4197743 + 74 1255515 ileT STM3989 -
Asx tRNA 4197858 4197930 + 73 1255516 alaT STM3990 -
23S ribosomal RNA 4198116 4201110 + 2995 1255517 rrlA STM3991 -
5S ribosomal RNA 4201302 4201423 + 122 1255518 rrfA STM3992 -
16S ribosomal RNA 4351130 4352673 + 1544 1255658 rrsB STM4132 -
Val tRNA 4352741 4352814 + 74 1255659 ileU STM4133 -
Ala tRNA 4352929 4353001 + 73 1255660 - STM4134 -
23S ribosomal RNA 4353187 4356180 + 2994 1255661 rrlB STM4135 -
5S ribosomal RNA 4356373 4356493 + 121 1255662 rrfB STM4136 -
Thr tRNA 4360046 4360118 + 73 1255668 thrU STM4142 -
Tyr tRNA 4360130 4360211 + 82 1255669 tyrU STM4143 -
Gly tRNA 4360331 4360402 + 72 1255670 glyT STM4144 -
Thr tRNA 4360412 4360484 + 73 1255671 thrT STM4145 -
16S ribosomal RNA 4394675 4396219 + 1545 1255703 rrsE STM4177 -
Sec tRNA 4396303 4396375 + 73 1255704 gltV STM4178 -
23S ribosomal RNA 4396611 4399604 + 2994 1255705 rrlE STM4179 -
5S ribosomal RNA 4399797 4399918 + 122 1255706 rrfE STM4180 -
Phe tRNA 4566577 4566649 - 73 1255847 pheR STM4321 -
Gly tRNA 4596412 4596484 + 73 1255878 glyV STM4352 -
Gly tRNA 4596644 4596716 + 73 1255879 glyX STM4353 -
Gly tRNA 4596876 4596948 + 73 1255880 glyY STM4354 -
Leu tRNA 4730996 4731077 + 82 1256013 leuX STM4487 -
Leu tRNA 4810613 4810696 - 84 1256079 leuV STM4553 -
Leu tRNA 4810731 4810814 - 84 1256080 leuP STM4554 -
Leu tRNA 4810845 4810928 - 84 1256081 leuQ STM4555 -
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Table 10.6: Known Salmonella sRNAs listed in the annotation file LT2 known sRNAs.txt.
Product Name Start End Strand Length GeneID Locus Locus tag Links
sRNA 13507 13591 + 84 1 IGR dnaK dnaJ tpke11 -
sRNA 126707 126796 - 90 2 IGR tbpA yabN sroA -
sRNA 128574 128812 + 239 3 IGR yabN leuD sgrS -
sRNA 176082 176238 - 157 4 IGR pdhR aceE tp2 -
sRNA 254130 254268 + 139 5 IGR map rpsB t44 -
sRNA 505384 505439 - 56 6 IGR clpX lon sraA -
sRNA 556005 556085 + 81 8 IGR ybaK ybaP sroB -
sRNA 728761 728913 - 153 9 IGR gltJ gltI sroC -
sRNA 902040 902128 - 89 10 IGR ybiP STM0835 rybA -
sRNA 942554 942632 - 79 11 IGR STM0869 STM0870 rybB -
sRNA 1275071 1275236 + 166 12 IGR yceF yceD sraB -
sRNA 1444832 1444938 - 107 13 IGR ydiL ydiK rprA -
sRNA 1450415 1450519 + 105 14 IGR ydiH STM1368 rydB -
sRNA 1729673 1729738 + 66 15 IGR STM1638 cybB rydC -
sRNA 1745678 1745786 - 109 16 IGR nifJ ynaF micC -
sRNA 1968053 1968155 - 103 17 IGR STM1871 STM1872 ryeB -
sRNA 2068649 2068736 - 88 18 IGR yodD yedP dsrA -
sRNA 2077175 2077269 + 95 19 IGR STM1994 ompS rseX -
sRNA 2213871 2214016 + 146 21 IGR yegD STM2126 ryeC -
sRNA 2231130 2231216 + 87 20 IGR yegQ STM2137 ryeE -
sRNA 2366913 2367005 + 93 22 IGR ompC yojN micF -
sRNA 2515608 2516006 - 399 23 IGR ddg yfdZ tpke70 -
sRNA 2674934 2675228 + 295 24 IGR STM2564 sseB ryfA -
sRNA 2707664 2707847 - 183 25 IGR yfhK purG sroF -
sRNA 2966853 2966926 + 74 27 IGR luxS gshA micA -
sRNA 2987638 2987745 + 108 28 IGR ygbD hypF C0664 -
sRNA 3044924 3045015 + 93 47 IGR invH STM2901 invR -
sRNA 3116697 3117059 - 363 29 IGR yqcC syd csrB -
sRNA 3135317 3135522 + 206 30 IGR gcvA ygdL gcvB -
sRNA 3170122 3170208 - 87 31 IGR aas galR omrA -
sRNA 3170323 3170408 - 86 32 IGR aas galR omrB -
sRNA 3222098 3222280 + 183 33 IGR ygfE ygfA ssrS -
sRNA 3222913 3223065 + 153 34 IGR ygfA serA rygC -
sRNA 3362327 3362474 - 148 35 IGR yqiK rfaE rygD -
sRNA 3392069 3392261 + 193 36 IGR ygjR ygjT sraF -
sRNA 3451437 3451607 + 174 38 IGR pnp rpsO sraG -
sRNA 3490383 3490500 + 118 39 IGR yhbL arcB sraH -
sRNA 3715401 3715495 - 95 40 IGR yhhX yhhY ryhB -
sRNA 3998018 3998147 - 130 41 IGR ilvB emrD istR -
sRNA 4141650 4141854 + 205 42 IGR yifK hemY sraJ -
sRNA 4209066 4209175 + 110 43 IGR polA yihA spot42 -
sRNA 4210157 4210400 + 244 44 IGR yihA yihI csrC -
sRNA 4342866 4342986 - 121 45 IGR argH oxyR oxyS -
sRNA 4504870 4505010 - 141 46 IGR soxR STM4267 sraL -
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Table 10.7: Predicted Salmonella sRNAs listed in the annotation file sRNAs
LT2 predicted sRNAs.txt.
Product Name Start End Strand Length GeneID Locus Locus tag Links
sRNA 46050 46114 - 65 1 IGR STM0038 nhaA STnc10 -
sRNA 51926 52260 + 335 2 IGR STM0042 rpsT STnc20 -
sRNA 58792 58923 + 132 3 IGR lytB STM0050 STnc30 -
sRNA 161464 161537 + 74 4 IGR secA mutT STnc40 -
sRNA 182458 182539 - 82 5 IGR lpdA-STM0155 STnc50 -
sRNA 230063 230277 - 215 6 IGR fhuB stfA STnc60 -
sRNA 670157 670305 + 149 7 IGR dsbG ahpC STnc70 -
sRNA 967580 967900 + 321 8 IGR STM0897 STM0898 STnc80 -
sRNA 974284 974363 + 80 9 IGR STM0903 STM0904 STnc90 -
sRNA 975011 975224 + 214 10 IGR STM0904 STM0905 STnc100 -
sRNA 976578 976765 + 188 11 IGR STM0905 STM0906 STnc110 -
sRNA 1004432 1004777 - 346 12 IGR STM0929 orfB STnc120 -
sRNA 1045098 1045232 - 135 13 IGR serS dmsA STnc130 -
sRNA 1113681 1113750 + 70 14 IGR STM1025 STM1026 STnc140 -
sRNA 1325649 1325914 - 266 15 IGR icdA STM1239 STnc150 -
sRNA 1345732 1345782 - 51 16 IGR STM1262 STM1263 STnc160 -
sRNA 1605784 1606116 - 333 17 IGR STM1528 STM1530 STnc170 -
sRNA 1807565 1807776 - 212 18 IGR acnA cysB STnc190 -
sRNA 1937518 1937652 + 135 19 IGR STM1841 kdgR STnc200 -
sRNA 1979550 1979598 - 49 20 IGR edd zwf STnc210 -
sRNA 2032404 2032580 + 177 21 IGR yecA STM1939 STnc220 -
sRNA 2078990 2079068 - 79 22 IGR ompS cspB STnc240 -
sRNA 2115370 2115452 + 83 23 IGR pocR pduF STnc250 -
sRNA 2147333 2147409 - 77 24 IGR yeeF yeeY STnc260 -
sRNA 2596789 2596882 - 94 25 IGR acrD yffB STnc270 -
sRNA 2966073 2966247 + 175 26 IGR STM2816 luxS STnc290 -
sRNA 3179540 3179622 + 82 27 IGR kduI yqeF STnc310 -
sRNA 3194914 3194996 - 83 28 IGR tnpA 4 STM3033 STnc320 -
sRNA 3283807 3283965 - 159 29 IGR STM3123 STM3124 STnc330 -
sRNA 3393267 3393327 - 61 30 IGR ygjT ygjU STnc340 -
sRNA 3404895 3404949 + 55 31 IGR yhaO tdcG STnc350 -
sRNA 3468497 3468553 - 57 32 IGR greA dacB STnc360 -
sRNA 3635756 3635884 - 129 33 IGR tnpA 5 yhfL STnc370 -
sRNA 3761373 3761440 - 68 34 IGR uspA yhiP STnc380 -
sRNA 3780254 3780402 + 149 35 IGRyhjB yhjC STnc390 -
sRNA 3839688 3839758 + 71 36 IGR STM3654 glyS STnc400 -
sRNA 3885629 3885736 - 108 37 IGR STM3691 lldP STnc410 -
sRNA 3902594 3902653 - 60 38 IGR yibD tdh STnc420 -
sRNA 4051145 4051340 + 196 39 IGR STM3844 STM3845 STnc430 -
sRNA 4072507 4072730 + 224 40 IGR glmU STM3863 STnc440 -
sRNA 4251480 4251539 - 60 41 IGR yiiG STM4041 STnc450 -
sRNA 4441898 4442059 - 162 42 IGR pgi yjbE STnc460 -
sRNA 4559193 4559277 + 85 43 IGR STM4310 tnpA 6 STnc470 -
sRNA 4645079 4645134 - 56 44 IGR ytfL msrA STnc480 -
sRNA 4758187 4758332 - 146 45 IGR STM4503 STM4504 STnc490 -
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Table 10.8: Coverage of known and candidate Salmonella sRNA loci in pyrosequencing data.
sRNA1 Alternative IDs2 Reference3 Adjacent genes4 Orientation5 Start6 End6 Reads Reads Enrichment9 Northern
coIP-Ctr7 Hfq-coIP8 blot10
STnc10 - V STM0038/nhaA →←→ 46114 46050 0 0 np
STnc20 - V STM0042/rpsT ←→← 51926 52260 1 2 2.0 np
STnc30 - V lytB/STM005 →→→ 58792 58923 1 0 np
STnc470 - IV STM0081/STM0082 →←← 94548 94770 0 70 ≥70.0 ≈ 1250nt
sgrS ryaA I yabN/leuD ←→← 128574 128812 3 61 20.3
STnc40 - V secA/mutT →→→ 161464 161537 0 0 np
STnc50 - V lpdA/STM0155 →←→ 182539 182458 0 0 np
STnc60 - V fhuB/stfA →←→ 230277 230063 0 0 np
isrA - II STM0294.ln/STM0295 →→→ 339338 339760 0 0
sroB rybC I ybaK/ybaP ←→← 556005 556085 27 1530 56.7
STnc480 - IV glxK/ylbA →←← 587848 587926 4 74 18.5 nd
STnc70 - V dsbG/ahpC ←→→ 670157 670305 5 7 1.4 np
sroC - I gltJ/gltI ←←← 728913 728761 26 898 34.5
rybB p25 III STM0869/STM0870 →←← 942632 942554 3 103 34.3
STnc80 - V STM0897/STM0898 ←→← 967580 967900 0 0 np
STnc90 - V STM0903/STM0904 →→← 974284 974363 0 0 np
STnc100 - V STM0904/STM0905 ←→→ 975011 975224 0 0 np
STnc110 - V STM0905/STM0906 →→→ 976578 976765 0 0 np
STnc120 - V STM0929/orfB ←←→ 1004777 1004432 0 0 np
STnc49011 - IV clpA/tnpA 1 →←→ 1024975 1025165 75 385 5.1 ≈ 85nt
STnc130 - V serS/dmsA →←→ 1045232 1045098 0 0 nd
isrB-1 - II sbcA/STM1010 ←→← 1104179 1104266 2 4 2.0
STnc140 - V STM1025/STM1026 ←→← 1113681 1113750 0 0 np
STnc500 - IV STM1127/STM1128 ←←← 1216157 1216440 7 84 12.0 ≈ 65nt
sraB pke2 I yceF/yceD ←→→ 1275071 1275236 0 0
STnc640 - IV icdA/STM1239 →→→ 1325636 1326082 0 10 ≥10.0 ≈ 1500nt
STnc150 - V icdA/STM1239 →←→ 1325914 1325649 0 1 ≥1.0 ≈ 90nt
isrC - II envF/msgA ←→← 1329145 1329432 0 1 ≥1.0
STnc510 - IV STM1245/pagC →→→ 1331440 1332250 4 28 7.0 nd
STnc520 - IV STM1248/STM1249 →←← 1332809 1334044 12 100 8.3 ≈ 80nt
STnc160 - V STM1262/STM1263 →←→ 1345782 1345732 0 0 np
isrD - II STM1261/STM1263 →←→ 1345788 1345738 0 0
ryhB-2 isrE II STM1273/yeaQ →←→ 1352987 1352875 0 0
STnc530 - IV yeaJ/yeaH →←→ 1359779 1360418 2 15 7.5 nd
continued on next page
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sRNA1 Alternative IDs2 Reference3 Adjacent genes4 Orientation5 Start6 End6 Reads Reads Enrichment9 Northern
coIP-Ctr7 Hfq-coIP8 blot10
STnc540 - IV himA/btuC →→→ 1419369 1419570 7 23 3.3 ≈ 85nt
rprA IS083 I ydiK/ydiL ←←← 1444938 1444832 37 286 7.7
rydB tpe7, IS082 I ydiH/STM1368 →→← 1450415 1450519 4 10 2.5
STnc550 - IV purR/sodB ←→← 1508946 1509412 6 10 1.7 nd
STnc57012 yneM ORF IV ydeI/ydeE →←← 1593723 1594413 2 21 10.5 ≈ 190nt
STnc560 IV ydeI/ydeE →→← 1593723 1594413 10 290 29.0 ≈ 90nt
STnc170 - V STM1528/STM1530 ←←→ 1606116 1605784 0 0 np
isrF - II STM1552/STM1554 →←← 1630160 1629871 1 0
rydC IS067 I STM1638/cybB →→← 1729673 1729738 5 245 49.0
micC IS063, tke8 III nifJ/ynaF →←→ 1745786 1745678 0 15 ≥15.0
STnc580 - IV dbpA/STM1656 ←←← 1749662 1750147 11 311 28.3 ≈ 100nt
STnc180 - V acnA/cysB ←←← 1807776 1807565 1 5 5.0 ≈ 2000nt
STnc190 - V STM1841/kdgR →→← 1937518 1937652 1 12 12.0 ≈ 500nt
ryeB tpke79 I STM1871/STM1872 →←← 1968155 1968053 24 653 27.2
STnc200 - V edd/zwf ←←← 1979598 1979550 0 3 ≥3.0 nd
STnc210 - V yecA/STM1939 ←→← 2032404 2032580 0 0 np
dsrA - I yodD/yedP →←→ 2068736 2068649 6 149 24.8
rseX - I STM1994/ompS ←→→ 2077175 2077269 0 3 ≥3.0
STnc220 - V ompS/cspB →←← 2079068 2078990 0 8 ≥8.0 nd
STnc230 - V pocR/pduF ←→← 2115370 2115452 0 0 np
STnc240 - V yeeF/yeeY ←←← 2147409 2147333 0 1 ≥1.0 np
ryeC tp11 I yegD/STM2126 →→→ 2213871 2214016 42 72 1.7
cyaR ryeE III yegQ/STM2137 →→→ 2231130 2231216 31 659 21.3
isrG - II STM2243/STM2244 ←→→ 2344732 2345013 0 0
micF - III ompC/yojN ←→→ 2366913 2367005 0 11 ≥11.0
isrH-2 - II glpC/STM2287 →←→ 2394582 2394303 0 0
isrH-1 - II glpC/STM2287 →←→ 2394753 2394303 0 0
STnc25012 ypfM ORF V acrD/yffB →←→ 2596882 2596789 6 24 4.0 ≈ 220nt
ryfA tp1 I STM2534/sseB →→← 2674934 2675228 3 6 2.0
glmY tke1, sroF I yfhK/purG ←←← 2707847 2707664 20 92 4.6
isrI - II STM2614/STM2616 →←← 2761576 2761329 0 2 ≥2.0
isrJ - II STM2614/STM2616 →←← 2762031 2761957 1 0
isrK - II STM2616/STM2617 ←←← 2762867 2762791 0 0
isrB-2 - II STM2631/sbcA →←→ 2770965 2770872 0 0
isrL - II smpB/STM2690 →←→ 2839399 2839055 0 0
isrM - II STM2762/STM2763 ←→→ 2905050 2905378 0 0
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sRNA1 Alternative IDs2 Reference3 Adjacent genes4 Orientation5 Start6 End6 Reads Reads Enrichment9 Northern
coIP-Ctr7 Hfq-coIP8 blot10
isrN - II STM2764/STM2765 ←→← 2906925 2907067 0 0
STnc260 - V STM2816/luxS ←→← 2966073 2966247 0 0 np
micA sraD I luxS/gshA ←→← 2966853 2966926 1 128 128.0
STnc590 - IV avrA/sprB ←←← 3010807 3010966 3 27 9.0 nd
STnc600 - IV hilD/hilA →→→ 3018766 3019855 3 68 22.7 nd
invR STnc270 III invH/STM2901 →→→ 3044924 3045014 113 3236 28.6
csrB - III yqcC/syd ←←← 3117059 3116697 69 67
gcvB IS145 III gcvA/ygdI ←→← 3135317 3135522 12 402 33.5
omrA rygB III aas/galR ←←→ 3170208 3170122 0 51 ≥51.0
omrB t59, rygA, sraE III aas/galR ←←→ 3170408 3170322 1 52 52.0
STnc280 - V kduI/yqeF ←→← 3179540 3179622 0 1 ≥1.0 np
STnc290 - V tnpA 4/STM3033 ←←← 3194996 3194914 2 72 36.0 ≈ 85nt
isrO - II STM3038/STM3039 ←→→ 3198380 3198580 0 0
ssrS - I ygfE/ygfA →→→ 3222098 3222280 836 451
rygC t27 I ygfA/serA →→← 3222913 3223065 14 17 1.2
STnc300 - V STM3123/STM3124 ←←→ 3283965 3283807 0 0 np
rygD tp8, C0730 I yqiK/rfaE →←← 3362474 3362327 17 104 6.1
sraF tpk1, IS160 I ygjR/ygjT →→→ 3392069 3392261 0 25 ≥25.0
STnc310 - V ygjT/ygjU →←→ 3393327 3393267 0 0 np
STnc320 - V yhaO/tdcG ←→← 3404895 3404949 0 1 ≥1.0 np
STnc610 - IV yhbC/metY ←←← 3458296 3458578 1 19 19.0 ≈ 1250nt
STnc330 - V greA/dacB ←←→ 3468553 3468497 1 12 12.0 ≈ 1500nt
sraH ryhA I yhbL/arcB ←→← 3490383 3490500 55 2292 41.7
STnc340 - V tnpA 5/yhfL ←←→ 3635884 3635756 0 0 nd
ryhB-1 sraI, IS176 I yhhX/yhhY ←←→ 3715495 3715401 0 2 ≥2.0
STnc350 - V uspA/yhiP →←→ 3761440 3761373 0 0 nd
STnc360 - V yhjB/yhjC ←→→ 3780254 3780402 0 0 np
STnc370 - V STM3654/glyS ←→← 3839688 3839758 0 0 np
STnc380 - V STM3691/lldP →←→ 3885736 3885629 0 0 np
STnc390 - V yibD/tdh ←←← 3902653 3902594 0 0 nd
istR-1 VI ilvB/emrD ←←→ 3998147 3998018 0 0 ≈ 75nt
istR-2 VI ilvB/emrD ←←→ 3998147 3998018 0 0 ≈ 140nt
STnc400 - V STM3844/STM3845 →→→ 4051145 4051340 112 42 ≈ 55nt
STnc410 - V glmU/STM3863 ←→← 4072507 4072730 0 0 np
glmZ k19, ryiA, sraJ I yifK/hemY →→← 4141650 4141854 20 196 9.8
spf spf I polA/yihA →→← 4209066 4209175 2 33 16.5
continued on next page
238
CH
A
PTER
10
.A
pp
endices
sRNA1 Alternative IDs2 Reference3 Adjacent genes4 Orientation5 Start6 End6 Reads Reads Enrichment9 Northern
coIP-Ctr7 Hfq-coIP8 blot10
csrC sraK, ryiB, tpk2 III yihA/yihI ←→→ 4210157 4210400 63 64
STnc420 - V yiiG/STM4041 →←← 4251539 4251480 0 0 np
isrP - II STM4097/STM4098 ←→← 4306719 4306866 0 2 ≥2.0
oxyS - I argH/oxyR →←→ 4342986 4342866 0 10 ≥10.0
STnc430 - V pgi/yjbE →←→ 4442059 4441898 0 0 np
STnc620 - IV ssb/STM4257 →→→ 4476817 4477856 4 41 10.3 nd
sraL ryjA III soxR/STM4267 →←→ 4505010 4504870 0 0
STnc630 - IV proP/basS →→← 4532473 4532638 1 27 27.0 nd
STnc440 - V STM4310/tnpA 6 →→→ 4559193 4559277 9 456 50.7 ≈ 85nt
STnc450 - V ytfL/msrA ←←← 4645134 4645079 0 0 np
STnc460 - V STM4503/STM4504 →←→ 4758332 4758187 0 0 np
isrQ - II STM4508/STM4509 ←→→ 4762997 4763158 0 0
1 Gene names of Salmonella sRNAs that were identified in this and previous studies. The identification method is given in the third column. sRNA names follow the Salmonella
and/or E. coli nomenclature referenced in Hershberg et al. (2003), Padalon-Brauch et al. (2008), and Papenfort et al. (2008).
2 Alternative sRNA IDs. References in Hershberg et al. (2003), Padalon-Brauch et al. (2008), and Papenfort et al. (2008) except STnc490, 500, 520, 540, 560, 570, 580, which have
been newly predicted in this study.
3 Evidence for sRNAs in Salmonella. (I) Conserved sRNAs found in Salmonella cDNA libraries and previously shown to be expressed in E. coli (relevant ref. in Papenfort et al.,
2008; Table 1). (II) sRNA previously predicted and validated on Northern blots in Salmonella by Padalon-Brauch et al. (2008). (III) sRNA previously validated on Northern
blots in Salmonella (Altier et al., 2000a; Figueroa-Bossi et al., 2006; Fortune et al., 2006; Papenfort et al., 2006, 2008; Pfeiffer et al., 2007; Sharma et al., 2007; Viegas et al.,
2007). (IV) sRNA predicted through cDNA sequencing and validated by Northern blot analysis in this study. (V) sRNA previously predicted by Pfeiffer et al. (2007) is recovered
in cDNA sequences and validated by Northern blot analysis in this study. (VI) IstR sRNAs (Vogel et al., 2004) were not recovered in cDNA sequences but their expression in
Salmonella was validated by Northern blot analysis in the complete study (Sittka et al., 2008).
4 Flanking genes of the intergenic region in which the sRNA candidate is located.
5 Orientation of sRNA candidate (middle) and flanking genes (→ and← denote location of a gene on the clockwise or the counterclockwise strand of the Salmonella chromosome).
6 Genomic location of sRNA candidate gene according to the Salmonella typhimurium LT2 genome. For STnc470 through STnc640 start and end of the entire intergenic region are
given.
7 Out of 145,873 sequences in total.
8 Out of 122,326 sequences in total.
9 Enrichment factor calculated by dividing the number of reads from Hfq coIP by the number of reads from the control coIP.
10 Denotes verification on Northern blot in this study for new RNA transcripts; the estimated size is given in nucleotides (np = not probed; nd = no detectable transcript).
11 The cDNA reads map antisense internally of the IS200 element. Based on sequence identity they map to all IS200 elements (tnpA 1 to tnpA 6).
12 STnc250 and STnc570 contain small ORFs annotated as ypfM and yneM, respectively, in E. coli (Wassarman et al., 2001).
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Table 10.9: DNA Oligonucleotides used for Northern Blot detection.
Name Sequence Target region
JVO-2405 CCTATGGGAGCGCGGTG STnc250
JVO-2406 GTCAGAATACGACATTTTGGTACTC STnc290
JVO-2407 TTATTTGGACTACCTGGATG STnc340
JVO-2408 TATGAGGAGGACAATTACCG STnc440
JVO-2445 TACCGGACAATAATCCCTAC STnc130
JVO-2446 GATAACCTGAGACCCCCCTG STnc150
JVO-2448 ATATAAACGCGCCAGTCCAT STnc180
JVO-2466 TCTGGCGGAACCTGCC STnc220
JVO-2468 CACACCTGTCGGGCGTT STnc310
JVO-2469 CGCAGTCCCAGGTCAGC STnc330
JVO-2498 CTTATGTGGGCGTTTTGTTT STnc350
JVO-2499 AATGACACCAACCTTTTACG STnc390
JVO-2500 CTAGAGGAGGCGCTAGAAAG STnc400
JVO-3140 CGGGTGGGATGAAATCGTAA STnc190
JVO-3141 TTAGTGTCTGGCGAAACGCT STnc400
JVO-3142 GTTGCTGCGGTGTAATAAGACA STnc180
JVO-3143 TACGTTTGAGCTCAGGGTCG STnc180
JVO-3144 TCATGTTACCGGTAAAATACCACC STnc200
JVO-3249 AGAGAGTCAGCGCCGGG STnc600
JVO-3250 AATTAAAACCACCCGCCG STnc620
JVO-3251 CAGGCTACCAACCACCTCC STnc590
JVO-3252 TATGGAGCGCAACGCC STnc580
JVO-3253 GCGGTCTGGTGTACCTTCC STnc610
JVO-3254 CGGGTCATCTTTCAGGCTG STnc540
JVO-3255 TGCTTATACGCTACCGGGC STnc560
JVO-3256 CTGCCTAACATCTCGTTTCTCC STnc570
JVO-3257 GCCACGGTTCTCACCG STnc480
JVO-3258 CAGCACACTACACAGGGTCG STnc630
JVO-3259 ACCTTGCTGGCGCTCTC STnc470
JVO-3260 CATCTTGCGGTCTGGCA STnc490
JVO-3261 CATCGCGTTGCCAACTT STnc500
JVO-3262 AAGACCCTGGCGCGGTT STnc520
JVO-3263 CTTAGCAGCCTTGTAGAAGAGC STnc640
JVO-3264 AAACTTGACACCGTTCGGC STnc510
JVO-3265 GTGCCTCCGAACGGAAG STnc530
JVO-3266 GCGACAATCACGCCCAG STnc550
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This section contains supplementary Figures and Tables to Chapter 6.
1 HP1067 <- 100
IG|433_HP1066_HP1067
IGR_jhp0358_jhp_0359 T
Consensus
101 -35 -10 +1 in 5'RACE 200
IG|433_HP1066_HP1067 TG T T G
IGR_jhp0358_jhp_0359 T
Consensus
201 <<<<<<< >>>>>>> 300
IG|433_HP1066_HP1067 G T AA G
IGR_jhp0358_jhp_0359 --
Consensus ..
301 400
IG|433_HP1066_HP1067 C T G T T ----- T T
IGR_jhp0358_jhp_0359 G C AACTT T
Consensus .....
401 HP1066 -> 495
IG|433_HP1066_HP1067 T
IGR_jhp0358_jhp_0359
Consensus
CATGCTCAGCTTCTAAAACATCTTCATAGCCTAAGCGTGAAAGTGTGTTTTTAATAATTCT CTCATAGTTGAGCTATCATCTACTACCAGTAGTTT
CATGCTCAGCTTCTAAAACATCTTCATAGCCTAAGCGTGAAAGTGTGTTTTTAATAATTCT CTCATAGTTGAGCTATCATCTACTACCAGTAGTTTCAA
CATGCTCAGCTTCTAAAACATCTTCATAGCCTAAGCGTGAAAGTGTGTTTTTAATAATTCT CTCATAGTTGAGCTATCATCTACTACCAGTAGTTTCAA
AG CTTCTCCTTTTAAGATTGCATTTAAATTAGGCTCTTTTTAAACAGCCAAAGCGTC AACGCCTTATAATAATAA C TTCCAAATAATAGCAT
AG CTTCTCCTTTTAAGATTGCATTTAAATTAGGCTCTTTTTAAACAGCCAAAGCGTC AACGCCTTATAATAATAAATC TTCCAAATAATAGCAT
AG CTTCTCCTTTTAAGATTGCATTTAAATTAGGCTCTTTTTAAACAGCCAAAGCGTC AACGCCTTATAATAATAAATC TTCCAAATAATAGCAT
GTTTTGATTAAAATTACCTTGACCGACAATAATCATTG CTAAATGGAGCGTTCAATGAGCGTTCT ATTTGTAAAAA TTCAGTTTGTTTGCTAT AT
GTTTTGATTAAAATTACCTTGACCGACAATAATCATTG CTAAATGGAGCGTTCAATGAGCGTTCT ATTTGTAAAAA TTCAGTTTGTTTGCTAT AT
GTTTTGATTAAAATTACCTTGACCGACAATAATCATTG CTAAATGGAGCGTTCAATGAGCGTTCT ATTTGTAAAAA TTCAGTTTGTTTGCTAT AT
AAT GTT AAAA TAATAA A A C CT TTGAG G GATAAAGGGTCATTGGATGGTTTGAAAAAAGAAAGACAAGGATTTTACAAG AA CA
AAT GTT AAAA TAATAA A A C CT TTGAG G GATAAAGGGTCATTGGATGGTTTGAAAAAAGAAAGACAAGGATTTTACAAG AAGTGCA
AAT GTT AAAA TAATAA A A C CT TTGAG G GATAAAGGGTCATTGGATGGTTTGAAAAAAGAAAGACAAGGATTTTACAAG AAGTGCA
TTATTTAAGAATTTTAATACTGAGTATGAGTTTTTTAAATATTTTAAATGCTGAAAATTTGAGTTA ATGTCTTCTTCTTATCAAATAGGCACGG
TTATTTAAGAATTTTAATACTGAGTATGAGTTTTTTAAATATTTTAAATGCTGAAAATTTGAGTTA ATGTCTTCTTCTTATCAAATAGGCACGG
TTATTTAAGAATTTTAATACTGAGTATGAGTTTTTTAAATATTTTAAATGCTGAAAATTTGAGTTA ATGTCTTCTTCTTATCAAATAGGCACGG
CAA
AT
GTG
C
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Figure 10.7: Alignment sRNA candidate IG433. The intergenic region between HP1067 and HP1066 as
well as 100 bp of the flanking genes from H. pylori strain 26695 was aligned with the homologous region of
H. pylori strain J99 using Multalign (Corpet, 1988). Predicted promoter and terminator are indicated in
yellow and blue, respectively. Brackets indicate paired bases in the predicted terminator stem-loop. Flanking
genes are indicated in grey and their start or stop codons are set in bold. The position of the transcriptional
start site according to 5’ RACE analysis is indicated by bold nucleotides.
1 HP1108 <- 100
IG|449_HP1107_HP1108 T T C
IGR_jhp1034_jhp1035 T GT G G T
Consensus
101 -35 -10 200
IG|449_HP1107_HP1108 TT GAATT G
IGR_jhp1034_jhp1035 -----T -
Consensus ..... .
201 <<<<<<<< >>>>>>>> 300
IG|449_HP1107_HP1108 T
IGR_jhp1034_jhp1035 G T T G
Consensus
301 HP1107 -> 400
IG|449_HP1107_HP1108 T T G G T
IGR_jhp1034_jhp1035 - G T T
Consensus .
401 489
IG|449_HP1107_HP1108 GG
IGR_jhp1034_jhp1035 AGCTTGATGAAAAATCAAAAAAACCTAAAT
Consensus ..............................
CTTGCACTTCTTTGCCTGTTTTTGAAATCACATCAGC A CC TTAGCGCC GTGAT GC CCTTG CC GCTCGTGCATGCCATCTAATTTGAAA
CTTGCACTTCTTTGCCTGTTTTTGAAATCACATCAGC A CC TTAGCGCC GTGAT GC CCTTG CC GCTCGTGCATGCCATCTAATTTGAAACAT
CTTGCACTTCTTTGCCTGTTTTTGAAATCACATCAGC A CC TTAGCGCC GTGAT GC CCTTG CC GCTCGTGCATGCCATCTAATTTGAAACAT
GGTAATATGTCTCC AATATCGTATAAAATAAATT AGCCTA AATTATACAAGAAAAACTATTAATGTGTCTTATAACAATATCTTTTTAGGA
GGTAATATGTCTCC AATATCGTATAAAATAAATT AGCCTA AATTATACAAGAAAAACTATTAATGTGTCTTATAACAATATCTTTTTAGGA
GGTAATATGTCTCC AATATCGTATAAAATAAATT AGCCTA AATTATACAAGAAAAACTATTAATGTGTCTTATAACAATATCTTTTTAGGA
ATTTTTATAGGAAAATGGGGGCATACC ACAAG ATTATGGCTATTTTATGGC ATTTATTCTAAAAAGA A GCGTTCTTAATAAAAACCACTAATATT
ATTTTTATAGGAAAATGGGGGCATACC ACAAG ATTATGGCTATTTTATGGC ATTTATTCTAAAAAGA A GCGTTCTTAATAAAAACCACTAATATT
ATTTTTATAGGAAAATGGGGGCATACC ACAAG ATTATGGCTATTTTATGGC ATTTATTCTAAAAAGA A GCGTTCTTAATAAAAACCACTAATATT
TATTTTAAACTTTGTTATTATT A GG GTGATTT ATTTTAGT TGTAT GGGCAAGT GGG AGGATAACA AAGGAATTGGGTTATGAATAAAAC
TATTTTAAACTTTGTTATTATT A GG GTGATTT ATTTTAGT TGTAT GGGCAAGTGTGGGG AGGATAACA AAGGAATTGGGTTATGAATAAAAC
TATTTTAAACTTTGTTATTATT A GG GTGATTT ATTTTAGT TGTAT GGGCAAGTGTGGGG AGGATAACA AAGGAATTGGGTTATGAATAAAAC
AAC TTAAAATATTAATGGGCATGGCGTTATTATCATCGCTTCAAGCCGCAGAGGCAG
AAC TTAAAATATTAATGGGCATGGCGTTATTATCATCGCTTCAAGCCGCAGAGGCAG
AAC TTAAAATATTAATGGGCATGGCGTTATTATCATCGCTTCAAGCCGCAGAGGCAG
CAT
GTG
C AC A A A
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Figure 10.8: Alignment sRNA candidate IG449. The intergenic region between HP1108 and HP1107 as
well as 100 bp of the flanking genes from H. pylori strain 26695 was aligned with the homologous region of
H. pylori strain J99 using Multalign (Corpet, 1988). Predicted promoter and terminator are indicated in
yellow and blue, respectively. Brackets indicate paired bases in the predicted terminator stem-loop. Flanking
genes are indicated in grey and their start or stop codons are set in bold.
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1 HP0175 <- 100
IG|75_HP0174_HP0175 C T G T
IGR_jhp0160_jhp0161 G
Consensus
101 -35 -10 200
IG|75_HP0174_HP0175 T
IGR_jhp0160_jhp0161 G T T T G G
Consensus
201 300
IG|75_HP0174_HP0175 AGT - G TG AT T TT
IGR_jhp0160_jhp0161 G --- T T G T T -- T T
Consensus ... . ..
301 +1 in 5'RACE 400
IG|75_HP0174_HP0175 G
IGR_jhp0160_jhp0161 G G G G T
Consensus
401 500
<<<<<< >>>>>>
IG|75_HP0174_HP0175 T T G - T A
IGR_jhp0160_jhp0161 T A G T - - G
Consensus . . .
501 HP0174 -> 600
IG|75_HP0174_HP0175 G T GC G GG TTTCA G T T
IGR_jhp0160_jhp0161 C T TT G----- T
Consensus .....
601 680
IG|75_HP0174_HP0175
IGR_jhp0160_jhp0161 TT GCTAGAATGCTTTTAATCAATCTTGGCCCTATCCTTTTGAGTTTGGCGT
+1 +1 in 5'RACE
TGTTATGCGTAG GTTATT GC TTATGAGCCGGCTTAGCCATCAAAAACGACG GCTCAACGC CCCACTAACGCTAAATTTAAGATATTTTTTTT
TGTTATGCGTAG GTTATT GC TTATGAGCCGGCTTAGCCATCAAAAACGACG GCTCAACGC CCCACTAACGCTAAATTTAAGATATTTTTTTTCAT
TGTTATGCGTAG GTTATT GC TTATGAGCCGGCTTAGCCATCAAAAACGACG GCTCAACGC CCCACTAACGCTAAATTTAAGATATTTTTTTTCAT
TGTGTGTTCTCCACTCTAAACTAATTTTCATCATTAAATTC CATTATAGCAAATTTAAAACAAAATCAGCTATCATGA A AG AAA TCA ATT A
TGTGTGTTCTCCACTCTAAACTAATTTTCATCATTAAATTC CATTATAGCAAATTTAAAACAAAATCAGCTATCATGA A AGAAAACTCA ATT A
TGTGTGTTCTCCACTCTAAACTAATTTTCATCATTAAATTC CATTATAGCAAATTTAAAACAAAATCAGCTATCATGA A AGAAAACTCA ATT A
G GTAAGAAATGCTTAA TATTCATTCCATT AAAG GGGT AAAA TGTTCGCCTCAG TGT TAATA T TTAT T T TTTGGTGTTAGTT
G GTAAGAAATGCTTAA TATTCATTCCATT AAAG GGGT AAAA TGTTCGCCTCAG TGT TAATA T TTAT T T TTTGGTGTTAGTT
G GTAAGAAATGCTTAA TATTCATTCCATT AAAG GGGT AAAA TGTTCGCCTCAG TGT TAATA T TTAT T T TTTGGTGTTAGTT
TTATTCTTTTTGGAAAG AAA AATGTTAAA A GATTCAAAAATTCTCGATGCAATTATGAATATAATATTCGTAATT TTGTTGTATG ATTCTCTT
TTATTCTTTTTGGAAAG AAAA AATGTTAAA A GATTCAAAAATTCTCGATGCAATTATGAATATAATATTCGTAATT TTGTTGTATG ATTCTCTT
TTATTCTTTTTGGAAAG AAAA AATGTTAAA A GATTCAAAAATTCTCGATGCAATTATGAATATAATATTCGTAATT TTGTTGTATG ATTCTCTT
CCTTGGTTACCAGGGTTATTATTCTTTATATTTGGT TTTTAGCATT CATGTTAT CCATA TTAA TAA TTCTATAC CT TTA TCAATCTCATA
CCTTGGTTACCAGGGTTATTATTCTTTATATTTGGT TTTTAGCATT CATGTTAT CCATA TTAA TAA TTCTATAC CT TTA TCAATCTCATA
CCTTGGTTACCAGGGTTATTATTCTTTATATTTGGT TTTTAGCATT CATGTTAT CCATA TTAA TAA TTCTATAC CT TTA TCAATCTCATA
TTGATAAGCTTACTAT TAAGATTAAGGGACT CGCTTAAAT CCCT AAAGTGAGT A AA G TTATGGTTTTGT T TATC AT
TTGATAAGCTTACTAT TAAGATTAAGGGACTTTGCGCTTAAAT CCCT AAAGTGAGT A AA G TTATGGTTTTGT T TATC AT
TTGATAAGCTTACTAT TAAGATTAAGGGACTTTGCGCTTAAAT CCCT AAAGTGAGT A AA G TTATGGTTTTGT T TATC AT
TTAAAAAAAGCTTTAATGATTTTTTAAGC
TTAAAAAAAGCTTTAATGATTTTTTAAGC
CAT
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TTG
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Figure 10.9: Alignment sRNA candidate IG75. The intergenic region between HP0175 and HP0174 as
well as 100 bp of the flanking genes from H. pylori strain 26695 was aligned with the homologous region
of H. pylori strain J99 using Multalign (Corpet, 1988). The predicted terminator is indicated in blue.
Brackets indicate paired bases in the predicted terminator stem-loop. The position of the transcriptional start
site according to 5’ RACE analysis is indicated by bold nucleotides and a predicted promoter which fits to
this start site is indicated in yellow. Alternative predicted promoters are indicated in green. Flanking genes
are indicated in grey and their start or stop codons are set in bold.
1 HP1178 -> 100
IG|480_HP1177_HP1178 T G T T G
IGR_jhp1103_jhp1104 T G C
Consensus
101 200
IG|480_HP1177_HP1178 ---- C T
IGR_jhp1103_jhp1104 TTTT T G G
Consensus ....
201 -35 -10 300
IG|480_HP1177_HP1178 T T TG
IGR_jhp1103_jhp1104 T T C
Consensus
301 <<<<<<<< >>>>>>>> 400
IG|480_HP1177_HP1178 TG T A
IGR_jhp1103_jhp1104 G -
Consensus .
401 500
IG|480_HP1177_HP1178 -- C - T T
IGR_jhp1103_jhp1104 TA T T G
Consensus .. .
501 600
IG|480_HP1177_HP1178 -
IGR_jhp1103_jhp1104 TG T
Consensus .
601 HP1177 -> 663
IG|480_HP1177_HP1178 T
IGR_jhp1103_jhp1104 T
A A A
C A C C A
a a c a a c c a
C A A
A A
c a a a a
G C A
C C CA
c g c a c ca
C
CC C
ccc c
C A
A G A
a c a g a
A C
a c
C
C
GTCTCAGATCACTT ATCACTAAAGAAGCC TAAGCCCTAAAGAAAGG TAGAAAGCTTTGATAACATGAT A T TGGCTTT GAGATGATGAGT
GTCTCAGATCACTT ATCACTAAAGAAGCC TAAGCCCTAAAGAAAGG TAGAAAGCTTTGATAACATGAT A T TGGCTTT GAGATGATGAGTTAG
GTCTCAGATCACTT ATCACTAAAGAAGCC TAAGCCCTAAAGAAAGG TAGAAAGCTTTGATAACATGAT A T TGGCTTT GAGATGATGAGTTAG
CCTTTTTTG CC CCATAAGTTAAGGATAAAATTTAAAGG AAA CCTTAAAGCTAAAAGCCTTAAGGGAACTTTGGAAAAAC AAAGCTATC TTT
CCTTTTTTG CC CCATAAGTTAAGGATAAAATTTAAAGG AAA CCTTAAAGCTAAAAGCCTTAAGGGAACTTTGGAAAAAC AAAGCTATC TTT
CCTTTTTTG CC CCATAAGTTAAGGATAAAATTTAAAGG AAA CCTTAAAGCTAAAAGCCTTAAGGGAACTTTGGAAAAAC AAAGCTATC TTT
TACAGAAA TTCGTTT ACAAAACTACCG TTCAATAAAACAAC ACT CCCAAAAA GAAATTT AGG GTTTTCC AGAGTTTTTGC
TACAGAAA TTCGTTT ACAAAACTACCG TTCAATAAAACAAC ACTTTACACCCCAAAAA GAAATTT AGGTATAATGTTTTCCAAGAGTTTTTGC
TACAGAAA TTCGTTT ACAAAACTACCG TTCAATAAAACAAC ACTTTACACCCCAAAAA GAAATTT AGGTATAATGTTTTCCAAGAGTTTTTGC
CATGTTTGGTAGCCATGACAAACTCCTTTTATGGATTTATCCCCATAAT ACTTATGGGGG GTTTATTTTACAACAATCTTTCTAAAA CCAAATCC
CATGTTTGGTAGCCATGACAAACTCCTTTTATGGATTTATCCCCATAAT ACTTATGGGGG GTTTATTTTACAACAATCTTTCTAAAA CCAAATCC
CATGTTTGGTAGCCATGACAAACTCCTTTTATGGATTTATCCCCATAAT ACTTATGGGGG GTTTATTTTACAACAATCTTTCTAAAA CCAAATCC
CAATTAAAT AAAAACACTCTTA AAGCTTGATTGAG GCATCAAAACACCCTAAAACTTTTTT GAAATCCAATAAATTT TG TA AATTAAACGCA
CAATTAAAT AAAAACACTCTTA AAGCTTGATTGAG GCATCAAAACACCCTAAAACTTTTTT GAAATCCAATAAATTT TG TA AATTAAACGCA
CAATTAAAT AAAAACACTCTTA AAGCTTGATTGAG GCATCAAAACACCCTAAAACTTTTTT GAAATCCAATAAATTT TG TA AATTAAACGCA
TTGTAAATAAATTCTCATTTTGATACATTTTT CAATAAAACATTACTTTAAGGAACAT TT AAAAAAACGAAAAAAACGATTCTGCTTTCTCTAA
TTGTAAATAAATTCTCATTTTGATACATTTTT CAATAAAACATTACTTTAAGGAACAT TTATGAAAAAAACGAAAAAAACGATTCTGCTTTCTCTAA
TTGTAAATAAATTCTCATTTTGATACATTTTT CAATAAAACATTACTTTAAGGAACAT TTATGAAAAAAACGAAAAAAACGATTCTGCTTTCTCTAA
CTCT GCGGCGTCATTGCTCCATGCTGAAGACAACGGCGTTTTTTTAAGCGTGGG TATCAAA
CTCT GCGGCGTCATTGCTCCATGCTGAAGACAACGGCGTTTTTTTAAGCGTGGG TATCAAA
TAG
ATG
+1 in 5'RACE
TTACAC TATAAT A
Figure 10.10: Alignment sRNA candidate IG480. The intergenic region between HP1178 and HP1177 as
well as 100 bp of the flanking genes from H. pylori strain 26695 was aligned with the homologous region
of H. pylori strain J99 using Multalign (Corpet, 1988). The predicted terminator is indicated in blue.
Brackets indicate paired bases in the predicted terminator stem-loop. The position of the transcriptional start
site according to 5’ RACE analysis is indicated by bold nucleotides and a predicted promoter which fits to
this start site is indicated in yellow. Alternative predicted promoters are indicated in green. Flanking genes
are indicated in grey and their start or stop codons are set in bold.
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1 HP1198 <- 100
IG|494_HP1198_HP1199 T G
IGR_jhp1121_jhp1122
Consensus
101 -35 -10 200
IG|494_HP1198_HP1199 T TT T -
IGR_jhp1121_jhp1122 - T T A
Consensus . .
201 300
<<<<<<<
IG|494_HP1198_HP1199 AA - ATC G T
IGR_jhp1121_jhp1122 -- G ---
Consensus .. . ...
301 >>>>>>> HP1199 <- 400
IG|494_HP1198_HP1199 G - G - G
IGR_jhp1121_jhp1122 A G
Consensus . .
401 427
IG|494_HP1198_HP1199
IGR_jhp1121_jhp1122
Consensus
TGTCTCGTTG AATAATAATAAATTAGG ACTTCTAAATCTGTTGGGGTTTTTGTAAAATCAGCTCTCAAGCGGTTTTTTAGGGGAATTTTTTTTGA
TGTCTCGTTG AATAATAATAAATTAGG ACTTCTAAATCTGTTGGGGTTTTTGTAAAATCAGCTCTCAAGCGGTTTTTTAGGGGAATTTTTTTTGACAT
TGTCTCGTTG AATAATAATAAATTAGG ACTTCTAAATCTGTTGGGGTTTTTGTAAAATCAGCTCTCAAGCGGTTTTTTAGGGGAATTTTTTTTGACAT
ATTTCAAGCCTTTGATCAAAAATTTTGAGTTATT AATGCATTAATTCAAGTAAGCATTGCAAAAGGAT T AAACTT A AACCAT CCATGATAAAA
ATTTCAAGCCTTTGATCAAAAATTTTGAGTTATT AATGCATTAATTCAAGTAAGCATTGCAAAAGGAT T AAACTT A AACCAT CCATGATAAAA
ATTTCAAGCCTTTGATCAAAAATTTTGAGTTATT AATGCATTAATTCAAGTAAGCATTGCAAAAGGAT T AAACTT A AACCAT CCATGATAAAA
ATACCAAA CCCACCTGCAATACTAACCACTTTAGGCCACACGCTCACAAACAAAATCATGG AGCAAAATC TGCC CACTAGA CAGAGAAAGGC
ATACCAAA CCCACCTGCAATACTAACCACTTTAGGCCACACGCTCACAAACAAAATCATGG AGCAAAATC TGCC CACTAGA CAGAGAAAGGC
ATACCAAA CCCACCTGCAATACTAACCACTTTAGGCCACACGCTCACAAACAAAATCATGG AGCAAAATC TGCC CACTAGA CAGAGAAAGGC
CAAA GGCCTTTCT TT TTTAAGTC CTTGACTTCAACCTTAGC CCTACTTCTTCAAGTTTCTTCTTGATGGTTTCAGCTTCTTCTTTATTCACG
CAAA GGCCTTTCT TT TTTAAGTCTTACTTGACTTCAACCTTAGC CCTACTTCTTCAAGTTTCTTCTTGATGGTTTCAGCTTCTTCTTTATTCACG
CAAA GGCCTTTCT TT TTTAAGTCTTACTTGACTTCAACCTTAGC CCTACTTCTTCAAGTTTCTTCTTGATGGTTTCAGCTTCTTCTTTATTCACG
CCCTCTTTAAGCACATGAGGGGTTTTT
CCCTCTTTAAGCACATGAGGGGTTTTT
CCCTCTTTAAGCACATGAGGGGTTTTT
CAT
TTA
C A
c a
C G
CC C
c cc c g
A G
a g
A A A
a a a
Figure 10.11: Alignment sRNA candidate IG494. The intergenic region between HP1198 and HP1199 as
well as 100 bp of the flanking genes from H. pylori strain 26695 was aligned with the homologous region of
H. pylori strain J99 using Multalign (Corpet, 1988). Predicted promoter and terminator are indicated in
yellow and blue, respectively. Brackets indicate paired bases in the predicted terminator stem-loop. Flanking
genes are indicated in grey and their start or stop codons are set in bold. The position of the transcriptional
start site according to 5’ RACE analysis is indicated by bold nucleotides.
>IG|550_HP1387_HP1388_plus
HP1387 ->
TAAAAGCAACCAGTTAAACGAAAGCTGTTTAATGGGGTTTATGGGGACTGAAATTTTAGC
ATCTCTATTTGATACTTTTGAATGTTGCCTAGTATTT TTTTATCGGTTACTTCGCAC
TCATCGTATATCTTTTTGTATTCTTGTATGATATTGACTTCATCGTTGTTTTTATTTTTC
-35 10 +1 site in 5'RACE
ATGCTCATAGTAGGATTATACTAAAATAATAAA TTATGTTATAGTTCGGTATCGTTTGT
<<<<<< >>>>>>
TTTTTTAAAGCAAAAAAGCCCCTTATAAAATAGGGGCTTTTTTGTTGCTATTTCTTGACT
TGTTTTAACTGCGCTATTTCTTTTTTTAACTTGGATACTTCTTGCTGTAGCGTTTTAAGT
CGGTTTTCTAACAACACCACTTTTGCAACTATTGAATACATATCAGCATTGGATTGCTGT
AGTTGTTCGTTGTTTATTTTTACTTTATTGTCAATCCTTACTAACGCCTTTGTGATTTCT
TTAATCAAGTTAGGATTAAGTGGGTTTATAAGCTTGTTAAAAACCTAACCCTTAAAAGTT
CAAAACAAAATAGCTAGAATTTTTGTCTTATTCTATTTTTGGTAGAATAATAATTTTTCA
CAAGGAATTACAC AATAATATTTGGTTTCAGTATAAAATTGGCAAGCAACTAGATGA
ATTAGAAATTGAAGATTCTTTATGTCTTTCTTTATTCAAATCTCTTGAAAATT
HP1388 ->
TGA
G
ATG
-
Figure 10.12: Small RNA candidate IG550. Small RNA candidate IG550 is located in the intergenic region
between HP1387 and HP1388 of H. pylori strain 26695. Predicted promoter and terminator are indicated in
yellow and blue, respectively. Brackets indicate paired bases in the predicted terminator stem-loop. The 100
bp of each flanking genes are indicated in grey and their start or stop codons are set in bold, respectively. The
position of the transcriptional start site according to 5’ RACE analysis is indicated by a bold nucleotide.
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Table 10.10: Biocomputationally predicted sRNA candidates in Helicobacter pylori.
IGR Strand Length Terminator LFG RFG Orientationc Start End Distance Distance
Score to LFG to RFG
IG75 P1 - 240 -3.18 HP0174
(hyp. protein)
HP0175 (cell
binding factor 2)
←←→ 181542 181781 108 84
IG75 P2d - 146 -3.18 HP0174
(hyp. protein)
HP0175 (cell
binding factor 2)
←←→ 181542 181687 108 178
IG433 - 101 -4.3 HP1066
(hyp. protein)
HP1067 (cheY) ←←→ 1126097 1126187 120 81
IG449 - 70 -3.05 HP1107 (omp23) HP1108 ( porC,
porG)
←←→ 1169977 1170046 99 92
IG480 - 81 -6.31 HP1177 (omp27) HP1178 (deoD) ←←← 1245700 1245780 192 184
IG494 + 174 -5.48 HP1198 (rpoBC) HP1199 (rplL) ←→← 1277094 1277267 45 6
IG550e + 75 -8.19 HP1387 (DNA
polymerase III
subunit ǫ)
HP1388
(hyp. protein)
→→→ 1449783 1449857 109 331
a LFG: left flanking gene.
b RFG: right flanking gene.
c Orientation of sRNA candidate (middle) and flanking genes (→ and← denote location of a gene on the clockwise or the counterclockwise strand of the Helicobacter chromosome).
d For IG75 two promoters were predicted
e sRNA candidate IG550 is specific to HP26695
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Table 10.11: Experimentally mapped Helicobacter pylori promoters based on primer extension or 5’RACE.
Number Gene Location Strand Distance +1 site in TSSa Classb Distance Comment Reference
AUG [bp] H. pylori [bp]c
26695
HP0011 hspA (groES) 9268..9624 - -59 9683 9683 P 0 σ80 Spohn & Scarlato,
1999b; Suerbaum
et al., 1994
HP0071 ureI 74747..75334 - -65 75399 75398 P 1 σ80 Akada et al., 2000;
Pflock et al., 2005
HP0073 ureAd 77240..77956 - -57 78012 78012 P 0 σ70 Shirai et al., 1999;
Spohn & Scarlato,
1999a
HP0088 rpoD 92952..94967 - -72 95039 95040 P -1 σ80 Beier et al., 1998
HP0097 hyp. prot. 101643..102356 - -40 102396 102396 P 0 σ70 McGowan et al.,
2003
HP0103 tlbB 109025..110722 - -140 110862 110862 P 0 σ80 Delany et al.,
2002b
HP0111 hrcA 118823..119653 - -15 119668 119668 P 0 σ80 Spohn & Scarlato,
1999b
HP0115 flaB 122948..124492 - -25 124517 124517 P 0 σ54 Spohn & Scarlato,
1999a
HP0119 hyp. prot. 129383..130768 - -43 130811 130811 P 0 σ80 Dietz et al., 2002
HP0166 response
regulator
173778..174455 - -67 174522 174520 P 2 σ80 Dietz et al., 2002;
Forsyth et al., 2002
HP0220 nifS 228339..229502 + -252 228087 228285 P -198 ? Pflock et al., 2007
HP0389 sodB 398432..399073 - -21 399094 399094 P 0 σ80 Pesci & Pickett,
1994
HP0407 bisC 419077..421467 + -34 419043 419043 P 0 σ70 McGowan et al.,
2003
HP0427 hyp. prot. 444265..444600 - 2 444598 444600 P -2 σ80 Dietz et al., 2002;
Mu¨ller et al., 2006;
Pflock et al., 2004
- cagBe P2 578740..579087 - P2:-581 579668 579669 O -1 σ70 Spohn et al., 1997,
HP0547 cagA 579921..583481 + P1:-104 579817 579817 P 0 σ70 Spohn et al., 1997
HP0578 hyp. prot. 608300..610336 - -58 610394 - P - ? McGowan et al.,
2003
continued on next page
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Number Gene Location Strand Distance +1 site in TSSa Classb Distance Comment Reference
AUG [bp] H. pylori [bp]c
26695
HP0600 spaB 635337..637118 - -27 637145 637146 P -1 σ70 McGowan et al.,
2003
HP0601 flaAd 637282..638814 + -50 637232 637232 P 0 σ28 (P-50) Leying et al., 1992;
McGowan et al.,
2003; Spohn &
Scarlato, 1999a
HP0653 pfr 698770..699273 - -29 699302 699301 P 1 σ80 Delany et al.,
2001b
HP0654 hyp. prot. 699570..700652 + -26 699544 699544 P 0 σ80 Delany et al.,
2001b
HP0682 hyp. prot. 732133..732513 - -6 732519 732519 P 0 σ80 Forsyth et al., 2002
HP0690 fadA 740559..741734 + -106 740453 740534 P -81 ? Pflock et al., 2007
HP0695 hyuA 745801..747942 + -39 745762 745763 P -1 σ80 Pflock et al., 2007
HP0698 hyp. prot. -
flgRf
750956..751045
(HP0698)
+ -22 750934 750935 P -1 σ80 Spohn & Scarlato,
1999a
HP0797 hpaA 965177..966724 - -80 (-72) 854819 854817 P 2 σ70(P-80), Jones et al., 1997;
McGowan et al.,
2003
HP0870 flgE 920417..922573 - -30 922603 922604 P -1 σ54 Spohn & Scarlato,
1999a
HP0875 katA 925571..927088 - -55 927143 927143 P 0 σ80 Delany et al.,
2001a
HP0876 frpB 927411..929786 + -78 927333 927332 P 1 σ80 Delany et al.,
2001a
HP0878 hyp. prot. 930391..930564 + -10 930313 930313 P 0 σ70 McGowan et al.,
2003
HP0906 hyp. prot. 956485..958068 + -45 956440 - P - σ54 Spohn & Scarlato,
1999a
HP0912 hopC 637282..638814 + -105 965072 965072 P 0 σ70 McGowan et al.,
2003; Odenbreit
et al., 1999
HP1010 ppk 1072429..1074456 + -43 1072386 - P - σ70 McGowan et al.,
2003
continued on next page
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Number Gene Location Strand Distance +1 site in TSSa Classb Distance Comment Reference
AUG [bp] H. pylori [bp]c
26695
HP1018-
HP1019
hyp. prot.-
htrA
1081440..1081586 + -42 1081398 1081400 P -2 σ80 Pflock et al., 2004
HP1024 cbpA 1087633..1088499 + -27 1087606 1087516 P 90 σ80 Spohn & Scarlato,
1999b
HP1027 fur 1090212..1090664 + -41 1090171 1090171 P 0 σ80 Delany et al.,
2002a
HP1041 flbA (flhA) 1100927..1103128 + -64 1100863 1100883 P -20 σ80 Schmitz et al.,
1997
HP1043 response
regulator
1104745..1105416 - -34 1105450 1105449 P 1 σ80 Delany et al.,
2002b
HP1067 cheY 1126268..1126642 + -84 1126184 1126183 P 1 σ80 Beier et al., 1997
HP1120 hyp. prot....
flgK
1186442..1186876 - -24 1186900 - P - σ54 Spohn & Scarlato,
1999a
HP1139 soj 1200639..1201433 - -117 1201550 1201551 S -1 σ70 McGowan et al.,
2003
HP1186 carbonic
anhydrase
1255772..1256380 + -43 1255729 1255729 P 0 σ80 Wen et al., 2007
HP1260 nuoA 1333813..1334214 + -38 1333775 1333777 P -2 σ70 McGowan et al.,
2003
HP1335 trmU 1395894..1396976 - -24 1397000 1396947 P 53 σ70 McGowan et al.,
2003
HP1362 dnaB 1422915..1424381 - -154 1424535 1424702 P -167 σ54 McGowan et al.,
2003
HP1400 fecA3 1461431..1463959 + -113 1461318 1461028 P 290 σ80 Ernst et al., 2006
HP1408 hyp. prot. 1477542..1477877 + 2 1477544 1477542 P 2 σ80 Dietz et al., 2002;
Mu¨ller et al., 2006;
Pflock et al., 2004
HP1423 orf03 1494708..1494962 - 0 1494962 1494962 P 0 σ80 Porwollik et al.,
1999
HP1432 histidine and
glutamine-
rich
protein
1502586..1502804 + -44 1502542 1502550 P -8 σ80 Forsyth et al., 2002
continued on next page
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Number Gene Location Strand Distance +1 site in TSSa Classb Distance Comment Reference
AUG [bp] H. pylori [bp]c
26695
HP1494 murE 1567157..1568500 + -39 1567118 - P - σ70 McGowan et al.,
2003
HP1512 frpB4 1584447..1587080 + -55 1584392 1584392 P 0 σ80 Ernst et al., 2006
HP1559 flgBC 1640954..1641376 - -25 1641401 1641505 P -104 σ54 Spohn & Scarlato,
1999a
HP1562 ceuE 1643982..1644983 - -25 1645008 1645007 P 1 σ80 Delany et al.,
2001a
HP1563 tsaA 1645224..1645820 + -96 1645128 1645128 P 0 σ80 Delany et al.,
2001a
HPnc6350 asRNA A 1245700.. 1245780 - - 1245780 1245780 0 σ80 5’ RACE, this
study
HPnc6320 asRNA B 1243405.. 1243474 - - 1243474 1243474 0 σ80 5’ RACE, this
study
HPnc7630 asRNA C 1503081.. 1503160 - - 1503160 1503160 0 σ80 5’ RACE, this
study
HPnc8170 asRNA D 1612518.. 1612596 - - 1612596 1612596 0 σ80 5’ RACE, this
study
HPnc0040 asRNA E 22856.. 22931 - - 22931 22931 0 σ80 5’ RACE, this
study
HPnc8060 asRNA F 1589890.. 1589984 - - 1589984 1589984 0 σ80 5’ RACE, this
study
HPnc7620 spRNA C 1503081..1503361 + - 1503081 1503081 0 σ80 5’ RACE, this
study
HPnc8160 spRNA D 1612518..1612827 + - 1612518 1612518 0 σ80 5’ RACE, this
study
HPnc6670 sRNA B 1307822..1307963 - - 1307963 1307963 0 σ80 5’ RACE, this
study
HPnc2090 sRNA C1 479770..479856 - - 479856 479856 0 σ80 5’ RACE, this
study
HPnc2640 sRNA D 568309..568522 - - 568522 568522 0 σ80 5’ RACE, this
study
HPnc2420 sRNA H 537522..537624 - - 537624 537624 0 σ80 5’ RACE, this
study
continued on next page
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Number Gene Location Strand Distance +1 site in TSSa Classb Distance Comment Reference
AUG [bp] H. pylori [bp]c
26695
HPnc4590 sRNA I 964751..964802 + - 964751 964751 0 σ80 5’ RACE, this
study
HPnc7830 sRNA MP1 1524441.. 1524681 - - 1524681 1524681 0 σ80 5’ RACE, this
study
HPnc6160 asRNA 3 1217306..1217378 + - 1217306 1217306 0 σ80 5’ RACE, this
study
HPnc4870 asRNA 5 998717..998848 + - 998717 998717 0 σ805’ RACE, this
study
HPnc7430 asRNA 10 1470865..1470983 - - 1470983 1470983 0 σ805’ RACE, this
study
HPnc1880 asRNA 11 445011.. 445139 - - 445139 445139 0 σ80 5’ RACE, this
study
HPnc1810 ssRNA IIIa 438178.. 438908 - - 438908 438908 0 σ80 5’ RACE, this
study
HPr01 23S rRNA 445248..448223 + - 444979 444979 P 0 σ80 5’ RACE, this
study
HPr06 23S rRNA 1473917..1476893 - - 1477163 1477163 P 0 σ80 5’ RACE, this
study
a Transcriptional start site (TSS) mapped in H. pylori 26695 based on 454 deep sequencing data.
b TSS class according to the manual annotation described in Section 6.1.5 in Chapter 6. P: primary, S: secondary, and O: orphan.
c Distance between the transcriptional start site described in the literature or mapped by 5’ RACE and the TSS based on the 454 data: TSSliterature/5’RACE - TSS454.
d Promoters for ureA and flaA were confirmed by 5’ RACE
e The cagB gene was identified in strain G27 but is not annotated in H. pylori 26695.
f The flgR promoter is located upstream of HP0698.
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Table 10.12: Read distribution on annotations.
Library Total
reads
<12
nt
No
match
in HP
26695
23S
rRNA
16S
rRNA
5S
rRNA
tRNA tmRNA RNase P
RNA
SRP
RNA
mRNA as
mRNA
IGR as
rRNAs,
hkRNAs
and
tRNAs
C- 528373 7515 75888 224307 101306 5411 38364 1998 1169 1282 60782 3272 7046 33
C+ 528169 14984 90257 81177 33560 18794 142788 1598 8849 5577 115119 6164 9246 56
AS- 427455 8265 63906 52012 42930 8634 45326 3683 2482 2683 169410 13383 14554 187
AS+ 540133 18019 108421 30899 9849 13935 133956 1525 8174 4868 159737 24203 26263 284
PL- 268841 5130 61008 49677 37018 4396 47628 1242 893 1168 51943 3790 4880 68
PL+ 315309 6602 57064 39014 14553 20032 89390 844 3248 2635 68218 5768 7838 103
AGS- 280713 4547 93030 44836 35744 4681 40998 982 696 876 44424 4498 5335 66
AGS+ 223705 5280 78117 18332 6510 10414 57476 375 1633 1842 35184 3881 4582 79
Huh7- 266621 865 66905 58946 38699 4858 8090 1076 533 205 75632 5415 5362 35
HuH7- 308759 657 100705 52265 12699 10927 20300 1313 2396 936 88559 11114 6751 137
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Table 10.13: Leaderless mRNAs in Helicobacter pylori. Genes that turned out to be leaderless during
transcriptional start site annotation in H. pylori 26695 based on deep sequencing data. Location indicates
start and end of the ORF in the H. pylori 2695 genome. “ R” following a gene name indicates that this gene
was reannotated based on the 454 data and conservation of the start codon in other Helicobacter strains.
Gene Location of AUG start
codon
Description
HP1529 1608997 - 1608995 dnaA; chromosomal replication initiation protein
HP1139 1201433 - 1201431 SpoOJ regulator (soj) chromosome partitioning protein
HP0925 988604 - 988606 recombination protein RecR
HP0376 384259 - 384261 ferrochelatase hemH
HP0929 991805 - 991807 geranyltranstransferase (IspA)
HP0413 426838 - 426836 putative transposase
HP0414 426876 - 426878 IS200 insertion sequence from SARA17
HP1008 1069967 - 1069969 IS200 insertion sequence from SARA17
HP1181 1249488 - 1249490 multidrug-efflux transporter
HP1183 1252759 - 1252757 Na+/H+ antiporter (napA)
HP1216 1293586 - 1293584 organic solvent tolerance protein
HP0818 R 870451 - 870453 osmoprotection protein (proWX)
HP0498 524081 - 524083 sodium- and chloride-dependent transporter;
neurotransmitter:Na+ symporter
HP1365 1427604 - 1427602 response regulator, OmpR family
HP0329 345305 - 345303 NH(3)-dependent NAD+ synthetase (nadE)
HP1394 1455819 - 1455817 hypothetical protein NAD+ kinase
HP0112 R 120046 - 120048 hypothetical protein
HP0427 444600 - 444598 hypothetical protein
HP0820 872931 - 872933 hypothetical protein
HP1408 1477542 - 1477544 hypothetical protein
HP1423 1494962 - 1494960 hypothetical protein
HP0151 R 161202 - 161204 hypothetical protein
HP0806 860357 - 860359 hypothetical protein
HP0897 R 950133 - 950135 hypothetical protein
HP1007 1069927 - 1069929 frameshift gene
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Table 10.14: DNA Oligonucleotides used for Northern Blot detection. Sequences are given in
5’→ 3’ direction.
Gene Name Oligo Sequence
rnpB RNase P RNA JVO-0210 CGAAGCGTGTATCAATTTAGAC
ffs SRP RNA JVO-0211 GGGACTCTGCTGTATTCCTAC
tmRNA tmRNA JVO-0212 CTGGAGCGTAATCTGTGTTG
5S rRNA 5S rRNA JVO-0485 TCGGAATGGTTAACTGGGTAGTTCCT
23S rRNA 23S rRNA JVO-0586 GCATAGCTTATCGCAGTCTAGT
HPnc6350 asRNA A JVO-0231 GAGTTTGTCATGGCTACCAA
HPnc6320 asRNA B JVO-0513 GCCATGGAAAATTAAAAATG
HPnc7630 asRNA C JVO-0514 CATGCCATGAAACACAAAAG
HPnc8170 asRNA D JVO-0548 GCAGACCAACATTGCA
HPnc8060 asRNA F JVO-0550 CTAATTTTTATTCCACTAGAGATTA
HPnc7620 spRNA C JVO-2303 CCTTTTGACATAGGATTTGC
HPnc8160 spRNA D JVO-2135 GATCGCATGGCATGCT
HPnc6561 6S RNA JVO-2136 AACACGAATCATCTAGGCGAT
HPnc5490 sRNA A JVO-2134 AAACCATAAGGAATGGTTGGAT
HPnc6670 sRNA B JVO-2621 AATGCTGAAGCTTCTAGAATGAT
HPnc2630 sRNA D JVO-2623 GATTTGTTTGTTTATGCCAAA
HPnc2240/
HPnc6000
asRNA 1a/b JVO-2133 GTGAACCATAGGTTGAGTTCCTATAG
HPnc2450 asRNA 7 JVO-2635 CGAGAAATACCTCCACACAAT
HPnc1880/
HPnc7450
asRNA 11 JVO-2702 GCGTTATAAAAAGATTAGGGATCA
HPnc1470 sRNA L JVO-2708 TTAAACTTTAACAACTCTTTAATTTTCAA
HPnc3320 ssRNA I JVO-2627 CTCATTTGTACATCCGCTTTA
HPnc1810/
HPnc7520
ssRNA IIIa/b JVO-2707 CTATCCTCTTTCTCTTTAGGAGTTG
HPnc4160 asRNA G JVO-2624 GTTGATTAAAATGCTAAGTTATAGTAAAGA
HPnc4170 spRNA G JVO-2625 CTGACGCTCTTACCTTAATTGA
HPnc2090/
HPnc5320
sRNA C1/2 JVO-2622 AGAAAAGGAGATAACCTAACATGA
HPnc4590 sRNA I JVO-2704 AAAGGAGATAACCAACTATGAAGTT
invR Salmonella InvR JVO-0222 GATAAATGCAACGTAAGAGACAAATG
sraH Salmonella SraH JVO-0157 GGGTGCGCGAATACTG
rrf Salmonella 5S rRNA JVO-0322 CTACGGCGTTTCACTTCTGAGTTC
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Table 10.15: DNA Oligonucleotides used for 5’ RACE analysis. Sequences are given in 5’→ 3’direction.
Gene Name Oligo Sequence
IG75 IG75 JVO-0226 AGAATGCATACAACAATAATTACG
IG433 IG433 JVO-0240 GAACGCTCCATTTA
IG550 IG550 JVO-0245 GGGGCTTTTTTG
HP0601 flaA JVO-0974 TCAATCGCTCCAATGAAGTT
HP0073 ureA JVO-0214 TACCGCTTCTACATAGTTAAGCTT
HPnc6350 asRNA A
(IG480)
JVO-0231 GAGTTTGTCATGGCTACCAA
HPnc6320 asRNA B JVO-0794 ATAAATTCTAAAAAGGAGTTTGCCA
HPnc7630 asRNA C JVO-0514 CATGCCATGAAACACAAAAG
HPnc8170 asRNA D JVO-0548 GCAGACCAACATTGCA
HPnc0040 asRNA E JVO-0549 GCCTCATAGTTAGGATATGG
HPnc8060 asRNA F JVO-0795 TCTAGGAGACTTCTATGAGAAAAAATC
HPnc7620 spRNA C JVO-2304 CTTTTGTGTTTCATGGCATG
HPnc8160 spRNA D JVO-2135 GATCGCATGGCATGCT
HPnc6670 sRNA B JVO-2621 AATGCTGAAGCTTCTAGAATGAT
HPnc2090 sRNA C1 JVO-2622 AGAAAAGGAGATAACCTAACATGA
HPnc2640 sRNA D JVO-2623 GATTTGTTTGTTTATGCCAAA
HPnc2420 sRNA H JVO-2703 ACACAAGGCAAGTGTGATAAAC
HPnc4590 sRNA I JVO-2704 AAAGGAGATAACCAACTATGAAGTT
HPnc7830 sRNA MP1 JVO-2709 CTCTCACGCATCATATCTATAAAG
HPnc6160 asRNA 3 JVO-2631 CTAATGTGACCGGTGTGTTG
HPnc4870 asRNA 5 JVO-2633 AAGAACAAGCCCTAAAATTTGT
HPnc7430 asRNA 10 JVO-2698 TGGGAATAAAGACTTGGAAAATTTAAGT
HPnc1880 asRNA 11 JVO-2702 GCGTTATAAAAAGATTAGGGATCA
HPnc1810 ssRNA IIIa JVO-2707 CTATCCTCTTTCTCTTTAGGAGTTG
HPr01 23S rRNA JVO-2741 AGCTTTTAGCTTGTAGAACTTGCTT
HPr06 23S rRNA JVO-2741 AGCTTTTAGCTTGTAGAACTTGCTT
